<?xml version="1.0" encoding="utf-8"?>


<DOCUMENT xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:noNamespaceSchemaLocation="dart3.xsd">

<DOCUMENT-HEADER AEXT-CLASS="Y">
<DOCUMENT-NAME ACODE="11011">사업보고서</DOCUMENT-NAME>
<FORMULA-VERSION ADATE="20210122">4.2</FORMULA-VERSION>
<COMPANY-NAME AREGCIK="01063237">(주)플럼라인생명과학</COMPANY-NAME>

<SUMMARY>
<EXTRACTION ACODE="LINK_FLAG" AFEATURE="BOTH">N</EXTRACTION>
<EXTRACTION ACODE="FIN_TYPE" AFEATURE="BOTH">A</EXTRACTION>
<EXTRACTION ACODE="CRP_RGS_NO_TEMP" AFEATURE="BOTH">110111-5304897</EXTRACTION>
</SUMMARY>
</DOCUMENT-HEADER>

<BODY>

<INSERTION ABASISNUMBER="SE1" AFREQUENCY="1" ADUPLICATION="N">
<COMMENT>◆click◆ 정정문서 작성시 『정오표』 삽입</COMMENT>
<LIBRARYLIST>정정신고(보고)-대표이사등의확인.LCommon</LIBRARYLIST>

<LIBRARY>
<FILENAME ATYPE="LCommon">정정신고(보고)-대표이사등의확인</FILENAME>

<CORRECTION>
<TITLE ATOC="Y" AASSOCNOTE="CORRECTION">정 정 신 고 (보고)</TITLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" WIDTH="600" BORDER="0">

<COLGROUP>
<COL WIDTH="591"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="600" HEIGHT="30"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="RIGHT" WIDTH="600" HEIGHT="30">2021년 08월 17일</TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<P></P>
<P USERMARK="F-14"></P>
<P USERMARK="F-14">1. 정정대상 공시서류 : 사업보고서</P>
<P></P>
<P USERMARK="F-14">2. 정정대상 공시서류의 최초제출일 : 2021년 03월 10일</P>
<P></P>
<P USERMARK="F-14">3. 정정사항</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" WIDTH="604" BORDER="1">

<COLGROUP>
<COL WIDTH="219"></COL>
<COL WIDTH="208"></COL>
<COL WIDTH="71"></COL>
<COL WIDTH="70"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH ALIGN="CENTER" WIDTH="228" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">항  목</TH>
<TH ALIGN="CENTER" WIDTH="217" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">정정 사유</TH>
<TH ALIGN="CENTER" WIDTH="80" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">정 정 전</TH>
<TH ALIGN="CENTER" WIDTH="79" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">정 정 후</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="228" HEIGHT="99" VALIGN="MIDDLE">II. 사업의 내용&cr;   (제약ㆍ바이오기업 공시)&cr; 2. 회사의 현황&cr; (4) 연구개발활동 </TD>
<TD WIDTH="217" HEIGHT="99" VALIGN="MIDDLE">2020년 사업보고서 비재무사항 점검에 따른 후속조치&cr;(모범사례 반영 내용 정정)</TD>
<TD WIDTH="80" HEIGHT="99" VALIGN="MIDDLE" ALIGN="CENTER">주1)</TD>
<TD WIDTH="79" HEIGHT="99" VALIGN="MIDDLE" ALIGN="CENTER">주2)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="228" HEIGHT="99" VALIGN="MIDDLE">II. 사업의 내용&cr;   (제약ㆍ바이오기업 공시)&cr; 2. 회사의 현황&cr; (5) 주요계약</TD>
<TD WIDTH="217" HEIGHT="99" VALIGN="MIDDLE">2020년 사업보고서 비재무사항 점검에 따른 후속조치&cr;(모범사례 반영 내용 추가)</TD>
<TD WIDTH="80" HEIGHT="99" VALIGN="MIDDLE" ALIGN="CENTER">-</TD>
<TD WIDTH="79" HEIGHT="99" VALIGN="MIDDLE" ALIGN="CENTER">주3)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="228" HEIGHT="76" VALIGN="MIDDLE">Ⅷ. 임원 및 직원등에 관한 사항&cr;2. 임원의 보수 등</TD>
<TD WIDTH="217" HEIGHT="76" VALIGN="MIDDLE">당해 보수지급금액 5억원 이상인 이사ㆍ감사에 해당사항이 없어 삭제하였습니다.</TD>
<TD WIDTH="80" HEIGHT="76" VALIGN="MIDDLE" ALIGN="CENTER">-</TD>
<TD WIDTH="79" HEIGHT="76" VALIGN="MIDDLE" ALIGN="CENTER">-</TD>
</TR>
</TBODY>
</TABLE>

<P>&cr;
<SPAN USERMARK=" B">주1) 정정 전&cr;</SPAN>
</P>

<P>
<SPAN USERMARK=" B">II. 사업의 내용&cr; 2. 회사의 현황&cr;  (4) 연구개발활동&cr;</SPAN>&cr;(가) 연구개발활동의 개요&cr;&cr;당사는 2015년 5월 20일 한국산업기술진흥협회로부터 기업부설연구소 인정을 받아 연구소를 통하여 바이오기술 기반 동물의약품을 연구 및 개발활동을 수행하고 있습니다.&cr;
</P>

<TABLE BORDER="1" WIDTH="625" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="67"></COL>
<COL WIDTH="358"></COL>
<COL WIDTH="173"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="76" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">일자</TD>
<TD WIDTH="367" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">내용</TD>
<TD WIDTH="182" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">비고</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="76" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2016.04</TD>
<TD WIDTH="367" HEIGHT="30">미국 WISTAR연구소와 공동 연구 및 개발 계약 체결</TD>
<TD WIDTH="182" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="76" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">2017.04</TD>
<TD WIDTH="367" HEIGHT="76">농생명산업 기술개발사업(반려견 항암 면역 치료제) 협약 체결&cr;</TD>
<TD WIDTH="182" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">건국대수의과 공동연구</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="76" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">2017.06</TD>
<TD WIDTH="367" HEIGHT="53">항암 면역치료 DNA백신 원천기술 강화를 위한 IP R&D사업수주 및 협약 체결</TD>
<TD WIDTH="182" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="76" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">2017.10</TD>
<TD WIDTH="367" HEIGHT="76">산학연협력 기술개발사업(3가 구제역DNAvaccine) 협약 체결&cr;</TD>
<TD WIDTH="182" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">안전성평가연구소&cr;공동연구</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="76" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">2017.10</TD>
<TD WIDTH="367" HEIGHT="76">창업도약패키지 지원사업(바이오기술 기반 동물DNA백신) 협약 체결&cr;</TD>
<TD WIDTH="182" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">충북테크노파크 주관</TD>
</TR>
</TBODY>
</TABLE>
<P>&cr;(나) 연구개발 담당조직&cr;&cr; 1) 연구소 현황&cr;</P>

<TABLE BORDER="1" WIDTH="626" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="152"></COL>
<COL WIDTH="190"></COL>
<COL WIDTH="156"></COL>
<COL WIDTH="92"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="161" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">연구소명</TD>
<TD WIDTH="199" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">위치</TD>
<TD WIDTH="165" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">연구내용</TD>
<TD WIDTH="101" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">설립일</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="161" HEIGHT="53">(주)플럼라인생명과학&cr;기업부설연구소</TD>
<TD WIDTH="199" HEIGHT="53">서울시 서초구 반포대로 222</TD>
<TD WIDTH="165" HEIGHT="53">바이오기술 기반 동물의약품 연구 및 개발</TD>
<TD WIDTH="101" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">2015.05.20</TD>
</TR>
</TBODY>
</TABLE>
<P>&cr;2) 연구개발인력 및 현황(보고서 제출일 현재)&cr;</P>

<TABLE BORDER="1" WIDTH="626" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="191"></COL>
<COL WIDTH="82"></COL>
<COL WIDTH="326"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">직위</TD>
<TD WIDTH="91" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">인원</TD>
<TD WIDTH="335" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">주요 업무</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" VALIGN="MIDDLE" HEIGHT="30">연구소장(상무이사)</TD>
<TD WIDTH="91" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">1</TD>
<TD WIDTH="335" VALIGN="MIDDLE" HEIGHT="30">임상, 연구 및 개발 총괄</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" VALIGN="MIDDLE" HEIGHT="30">차장(책임연구원)</TD>
<TD WIDTH="91" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">1</TD>
<TD WIDTH="335" VALIGN="MIDDLE" HEIGHT="30">연구 및 연구행정 관리</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" VALIGN="MIDDLE" HEIGHT="30">연구원(선임 및 주임연구원)</TD>
<TD WIDTH="91" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">3</TD>
<TD WIDTH="335" VALIGN="MIDDLE" HEIGHT="30">연구 및 연구관련 행정업무</TD>
</TR>
</TBODY>
</TABLE>
<P>&cr;3) 연구개발비용                                                                               (단위: 천원)</P>

<TABLE BORDER="1" WIDTH="623" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="58"></COL>
<COL WIDTH="104"></COL>
<COL WIDTH="139"></COL>
<COL WIDTH="139"></COL>
<COL WIDTH="138"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD COLSPAN="2" WIDTH="180" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" USERMARK=" BC0XD7D7D7">
<P>구 분</P>
</TD>

<TD WIDTH="148" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" USERMARK=" BC0XD7D7D7">
<P>2020년&cr;(제7기)</P>
</TD>

<TD WIDTH="148" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" USERMARK=" BC0XD7D7D7">
<P>2019년&cr;(제6기)</P>
</TD>

<TD WIDTH="147" ALIGN="CENTER" HEIGHT="53" USERMARK=" BC0XD7D7D7">
<P>2018년&cr;(제5기)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ROWSPAN="6" WIDTH="67" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="180">
<P>자산</P>
<P>처리</P>
</TD>

<TD WIDTH="113" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>원재료비</P>
</TD>

<TD WIDTH="148" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>-</P>
</TD>

<TD WIDTH="148" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>-</P>
</TD>

<TD WIDTH="147" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>-</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="113" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>인건비</P>
</TD>

<TD WIDTH="148" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>-</P>
</TD>

<TD WIDTH="148" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>-</P>
</TD>

<TD WIDTH="147" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>-</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="113" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>감가상각비</P>
</TD>

<TD WIDTH="148" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>-</P>
</TD>

<TD WIDTH="148" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>-</P>
</TD>

<TD WIDTH="147" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>-</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="113" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>위탁용역비</P>
</TD>

<TD WIDTH="148" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>-</P>
</TD>

<TD WIDTH="148" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>-</P>
</TD>

<TD WIDTH="147" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>-</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="113" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>기타 경비</P>
</TD>

<TD WIDTH="148" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>-</P>
</TD>

<TD WIDTH="148" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>-</P>
</TD>

<TD WIDTH="147" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>-</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="113" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>소 계</P>
</TD>

<TD WIDTH="148" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>-</P>
</TD>

<TD WIDTH="148" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>-</P>
</TD>

<TD WIDTH="147" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>-</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ROWSPAN="3" WIDTH="67" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="90">
<P>비용</P>
<P>처리</P>
</TD>

<TD WIDTH="113" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>제조원가</P>
</TD>

<TD WIDTH="148" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>-</P>
</TD>

<TD WIDTH="148" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>-</P>
</TD>

<TD WIDTH="147" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>-</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="113" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>판관비</P>
</TD>
<TD WIDTH="148" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">759,672</TD>
<TD WIDTH="148" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,952,536</TD>
<TD WIDTH="147" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,211,668</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="113" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">소 계</TD>
<TD WIDTH="148" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">759,672</TD>
<TD WIDTH="148" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,952,536</TD>
<TD WIDTH="147" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,211,668</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="2" WIDTH="180" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">연구개발비용 계*</TD>
<TD WIDTH="148" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">759,672</TD>
<TD WIDTH="148" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,952,536</TD>
<TD WIDTH="147" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,211,668</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="2" WIDTH="180" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">(정부보조금)</TD>
<TD WIDTH="148" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="148" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="147" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="2" WIDTH="180" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">정부보조금 차감 후&cr;연구개발 비용 합계</TD>
<TD WIDTH="148" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">759,672</TD>
<TD WIDTH="148" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">2,952,536</TD>
<TD WIDTH="147" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">1,211,668</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="2" WIDTH="180" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">연구개발비/매출액비율&cr;[연구개발비용계÷&cr;당기매출액×100]</TD>
<TD WIDTH="148" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="76">N/A%</TD>
<TD WIDTH="148" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="76">N/A%</TD>
<TD WIDTH="147" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="76">N/A%</TD>
</TR>
</TBODY>
</TABLE>
<P>주) 연구개발비용은 전액 경상연구개발비(판관비)로 계상하고 있으며, '연구개발비용 계'란의 금액은 정부보조금을 차감하기 전의 연구개발비용 지출 총액입니다.&cr;</P>
<P>4) 연구개발 현황 및 실적&cr;가) 연구개발 현황</P>

<TABLE BORDER="1" WIDTH="627" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="180"></COL>
<COL WIDTH="280"></COL>
<COL WIDTH="92"></COL>
<COL WIDTH="39"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="189" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" USERMARK=" BC0XD7D7D7">지원 사업명&cr;(시행기관)</TD>
<TD WIDTH="289" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" USERMARK=" BC0XD7D7D7">연구과제</TD>
<TD WIDTH="101" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" USERMARK=" BC0XD7D7D7">과제수행&cr;(연구)기간</TD>
<TD WIDTH="48" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" USERMARK=" BC0XD7D7D7">현황</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="189" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">농생명산업 기술개발사업&cr;(농림식품기술기획평가원)</TD>
<TD WIDTH="289" HEIGHT="53">플라스미드DNA백신기술을 이용한 반려견 항암 면역치료제 개발</TD>
<TD WIDTH="101" HEIGHT="53">2017.04.21&cr;~2018.12.31</TD>
<TD WIDTH="48" HEIGHT="53">과제&cr;종료</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="189" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">산학연협력 기술개발사업&cr;(중소기업기술정보진흥원)</TD>
<TD WIDTH="289" HEIGHT="76">3가 구제역DNAvaccine의 목적동물 면역원성 검증 시험</TD>
<TD WIDTH="101" HEIGHT="76">2017.10.01&cr;~2018.09.30</TD>
<TD WIDTH="48" HEIGHT="76">과제&cr;종료&cr;</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="189" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">창업도약패키지 지원사업&cr;(중소벤처기업부)</TD>
<TD WIDTH="289" HEIGHT="76">바이오 기술 기반 동물DNA백신 개발</TD>
<TD WIDTH="101" HEIGHT="76">2017.10.31&cr;~2018.10.30</TD>
<TD WIDTH="48" HEIGHT="76">과제&cr;종료&cr;</TD>
</TR>
</TBODY>
</TABLE>
<P> &cr;나) 연구개발 실적</P>

<TABLE BORDER="1" WIDTH="625" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="98"></COL>
<COL WIDTH="164"></COL>
<COL WIDTH="164"></COL>
<COL WIDTH="163"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="107" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">지원 사업명</TD>
<TD WIDTH="173" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">연구과제</TD>
<TD WIDTH="173" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">연구결과</TD>
<TD WIDTH="172" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">기대효과</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="107" HEIGHT="99">농생명산업&cr;기술개발사업</TD>
<TD WIDTH="173" HEIGHT="99">플라스미드 DNA백신 기술을 이용한 반려견 항암 면역치료제 개발</TD>
<TD WIDTH="173" HEIGHT="99">임상시험을 위한 기초자료 확보를 위해 마우스, 실험견, 환견을 대상으로 한 실험 데이터 확보</TD>
<TD WIDTH="172" HEIGHT="99"> 반려견 고형암 치료에 사용, 전 세계 반려견 항암 치료 시장 대체, 동물복지 향상</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="107" HEIGHT="122">산학연협력&cr;기술개발사업</TD>
<TD WIDTH="173" HEIGHT="122">3가 구제역DNAvaccine의 목적동물 면역원성 검증 시험</TD>
<TD WIDTH="173" HEIGHT="122">전 세계 최초 3가 구제역 DNA백신의 안전성 및 효능을 검증하여 향후 상용화 백신으로 개발하기 위한 기초자료 마련</TD>
<TD WIDTH="172" HEIGHT="122">효율적 면역반응 유도, 정부 구제역정책과 부합한 신속대응 및 생산, 해외수입 대체</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="107" HEIGHT="76">창업도약패키지 지원사업</TD>
<TD WIDTH="173" HEIGHT="76">바이오 기술 기반 동물&cr;DNA백신 개발</TD>
<TD WIDTH="173" HEIGHT="76">DNA백신의 상용화 및 판매를 위한 기초자료 마련</TD>
<TD WIDTH="172" HEIGHT="76">면역력 증강 , 전염성 질환 백신 시장 대체 및 시장 확대</TD>
</TR>
</TBODY>
</TABLE>

<P>&cr;
<SPAN USERMARK=" B">주2) 정정 후&cr;</SPAN>
</P>

<P>
<SPAN USERMARK=" B">II. 사업의 내용&cr; 2. 회사의 현황&cr;  (4) 연구개발활동&cr;&cr;</SPAN>
<SPAN>(가) 연구개발활동의 개요&cr;&cr;</SPAN>
<SPAN>당사는 2015년 5월 20일 한국산업기술진흥협회로부터 기업부설연구소 인정을 받아 연구소를 통하여 바이오기술 기반 동물DNA의약품의 연구 및 개발활동을 수행하고 있습니다.</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="626">

<COLGROUP>
<COL WIDTH="152"></COL>
<COL WIDTH="169"></COL>
<COL WIDTH="161"></COL>
<COL WIDTH="108"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" BC0XD7D7D7" WIDTH="161" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">연구소명</TD>
<TD USERMARK=" BC0XD7D7D7" WIDTH="178" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">위치</TD>
<TD USERMARK=" BC0XD7D7D7" WIDTH="170" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">연구내용</TD>
<TD USERMARK=" BC0XD7D7D7" WIDTH="117" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">설립일</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="161" HEIGHT="76">(주)플럼라인생명과학 &cr;기업부설연구소</TD>
<TD WIDTH="178" HEIGHT="76">서울시 서초구 반포대로 222</TD>
<TD WIDTH="170" HEIGHT="76">바이오기술 기반 동물&cr;DNA의약품 연구 및 개발</TD>
<TD WIDTH="117" HEIGHT="76" ALIGN="CENTER" VALIGN="MIDDLE">2015.05.20</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN>&cr;(나) 연구개발 담당조직&cr; 1) 연구개발 조직 구성</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="623">

<COLGROUP>
<COL WIDTH="111"></COL>
<COL WIDTH="162"></COL>
<COL WIDTH="323"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" BC0XD7D7D7" WIDTH="120" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">구  분</TD>
<TD USERMARK=" BC0XD7D7D7" WIDTH="171" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">본부/부문</TD>
<TD USERMARK=" BC0XD7D7D7" WIDTH="332" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">주요 업무</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="120" HEIGHT="196" ROWSPAN="5" VALIGN="MIDDLE" ALIGN="CENTER">연구소</TD>
<TD WIDTH="171" HEIGHT="30" VALIGN="MIDDLE">글로벌 신약개발 본부</TD>
<TD WIDTH="332" HEIGHT="30" VALIGN="MIDDLE">연구소 총괄 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="171" HEIGHT="53" VALIGN="MIDDLE">반려동물부문</TD>
<TD WIDTH="332" HEIGHT="53" VALIGN="MIDDLE">반려견 DNA면역조절제, 반려견 DNA 면역항암제 등 연구개발</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="171" HEIGHT="53" VALIGN="MIDDLE">가축부문</TD>
<TD WIDTH="332" HEIGHT="53" VALIGN="MIDDLE">아프리카돼지열병DNA백신, 구제역3가DNA백신 등 연구개발</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="171" HEIGHT="30" VALIGN="MIDDLE">글로벌 임상부문</TD>
<TD WIDTH="332" HEIGHT="30" VALIGN="MIDDLE">글로벌 임상시험</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="171" HEIGHT="30" VALIGN="MIDDLE">연구지원부문</TD>
<TD WIDTH="332" HEIGHT="30" VALIGN="MIDDLE">연구지원</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN></SPAN>
</P>

<IMAGE>
<IMG WIDTH="600" HEIGHT="200" ALIGN="CENTER" HSPACE="0">연구소 조직도.jpg</IMG>
<IMG-CAPTION ATOC="N">연구소 조직도</IMG-CAPTION>
</IMAGE>

<P>
<SPAN>&cr; 2) 연구개발 인력 현황</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="610">

<COLGROUP>
<COL WIDTH="121"></COL>
<COL WIDTH="166"></COL>
<COL WIDTH="68"></COL>
<COL WIDTH="67"></COL>
<COL WIDTH="67"></COL>
<COL WIDTH="67"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="2" ROWSPAN="2" WIDTH="305" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" USERMARK=" BC0XD7D7D7">구  분</TD>
<TD COLSPAN="4" WIDTH="305" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">인  원</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="77" HEIGHT="30" USERMARK=" BC0XD7D7D7">박 사</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="76" HEIGHT="30" USERMARK=" BC0XD7D7D7">석 사</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="76" HEIGHT="30" USERMARK=" BC0XD7D7D7">기 타</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="76" HEIGHT="30" USERMARK=" BC0XD7D7D7">합 계</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="5" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="130" HEIGHT="150">연구소</TD>
<TD VALIGN="MIDDLE" WIDTH="175" HEIGHT="30">글로벌 신약개발 본부</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="77" HEIGHT="30">1</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="76" HEIGHT="30">-</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="76" HEIGHT="30">-</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="76" HEIGHT="30">1</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="175" HEIGHT="30">반려동물부문</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="77" HEIGHT="30">1</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="76" HEIGHT="30">-</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="76" HEIGHT="30">-</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="76" HEIGHT="30">1</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="175" HEIGHT="30">가축부문</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="77" HEIGHT="30">-</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="76" HEIGHT="30">1</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="76" HEIGHT="30">-</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="76" HEIGHT="30">1</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="175" HEIGHT="30">글로벌 임상부문</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="77" HEIGHT="30">-</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="76" HEIGHT="30">1</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="76" HEIGHT="30">-</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="76" HEIGHT="30">1</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="175" HEIGHT="30">연구지원부문</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="77" HEIGHT="30">-</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="76" HEIGHT="30">-</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="76" HEIGHT="30">1</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="76" HEIGHT="30">1</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="2" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="305" HEIGHT="30" USERMARK=" BC0XD7D7D7">합  계</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="77" HEIGHT="30" USERMARK=" BC0XD7D7D7">2</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="76" HEIGHT="30" USERMARK=" BC0XD7D7D7">2</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="76" HEIGHT="30" USERMARK=" BC0XD7D7D7">1</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="76" HEIGHT="30" USERMARK=" BC0XD7D7D7">5</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN>&cr; 3) 핵심 연구인력</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="627">

<COLGROUP>
<COL WIDTH="69"></COL>
<COL WIDTH="54"></COL>
<COL WIDTH="69"></COL>
<COL WIDTH="129"></COL>
<COL WIDTH="261"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">직 위</TD>
<TD WIDTH="63" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">성 명</TD>
<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">담당업무</TD>
<TD WIDTH="138" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">주요 경력</TD>
<TD WIDTH="270" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">주요 연구실적</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="2560">연구소장&cr; (상무)</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="63" HEIGHT="2560">김은진</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="78" HEIGHT="2560">연구총괄</TD>
<TD WIDTH="138" VALIGN="MIDDLE" HEIGHT="2560"> - 에이비온㈜ 부설연구소 : 전문위원&cr; - 서울대학교 생명과학부 &cr;: 연수연구원&cr; - 연세대학교 의생명과학부 : 강사/&cr; 연구조교수</TD>
<TD VALIGN="MIDDLE" WIDTH="270" HEIGHT="2560">논문:&cr;1. Sclerostin inhibits Wnt signaling through tandem interaction with two LRP6 ectodomains (2020, Nature.  Communication.)&cr;2. Cyclized Oligopeptide Targeting LRP5/6-DKK1 Interaction Reduces the Growth of Tumor Burden in a Multiple Myeloma Mouse Model (2017, Yonsei Med. J)&cr;3. The systemic effects of sclerostin overexpression using ΦC31 integrase in mice (2016, Biochem Biophys Res Commun.)&cr;4. Pax6 expressed in osteocytes inhibits canonical Wnt signaling &cr;(2013, Molecules and Cells)&cr;5. miR-182 is a negative regulator of osteoblast proliferation, differentiation, and skeletogenesis through targeting FoxO1(2012, Journal of Bone and Mineral Research)&cr;6. Estimating P-Coverage of Biosynthetic Pathways in DNA Libraries and Screening by Genetic Selection: Biotin Biosynthesis in the Marine Microorganism Chromohalobacter (2008, Molecular BioSystems)&cr;7. Evidence for a Proton Transfer Network and a Required Persulfide-Bond-Forming Cysteine Residue in Ni-Containing Carbon Monoxide Dehydrogenases&cr;(2004, Biochemistry)&cr;8. Ni-Zn-[Fe4-S4]andNi-Ni-[Fe4-S4]clustersinclosedandopena subunits of acetyl-CoA synthase/carbon monoxide dehydrogenase (2003, Nature Structural & Molecular Biology)&cr;&cr;국제 학회발표:&cr;1. DKK1 Inhibiting Oligopeptide Reduces Tumor Burden and Bony Destruction in a Mouse Model for Multiple Myeloma (MOPC315.BM.Luc+) (2015, Endocrine Society's 97th Annual Meeting and Expo, USA)&cr;2. Flavonoid class compounds abrogating sclerostin induced inhibition of Wnt/beta catenin signaling (2014, The America Society of Bone and Mineral Research Annual Meeting, USA)&cr;3.The NXI motif and its neighboring residues of Sclerostin play an important role for the inhibition of Wnt/beta -catenin signaling (2013, International Bone and Mineral Society/The Japan Society of Bone and Mineral Research Joint Meeting, Japan)&cr;4.C165R mutant Sclerostin retained a comparable inhibitory potency to the wild type on wnt-beta catenin signaling despite of inappropriate folding (2013, International Bone and Mineral Society/The Japan Society of Bone and Mineral Research Joint Meeting, Japan)&cr;5.Structure and function of the active loop resign of Sclerostin (2013, Seoul International Congress of Endocrinology and Metabolism, Korea)&cr;6.PEST domain of Sclerostin may not regulate the stability of Sclerostin (2013, Seoul International Congress of Endocrinology and Metabolism, Korea)&cr;7. Cysteine Mutants of Sclerostin Retained a Comparable Inhibitory Potency on Wnt/β-Catenin Signaling Despite of Inappropriate Folding (2012, The America Society of Bone and Mineral Research Annual Meeting, USA)&cr;8. Oliogopeptide based Sclerostin inhibitor abrogated Wnt/b-catenin signaling inhibited by Sclerostin in both MC3T3E1 and INS-1 cells (2012, The America Society of Bone and Mineral Research Annual Meeting, USA)&cr;9. Sequential Expression of Sox11 and Sox4 Is Essential for Osteoblastogenesis and Bone Development (2012, The America Society of Bone and Mineral Research Annual Meeting, USA)&cr;10. Study on structure and Function of Sclerostin by Site Directed Mutagenesis of Cysteine-knot and Finger 2 residues (2011, The America Society of Bone and Mineral Research Annual Meeting, USA)&cr;11. Construction and analysis of cDNA libraries from Marine Microbial sources&cr;(2004, Industry University Cooperative Chemistry Program Symposium, USA)&cr;12. Mutational analysis of particular histidine residues and various ligands to the C-cluster of CODHct (2004, CBI Conference, USA)&cr;13.Characterization of site-directed mutant of Ni-Fe-S containing enzyme Acetyl-CoA Synthase/CODHct (2002, CBI Conference, USA)&cr;14.Crystallization and characterization studies of a subunit and CODHc (2001, CBI Conference, USA) </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="78" HEIGHT="996">책임&cr;연구원</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="63" HEIGHT="996">엄태기</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="78" HEIGHT="996">연구개발</TD>
<TD VALIGN="MIDDLE" WIDTH="138" HEIGHT="996"> - 한양대학교 : 생화학/분자생물학 박사&cr; - 한국생명공학연구원 유전체구조연구센터 : 박사 후 연구원</TD>
<TD VALIGN="MIDDLE" WIDTH="270" HEIGHT="996">논문:&cr;1. Gamma-secretase inhibitor reduces allergic pulmonary inflammation by modulating Th1 and Th2 responses. (2009, Am J Respir Crit Care Med.).&cr;2.Effect of single nucleotide polymorphisms within the interleukin-4 promoter on aspirin intolerance in asthmatics and interleukin-4 promoter activity. (2010, Pharmacogenet Genomics.)&cr;3.The crucial role of GATA-1 in CCR3 gene transcription: modulated balance by multiple GATA elements in the CCR3 regulatory region. (2010,  J Immunol. 2010)&cr;4. CpG methylation at GATA elements in the regulatory region of CCR3 positively correlates with CCR3 transcription. &cr;(2012, Exp Mol Med.)&cr;5.Eosinophil development, regulation of eosinophil-specific genes, and role of eosinophils in the pathogenesis of asthma. (2012, Allergy Asthma Immunol Res.)&cr;6. Different GATA factors dictate CCR3 transcription in allergic inflammatory cells in a cell type-specific manner. (2013, J Immunol.)&cr;7. Epigenetic modification of TLR4 promotes activation of NF-κB by regulating methyl-CpG-binding domain protein 2 and Sp1 in gastric cancer. (2016, Oncotarget.)&cr;8. Olig2 is expressed late in human eosinophil development and controls Siglec-8 expression. (2016, J Leukoc Biol). &cr;9. Tescalcin expression contributes to invasive and metastatic activity in colorectal cancer. (2016, Tumour Biol.)&cr;10. GPNMB promotes proliferation of developing eosinophils. (2017, J Biochem)</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN>&cr;4) 연구개발비용</SPAN>                                                                               (단위: 천원) 
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="619">

<COLGROUP>
<COL WIDTH="87"></COL>
<COL WIDTH="127"></COL>
<COL WIDTH="88"></COL>
<COL WIDTH="88"></COL>
<COL WIDTH="88"></COL>
<COL WIDTH="87"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="2" ROWSPAN="2" WIDTH="232" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" USERMARK=" BC0XD7D7D7">과목</TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">2020년도</TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">2019년도</TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">2018년도</TD>
<TD ROWSPAN="2" WIDTH="96" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" USERMARK=" BC0XD7D7D7">비고</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">(제7기)</TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">(제6기)</TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">(제5기)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="6" WIDTH="96" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="180">비용의&cr; 성격별 분류</TD>
<TD WIDTH="136" VALIGN="MIDDLE" HEIGHT="30">원재료비</TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">118,402</TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">84,049</TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">444,801</TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="136" VALIGN="MIDDLE" HEIGHT="30">인건비</TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">329,977</TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">348,626</TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">328,972</TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="136" VALIGN="MIDDLE" HEIGHT="30">감가상각비</TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">28,255</TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">29,630</TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">29,190</TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="136" VALIGN="MIDDLE" HEIGHT="30">위탁용역비</TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">165,208</TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">28,254</TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">131,536</TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="136" VALIGN="MIDDLE" HEIGHT="30">기타</TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">87,830</TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,461,977</TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">277,169</TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="136" VALIGN="MIDDLE" HEIGHT="30" USERMARK=" BC0XD7D7D7">연구개발비용 합계</TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" BC0XD7D7D7">    729,672</TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" BC0XD7D7D7"> 2,952,536</TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" BC0XD7D7D7"> 1,211,668</TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="6" WIDTH="96" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="180">회계처리&cr;내역</TD>
<TD WIDTH="136" VALIGN="MIDDLE" HEIGHT="30">판매비와관리비</TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">729,672</TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,952,536</TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,211,668</TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="136" VALIGN="MIDDLE" HEIGHT="30">제조경비</TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="136" VALIGN="MIDDLE" HEIGHT="30">개발비(무형자산)</TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="136" VALIGN="MIDDLE" HEIGHT="30">회계처리금액 계</TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">729,672</TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,952,536</TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,211,668</TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="136" VALIGN="MIDDLE" HEIGHT="30">정부보조금</TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="136" VALIGN="MIDDLE" HEIGHT="30" USERMARK=" BC0XD7D7D7">연구개발비용 합계</TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" BC0XD7D7D7">729,672</TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" BC0XD7D7D7">2,952,536</TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" BC0XD7D7D7">1,211,668</TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="2" WIDTH="232" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">연구개발비 / 매출액 비율&cr;[연구개발비용계÷&cr;당기매출액×100]</TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">N/A%</TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">N/A%</TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">N/A%</TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76"></TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<P></P>

<P>
<SPAN>5) 연</SPAN>
<SPAN>구개발실적&cr; 가) 연구개발 진행 현황</SPAN>
<SPAN></SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="680">

<COLGROUP>
<COL WIDTH="54"></COL>
<COL WIDTH="161"></COL>
<COL WIDTH="168"></COL>
<COL WIDTH="55"></COL>
<COL WIDTH="62"></COL>
<COL WIDTH="53"></COL>
<COL WIDTH="64"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="2" WIDTH="63" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="83" USERMARK=" BC0XD7D7D7">구분</TD>
<TD ROWSPAN="2" WIDTH="170" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="83" USERMARK=" BC0XD7D7D7">품목</TD>
<TD ROWSPAN="2" WIDTH="177" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="83" USERMARK=" BC0XD7D7D7">적응증</TD>
<TD ROWSPAN="2" WIDTH="64" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="83" USERMARK=" BC0XD7D7D7">연구&cr;시작일</TD>
<TD COLSPAN="2" WIDTH="133" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">현재 진행단계</TD>
<TD ROWSPAN="2" WIDTH="73" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="83" USERMARK=" BC0XD7D7D7">비고</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="71" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" USERMARK=" BC0XD7D7D7">단계&cr;(국가)</TD>
<TD WIDTH="62" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" USERMARK=" BC0XD7D7D7">승인일</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="4" WIDTH="63" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="212">동물용&cr;바이오&cr;신약</TD>
<TD WIDTH="170" VALIGN="MIDDLE" HEIGHT="53">PLS-D1000 (반려견DNA면역조절제)</TD>
<TD WIDTH="177" VALIGN="MIDDLE" HEIGHT="53">노령견 CD8+ T세포 증가</TD>
<TD WIDTH="64" VALIGN="MIDDLE" HEIGHT="53" ALIGN="CENTER">2018년&cr; 08월</TD>
<TD WIDTH="71" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">임상2상&cr;(한국)</TD>
<TD WIDTH="62" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">-</TD>
<TD WIDTH="73" VALIGN="MIDDLE" HEIGHT="53" ALIGN="CENTER">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="170" VALIGN="MIDDLE" HEIGHT="53">PLS-D5000 (반려견DNA면역항암제)</TD>
<TD WIDTH="177" VALIGN="MIDDLE" HEIGHT="53">B-세포 림프종, 흑색종, &cr;고형암 면역항암제</TD>
<TD WIDTH="64" VALIGN="MIDDLE" HEIGHT="53" ALIGN="CENTER">2017년&cr; 04월</TD>
<TD WIDTH="71" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">임상2상&cr;(한국)</TD>
<TD WIDTH="62" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">-</TD>
<TD WIDTH="73" VALIGN="MIDDLE" HEIGHT="53" ALIGN="CENTER">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="170" VALIGN="MIDDLE" HEIGHT="53">PLS-ASF (아프리카돼지열병DNA백신)</TD>
<TD WIDTH="177" VALIGN="MIDDLE" HEIGHT="53">아프리카돼지열병 감염 예방</TD>
<TD WIDTH="64" VALIGN="MIDDLE" HEIGHT="53" ALIGN="CENTER">2019년&cr; 12월</TD>
<TD WIDTH="71" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">전임상&cr;(한국)</TD>
<TD WIDTH="62" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">-</TD>
<TD WIDTH="73" VALIGN="MIDDLE" HEIGHT="53" ALIGN="CENTER">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="170" VALIGN="MIDDLE" HEIGHT="53">PLS-FMD (구제역3가(A·O·Asia1)DNA백신)</TD>
<TD WIDTH="177" VALIGN="MIDDLE" HEIGHT="53">구제역 감염 예방</TD>
<TD WIDTH="64" VALIGN="MIDDLE" HEIGHT="53" ALIGN="CENTER">2017년&cr; 08월</TD>
<TD WIDTH="71" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">전임상&cr;전단계</TD>
<TD WIDTH="62" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">-</TD>
<TD WIDTH="73" VALIGN="MIDDLE" HEIGHT="53" ALIGN="CENTER">-</TD>
</TR>
</TBODY>
</TABLE>

<P USERMARK=" B">
<SPAN USERMARK=" !B"> * 현재진행 단계는 농림축산검역본부의 동물용의약품 기준입니다.&cr;&cr; ① PLS-D1000 (반려견DNA면역조절제)</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="622">

<COLGROUP>
<COL WIDTH="116"></COL>
<COL WIDTH="488"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="125" VALIGN="MIDDLE" HEIGHT="30" USERMARK=" BC0XD7D7D7" ALIGN="CENTER">구  분</TD>
<TD WIDTH="497" VALIGN="MIDDLE" HEIGHT="30">바이오 신약</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="125" HEIGHT="30" USERMARK=" BC0XD7D7D7" ALIGN="CENTER">적응증</TD>
<TD VALIGN="MIDDLE" WIDTH="497" HEIGHT="30">노령견 면역력 증가</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="125" HEIGHT="30" USERMARK=" BC0XD7D7D7" ALIGN="CENTER">작용기전</TD>
<TD VALIGN="MIDDLE" WIDTH="497" HEIGHT="30">GHRH-GH-IGF1 Axis에 의한 Immuno-modulation</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="125" HEIGHT="30" USERMARK=" BC0XD7D7D7" ALIGN="CENTER">제품의 특성</TD>
<TD VALIGN="MIDDLE" WIDTH="497" HEIGHT="30">DNA 플라스미드 기반의 혁신 동물용의약품</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="125" HEIGHT="30" USERMARK=" BC0XD7D7D7" ALIGN="CENTER">진행경과</TD>
<TD VALIGN="MIDDLE" WIDTH="497" HEIGHT="30">임상 2상(한국)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="125" HEIGHT="30" USERMARK=" BC0XD7D7D7" ALIGN="CENTER">향후계획</TD>
<TD VALIGN="MIDDLE" WIDTH="497" HEIGHT="30">2023년 이후 승인 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="125" HEIGHT="30" USERMARK=" BC0XD7D7D7" ALIGN="CENTER">경쟁제품</TD>
<TD VALIGN="MIDDLE" WIDTH="497" HEIGHT="30">반려견전용으로 시판허가 받은 제품이 없어 특정하기 어려움</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="125" HEIGHT="30" USERMARK=" BC0XD7D7D7" ALIGN="CENTER">관련논문 등</TD>
<TD VALIGN="MIDDLE" WIDTH="497" HEIGHT="30">연구진행과정으로 추후 임상완료 후 논문 게재 및 학회발표 예정</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="125" HEIGHT="30" USERMARK=" BC0XD7D7D7" ALIGN="CENTER">시장규모</TD>
<TD VALIGN="MIDDLE" WIDTH="497" HEIGHT="30"> -</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="125" HEIGHT="30" USERMARK=" BC0XD7D7D7" ALIGN="CENTER">기타사항</TD>
<TD VALIGN="MIDDLE" WIDTH="497" HEIGHT="30"> -</TD>
</TR>
</TBODY>
</TABLE>

<P USERMARK=" B">
<SPAN USERMARK=" !B">&cr; ② PLS-D5000 (반려견DNA면역항암제)</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="620">

<COLGROUP>
<COL WIDTH="116"></COL>
<COL WIDTH="486"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="125" VALIGN="MIDDLE" HEIGHT="30" USERMARK=" BC0XD7D7D7">구  분</TD>
<TD WIDTH="495" VALIGN="MIDDLE" HEIGHT="30">바이오 신약</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="125" HEIGHT="30" USERMARK=" BC0XD7D7D7">적응증</TD>
<TD VALIGN="MIDDLE" WIDTH="495" HEIGHT="30">B-세포 림프종, 흑색종, 고형암 면역항암제</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="125" HEIGHT="53" USERMARK=" BC0XD7D7D7">작용기전</TD>
<TD VALIGN="MIDDLE" WIDTH="495" HEIGHT="53">암세포에서 과발현되어 암세포 증식에 관여하는 TERT를 면역독성 T세포가 항원으로 인식, 공격하여 암세포의 사멸 유도</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="125" HEIGHT="30" USERMARK=" BC0XD7D7D7">제품의 특성</TD>
<TD VALIGN="MIDDLE" WIDTH="495" HEIGHT="30">DNA 플라스미드 기반의 혁신 동물용의약품</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="125" HEIGHT="30" USERMARK=" BC0XD7D7D7">진행경과</TD>
<TD VALIGN="MIDDLE" WIDTH="495" HEIGHT="30">임상 2상(한국)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="125" HEIGHT="30" USERMARK=" BC0XD7D7D7">향후계획</TD>
<TD VALIGN="MIDDLE" WIDTH="495" HEIGHT="30">2024년 이후 승인</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="125" HEIGHT="99" USERMARK=" BC0XD7D7D7">경쟁제품</TD>
<TD VALIGN="MIDDLE" WIDTH="495" HEIGHT="99">현재, 반려견의 B-세포 림프종 치료는 화학요법(chemotherapy), 방사선치료, 면역요법(Immunotherapy)으로 치료하고 있으며, 표준요법으로 CHOP 화학요법으로 치료하고 있음. 방사선 치료는 주로 수술 후 보조요법으로 사용하고 아직 상용화된 면역요법은 없으며 개발단계임.</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="125" HEIGHT="30" USERMARK=" BC0XD7D7D7">관련논문 등</TD>
<TD VALIGN="MIDDLE" WIDTH="495" HEIGHT="30">연구진행과정으로 추후 임상완료 후 논문 게재 및 학회발표 예정</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="125" HEIGHT="76" USERMARK=" BC0XD7D7D7">시장규모</TD>
<TD VALIGN="MIDDLE" WIDTH="495" HEIGHT="76">반려견 항암제 시장 2026년:  US$909Mn(약 1조원)&cr;산정기준:  Coherent Market Insights, CAGR10.9%: 2019-2026&cr;US$1=KRW1,100원 적용</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="125" HEIGHT="30" USERMARK=" BC0XD7D7D7">기타사항</TD>
<TD VALIGN="MIDDLE" WIDTH="495" HEIGHT="30">농기평과제 성공 수행 완료</TD>
</TR>
</TBODY>
</TABLE>

<P USERMARK=" B">
<SPAN USERMARK=" !B">&cr; ③ PLS-ASF (아프리카돼지열병DNA백신) </SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="622">

<COLGROUP>
<COL WIDTH="116"></COL>
<COL WIDTH="488"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="125" VALIGN="MIDDLE" HEIGHT="30" USERMARK=" BC0XD7D7D7">구  분</TD>
<TD WIDTH="497" VALIGN="MIDDLE" HEIGHT="30">바이오 신약</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="125" HEIGHT="30" USERMARK=" BC0XD7D7D7">적응증</TD>
<TD VALIGN="MIDDLE" WIDTH="497" HEIGHT="30">아프리카돼지열병 감염예방</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="125" HEIGHT="76" USERMARK=" BC0XD7D7D7">작용기전</TD>
<TD VALIGN="MIDDLE" WIDTH="497" HEIGHT="76">아프리카돼지열병 바이러스의 150여개의 단백질에서 세포면역원성을 높이는 부분을 선별해서 제작한 백신을 DNA 플라스미드 형태로 주입하고 체내에서 생존율에 주된 영향을 주는 세포면역원성을 유도함</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="125" HEIGHT="30" USERMARK=" BC0XD7D7D7">제품의 특성</TD>
<TD VALIGN="MIDDLE" WIDTH="497" HEIGHT="30">DNA 플라스미드 기반의 혁신 동물용의약품</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="125" HEIGHT="30" USERMARK=" BC0XD7D7D7">진행경과</TD>
<TD VALIGN="MIDDLE" WIDTH="497" HEIGHT="30">전임상(한국)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="125" HEIGHT="30" USERMARK=" BC0XD7D7D7">향후계획</TD>
<TD VALIGN="MIDDLE" WIDTH="497" HEIGHT="30">2025년 이후 승인</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="125" HEIGHT="746" USERMARK=" BC0XD7D7D7">경쟁제품</TD>

<TD VALIGN="MIDDLE" WIDTH="497" HEIGHT="746">
<P>아프리카돼지열병 백신의 연구는 1960년대 이후 꾸준히 진행되고 있으며, 약독화 생백신, 불활화 백신, 재조합 단백질 백신, 바이러스 벡터 백신, 등 현재까지 다양한 시도가 이루어졌으나, 현재까지 상업적으로 적용할 만큼 효과적인 백신은 개발되지 못함&cr;&cr;여러 형태의 각 백신 후보군들은 각각 장단점이 존재하는데 현재 방어능을 확인할 수 있는 것은 약독화 생백신임. 그러나 균주에 따라서 방어능이 다양하게 나타났으며, 만성형의 병증에  해당하는 발열과 관절염등의 병변을 보이고 또한 병원성이 회복될 수 있는 잠재적 가능성과 안전성 면에서 취약함&cr;&cr;2021년 3분기에 베트남에서 최초로 상업용 ASF백신이 출시 될 것으로 발표함. ASF 백신에 사용될 'ASFV-G-Delta I177L'는 미국 USDA 산하 PIADC에서 개발한 유전자 삭제기술을 이용한 약독화 백신임. &cr;&cr;이외에 유전자 삭제기술 이용한 약독화 백신은 현재 연구개발 단계에 있으며 아래의 표와 같음.&cr;</P>

<IMAGE>
<IMG WIDTH="417" HEIGHT="281" ALIGN="CENTER" HSPACE="0">pls-asf 연구개발 단계.jpg</IMG>
<IMG-CAPTION ATOC="N">ASF 백신 연구개발 단계</IMG-CAPTION>
</IMAGE>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="125" HEIGHT="30" USERMARK=" BC0XD7D7D7">관련논문 등</TD>
<TD VALIGN="MIDDLE" WIDTH="497" HEIGHT="30">연구진행과정으로 추후 임상완료 후 논문 게재 및 학회발표 예정</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="125" HEIGHT="30" USERMARK=" BC0XD7D7D7">시장규모</TD>
<TD VALIGN="MIDDLE" WIDTH="497" HEIGHT="30">중국시장(전세계50%) 약 2조5500 억원으로 추정(중국 화촹(華創)증권)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="125" HEIGHT="30" USERMARK=" BC0XD7D7D7">기타사항</TD>
<TD VALIGN="MIDDLE" WIDTH="497" HEIGHT="30">-</TD>
</TR>
</TBODY>
</TABLE>

<P USERMARK=" B">
<SPAN USERMARK=" !B">&cr; ④ PLS-FMD(구제역3가(A·O·Asia1) DNA백신) </SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="621">

<COLGROUP>
<COL WIDTH="116"></COL>
<COL WIDTH="487"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="125" VALIGN="MIDDLE" HEIGHT="30" USERMARK=" BC0XD7D7D7">구  분</TD>
<TD WIDTH="496" VALIGN="MIDDLE" HEIGHT="30">바이오 신약</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="125" HEIGHT="30" USERMARK=" BC0XD7D7D7">적응증</TD>
<TD VALIGN="MIDDLE" WIDTH="496" HEIGHT="30">구제역 감염 예방</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="125" HEIGHT="76" USERMARK=" BC0XD7D7D7">작용기전</TD>
<TD VALIGN="MIDDLE" WIDTH="496" HEIGHT="76">구제역 바이러스의 구조 단백질 부분을 DNA 형태로 제작해 체내에서 발현되는 단백질이 capsid를 형성해 항원항체 반응을 유도하고 세포내에서 발현된 펩타이드가 MHC-1 기전에 의해 세포성 면역성도 동시에 유도함</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="125" HEIGHT="30" USERMARK=" BC0XD7D7D7">제품의 특성</TD>
<TD VALIGN="MIDDLE" WIDTH="496" HEIGHT="30">DNA 플라스미드 기반의 혁신 동물용의약품</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="125" HEIGHT="30" USERMARK=" BC0XD7D7D7">진행경과</TD>
<TD VALIGN="MIDDLE" WIDTH="496" HEIGHT="30">전임상(한국)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="125" HEIGHT="30" USERMARK=" BC0XD7D7D7">향후계획</TD>
<TD VALIGN="MIDDLE" WIDTH="496" HEIGHT="30">2026년 이후 승인</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="125" HEIGHT="356" USERMARK=" BC0XD7D7D7">경쟁제품</TD>

<TD VALIGN="MIDDLE" WIDTH="496" HEIGHT="356">
<P>현재 상용화된 구제역 백신은 불활화 백신으로 영국 메링거잉겔하임, 러시아의 FGBI ARRIAH, 그리고 아르헨티나의 Biogenesis Bago에서 생산한 백신을 수입하고 있음.</P>

<IMAGE>
<IMG WIDTH="487" HEIGHT="167" ALIGN="CENTER" HSPACE="0">백신별 접종방법.jpg</IMG>
<IMG-CAPTION ATOC="N">백신별 접종방법</IMG-CAPTION>
</IMAGE>
<P>다른 형태의 상용화된 구제역 백신 없으며, 최근 국내 파로스 백신의 구제역 재조합단백질 백신인 'PharoVax-FMD' 농림축산검역본부로 부터 제조품목허가를 받음</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="125" HEIGHT="30" USERMARK=" BC0XD7D7D7">관련논문 등</TD>
<TD VALIGN="MIDDLE" WIDTH="496" HEIGHT="30">연구진행과정으로 추후 임상완료 후 논문 게재 및 학회발표 예정</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="125" HEIGHT="99" USERMARK=" BC0XD7D7D7">시장규모</TD>
<TD VALIGN="MIDDLE" WIDTH="496" HEIGHT="99">세계시장: 약 1.16조 &cr;산정기준: MarketWatch 2021 report, 2020 $966.4 Mn,&cr;             9.6% CAGR, 2026 $1675 Mn, US$1=KRW1,100원 적용&cr;국내시장: 약 1천억원 (한국농촌경제신문)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="125" HEIGHT="30" USERMARK=" BC0XD7D7D7">기타사항</TD>
<TD VALIGN="MIDDLE" WIDTH="496" HEIGHT="30">중기청 과제 성공 수행 완료</TD>
</TR>
</TBODY>
</TABLE>

<P USERMARK=" B">
<SPAN USERMARK=" !B">&cr;나) 연구개발 완료 실적&cr;</SPAN>
<SPAN USERMARK=" !B">해당사항이 없습니다.&cr;</SPAN>
<SPAN USERMARK=" !B">&cr;다) 연구개발활동 및 판매 중단 현황&cr;해당사항이 없습니다.&cr;&cr;라) 기타 연구개발 실적</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="677">

<COLGROUP>
<COL WIDTH="164"></COL>
<COL WIDTH="91"></COL>
<COL WIDTH="193"></COL>
<COL WIDTH="193"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="173" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK=" BC0XD7D7D7">연구과제</TD>
<TD WIDTH="100" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK=" BC0XD7D7D7">지원 사업명</TD>
<TD WIDTH="202" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK=" BC0XD7D7D7">연구결과</TD>
<TD WIDTH="202" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK=" BC0XD7D7D7">기대효과</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="173" HEIGHT="99" VALIGN="MIDDLE">플라스미드 DNA백신 기술을 이용한 반려견 항암 면역치료제 개발</TD>
<TD WIDTH="100" HEIGHT="99" VALIGN="MIDDLE">농생명산업 &cr;기술개발사업</TD>
<TD WIDTH="202" HEIGHT="99" VALIGN="MIDDLE">임상시험을 위한 기초자료 확보를 위해 마우스, 실험견, 환견을 대상으로 한 실험 데이터 확보</TD>
<TD WIDTH="202" HEIGHT="99" VALIGN="MIDDLE"> 반려견 고형암 치료에 사용, 전 세계 반려견 항암 치료 시장 대체, 동물복지 향상</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="173" HEIGHT="122" VALIGN="MIDDLE">3가 구제역DNAvaccine의 목적동물 면역원성 검증 시험</TD>
<TD WIDTH="100" HEIGHT="122" VALIGN="MIDDLE">산학연협력&cr;기술개발사업</TD>
<TD WIDTH="202" HEIGHT="122" VALIGN="MIDDLE">전 세계 최초 3가 구제역 DNA백신의 안전성 및 효능을 검증하여 향후 상용화 백신으로 개발하기 위한 기초자료 마련</TD>
<TD WIDTH="202" HEIGHT="122" VALIGN="MIDDLE">효율적 면역반응 유도, 정부 구제역정책과 부합한 신속대응 및 생산, 해외수입 대체</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="173" HEIGHT="53" VALIGN="MIDDLE">바이오 기술 기반 동물&cr;DNA백신 개발</TD>
<TD WIDTH="100" HEIGHT="53" VALIGN="MIDDLE">창업도약패키지 지원사업</TD>
<TD WIDTH="202" HEIGHT="53" VALIGN="MIDDLE">DNA백신의 상용화 및 판매를 위한 기초자료 마련</TD>
<TD WIDTH="202" HEIGHT="53" VALIGN="MIDDLE">면역력 증강 , 전염성 질환 백신 시장 대체 및 시장 확대</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK=" B">&cr;&cr;주3) 정정 후&cr;</SPAN>&cr;
<SPAN USERMARK=" B">II. 사업의 내용&cr; 2. 회사의 현황&cr;</SPAN>
<SPAN USERMARK=" B">(5) 경영상의 주요계약&cr;</SPAN>
</P>

<P>
<SPAN USERMARK="F-14 0XFF1200 B"></SPAN> 1) 라이센스아웃(License-out) 계약&cr;                                                                                                   (단위: 천USD)
</P>

<TABLE ACLASS="NORMAL" WIDTH="626" BORDER="1" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="75"></COL>
<COL WIDTH="79"></COL>
<COL WIDTH="68"></COL>
<COL WIDTH="78"></COL>
<COL WIDTH="77"></COL>
<COL WIDTH="75"></COL>
<COL WIDTH="51"></COL>
<COL WIDTH="51"></COL>
</COLGROUP>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="84" HEIGHT="53" USERMARK=" BC0XD7D7D7">품목</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="88" HEIGHT="53" USERMARK=" BC0XD7D7D7">계약상대방</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="77" HEIGHT="53" USERMARK=" BC0XD7D7D7">대상지역</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="87" HEIGHT="53" USERMARK=" BC0XD7D7D7">계약&cr;체결일</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="86" HEIGHT="53" USERMARK=" BC0XD7D7D7">계약&cr;종료일</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="84" HEIGHT="53" USERMARK=" BC0XD7D7D7">총계약금액</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="60" HEIGHT="53" USERMARK=" BC0XD7D7D7">수취&cr;금액</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="60" HEIGHT="53" USERMARK=" BC0XD7D7D7">진행&cr;단계</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="84" HEIGHT="53">PLS-ASF</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="88" HEIGHT="53">(주)중한&cr;바이오</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="77" HEIGHT="53">중국</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="87" HEIGHT="53"> 2020년&cr; 8월 24일</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="86" HEIGHT="53">2040년&cr;8월 23일</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="84" HEIGHT="53">
<SPAN USERMARK=" BC0X31FFFF">16,400</SPAN>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="60" HEIGHT="53">-</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="60" HEIGHT="53"> 전임상</TD>
</TR>
</TBODY>
</TABLE>
<P>* 계약조항에 따라 취소 사유 발생시 계약이 해지될 수 있음.&cr; &cr;  2) 라이센스인(License-in)계약&cr;                                                                                                   (단위: 천USD)</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="626">

<COLGROUP>
<COL WIDTH="77"></COL>
<COL WIDTH="77"></COL>
<COL WIDTH="68"></COL>
<COL WIDTH="78"></COL>
<COL WIDTH="77"></COL>
<COL WIDTH="81"></COL>
<COL WIDTH="48"></COL>
<COL WIDTH="48"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" BC0XD7D7D7" WIDTH="86" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">품목</TD>
<TD USERMARK=" BC0XD7D7D7" WIDTH="86" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">계약상대방</TD>
<TD USERMARK=" BC0XD7D7D7" WIDTH="77" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">대상지역</TD>
<TD USERMARK=" BC0XD7D7D7" WIDTH="87" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">계약&cr;체결일</TD>
<TD USERMARK=" BC0XD7D7D7" WIDTH="86" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">계약&cr;종료일</TD>
<TD USERMARK=" BC0XD7D7D7" WIDTH="90" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">총계약금액</TD>
<TD USERMARK=" BC0XD7D7D7" WIDTH="57" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">지급&cr;금액</TD>
<TD USERMARK=" BC0XD7D7D7" WIDTH="57" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">진행&cr;단계</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="86" HEIGHT="76" ALIGN="CENTER" VALIGN="MIDDLE">FMDV</TD>
<TD WIDTH="86" HEIGHT="76" ALIGN="CENTER" VALIGN="MIDDLE">Inovio Pharmaceuticals, Inc. </TD>
<TD WIDTH="77" HEIGHT="76" ALIGN="CENTER" VALIGN="MIDDLE">한국 등</TD>
<TD WIDTH="87" HEIGHT="76" ALIGN="CENTER" VALIGN="MIDDLE">2016년&cr;08월 15일</TD>
<TD WIDTH="86" HEIGHT="76" ALIGN="CENTER" VALIGN="MIDDLE">2039년&cr;08월 15일</TD>
<TD WIDTH="90" HEIGHT="76" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="57" HEIGHT="76" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="57" HEIGHT="76" ALIGN="CENTER" VALIGN="MIDDLE">임상&cr;준비</TD>
</TR>
</TBODY>
</TABLE>
<P>* 임상 진입 시 단계별 마일스톤 지급 발생 예정&cr;</P>
<P>3) 판매계약</P>
<P>                                                                                                   (단위: 천USD)</P>

<TABLE ACLASS="NORMAL" WIDTH="626" BORDER="1" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="78"></COL>
<COL WIDTH="82"></COL>
<COL WIDTH="179"></COL>
<COL WIDTH="48"></COL>
<COL WIDTH="48"></COL>
<COL WIDTH="45"></COL>
<COL WIDTH="38"></COL>
<COL WIDTH="36"></COL>
</COLGROUP>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="87" HEIGHT="53" USERMARK=" BC0XD7D7D7">품목</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="91" HEIGHT="53" USERMARK=" BC0XD7D7D7">계약&cr;상대방</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="188" HEIGHT="53" USERMARK=" BC0XD7D7D7">계약 목적 등</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="57" HEIGHT="53" USERMARK=" BC0XD7D7D7">계약&cr;체결일</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="57" HEIGHT="53" USERMARK=" BC0XD7D7D7">계약&cr;종료일</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="54" HEIGHT="53" USERMARK=" BC0XD7D7D7">계약&cr;금액</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="47" HEIGHT="53" USERMARK=" BC0XD7D7D7">수취금액</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="45" HEIGHT="53" USERMARK=" BC0XD7D7D7">비고</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="87" HEIGHT="76">LifeTide?&cr; SW5.0</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="91" HEIGHT="76">APIAM&cr;(호주)</TD>
<TD WIDTH="188" HEIGHT="76"> LifeTide? SW5.0(돼지DNA면역조절제)의 독점판매계약 체결</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="57" HEIGHT="76">2018년&cr;07월&cr;18일</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="57" HEIGHT="76">2038년&cr;07월&cr;17일</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="54" HEIGHT="76">300</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="47" HEIGHT="76">300</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="45" HEIGHT="76">-</TD>
</TR>
</TBODY>
</TABLE>
<P>* 계약조항에 따라 계약의 해지 및 계약금 반환이 될 수 있음.&cr;</P>
<P>3) 기타계약</P>
<P>                                                                                        (단위: 천USD,백만원)</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="628">

<COLGROUP>
<COL WIDTH="78"></COL>
<COL WIDTH="82"></COL>
<COL WIDTH="179"></COL>
<COL WIDTH="48"></COL>
<COL WIDTH="48"></COL>
<COL WIDTH="45"></COL>
<COL WIDTH="38"></COL>
<COL WIDTH="38"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" BC0XD7D7D7" WIDTH="87" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">품목</TD>
<TD USERMARK=" BC0XD7D7D7" WIDTH="91" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">계약&cr;상대방</TD>

<TD USERMARK=" BC0XD7D7D7" WIDTH="188" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">
<SPAN>계약 목적 등</SPAN>
</TD>
<TD USERMARK=" BC0XD7D7D7" WIDTH="57" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">계약&cr;체결일</TD>
<TD USERMARK=" BC0XD7D7D7" WIDTH="57" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">계약&cr;종료일</TD>
<TD USERMARK=" BC0XD7D7D7" WIDTH="54" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">계약&cr;금액</TD>
<TD USERMARK=" BC0XD7D7D7" WIDTH="47" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">지급&cr;금액</TD>
<TD USERMARK=" BC0XD7D7D7" WIDTH="47" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">비고</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="87" HEIGHT="76" ALIGN="CENTER" VALIGN="MIDDLE">자산인수</TD>
<TD WIDTH="91" HEIGHT="76" VALIGN="MIDDLE">VGX Animal Health</TD>
<TD WIDTH="188" HEIGHT="76" VALIGN="MIDDLE"> 회사 설립을 위한 자산인수 계약</TD>
<TD WIDTH="57" HEIGHT="76" ALIGN="CENTER" VALIGN="MIDDLE">2014년&cr;05월&cr;23일</TD>
<TD WIDTH="57" HEIGHT="76" ALIGN="CENTER" VALIGN="MIDDLE">2039년&cr;05월&cr;22일</TD>
<TD WIDTH="54" HEIGHT="76" ALIGN="RIGHT" VALIGN="MIDDLE">2,000</TD>
<TD WIDTH="47" HEIGHT="76" ALIGN="RIGHT" VALIGN="MIDDLE">2,000</TD>
<TD WIDTH="47" HEIGHT="76" ALIGN="CENTER" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="87" HEIGHT="76" ALIGN="CENTER" VALIGN="MIDDLE">PLS-ASF</TD>
<TD WIDTH="91" HEIGHT="76" ALIGN="CENTER" VALIGN="MIDDLE">Inovio Pharmaceuticals, Inc. </TD>
<TD WIDTH="188" HEIGHT="76"> PLS-ASF(아프리카돼지열병백신)의 공동연구 개발</TD>
<TD WIDTH="57" HEIGHT="76" ALIGN="CENTER" VALIGN="MIDDLE">2019년&cr;05월&cr;13일</TD>
<TD WIDTH="57" HEIGHT="76" ALIGN="CENTER" VALIGN="MIDDLE">완료&cr;시까지</TD>
<TD WIDTH="54" HEIGHT="76" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="47" HEIGHT="76" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="47" HEIGHT="76" ALIGN="CENTER" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="87" HEIGHT="76" ALIGN="CENTER" VALIGN="MIDDLE">LifeTide?&cr; SW5.0</TD>
<TD WIDTH="91" HEIGHT="76" ALIGN="CENTER" VALIGN="MIDDLE">(주)유바이오로직스</TD>
<TD WIDTH="188" HEIGHT="76"> LifeTide?SW5.0(돼지DNA면역조절제)의 위탁생산계약</TD>
<TD WIDTH="57" HEIGHT="76" ALIGN="CENTER" VALIGN="MIDDLE">2020년&cr;08월&cr;25일</TD>
<TD WIDTH="57" HEIGHT="76" ALIGN="CENTER" VALIGN="MIDDLE">완료&cr;시까지</TD>
<TD WIDTH="54" HEIGHT="76" ALIGN="RIGHT" VALIGN="MIDDLE">45</TD>
<TD WIDTH="47" HEIGHT="76" ALIGN="RIGHT" VALIGN="MIDDLE">4.5</TD>
<TD WIDTH="47" HEIGHT="76" ALIGN="CENTER" VALIGN="MIDDLE">-</TD>
</TR>
</TBODY>
</TABLE>

<P>* 임상진입 시 단계별 마일스톤 지급 발생 예정&cr;** 계약조항에 따라 취소 사유 발생시 계약이 해지될 수 있음.&cr;
</P>
<PGBRK></PGBRK>
</CORRECTION>

<SECTION-1 AID="CEO-CERT-COR" ACLASS="MANDATORY" APARTSOURCE="SOURCE">
<TITLE ATOC="Y" AASSOCNOTE="TTL_CEO_CERT_COR">【 대표이사 등의 확인 】</TITLE>

<APPENDIX ATYPE="IMAGE">
<COMMENT>◆click◆ 대표이사 등이 서명한 『확인서』 그림파일 삽입</COMMENT>
</APPENDIX>
<P></P>

<IMAGE>
<IMG WIDTH="589" HEIGHT="835" ALIGN="CENTER" HSPACE="0">대표이사등 확인서.jpg</IMG>
<IMG-CAPTION ATOC="N">대표이사등 확인서</IMG-CAPTION>
</IMAGE>
<PGBRK></PGBRK>
</SECTION-1>
</LIBRARY>
</INSERTION>

<COVER>
<P></P>
<COVER-TITLE ATOC="Y" AASSOCNOTE="COVER">사 업 보 고 서</COVER-TITLE>
<P>&cr;&cr;&cr;</P>
<P USERMARK="F-16">                                    (제 7 기)</P>

<TABLE-GROUP ACLASS="COVER" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="600" BORDER="0">

<COLGROUP>
<COL WIDTH="209"></COL>
<COL WIDTH="153"></COL>
<COL WIDTH="211"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD CLASS="NORMAL" ROWSPAN="2" ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="218" HEIGHT="60" AUPDATECONT="N">사업연도</TD>
<TU CLASS="NORMAL" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="162" HEIGHT="30" AUNIT="PERIODFROM" AUNITVALUE="20200101">2020년 01월 01일</TU>
<TD CLASS="NORMAL" VALIGN="MIDDLE" WIDTH="220" HEIGHT="30" AUPDATECONT="N"> 부터</TD>
</TR>

<TR ACOPY="N" ADELETE="N">
<TU CLASS="NORMAL" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="162" HEIGHT="30" AUNIT="PERIODTO" AUNITVALUE="20201231">2020년 12월 31일</TU>
<TD CLASS="NORMAL" VALIGN="MIDDLE" WIDTH="220" HEIGHT="30" AUPDATECONT="N"> 까지</TD>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P></P>

<TABLE AFIXTABLE="N" BORDER="0" WIDTH="600" ACLASS="NORMAL">

<COLGROUP>
<COL WIDTH="191"></COL>
<COL WIDTH="391"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30">금융위원회</TD>
<TD WIDTH="400" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30">한국거래소 귀중</TD>
<TD WIDTH="400" HEIGHT="30" ALIGN="RIGHT">2021년    03월   10일</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30"></TD>
<TD WIDTH="400" HEIGHT="30"></TD>
</TR>
</TBODY>
</TABLE>

<TABLE-GROUP ACLASS="PB_VAL" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="600" BORDER="0">

<COLGROUP>
<COL WIDTH="191"></COL>
<COL WIDTH="391"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="200" HEIGHT="30" AUPDATECONT="N">제출대상법인 유형 :</TD>
<TU WIDTH="400" HEIGHT="30" AUNIT="PB_TYPE" AUNITVALUE="1">주권상장법인</TU>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30" AUPDATECONT="N"></TD>
<TD WIDTH="400" HEIGHT="30"></TD>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="200" HEIGHT="30" AUPDATECONT="N">면제사유발생 :</TD>
<TU WIDTH="400" HEIGHT="30" AUNIT="PB_CAMNT" AUNITVALUE="-">해당사항 없음</TU>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>

<TABLE AFIXTABLE="N" BORDER="0" WIDTH="600" ACLASS="NORMAL">

<COLGROUP>
<COL WIDTH="191"></COL>
<COL WIDTH="391"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30"></TD>
<TD WIDTH="400" HEIGHT="30"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30">회      사      명 :</TD>
<TD WIDTH="400" HEIGHT="30">주식회사 플럼라인생명과학</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30"></TD>
<TD WIDTH="400" HEIGHT="30"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30">대   표    이   사 :</TD>
<TD WIDTH="400" HEIGHT="30">김앤토니경태</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30"></TD>
<TD WIDTH="400" HEIGHT="30"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30">본  점  소  재  지 :</TD>
<TD WIDTH="400" HEIGHT="30">서울시 서초구 서초대로 34길 18, 4층</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30"></TD>
<TD WIDTH="400" HEIGHT="30">(전  화)02-582-3540</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30"></TD>
<TD WIDTH="400" HEIGHT="30">(홈페이지) http://www.plsdna.com</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30"></TD>
<TD WIDTH="400" HEIGHT="30"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30">작  성  책  임  자 :</TD>
<TD WIDTH="400" HEIGHT="30">(직  책)이사    (성  명)김성신</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30"></TD>
<TD WIDTH="400" HEIGHT="30">(전  화)02-582-3542</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30"></TD>
<TD WIDTH="400" HEIGHT="30"></TD>
</TR>
</TBODY>
</TABLE>
<PGBRK></PGBRK>
</COVER>

<TOC>
<TITLE ATOC="N">목     차</TITLE>
<P></P>

<TABLE ACLASS="NORMAL" WIDTH="600" BORDER="0">

<COLGROUP>
<COL WIDTH="341"></COL>
<COL WIDTH="191"></COL>
<COL WIDTH="41"></COL>
</COLGROUP>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="350" HEIGHT="32">【 대표이사 등의 확인 】</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="200" HEIGHT="32">-----------------------</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="50" HEIGHT="32">1</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="350" HEIGHT="32">I. 회사의 개요</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="200" HEIGHT="32">-----------------------</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="50" HEIGHT="32">3</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="350" HEIGHT="32">   1. 회사의 개요</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="200" HEIGHT="32">-----------------------</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="50" HEIGHT="32">3</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="350" HEIGHT="32">   2. 회사의 연혁</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="200" HEIGHT="32">-----------------------</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="50" HEIGHT="32">4</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="350" HEIGHT="32">   3. 자본금 변동사항</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="200" HEIGHT="32">-----------------------</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="50" HEIGHT="32">5</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="350" HEIGHT="32">   4. 주식의 총수 등</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="200" HEIGHT="32">-----------------------</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="50" HEIGHT="32">7</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="350" HEIGHT="32">   5. 의결권 현황</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="200" HEIGHT="32">-----------------------</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="50" HEIGHT="32">12</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="350" HEIGHT="32">   6. 배당에 관한 사항 등</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="200" HEIGHT="32">-----------------------</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="50" HEIGHT="32">13</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="350" HEIGHT="32">   7. 정관에 관한 사항 등</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="200" HEIGHT="32">-----------------------</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="50" HEIGHT="32">14</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="350" HEIGHT="32">II. 사업의 내용</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="200" HEIGHT="32">-----------------------</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="50" HEIGHT="32">16</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="350" HEIGHT="32">III. 재무에 관한 사항</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="200" HEIGHT="32">-----------------------</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="50" HEIGHT="32">44</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="350" HEIGHT="32">   1. 요약재무정보</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="200" HEIGHT="32">-----------------------</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="50" HEIGHT="32">44</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="350" HEIGHT="30">   2. 연결재무제표</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="200" HEIGHT="30">-----------------------</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="50" HEIGHT="30">45</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="350" HEIGHT="30">   3. 연결재무제표 주석</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="200" HEIGHT="30">-----------------------</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="50" HEIGHT="30">45</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="350" HEIGHT="30">   4. 재무제표</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="200" HEIGHT="30">-----------------------</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="50" HEIGHT="30">45</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="350" HEIGHT="30">   5. 재무제표 주석</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="200" HEIGHT="30">-----------------------</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="50" HEIGHT="30">50</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="350" HEIGHT="30">   6. 기타 재무에 관한 사항</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="200" HEIGHT="30">-----------------------</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="50" HEIGHT="30">72</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="350" HEIGHT="30">IV. 이사의 경영진단 및 분석의견</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="200" HEIGHT="30">-----------------------</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="50" HEIGHT="30">75</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="350" HEIGHT="30">V. 감사인의 감사의견 등</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="200" HEIGHT="30">-----------------------</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="50" HEIGHT="30">79</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="350" HEIGHT="30">VI. 이사회 등 회사의 기관에 관한 사항</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="200" HEIGHT="30">-----------------------</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="50" HEIGHT="30">80</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="350" HEIGHT="30">   1. 이사회에 관한 사항</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="200" HEIGHT="30">-----------------------</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="50" HEIGHT="30">80</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="350" HEIGHT="30">   2. 감사제도에 관한 사항</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="200" HEIGHT="30">-----------------------</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="50" HEIGHT="30">80</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="350" HEIGHT="30">   3. 주주의 의결권 행사에 관한 사항</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="200" HEIGHT="30">-----------------------</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="50" HEIGHT="30">81</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="350" HEIGHT="30">VII. 주주에 관한 사항</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="200" HEIGHT="30">-----------------------</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="50" HEIGHT="30">83</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="350" HEIGHT="30">VIII. 임원 및 직원 등에 관한 사항</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="200" HEIGHT="30">-----------------------</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="50" HEIGHT="30">85</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="350" HEIGHT="30">   1. 임원 및 직원 등의 현황</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="200" HEIGHT="30">-----------------------</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="50" HEIGHT="30">85</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="350" HEIGHT="30">   2. 임원의 보수 등</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="200" HEIGHT="30">-----------------------</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="50" HEIGHT="30">86</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="350" HEIGHT="30">IX. 계열회사 등에 관한 사항</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="200" HEIGHT="30">-----------------------</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="50" HEIGHT="30">90</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="350" HEIGHT="30">X. 이해관계자와의 거래내용</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="200" HEIGHT="30">-----------------------</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="50" HEIGHT="30">91</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="350" HEIGHT="30">XI. 그 밖에 투자자 보호를 위하여 필요한 사항</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="200" HEIGHT="30">-----------------------</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="50" HEIGHT="30">93</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="350" HEIGHT="30">【 전문가의 확인 】</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="200" HEIGHT="30">-----------------------</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="50" HEIGHT="30">95</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="350" HEIGHT="30">   1. 전문가의 확인</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="200" HEIGHT="30">-----------------------</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="50" HEIGHT="30">95</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="350" HEIGHT="30">   2. 전문가와의 이해관계</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="200" HEIGHT="30">-----------------------</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="50" HEIGHT="30">95</TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<PGBRK></PGBRK>
</TOC>

<SECTION-1 AID="CEO-CERT" ACLASS="MANDATORY" APARTSOURCE="SOURCE">
<TITLE ATOC="Y" AASSOCNOTE="TTL_CEO_CERT">【 대표이사 등의 확인 】</TITLE>

<APPENDIX ATYPE="IMAGE">
<COMMENT>◆click◆ 대표이사 등이 서명한 『확인서』 그림파일 삽입</COMMENT>
</APPENDIX>

<IMAGE>
<IMG WIDTH="591" HEIGHT="838" ALIGN="CENTER" HSPACE="0">대표이사등의 확인서.jpg</IMG>
<IMG-CAPTION ATOC="N">대표이사등의 확인서</IMG-CAPTION>
</IMAGE>
<PGBRK></PGBRK>
</SECTION-1>

<SECTION-1 ACLASS="MANDATORY" APARTSOURCE="SOURCE">
<TITLE ATOC="Y">I. 회사의 개요</TITLE>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-0-1-1-0">1. 회사의 개요</TITLE>

<INSERTION ABASISNUMBER="SE1" AFREQUENCY="0" ADUPLICATION="N">
<COMMENT>◆click◆『연결재무제표를작성하는주권상장법인』 삽입</COMMENT>
<LIBRARYLIST>11011#*연결재무제표를작성하는주권상장법인.dsl</LIBRARYLIST>
</INSERTION>
<P></P>

<P>
<SPAN USERMARK=" B">가. 회사의 법적, 상업적 명칭&cr;</SPAN>&cr;'주식회사 플럼라인생명과학'으로 표기합니다. 또한 영문으로는 "Plumbline Life Sciences, Inc."라 표기합니다.&cr;&cr;
<SPAN USERMARK=" B">나. 설립일자 및 존속기간&cr;</SPAN>&cr;당사는 2014년 01월 02일에 설립되었습니다.&cr;&cr;
<SPAN USERMARK=" B">다. 본사의 주소, 전화번호 및 홈페이지&cr;</SPAN>&cr;주소 : 서울시 서초구 서초대로 34길 18, 4층&cr;전화번호 : 02-582-3540&cr;홈페이지 : http://www.plsdna.com&cr;&cr;
<SPAN USERMARK=" B">라. 중소기업 해당여부&cr;</SPAN>&cr;당사는 보고서 제출일 현재 중소기업기본법 제2조에 의한 중소기업에 해당됩니다.&cr;
<SPAN>&cr;</SPAN>
<SPAN></SPAN>
<SPAN USERMARK=" B">마. 벤처기업/이노비즈기업 해당 여부&cr;</SPAN>
<SPAN>&cr;</SPAN>당사는 벤처기업육성에 관한 특별조치법 제25조의 규정에 의한 벤처기업에 해당합니다.&cr;&cr;
<SPAN USERMARK=" B">바. 주요사업의 내용&cr;</SPAN>&cr;당사는 물리ㆍ화학 및 생물학 연구개발업을 영위하고 있습니다. 기타의 자세한 사항은 동 보고서의 'Ⅱ. 사업의 내용’을 참조하시기 바랍니다.
</P>
<P></P>
<P USERMARK=" B">사. 회사의 주권상장(또는 등록ㆍ지정)여부 및 특례상장에 관한 사항&cr;</P>

<TABLE-GROUP ACLASS="SPC_CRT" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="602" BORDER="1">

<COLGROUP>
<COL WIDTH="165"></COL>
<COL WIDTH="165"></COL>
<COL WIDTH="104"></COL>
<COL WIDTH="132"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="N" ADELETE="N">
<TH WIDTH="174" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">주권상장&cr;(또는 등록ㆍ지정)여부</TH>
<TH WIDTH="174" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">주권상장&cr;(또는 등록ㆍ지정)일자</TH>
<TH WIDTH="113" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">특례상장 등&cr;여부</TH>
<TH WIDTH="141" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">특례상장 등&cr;적용법규</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TE WIDTH="174" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="SPC_CHK">코넥스시장</TE>
<TU WIDTH="174" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUNIT="SPC_DATE" AUNITVALUE="20150728">2015년 07월 28일</TU>
<TE WIDTH="113" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="SPC_CHP">-</TE>
<TE WIDTH="141" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="SPC_LAW">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P></P>
<P></P>
</SECTION-2>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-0-1-2-0">2. 회사의 연혁</TITLE>
<P></P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="643">

<COLGROUP>
<COL WIDTH="110"></COL>
<COL WIDTH="515"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="119" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>일자</P>
</TH>

<TH WIDTH="524" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>회사연혁</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="119" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P>2014.01</P>
</TD>

<TD WIDTH="524" HEIGHT="30" VALIGN="MIDDLE">
<P>(주)플럼라인생명과학 설립</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="119" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P>2014.01</P>
</TD>

<TD WIDTH="524" HEIGHT="30" VALIGN="MIDDLE">
<P>대표이사 미합중국인 김앤토니경태 취임</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="119" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P>2014.05</P>
</TD>

<TD WIDTH="524" HEIGHT="30" VALIGN="MIDDLE">
<P>VGX Animal Health의 자산 100% 인수</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="119" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P>2014.08</P>
</TD>
<TD WIDTH="524" HEIGHT="30" VALIGN="MIDDLE">100% 자회사 미국법인 Plumbline Life Sciences, U.S.A 설립</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="119" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P>2014.01~12</P>
</TD>

<TD WIDTH="524" HEIGHT="30" VALIGN="MIDDLE">
<P>자본금 증자 (유상증자, 무상증자 / 증자 후 자본금 502백만원) </P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="119" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P>2015.03</P>
</TD>

<TD WIDTH="524" HEIGHT="30" VALIGN="MIDDLE">
<P>벤처기업 등록 (제20150300072호)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="119" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P>2015.05</P>
</TD>

<TD WIDTH="524" HEIGHT="30" VALIGN="MIDDLE">
<P>지정자문계약 체결 (대신증권)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="119" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P>2015.01~06</P>
</TD>

<TD WIDTH="524" HEIGHT="30" VALIGN="MIDDLE">
<P>자본금 증자 (유상증자, 무상증자 / 증자 후 자본금 1,173백만원) </P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="119" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P>2015.06</P>
</TD>

<TD WIDTH="524" HEIGHT="30" VALIGN="MIDDLE">
<P>사외이사 김균 및 감사 김주현 취임</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="119" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P>2015.07</P>
</TD>

<TD WIDTH="524" HEIGHT="30" VALIGN="MIDDLE">
<P>한국거래소 코넥스시장 상장 </P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="119" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2016.03</TD>
<TD WIDTH="524" HEIGHT="30" VALIGN="MIDDLE">사외이사 김균 사임 및 김덕상 취임</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="119" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2016.04</TD>
<TD WIDTH="524" HEIGHT="30" VALIGN="MIDDLE">미국 Wistar 연구소와 공동 연구 및 개발 계약 체결</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="119" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2016.06</TD>
<TD WIDTH="524" HEIGHT="30" VALIGN="MIDDLE">사내이사 김균 취임</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="119" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2016.12</TD>
<TD WIDTH="524" HEIGHT="30" VALIGN="MIDDLE">자본금 증자 (유상증자 / 증자 후 자본금 1,178백만원)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="119" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2017.04</TD>
<TD WIDTH="524" HEIGHT="30" VALIGN="MIDDLE">서초구 가톨릭대학교 성의회관으로 연구소 이전</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="119" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2017.04</TD>
<TD WIDTH="524" HEIGHT="30" VALIGN="MIDDLE">반려견DNA면역항암제(PLS-D5000)정부국책과제 선정(고형암 적응증)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="119" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2017.06</TD>
<TD WIDTH="524" HEIGHT="30" VALIGN="MIDDLE">항암 면역치료 DNA백신 원천기술 강화를 위한 IP R&D사업수주 및 협약체결</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="119" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2017.07</TD>
<TD WIDTH="524" HEIGHT="30" VALIGN="MIDDLE">자본금 증자 (유상증자 / 증자 후 자본금 1,210백만원)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="119" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2017.08</TD>
<TD WIDTH="524" HEIGHT="30" VALIGN="MIDDLE">지정자문계약 해지 (대신증권) 및 체결 (키움증권)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="119" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2017.10</TD>
<TD WIDTH="524" HEIGHT="30" VALIGN="MIDDLE">3가 구제역DNAvaccine의 목적동물 면역원성 검증 시험 정부국책과제 선정</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="119" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2017.10</TD>
<TD WIDTH="524" HEIGHT="30" VALIGN="MIDDLE">4차 산업혁명분야 바이오 기술 기반 동물DNA 백신 개발 정부국책과제 선정</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="119" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2018.03</TD>
<TD WIDTH="524" HEIGHT="30" VALIGN="MIDDLE">자본금 증자 (유상증자 / 증자 후 자본금 1,290백만원)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="119" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2018.05</TD>
<TD WIDTH="524" HEIGHT="30" VALIGN="MIDDLE">돼지DNA면역조절제(LifeTide?SW5) 수입품목허가 - 검역본부</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="119" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2018.07</TD>
<TD WIDTH="524" HEIGHT="30" VALIGN="MIDDLE">호주 APIAM사와 LifeTide?SW5 판매계약 체결</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="119" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2018.11</TD>
<TD WIDTH="524" HEIGHT="30" VALIGN="MIDDLE">자본금 증자 (유상증자 / 증자 후 자본금 1,308백만원)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="119" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2019.03</TD>
<TD WIDTH="524" HEIGHT="30" VALIGN="MIDDLE">제 1회차 전환사채 발행 (발행 규모 1,000백만원)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="119" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2019.07</TD>
<TD WIDTH="524" HEIGHT="30" VALIGN="MIDDLE">사외이사 김덕상 사임</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="119" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2019.08</TD>
<TD WIDTH="524" HEIGHT="30" VALIGN="MIDDLE">제 2회차 전환사채 발행 (발행 규모 450백만원)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="119" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2019.11</TD>
<TD WIDTH="524" HEIGHT="30" VALIGN="MIDDLE">자본금 증자 (유상증자 외 / 증자 후 자본금 1,319백만원)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="119" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2020.01</TD>
<TD WIDTH="524" HEIGHT="30" VALIGN="MIDDLE">자본금 증자 (유상증자 외/ 증자 후 자본금 1,358백만원)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="119" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2020.02</TD>
<TD WIDTH="524" HEIGHT="30" VALIGN="MIDDLE">자본금 증자 (유상증자 외/ 증자 후 자본금 1,394백만원)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="119" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2020.03</TD>
<TD WIDTH="524" HEIGHT="30" VALIGN="MIDDLE">자본금 증자 (유상증자 외/ 증자 후 자본금 1,495백만원)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="119" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2020.04</TD>
<TD WIDTH="524" HEIGHT="30" VALIGN="MIDDLE">서울시 서초구 서초대로34길 18, 4층(유노피스빌딩)으로 본점 이전</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="119" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2020.08</TD>
<TD WIDTH="524" HEIGHT="30" VALIGN="MIDDLE">㈜중한바이오사와 PLS-ASF 독점 라이선스계약 체결</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="119" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2020.08</TD>
<TD WIDTH="524" HEIGHT="30" VALIGN="MIDDLE">㈜유바이오로직스사와 LifeTide?SW5 위탁생산 계약 체결</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="119" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2020.10</TD>
<TD WIDTH="524" HEIGHT="30" VALIGN="MIDDLE">사내이사 김균 사임</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="119" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2020.10</TD>
<TD WIDTH="524" HEIGHT="30" VALIGN="MIDDLE">특허 등록 (제10-2165358호)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="119" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2020.10</TD>
<TD WIDTH="524" HEIGHT="30" VALIGN="MIDDLE">자본금 증자(전환권행사 / 행사 후 자본금 1,517백만원)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="119" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2020.12</TD>
<TD WIDTH="524" HEIGHT="30" VALIGN="MIDDLE">자본금 증자 (유상증자 / 증자 후 자본금 1,567백만원)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="119" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2020.12</TD>
<TD WIDTH="524" HEIGHT="30" VALIGN="MIDDLE">벤처기업 등록 (제20200116379호)</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL11"></P>
</SECTION-2>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-0-1-3-0">3. 자본금 변동사항</TITLE>
<P></P>
<P USERMARK=" B">증자(감자)현황</P>

<TABLE-GROUP ACLASS="INC_STAT" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="674" BORDER="0">

<COLGROUP>
<COL WIDTH="70"></COL>
<COL WIDTH="142"></COL>
<COL WIDTH="58"></COL>
<COL WIDTH="368"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="79" HEIGHT="30" AUPDATECONT="N">(기준일 : </TD>
<TU ALIGN="CENTER" VALIGN="BOTTOM" WIDTH="151" HEIGHT="30" AUNIT="BASE_DT" AUNITVALUE="20201231">2020년 12월 31일</TU>
<TD VALIGN="BOTTOM" WIDTH="67" HEIGHT="30" AUPDATECONT="N">)</TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="377" HEIGHT="30" AUNIT="WONSTOCK" AUNITVALUE="1">(단위 : 원, 주)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="675" BORDER="1">

<COLGROUP>
<COL WIDTH="128"></COL>
<COL WIDTH="149"></COL>
<COL WIDTH="62"></COL>
<COL WIDTH="73"></COL>
<COL WIDTH="66"></COL>
<COL WIDTH="79"></COL>
<COL WIDTH="55"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="N" ADELETE="N">
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="137" HEIGHT="106" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">주식발행&cr;(감소)일자</TH>
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="158" HEIGHT="106" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">발행(감소)&cr;형태</TH>
<TH COLSPAN="5" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="380" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">발행(감소)한 주식의 내용</TH>
</TR>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="71" HEIGHT="76" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">주식의 종류</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="82" HEIGHT="76" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">수량</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="75" HEIGHT="76" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">주당&cr;액면가액</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="88" HEIGHT="76" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">주당발행&cr;(감소)가액</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="64" HEIGHT="76" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">비고</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="N">
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="137" HEIGHT="76" AUNIT="INC_DT" AUNITVALUE="20150102">2015년 01월 02일</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="158" HEIGHT="76" AUNIT="INC_DR_KND" AUNITVALUE="-">-</TU>

<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="71" HEIGHT="76" ACODE="INC_STK_KND">
<P USERMARK="F-GL11">보통주</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="82" HEIGHT="76" ACODE="INC_CNT">
<P USERMARK="F-GL11">52,000</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="75" HEIGHT="76" ACODE="INC_PAR_AMT">
<P USERMARK="F-GL11">500</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="88" HEIGHT="76" ACODE="INC_SL_AMT">
<P USERMARK="F-GL11">500</P>
</TE>
<TD VALIGN="MIDDLE" WIDTH="64" HEIGHT="76" ALIGN="CENTER">설립&cr;자본금</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="137" HEIGHT="34" AUNIT="INC_DT" AUNITVALUE="20140205">2014년 02월 05일</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="158" HEIGHT="34" AUNIT="INC_DR_KND" AUNITVALUE="02">유상증자(주주배정)</TU>

<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="71" HEIGHT="34" ACODE="INC_STK_KND">
<P USERMARK="F-GL11">보통주</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="82" HEIGHT="34" ACODE="INC_CNT">
<P USERMARK="F-GL11">8,000</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="75" HEIGHT="34" ACODE="INC_PAR_AMT">
<P USERMARK="F-GL11">500</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="88" HEIGHT="34" ACODE="INC_SL_AMT">
<P USERMARK="F-GL11">500</P>
</TE>
<TD VALIGN="MIDDLE" WIDTH="64" HEIGHT="34" ALIGN="CENTER">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="137" HEIGHT="34" AUNIT="INC_DT" AUNITVALUE="20140614">2014년 06월 14일</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="158" HEIGHT="34" AUNIT="INC_DR_KND" AUNITVALUE="04">유상증자(제3자배정)</TU>

<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="71" HEIGHT="34" ACODE="INC_STK_KND">
<P USERMARK="F-GL11">보통주</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="82" HEIGHT="34" ACODE="INC_CNT">
<P USERMARK="F-GL11">400</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="75" HEIGHT="34" ACODE="INC_PAR_AMT">
<P USERMARK="F-GL11">500</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="88" HEIGHT="34" ACODE="INC_SL_AMT">
<P USERMARK="F-GL11">250,000</P>
</TE>
<TD VALIGN="MIDDLE" WIDTH="64" HEIGHT="34" ALIGN="CENTER">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="137" HEIGHT="34" AUNIT="INC_DT" AUNITVALUE="20140704">2014년 07월 04일</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="158" HEIGHT="34" AUNIT="INC_DR_KND" AUNITVALUE="04">유상증자(제3자배정)</TU>

<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="71" HEIGHT="34" ACODE="INC_STK_KND">
<P USERMARK="F-GL11">보통주</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="82" HEIGHT="34" ACODE="INC_CNT">
<P USERMARK="F-GL11">200</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="75" HEIGHT="34" ACODE="INC_PAR_AMT">
<P USERMARK="F-GL11">500</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="88" HEIGHT="34" ACODE="INC_SL_AMT">
<P USERMARK="F-GL11">250,000</P>
</TE>
<TD VALIGN="MIDDLE" WIDTH="64" HEIGHT="34" ALIGN="CENTER">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="137" HEIGHT="34" AUNIT="INC_DT" AUNITVALUE="20141014">2014년 10월 14일</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="158" HEIGHT="34" AUNIT="INC_DR_KND" AUNITVALUE="04">유상증자(제3자배정)</TU>

<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="71" HEIGHT="34" ACODE="INC_STK_KND">
<P USERMARK="F-GL11">보통주</P>
</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="82" HEIGHT="34" ACODE="INC_CNT">711</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="75" HEIGHT="34" ACODE="INC_PAR_AMT">
<P USERMARK="F-GL11">500</P>
</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="88" HEIGHT="34" ACODE="INC_SL_AMT">250,096</TE>
<TD VALIGN="MIDDLE" WIDTH="64" HEIGHT="34" ALIGN="CENTER">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="137" HEIGHT="34" AUNIT="INC_DT" AUNITVALUE="20141024">2014년 10월 24일</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="158" HEIGHT="34" AUNIT="INC_DR_KND" AUNITVALUE="04">유상증자(제3자배정)</TU>

<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="71" HEIGHT="34" ACODE="INC_STK_KND">
<P USERMARK="F-GL11">보통주</P>
</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="82" HEIGHT="34" ACODE="INC_CNT">578</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="75" HEIGHT="34" ACODE="INC_PAR_AMT">
<P USERMARK="F-GL11">500</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="88" HEIGHT="34" ACODE="INC_SL_AMT">
<P USERMARK="F-GL11">249,856</P>
</TE>
<TD VALIGN="MIDDLE" WIDTH="64" HEIGHT="34" ALIGN="CENTER">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="137" HEIGHT="34" AUNIT="INC_DT" AUNITVALUE="20141120">2014년 11월 20일</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="158" HEIGHT="34" AUNIT="INC_DR_KND" AUNITVALUE="10">무상증자</TU>

<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="71" HEIGHT="34" ACODE="INC_STK_KND">
<P USERMARK="F-GL11">보통주</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="82" HEIGHT="34" ACODE="INC_CNT">
<P USERMARK="F-GL11">923,641</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="75" HEIGHT="34" ACODE="INC_PAR_AMT">
<P USERMARK="F-GL11">500</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="88" HEIGHT="34" ACODE="INC_SL_AMT">
<P USERMARK="F-GL11">500</P>
</TE>
<TD VALIGN="MIDDLE" WIDTH="64" HEIGHT="34" ALIGN="CENTER">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="137" HEIGHT="34" AUNIT="INC_DT" AUNITVALUE="20150127">2015년 01월 27일</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="158" HEIGHT="34" AUNIT="INC_DR_KND" AUNITVALUE="04">유상증자(제3자배정)</TU>

<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="71" HEIGHT="34" ACODE="INC_STK_KND">
<P USERMARK="F-GL11">보통주</P>
</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="82" HEIGHT="34" ACODE="INC_CNT">18,561</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="75" HEIGHT="34" ACODE="INC_PAR_AMT">
<P USERMARK="F-GL11">500</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="88" HEIGHT="34" ACODE="INC_SL_AMT">
<P USERMARK="F-GL11">15,000</P>
</TE>
<TD VALIGN="MIDDLE" WIDTH="64" HEIGHT="34" ALIGN="CENTER">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="137" HEIGHT="30" AUNIT="INC_DT" AUNITVALUE="20150203">2015년 02월 03일</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="158" HEIGHT="30" AUNIT="INC_DR_KND" AUNITVALUE="04">유상증자(제3자배정)</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="71" HEIGHT="30" ACODE="INC_STK_KND">보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="82" HEIGHT="30" ACODE="INC_CNT">200</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="75" HEIGHT="30" ACODE="INC_PAR_AMT">500</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="88" HEIGHT="30" ACODE="INC_SL_AMT">15,000</TE>
<TD VALIGN="MIDDLE" WIDTH="64" HEIGHT="30" ALIGN="CENTER">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="137" HEIGHT="30" AUNIT="INC_DT" AUNITVALUE="20150206">2015년 02월 06일</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="158" HEIGHT="30" AUNIT="INC_DR_KND" AUNITVALUE="04">유상증자(제3자배정)</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="71" HEIGHT="30" ACODE="INC_STK_KND">보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="82" HEIGHT="30" ACODE="INC_CNT">495,709</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="75" HEIGHT="30" ACODE="INC_PAR_AMT">500</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="88" HEIGHT="30" ACODE="INC_SL_AMT">500</TE>
<TD VALIGN="MIDDLE" WIDTH="64" HEIGHT="30" ALIGN="CENTER">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="137" HEIGHT="30" AUNIT="INC_DT" AUNITVALUE="20150228">2015년 02월 28일</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="158" HEIGHT="30" AUNIT="INC_DR_KND" AUNITVALUE="04">유상증자(제3자배정)</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="71" HEIGHT="30" ACODE="INC_STK_KND">우선주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="82" HEIGHT="30" ACODE="INC_CNT">200,000</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="75" HEIGHT="30" ACODE="INC_PAR_AMT">500</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="88" HEIGHT="30" ACODE="INC_SL_AMT">10,000</TE>
<TD VALIGN="MIDDLE" WIDTH="64" HEIGHT="30" ALIGN="CENTER">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="137" HEIGHT="30" AUNIT="INC_DT" AUNITVALUE="20150314">2015년 03월 14일</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="158" HEIGHT="30" AUNIT="INC_DR_KND" AUNITVALUE="04">유상증자(제3자배정)</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="71" HEIGHT="30" ACODE="INC_STK_KND">우선주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="82" HEIGHT="30" ACODE="INC_CNT">100,000</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="75" HEIGHT="30" ACODE="INC_PAR_AMT">500</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="88" HEIGHT="30" ACODE="INC_SL_AMT">10,000</TE>
<TD VALIGN="MIDDLE" WIDTH="64" HEIGHT="30" ALIGN="CENTER">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="137" HEIGHT="30" AUNIT="INC_DT" AUNITVALUE="20150512">2015년 05월 12일</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="158" HEIGHT="30" AUNIT="INC_DR_KND" AUNITVALUE="04">유상증자(제3자배정)</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="71" HEIGHT="30" ACODE="INC_STK_KND">보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="82" HEIGHT="30" ACODE="INC_CNT">100,000</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="75" HEIGHT="30" ACODE="INC_PAR_AMT">500</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="88" HEIGHT="30" ACODE="INC_SL_AMT">10,000</TE>
<TD VALIGN="MIDDLE" WIDTH="64" HEIGHT="30" ALIGN="CENTER">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="137" HEIGHT="30" AUNIT="INC_DT" AUNITVALUE="20150618">2015년 06월 18일</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="158" HEIGHT="30" AUNIT="INC_DR_KND" AUNITVALUE="04">유상증자(제3자배정)</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="71" HEIGHT="30" ACODE="INC_STK_KND">보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="82" HEIGHT="30" ACODE="INC_CNT">246,600</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="75" HEIGHT="30" ACODE="INC_PAR_AMT">500</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="88" HEIGHT="30" ACODE="INC_SL_AMT">15,000</TE>
<TD VALIGN="MIDDLE" WIDTH="64" HEIGHT="30" ALIGN="CENTER">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="137" HEIGHT="30" AUNIT="INC_DT" AUNITVALUE="20150618">2015년 06월 18일</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="158" HEIGHT="30" AUNIT="INC_DR_KND" AUNITVALUE="04">유상증자(제3자배정)</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="71" HEIGHT="30" ACODE="INC_STK_KND">우선주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="82" HEIGHT="30" ACODE="INC_CNT">200,100</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="75" HEIGHT="30" ACODE="INC_PAR_AMT">500</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="88" HEIGHT="30" ACODE="INC_SL_AMT">15,000</TE>
<TD VALIGN="MIDDLE" WIDTH="64" HEIGHT="30" ALIGN="CENTER">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="137" HEIGHT="30" AUNIT="INC_DT" AUNITVALUE="20161205">2016년 12월 05일</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="158" HEIGHT="30" AUNIT="INC_DR_KND" AUNITVALUE="04">유상증자(제3자배정)</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="71" HEIGHT="30" ACODE="INC_STK_KND">보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="82" HEIGHT="30" ACODE="INC_CNT">10,000</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="75" HEIGHT="30" ACODE="INC_PAR_AMT">500</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="88" HEIGHT="30" ACODE="INC_SL_AMT">20,000</TE>
<TD VALIGN="MIDDLE" WIDTH="64" HEIGHT="30" ALIGN="CENTER">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="137" HEIGHT="30" AUNIT="INC_DT" AUNITVALUE="20170713">2017년 07월 13일</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="158" HEIGHT="30" AUNIT="INC_DR_KND" AUNITVALUE="04">유상증자(제3자배정)</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="71" HEIGHT="30" ACODE="INC_STK_KND">우선주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="82" HEIGHT="30" ACODE="INC_CNT">63,500</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="75" HEIGHT="30" ACODE="INC_PAR_AMT">500</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="88" HEIGHT="30" ACODE="INC_SL_AMT">10,000</TE>
<TD VALIGN="MIDDLE" WIDTH="64" HEIGHT="30" ALIGN="CENTER">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="137" HEIGHT="30" AUNIT="INC_DT" AUNITVALUE="20180308">2018년 03월 08일</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="158" HEIGHT="30" AUNIT="INC_DR_KND" AUNITVALUE="04">유상증자(제3자배정)</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="71" HEIGHT="30" ACODE="INC_STK_KND">보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="82" HEIGHT="30" ACODE="INC_CNT">98,000</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="75" HEIGHT="30" ACODE="INC_PAR_AMT">500</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="88" HEIGHT="30" ACODE="INC_SL_AMT">10,000</TE>
<TD VALIGN="MIDDLE" WIDTH="64" HEIGHT="30" ALIGN="CENTER">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="137" HEIGHT="30" AUNIT="INC_DT" AUNITVALUE="20180308">2018년 03월 08일</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="158" HEIGHT="30" AUNIT="INC_DR_KND" AUNITVALUE="04">유상증자(제3자배정)</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="71" HEIGHT="30" ACODE="INC_STK_KND">우선주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="82" HEIGHT="30" ACODE="INC_CNT">45,000</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="75" HEIGHT="30" ACODE="INC_PAR_AMT">500</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="88" HEIGHT="30" ACODE="INC_SL_AMT">10,000</TE>
<TD VALIGN="MIDDLE" WIDTH="64" HEIGHT="30" ALIGN="CENTER">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="137" HEIGHT="30" AUNIT="INC_DT" AUNITVALUE="20181102">2018년 11월 02일</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="158" HEIGHT="30" AUNIT="INC_DR_KND" AUNITVALUE="04">유상증자(제3자배정)</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="71" HEIGHT="30" ACODE="INC_STK_KND">보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="82" HEIGHT="30" ACODE="INC_CNT">30,000</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="75" HEIGHT="30" ACODE="INC_PAR_AMT">500</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="88" HEIGHT="30" ACODE="INC_SL_AMT">10,000</TE>
<TD VALIGN="MIDDLE" WIDTH="64" HEIGHT="30" ALIGN="CENTER">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="137" HEIGHT="30" AUNIT="INC_DT" AUNITVALUE="20181102">2018년 11월 02일</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="158" HEIGHT="30" AUNIT="INC_DR_KND" AUNITVALUE="04">유상증자(제3자배정)</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="71" HEIGHT="30" ACODE="INC_STK_KND">우선주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="82" HEIGHT="30" ACODE="INC_CNT">5,000</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="75" HEIGHT="30" ACODE="INC_PAR_AMT">500</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="88" HEIGHT="30" ACODE="INC_SL_AMT">10,000</TE>
<TD VALIGN="MIDDLE" WIDTH="64" HEIGHT="30" ALIGN="CENTER">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="137" HEIGHT="30" AUNIT="INC_DT" AUNITVALUE="20191128">2019년 11월 28일</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="158" HEIGHT="30" AUNIT="INC_DR_KND" AUNITVALUE="04">유상증자(제3자배정)</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="71" HEIGHT="30" ACODE="INC_STK_KND">보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="82" HEIGHT="30" ACODE="INC_CNT">20,000</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="75" HEIGHT="30" ACODE="INC_PAR_AMT">500</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="88" HEIGHT="30" ACODE="INC_SL_AMT">11,000</TE>
<TD VALIGN="MIDDLE" WIDTH="64" HEIGHT="30" ALIGN="CENTER">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="137" HEIGHT="30" AUNIT="INC_DT" AUNITVALUE="20200103">2020년 01월 03일</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="158" HEIGHT="30" AUNIT="INC_DR_KND" AUNITVALUE="09">출자전환</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="71" HEIGHT="30" ACODE="INC_STK_KND">보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="82" HEIGHT="30" ACODE="INC_CNT">80,000</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="75" HEIGHT="30" ACODE="INC_PAR_AMT">500</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="88" HEIGHT="30" ACODE="INC_SL_AMT">11,000</TE>
<TD VALIGN="MIDDLE" WIDTH="64" HEIGHT="30" ALIGN="CENTER">예수금</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="137" HEIGHT="30" AUNIT="INC_DT" AUNITVALUE="20200207">2020년 02월 07일</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="158" HEIGHT="30" AUNIT="INC_DR_KND" AUNITVALUE="04">유상증자(제3자배정)</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="71" HEIGHT="30" ACODE="INC_STK_KND">보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="82" HEIGHT="30" ACODE="INC_CNT">72,000</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="75" HEIGHT="30" ACODE="INC_PAR_AMT">500</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="88" HEIGHT="30" ACODE="INC_SL_AMT">11,000</TE>
<TD VALIGN="MIDDLE" WIDTH="64" HEIGHT="30" ALIGN="CENTER">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="137" HEIGHT="53" AUNIT="INC_DT" AUNITVALUE="20200304">2020년 03월 04일</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="158" HEIGHT="53" AUNIT="INC_DR_KND" AUNITVALUE="09">출자전환</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="71" HEIGHT="53" ACODE="INC_STK_KND">보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="82" HEIGHT="53" ACODE="INC_CNT">202,050</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="75" HEIGHT="53" ACODE="INC_PAR_AMT">500</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="88" HEIGHT="53" ACODE="INC_SL_AMT">11,000</TE>
<TD VALIGN="MIDDLE" WIDTH="64" HEIGHT="53" ALIGN="CENTER">미지급금</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="137" HEIGHT="30" AUNIT="INC_DT" AUNITVALUE="20201016">2020년 10월 16일</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="158" HEIGHT="30" AUNIT="INC_DR_KND" AUNITVALUE="05">전환권행사</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="71" HEIGHT="30" ACODE="INC_STK_KND">보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="82" HEIGHT="30" ACODE="INC_CNT">45,000</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="75" HEIGHT="30" ACODE="INC_PAR_AMT">500</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="88" HEIGHT="30" ACODE="INC_SL_AMT">10,000</TE>
<TD VALIGN="MIDDLE" WIDTH="64" HEIGHT="30" ALIGN="CENTER">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="137" HEIGHT="30" AUNIT="INC_DT" AUNITVALUE="20201204">2020년 12월 04일</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="158" HEIGHT="30" AUNIT="INC_DR_KND" AUNITVALUE="04">유상증자(제3자배정)</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="71" HEIGHT="30" ACODE="INC_STK_KND">우선주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="82" HEIGHT="30" ACODE="INC_CNT">100,000</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="75" HEIGHT="30" ACODE="INC_PAR_AMT">500</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="88" HEIGHT="30" ACODE="INC_SL_AMT">11,000</TE>
<TD VALIGN="MIDDLE" WIDTH="64" HEIGHT="30" ALIGN="CENTER">-</TD>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P></P>

<INSERTION ABASISNUMBER="SE1" AFREQUENCY="1" ADUPLICATION="N">
<COMMENT>◆click◆ 『미상환 전환사채 발행현황』 삽입</COMMENT>
<LIBRARYLIST>11011#*미상환전환사채발행현황.dsl</LIBRARYLIST>

<LIBRARY>
<FILENAME ATYPE="dsl">2_미상환전환사채발행현황</FILENAME>

<TABLE-GROUP ACLASS="CB" ADELETETABLE="N">
<TITLE ATOC="N">미상환 전환사채 발행현황</TITLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="685" BORDER="0">

<COLGROUP>
<COL WIDTH="70"></COL>
<COL WIDTH="142"></COL>
<COL WIDTH="58"></COL>
<COL WIDTH="379"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="79" HEIGHT="30" AUPDATECONT="N">(기준일 : </TD>
<TU ALIGN="CENTER" VALIGN="BOTTOM" WIDTH="151" HEIGHT="30" AUNIT="BASE_DT" AUNITVALUE="20201231">2020년 12월 31일</TU>
<TD VALIGN="BOTTOM" WIDTH="67" HEIGHT="30" AUPDATECONT="N">)</TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="388" HEIGHT="30" AUNIT="WONSTOCK" AUNITVALUE="1">(단위 : 원, 주)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="1066" BORDER="1">

<COLGROUP>
<COL WIDTH="83"></COL>
<COL WIDTH="39"></COL>
<COL WIDTH="88"></COL>
<COL WIDTH="87"></COL>
<COL WIDTH="113"></COL>
<COL WIDTH="99"></COL>
<COL WIDTH="86"></COL>
<COL WIDTH="41"></COL>
<COL WIDTH="99"></COL>
<COL WIDTH="111"></COL>
<COL WIDTH="74"></COL>
<COL WIDTH="38"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="N" ADELETE="N">
<TH WIDTH="92" HEIGHT="106" ROWSPAN="2" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" VALIGN="MIDDLE" ALIGN="CENTER">종류＼구분</TH>
<TH WIDTH="48" HEIGHT="106" ROWSPAN="2" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" VALIGN="MIDDLE" ALIGN="CENTER">회차</TH>
<TH WIDTH="97" HEIGHT="106" ROWSPAN="2" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" VALIGN="MIDDLE" ALIGN="CENTER">발행일</TH>
<TH WIDTH="96" HEIGHT="106" ROWSPAN="2" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" VALIGN="MIDDLE" ALIGN="CENTER">만기일</TH>
<TH WIDTH="122" HEIGHT="106" ROWSPAN="2" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" VALIGN="MIDDLE" ALIGN="CENTER">권면(전자등록)총액</TH>
<TH WIDTH="108" HEIGHT="106" ROWSPAN="2" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" VALIGN="MIDDLE" ALIGN="CENTER">전환대상&cr;주식의 종류</TH>
<TH WIDTH="95" HEIGHT="106" ROWSPAN="2" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" VALIGN="MIDDLE" ALIGN="CENTER">전환청구가능기간</TH>
<TH WIDTH="158" HEIGHT="30" COLSPAN="2" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" VALIGN="MIDDLE" ALIGN="CENTER">전환조건</TH>
<TH WIDTH="203" HEIGHT="30" COLSPAN="2" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" VALIGN="MIDDLE" ALIGN="CENTER">미상환사채</TH>
<TH WIDTH="47" HEIGHT="106" ROWSPAN="2" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" VALIGN="MIDDLE" ALIGN="CENTER">비고</TH>
</TR>

<TR ACOPY="N" ADELETE="N">
<TH WIDTH="50" HEIGHT="76" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" VALIGN="MIDDLE" ALIGN="CENTER">전환비율&cr;(%)</TH>
<TH WIDTH="108" HEIGHT="76" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" VALIGN="MIDDLE" ALIGN="CENTER">전환가액</TH>
<TH WIDTH="120" HEIGHT="76" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" VALIGN="MIDDLE" ALIGN="CENTER">권면(전자등록)총액</TH>
<TH WIDTH="83" HEIGHT="76" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" VALIGN="MIDDLE" ALIGN="CENTER">전환가능주식수</TH>
</TR>
</THEAD>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="N">
<TE WIDTH="92" HEIGHT="53" ACODE="CB_KND" ALIGN="CENTER" VALIGN="MIDDLE">전환사채</TE>
<TE WIDTH="48" HEIGHT="53" ACODE="CB_SEQ" ALIGN="CENTER" VALIGN="MIDDLE">1</TE>
<TU WIDTH="97" HEIGHT="53" AUNIT="CB_DT" AUNITVALUE="20190322" ALIGN="CENTER" VALIGN="MIDDLE">2019년 03월 22일</TU>
<TU WIDTH="96" HEIGHT="53" AUNIT="CB_FDT" AUNITVALUE="20220322" ALIGN="CENTER" VALIGN="MIDDLE">2022년 03월 22일</TU>
<TE WIDTH="122" HEIGHT="53" ACODE="CB_EN" ALIGN="RIGHT" VALIGN="MIDDLE">1,000,000,000</TE>
<TE WIDTH="108" HEIGHT="53" ACODE="CB_KN" ALIGN="CENTER" VALIGN="MIDDLE">보통주</TE>
<TE WIDTH="95" HEIGHT="53" ACODE="CB_PE" ALIGN="CENTER" VALIGN="MIDDLE">2021년 03월 22일</TE>
<TE WIDTH="50" HEIGHT="53" ACODE="CB_RAT" ALIGN="RIGHT" VALIGN="MIDDLE">100</TE>
<TE WIDTH="108" HEIGHT="53" ACODE="CB_PR" ALIGN="RIGHT" VALIGN="MIDDLE">10,000</TE>
<TE WIDTH="120" HEIGHT="53" ACODE="CB_AMN" ALIGN="RIGHT" VALIGN="MIDDLE">1,000,000,000</TE>
<TE WIDTH="83" HEIGHT="53" ACODE="CB_CN" ALIGN="RIGHT" VALIGN="MIDDLE">100,000</TE>
<TE WIDTH="47" HEIGHT="53" ACODE="NOTE" ALIGN="CENTER" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="92" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" AUPDATECONT="N">합 계</TD>
<TD WIDTH="48" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" AUPDATECONT="N">-</TD>
<TD WIDTH="97" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" AUPDATECONT="N">-</TD>
<TD WIDTH="96" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" AUPDATECONT="N">-</TD>
<TE WIDTH="122" HEIGHT="30" ACODE="CB_ENT" ALIGN="RIGHT" VALIGN="MIDDLE">1,000,000,000</TE>
<TE WIDTH="108" HEIGHT="30" ACODE="CB_KNT" ALIGN="CENTER" VALIGN="MIDDLE">-</TE>
<TD WIDTH="95" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" AUPDATECONT="N">-</TD>
<TE WIDTH="50" HEIGHT="30" ACODE="CB_RATT" ALIGN="RIGHT" VALIGN="MIDDLE">100</TE>
<TE WIDTH="108" HEIGHT="30" ACODE="CB_PRT" ALIGN="RIGHT" VALIGN="MIDDLE">10,000</TE>
<TE WIDTH="120" HEIGHT="30" ACODE="CB_AMNT" ALIGN="RIGHT" VALIGN="MIDDLE">1,000,000,000</TE>
<TE WIDTH="83" HEIGHT="30" ACODE="CB_CNT" ALIGN="RIGHT" VALIGN="MIDDLE">100,000</TE>
<TE WIDTH="47" HEIGHT="30" ACODE="NOTET" ALIGN="CENTER" VALIGN="MIDDLE">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>

<P>(*) 제1회 전환사채에 대한 채권자의 조기상환청구권에 대한 조건은 2021년 2월 중에 삭제하였습니다.&cr;
<SPAN>(*) 제2회 전환사채는 2020년 10월 16일 전환청구 되었습니다.</SPAN>
</P>
</LIBRARY>
</INSERTION>
<P></P>

<INSERTION ABASISNUMBER="SE1" AFREQUENCY="0" ADUPLICATION="N">
<COMMENT>◆click◆ 『미상환 신주인수권부사채 등 발행현황』 삽입</COMMENT>
<LIBRARYLIST>11011#*미상환신주인수권부사채등발행현황.dsl</LIBRARYLIST>
</INSERTION>
<P></P>

<INSERTION ABASISNUMBER="SE1" AFREQUENCY="0" ADUPLICATION="N">
<COMMENT>◆click◆ 『미상환 전환형 조건부자본증권 등 발행현황』 삽입</COMMENT>
<LIBRARYLIST>11011#*미상환전환형조건부자본증권등발행현황.dsl</LIBRARYLIST>
</INSERTION>
<P></P>
<P></P>
</SECTION-2>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-0-1-4-0">4. 주식의 총수 등</TITLE>

<P>&cr;
<SPAN USERMARK=" B">가. 주식의 총수</SPAN>
</P>

<TABLE-GROUP ACLASS="TOT_STK" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="663" BORDER="0">

<COLGROUP>
<COL WIDTH="71"></COL>
<COL WIDTH="143"></COL>
<COL WIDTH="97"></COL>
<COL WIDTH="316"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="80" HEIGHT="30" AUPDATECONT="N">(기준일 : </TD>
<TU ALIGN="CENTER" VALIGN="BOTTOM" WIDTH="152" HEIGHT="30" AUNIT="BASE_DT" AUNITVALUE="20201231">2020년 12월 31일</TU>
<TD VALIGN="BOTTOM" WIDTH="106" HEIGHT="30" AUPDATECONT="N">)</TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="325" HEIGHT="30" AUNIT="STOCK" AUNITVALUE="1">(단위 : 주)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="665" BORDER="1">

<COLGROUP>
<COL WIDTH="25"></COL>
<COL WIDTH="204"></COL>
<COL WIDTH="96"></COL>
<COL WIDTH="96"></COL>
<COL WIDTH="95"></COL>
<COL WIDTH="95"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="N" ADELETE="N">
<TH ROWSPAN="2" COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="247" HEIGHT="60" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">구  분</TH>
<TH COLSPAN="3" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="314" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" AUPDATECONT="N">주식의 종류</TH>
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="104" HEIGHT="60" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">비고</TH>
</TR>

<TR ACOPY="N" ADELETE="N">
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="105" HEIGHT="30" ACOPYCOL="N" ACODE="STK_KND_TOT" ADELETECOL="N" AMOVECOL="N">보통주</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="105" HEIGHT="30" ACOPYCOL="Y" ACODE="STK_KND_TOT" ADELETECOL="Y" AMOVECOL="N">종류주식</TE>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="104" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">합계</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD COLSPAN="2" VALIGN="MIDDLE" WIDTH="247" HEIGHT="30" AUPDATECONT="N"> Ⅰ. 발행할 주식의 총수</TD>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="105" HEIGHT="30" ACODE="ISU_STK1">88,000,000</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="105" HEIGHT="30" ACODE="ISU_STK1">2,000,000</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="104" HEIGHT="30" ACODE="SUM_ISU_STK1">90,000,000</TE>
<TE VALIGN="MIDDLE" WIDTH="104" HEIGHT="30" ALIGN="CENTER" ACODE="NOTE">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD COLSPAN="2" VALIGN="MIDDLE" WIDTH="247" HEIGHT="30" AUPDATECONT="N"> Ⅱ. 현재까지 발행한 주식의 총수</TD>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="105" HEIGHT="30" ACODE="ISU_STK2">2,867,050</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="105" HEIGHT="30" ACODE="ISU_STK2">713,600</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="104" HEIGHT="30" ACODE="SUM_ISU_STK2">3,580,650</TE>
<TE VALIGN="MIDDLE" WIDTH="104" HEIGHT="30" ALIGN="CENTER" ACODE="NOTE1">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD COLSPAN="2" VALIGN="MIDDLE" WIDTH="247" HEIGHT="30" AUPDATECONT="N"> Ⅲ. 현재까지 감소한 주식의 총수</TD>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="105" HEIGHT="30" ACODE="TOT_RST">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="105" HEIGHT="30" ACODE="TOT_RST">446,600</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="104" HEIGHT="30" ACODE="SUM_RST">446,600</TE>
<TE VALIGN="MIDDLE" WIDTH="104" HEIGHT="30" ALIGN="CENTER" ACODE="NOTE2">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD ROWSPAN="4" VALIGN="MIDDLE" WIDTH="34" HEIGHT="120" AUPDATECONT="N"></TD>
<TD VALIGN="MIDDLE" WIDTH="213" HEIGHT="30" AUPDATECONT="N"> 1. 감자</TD>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="105" HEIGHT="30" ACODE="RDC_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="105" HEIGHT="30" ACODE="RDC_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="104" HEIGHT="30" ACODE="SUM_RDC_CNT">-</TE>
<TE VALIGN="MIDDLE" WIDTH="104" HEIGHT="30" ALIGN="CENTER" ACODE="NOTE3">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="MIDDLE" WIDTH="213" HEIGHT="30" AUPDATECONT="N"> 2. 이익소각</TD>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="105" HEIGHT="30" ACODE="DST_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="105" HEIGHT="30" ACODE="DST_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="104" HEIGHT="30" ACODE="SUM_DST_CNT">-</TE>
<TE VALIGN="MIDDLE" WIDTH="104" HEIGHT="30" ALIGN="CENTER" ACODE="NOTE4">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="MIDDLE" WIDTH="213" HEIGHT="30" AUPDATECONT="N"> 3. 상환주식의 상환</TD>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="105" HEIGHT="30" ACODE="RFD_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="105" HEIGHT="30" ACODE="RFD_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="104" HEIGHT="30" ACODE="SUM_RFD_CNT">-</TE>
<TE VALIGN="MIDDLE" WIDTH="104" HEIGHT="30" ALIGN="CENTER" ACODE="NOTE5">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="MIDDLE" WIDTH="213" HEIGHT="30" AUPDATECONT="N"> 4. 기타</TD>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="105" HEIGHT="30" ACODE="ETC_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="105" HEIGHT="30" ACODE="ETC_CNT">446,600</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="104" HEIGHT="30" ACODE="SUM_ETC_CNT">446,600</TE>
<TE VALIGN="MIDDLE" WIDTH="104" HEIGHT="30" ALIGN="CENTER" ACODE="NOTE6">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD COLSPAN="2" VALIGN="MIDDLE" WIDTH="247" HEIGHT="30" AUPDATECONT="N"> Ⅳ. 발행주식의 총수 (Ⅱ-Ⅲ)</TD>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="105" HEIGHT="30" ACODE="ISU_STK3">2,867,050</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="105" HEIGHT="30" ACODE="ISU_STK3">267,000</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="104" HEIGHT="30" ACODE="SUM_ISU_STK3">3,134,050</TE>
<TE VALIGN="MIDDLE" WIDTH="104" HEIGHT="30" ALIGN="CENTER" ACODE="NOTE7">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD COLSPAN="2" VALIGN="MIDDLE" WIDTH="247" HEIGHT="30" AUPDATECONT="N"> Ⅴ. 자기주식수</TD>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="105" HEIGHT="30" ACODE="TRS_STK">92,134</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="105" HEIGHT="30" ACODE="TRS_STK">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="104" HEIGHT="30" ACODE="SUM_TRS_STK">92,134</TE>
<TE VALIGN="MIDDLE" WIDTH="104" HEIGHT="30" ALIGN="CENTER" ACODE="NOTE8">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD COLSPAN="2" VALIGN="MIDDLE" WIDTH="247" HEIGHT="30" AUPDATECONT="N"> Ⅵ. 유통주식수 (Ⅳ-Ⅴ)</TD>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="105" HEIGHT="30" ACODE="FLT_STK">2,774,916</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="105" HEIGHT="30" ACODE="FLT_STK">267,000</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="104" HEIGHT="30" ACODE="SUM_FLT_STK">3,041,916</TE>
<TE VALIGN="MIDDLE" WIDTH="104" HEIGHT="30" ALIGN="CENTER" ACODE="NOTE9">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P></P>

<INSERTION ABASISNUMBER="SE1" AFREQUENCY="1" ADUPLICATION="N">
<COMMENT>◆click◆ 『자기주식 취득 및 처분 현황』 삽입</COMMENT>
<LIBRARYLIST>11011#*자기주식취득및처분현황.dsl</LIBRARYLIST>

<LIBRARY>
<FILENAME ATYPE="dsl">5_자기주식취득및처분현황</FILENAME>
<P USERMARK=" B">나. 자기주식 취득 및 처분현황</P>

<TABLE-GROUP ACLASS="OWN_SHR" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="766" BORDER="0">

<COLGROUP>
<COL WIDTH="71"></COL>
<COL WIDTH="143"></COL>
<COL WIDTH="139"></COL>
<COL WIDTH="377"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="80" HEIGHT="30" AUPDATECONT="N">(기준일 : </TD>
<TU ALIGN="CENTER" VALIGN="BOTTOM" WIDTH="152" HEIGHT="30" AUNIT="BASE_DT" AUNITVALUE="20201231">2020년 12월 31일</TU>
<TD VALIGN="BOTTOM" WIDTH="148" HEIGHT="30" AUPDATECONT="N">)</TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="386" HEIGHT="30" AUNIT="STOCK" AUNITVALUE="1">(단위 : 주)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="767" BORDER="1">

<COLGROUP>
<COL WIDTH="53"></COL>
<COL WIDTH="49"></COL>
<COL WIDTH="114"></COL>
<COL WIDTH="90"></COL>
<COL WIDTH="62"></COL>
<COL WIDTH="64"></COL>
<COL WIDTH="65"></COL>
<COL WIDTH="63"></COL>
<COL WIDTH="60"></COL>
<COL WIDTH="57"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="243" HEIGHT="60" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="2" COLSPAN="3">취득방법</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="99" HEIGHT="60" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="2">주식의 종류</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="71" HEIGHT="60" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="2">기초수량</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="219" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" COLSPAN="3">변동 수량</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="69" HEIGHT="60" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="2">기말수량</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="66" HEIGHT="60" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="2">비고</TH>
</TR>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="73" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">취득(+)</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="74" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">처분(-)</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="72" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">소각(-)</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD ROWSPAN="14" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="62" HEIGHT="420" AUPDATECONT="N">배당&cr;가능&cr;이익&cr;범위&cr;이내&cr;취득</TD>
<TD ROWSPAN="8" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="58" HEIGHT="240" AUPDATECONT="N">직접&cr;취득</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="123" HEIGHT="60" AUPDATECONT="N" ROWSPAN="2">장내 &cr;직접 취득</TD>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="99" HEIGHT="30" ACODE="AJ_STK_KND">보통주식</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="71" HEIGHT="30" ACODE="AJ_STK_BGN">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="73" HEIGHT="30" ACODE="AJ_STK_ACQ">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="74" HEIGHT="30" ACODE="AJ_STK_TRD">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="72" HEIGHT="30" ACODE="AJ_STK_RTM">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="69" HEIGHT="30" ACODE="AJ_STK_END">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="66" HEIGHT="30" ACODE="OWN_NOTE">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="N">
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="99" HEIGHT="30" ACODE="AJ_STK_KND">기타주식</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="71" HEIGHT="30" ACODE="AJ_STK_BGN">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="73" HEIGHT="30" ACODE="AJ_STK_ACQ">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="74" HEIGHT="30" ACODE="AJ_STK_TRD">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="72" HEIGHT="30" ACODE="AJ_STK_RTM">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="69" HEIGHT="30" ACODE="AJ_STK_END">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="66" HEIGHT="30" ACODE="OWN_NOTE">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="123" HEIGHT="60" AUPDATECONT="N" ROWSPAN="2">장외&cr;직접 취득</TD>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="99" HEIGHT="30" ACODE="AO_STK_KND">보통주식</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="71" HEIGHT="30" ACODE="AO_STK_BGN">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="73" HEIGHT="30" ACODE="AO_STK_ACQ">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="74" HEIGHT="30" ACODE="AO_STK_TRD">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="72" HEIGHT="30" ACODE="AO_STK_RTM">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="69" HEIGHT="30" ACODE="AO_STK_END">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="66" HEIGHT="30" ACODE="OWN_NOTE9">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="N">
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="99" HEIGHT="30" ACODE="AO_STK_KND">기타주식</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="71" HEIGHT="30" ACODE="AO_STK_BGN">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="73" HEIGHT="30" ACODE="AO_STK_ACQ">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="74" HEIGHT="30" ACODE="AO_STK_TRD">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="72" HEIGHT="30" ACODE="AO_STK_RTM">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="69" HEIGHT="30" ACODE="AO_STK_END">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="66" HEIGHT="30" ACODE="OWN_NOTE9">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="123" HEIGHT="60" AUPDATECONT="N" ROWSPAN="2">공개매수</TD>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="99" HEIGHT="30" ACODE="AK_STK_KND">보통주식</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="71" HEIGHT="30" ACODE="AK_STK_BGN">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="73" HEIGHT="30" ACODE="AK_STK_ACQ">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="74" HEIGHT="30" ACODE="AK_STK_TRD">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="72" HEIGHT="30" ACODE="AK_STK_RTM">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="69" HEIGHT="30" ACODE="AK_STK_END">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="66" HEIGHT="30" ACODE="OWN_NOTE1">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="N">
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="99" HEIGHT="30" ACODE="AK_STK_KND">기타주식</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="71" HEIGHT="30" ACODE="AK_STK_BGN">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="73" HEIGHT="30" ACODE="AK_STK_ACQ">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="74" HEIGHT="30" ACODE="AK_STK_TRD">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="72" HEIGHT="30" ACODE="AK_STK_RTM">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="69" HEIGHT="30" ACODE="AK_STK_END">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="66" HEIGHT="30" ACODE="OWN_NOTE1">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="123" HEIGHT="60" AUPDATECONT="N" ROWSPAN="2">소계(a)</TD>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="99" HEIGHT="30" ACODE="ASUM_STK_KND">보통주식</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="71" HEIGHT="30" ACODE="ASUM_STK_BGN">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="73" HEIGHT="30" ACODE="ASUM_STK_ACQ">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="74" HEIGHT="30" ACODE="ASUM_STK_TRD">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="72" HEIGHT="30" ACODE="ASUM_STK_RTM">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="69" HEIGHT="30" ACODE="ASUM_STK_END">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="66" HEIGHT="30" ACODE="OWN_NOTE3">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="N">
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="99" HEIGHT="30" ACODE="ASUM_STK_KND">기타주식</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="71" HEIGHT="30" ACODE="ASUM_STK_BGN">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="73" HEIGHT="30" ACODE="ASUM_STK_ACQ">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="74" HEIGHT="30" ACODE="ASUM_STK_TRD">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="72" HEIGHT="30" ACODE="ASUM_STK_RTM">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="69" HEIGHT="30" ACODE="ASUM_STK_END">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="66" HEIGHT="30" ACODE="OWN_NOTE3">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD ROWSPAN="6" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="58" HEIGHT="180" AUPDATECONT="N">신탁&cr;계약에 의한&cr;취득</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="123" HEIGHT="60" AUPDATECONT="N" ROWSPAN="2">수탁자 보유물량</TD>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="99" HEIGHT="30" ACODE="BS_STK_KND">보통주식</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="71" HEIGHT="30" ACODE="BS_STK_BGN">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="73" HEIGHT="30" ACODE="BS_STK_ACQ">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="74" HEIGHT="30" ACODE="BS_STK_TRD">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="72" HEIGHT="30" ACODE="BS_STK_RTM">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="69" HEIGHT="30" ACODE="BS_STK_END">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="66" HEIGHT="30" ACODE="OWN_NOTE4">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="N">
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="99" HEIGHT="30" ACODE="BS_STK_KND">기타주식</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="71" HEIGHT="30" ACODE="BS_STK_BGN">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="73" HEIGHT="30" ACODE="BS_STK_ACQ">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="74" HEIGHT="30" ACODE="BS_STK_TRD">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="72" HEIGHT="30" ACODE="BS_STK_RTM">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="69" HEIGHT="30" ACODE="BS_STK_END">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="66" HEIGHT="30" ACODE="OWN_NOTE4">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="123" HEIGHT="60" AUPDATECONT="N" ROWSPAN="2">현물보유물량</TD>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="99" HEIGHT="30" ACODE="BH_STK_KND">보통주식</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="71" HEIGHT="30" ACODE="BH_STK_BGN">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="73" HEIGHT="30" ACODE="BH_STK_ACQ">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="74" HEIGHT="30" ACODE="BH_STK_TRD">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="72" HEIGHT="30" ACODE="BH_STK_RTM">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="69" HEIGHT="30" ACODE="BH_STK_END">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="66" HEIGHT="30" ACODE="OWN_NOTE5">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="N">
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="99" HEIGHT="30" ACODE="BH_STK_KND">기타주식</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="71" HEIGHT="30" ACODE="BH_STK_BGN">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="73" HEIGHT="30" ACODE="BH_STK_ACQ">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="74" HEIGHT="30" ACODE="BH_STK_TRD">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="72" HEIGHT="30" ACODE="BH_STK_RTM">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="69" HEIGHT="30" ACODE="BH_STK_END">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="66" HEIGHT="30" ACODE="OWN_NOTE5">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="123" HEIGHT="60" AUPDATECONT="N" ROWSPAN="2">소계(b)</TD>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="99" HEIGHT="30" ACODE="BSUM_STK_KND">보통주식</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="71" HEIGHT="30" ACODE="BSUM_STK_BGN">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="73" HEIGHT="30" ACODE="BSUM_STK_ACQ">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="74" HEIGHT="30" ACODE="BSUM_STK_TRD">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="72" HEIGHT="30" ACODE="BSUM_STK_RTM">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="69" HEIGHT="30" ACODE="BSUM_STK_END">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="66" HEIGHT="30" ACODE="OWN_NOTE6">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="N">
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="99" HEIGHT="30" ACODE="BSUM_STK_KND">기타주식</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="71" HEIGHT="30" ACODE="BSUM_STK_BGN">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="73" HEIGHT="30" ACODE="BSUM_STK_ACQ">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="74" HEIGHT="30" ACODE="BSUM_STK_TRD">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="72" HEIGHT="30" ACODE="BSUM_STK_RTM">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="69" HEIGHT="30" ACODE="BSUM_STK_END">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="66" HEIGHT="30" ACODE="OWN_NOTE6">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="243" HEIGHT="60" AUPDATECONT="N" COLSPAN="3">기타 취득(c)</TD>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="99" HEIGHT="30" ACODE="ETC_STK_KND">보통주식</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="71" HEIGHT="30" ACODE="ETC_STK_BGN">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="73" HEIGHT="30" ACODE="ETC_STK_ACQ"> 92,134</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="74" HEIGHT="30" ACODE="ETC_STK_TRD">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="72" HEIGHT="30" ACODE="ETC_STK_RTM">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="69" HEIGHT="30" ACODE="ETC_STK_END"> 92,134</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="66" HEIGHT="30" ACODE="OWN_NOTE7">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="N">
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="99" HEIGHT="30" ACODE="ETC_STK_KND">기타주식</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="71" HEIGHT="30" ACODE="ETC_STK_BGN">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="73" HEIGHT="30" ACODE="ETC_STK_ACQ">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="74" HEIGHT="30" ACODE="ETC_STK_TRD">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="72" HEIGHT="30" ACODE="ETC_STK_RTM">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="69" HEIGHT="30" ACODE="ETC_STK_END">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="66" HEIGHT="30" ACODE="OWN_NOTE7">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="243" HEIGHT="60" AUPDATECONT="N" COLSPAN="3">총 계(a+b+c)</TD>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="99" HEIGHT="30" ACODE="TOT_STK_KND">보통주식</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="71" HEIGHT="30" ACODE="TOT_STK_BGN">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="73" HEIGHT="30" ACODE="TOT_STK_ACQ"> 92,134</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="74" HEIGHT="30" ACODE="TOT_STK_TRD">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="72" HEIGHT="30" ACODE="TOT_STK_RTM">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="69" HEIGHT="30" ACODE="TOT_STK_END"> 92,134</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="66" HEIGHT="30" ACODE="OWN_NOTE8">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="N">
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="99" HEIGHT="30" ACODE="TOT_STK_KND">기타주식</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="71" HEIGHT="30" ACODE="TOT_STK_BGN">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="73" HEIGHT="30" ACODE="TOT_STK_ACQ">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="74" HEIGHT="30" ACODE="TOT_STK_TRD">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="72" HEIGHT="30" ACODE="TOT_STK_RTM">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="69" HEIGHT="30" ACODE="TOT_STK_END">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="66" HEIGHT="30" ACODE="OWN_NOTE8">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P>주) 최대주주인 김앤토니경태 대표이사가 보통주 주권 92,134주를 자기주식으로 무상증여했습니다. &cr;</P>
</LIBRARY>
</INSERTION>

<INSERTION ABASISNUMBER="LE0" AFREQUENCY="1" ADUPLICATION="Y">
<COMMENT>◆click◆ 『종류주식(명칭) 발행현황』 삽입</COMMENT>
<LIBRARYLIST>11011#*종류주식발행현황.dsl</LIBRARYLIST>

<LIBRARY>
<FILENAME ATYPE="dsl">24_종류주식발행현황</FILENAME>

<P>
<SPAN USERMARK=" B">다. 종류주식 발행현황</SPAN>
</P>

<TABLE-GROUP ACLASS="ISS_CURR" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="622" BORDER="0">

<COLGROUP>
<COL WIDTH="281"></COL>
<COL WIDTH="323"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="290" HEIGHT="30" AUPDATECONT="N"></TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="332" HEIGHT="30" AUNIT="WON" AUNITVALUE="1">(단위 : 원)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="622" BORDER="1">

<COLGROUP>
<COL WIDTH="63"></COL>
<COL WIDTH="76"></COL>
<COL WIDTH="123"></COL>
<COL WIDTH="158"></COL>
<COL WIDTH="157"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="289" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" COLSPAN="3" AUPDATECONT="N">발행일자</TD>
<TU WIDTH="333" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUNIT="ISS_DATE" AUNITVALUE="20150314" COLSPAN="2">2015년 03월 14일</TU>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="289" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" COLSPAN="3" AUPDATECONT="N">주당 발행가액(액면가액)</TD>
<TE WIDTH="167" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="ISS_PRC">10,000</TE>
<TE WIDTH="166" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="ISS_PRCK">500</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="289" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" COLSPAN="3" AUPDATECONT="N">발행총액(발행주식수)</TD>
<TE WIDTH="167" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="ISS_TOT">1,000,000,000</TE>
<TE WIDTH="166" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="ISS_TOTK">100,000</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="289" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" COLSPAN="3" AUPDATECONT="N">현재 잔액(현재 주식수)</TD>
<TE WIDTH="167" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="ISS_PNT">1,000,000,000</TE>
<TE WIDTH="166" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="ISS_PNTK">100,000</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="72" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="814" ROWSPAN="12" AUPDATECONT="N">주식의&cr;내용</TD>
<TD WIDTH="217" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" COLSPAN="2" AUPDATECONT="N">이익배당에 관한 사항</TD>
<TE WIDTH="333" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="STK_BET" COLSPAN="2">참가적, 누적적 우선주(배당률 : 0%)</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="217" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" COLSPAN="2" AUPDATECONT="N">잔여재산분배에 관한 사항</TD>
<TE WIDTH="333" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACODE="STK_PRO" COLSPAN="2">잔여재산분배에 있어 보통주에 대해 우선권이 있음</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="85" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="350" ROWSPAN="5" AUPDATECONT="N">상환에&cr;관한 사항</TD>
<TD WIDTH="132" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="115" AUPDATECONT="N">상환조건</TD>

<TE WIDTH="333" VALIGN="MIDDLE" HEIGHT="115" ACODE="STK_REP" COLSPAN="2">
<P USERMARK="F-GL11">상환은 배당 가능한 이익이 있을 때에만 가능</P>
<P USERMARK="F-GL11">배당가능이익이 있음에도 불구하고 상환의무를 이행하지 아니한 경우 상환가액에 대하여 17%의 이율에 의한 지연배상금을 가산</P>
</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="132" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" AUPDATECONT="N">상환방법</TD>
<TE WIDTH="333" VALIGN="MIDDLE" HEIGHT="53" ACODE="STK_WAY" COLSPAN="2">상환청구가 있는 날로부터 1개월 이내에 현금으로 상환</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="132" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="99" AUPDATECONT="N">상환기간</TD>
<TE WIDTH="333" VALIGN="MIDDLE" HEIGHT="99" ACODE="STK_DAT" COLSPAN="2">발행 후 3년 경과일로부터 청구를 통해 상환 가능하며, 상환청구가 있었음에도 상환되지 아니한 경우에는 상환기간은 상환이 완료될 때까지 연장 </TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="132" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">주당 상환가액</TD>
<TE WIDTH="333" VALIGN="MIDDLE" HEIGHT="30" ACODE="STK_PRC" COLSPAN="2" ALIGN="CENTER">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="132" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" AUPDATECONT="N">1년 이내&cr;상환 예정인 경우</TD>
<TE WIDTH="333" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACODE="STK_ONE" COLSPAN="2">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="85" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="351" ROWSPAN="4" AUPDATECONT="N">전환에&cr;관한 사항</TD>
<TD WIDTH="132" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76" AUPDATECONT="N">전환조건&cr;(전환비율 변동여부 포함)</TD>
<TE WIDTH="333" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76" ACODE="STK_CHA" COLSPAN="2">우선주 1주당 보통주 1주로 전환&cr;(1:1)</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="132" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="169" AUPDATECONT="N">전환청구기간</TD>

<TE WIDTH="333" VALIGN="MIDDLE" HEIGHT="169" ACODE="STK_CDA" COLSPAN="2">
<P USERMARK="F-GL11">1) 전환상환주식의 최초발행일 익일부터 10년이 되는 날까지("전환권 행사기간") 우선주식의 전부 또는 일부를 보통주로 전환가능,</P>
<P USERMARK="F-GL11">2) 전환권 행사없이 전환권 행사기간이 경과하면 전환권 행사기간 종료일 다음날부터 보통주로 전환</P>
</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="132" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" AUPDATECONT="N">전환으로 발행할&cr;주식의 종류</TD>
<TE WIDTH="333" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACODE="STK_KID" COLSPAN="2">보통주</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="132" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" AUPDATECONT="N">전환으로&cr;발행할 주식수</TD>
<TE WIDTH="333" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACODE="STK_CHT" COLSPAN="2">100,000</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="217" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" COLSPAN="2" AUPDATECONT="N">의결권에 관한 사항</TD>
<TE WIDTH="333" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="STK_VOT" COLSPAN="2">1주당 1개의 의결권</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="289" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" COLSPAN="3" AUPDATECONT="N">기타 투자 판단에 참고할 사항&cr;(주주간 약정 및 재무약정 사항 등)</TD>
<TE WIDTH="333" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACODE="ISS_ETC" COLSPAN="2">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P></P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="621">

<COLGROUP>
<COL WIDTH="280"></COL>
<COL WIDTH="323"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="289" HEIGHT="30" VALIGN="BOTTOM"></TD>
<TD WIDTH="332" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">(단위 : 원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="621">

<COLGROUP>
<COL WIDTH="63"></COL>
<COL WIDTH="76"></COL>
<COL WIDTH="122"></COL>
<COL WIDTH="158"></COL>
<COL WIDTH="157"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="288" HEIGHT="30" COLSPAN="3" ALIGN="CENTER" VALIGN="MIDDLE">발행일자</TD>
<TD WIDTH="333" HEIGHT="30" COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE">2017년 07월 14일</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="288" HEIGHT="30" COLSPAN="3" ALIGN="CENTER" VALIGN="MIDDLE">주당 발행가액(액면가액)</TD>
<TD WIDTH="167" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">10,000</TD>
<TD WIDTH="166" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">500</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="288" HEIGHT="30" COLSPAN="3" ALIGN="CENTER" VALIGN="MIDDLE">발행총액(발행주식수)</TD>
<TD WIDTH="167" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">635,000,000</TD>
<TD WIDTH="166" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">63,500</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="288" HEIGHT="30" COLSPAN="3" ALIGN="CENTER" VALIGN="MIDDLE">현재 잔액(현재 주식수)</TD>
<TD WIDTH="167" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">620,000,000</TD>
<TD WIDTH="166" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">62,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="72" HEIGHT="613" ROWSPAN="12" ALIGN="CENTER" VALIGN="MIDDLE">주식의&cr;내용</TD>
<TD WIDTH="216" HEIGHT="30" COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE">이익배당에 관한 사항</TD>
<TD WIDTH="333" HEIGHT="30" COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE">참가적, 누적적 우선주(배당률 : 0%)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="216" HEIGHT="53" COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE">잔여재산분배에 관한 사항</TD>
<TD WIDTH="333" HEIGHT="53" COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE">잔여재산분배에 있어 보통주에 대해 우선권이 있음</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="85" HEIGHT="173" ROWSPAN="5" ALIGN="CENTER" VALIGN="MIDDLE">상환에&cr;관한 사항</TD>
<TD WIDTH="131" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">상환조건</TD>
<TD WIDTH="333" HEIGHT="30" COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="131" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">상환방법</TD>
<TD WIDTH="333" HEIGHT="30" COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="131" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">상환기간</TD>
<TD WIDTH="333" HEIGHT="30" COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="131" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">주당 상환가액</TD>
<TD WIDTH="333" HEIGHT="30" COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="131" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">1년 이내&cr;상환 예정인 경우</TD>
<TD WIDTH="333" HEIGHT="53" COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="85" HEIGHT="327" ROWSPAN="4" ALIGN="CENTER" VALIGN="MIDDLE">전환에&cr;관한 사항</TD>
<TD WIDTH="131" HEIGHT="76" ALIGN="CENTER" VALIGN="MIDDLE">전환조건&cr;(전환비율 변동여부 포함)</TD>
<TD WIDTH="333" HEIGHT="76" COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE">우선주 1주당 보통주 1주로 전환&cr;(1:1)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="131" HEIGHT="145" ALIGN="CENTER" VALIGN="MIDDLE">전환청구기간</TD>

<TD WIDTH="333" HEIGHT="145" COLSPAN="2" VALIGN="MIDDLE">
<P>1) 전환주식의 최초발행일 익일부터 5년이 되는 날까지("전환권 행사기간") 우선주식의 전부 또는 일부를 보통주로 전환가능,</P>
<P>2) 전환권 행사없이 전환권 행사기간이 경과하면 전환권 행사기간 종료일 다음날부터 보통주로 전환</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="131" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">전환으로 발행할&cr;주식의 종류</TD>
<TD WIDTH="333" HEIGHT="53" COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE">보통주</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="131" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">전환으로&cr;발행할 주식수</TD>
<TD WIDTH="333" HEIGHT="53" COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE">63,500</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="216" HEIGHT="30" COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE">의결권에 관한 사항</TD>
<TD WIDTH="333" HEIGHT="30" COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE">1주당 1개의 의결권</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="288" HEIGHT="76" COLSPAN="3" ALIGN="CENTER" VALIGN="MIDDLE">기타 투자 판단에 참고할 사항&cr;(주주간 약정 및 재무약정 사항 등)</TD>
<TD WIDTH="333" HEIGHT="76" COLSPAN="2" VALIGN="MIDDLE">전환청구기간의 변경&cr;원계약: 최초발행일 익일부터 5년이 되는 날까지&cr;변경계약: 최초발행일 익일로부터 5년 이내</TD>
</TR>
</TBODY>
</TABLE>
</LIBRARY>
</INSERTION>
<P></P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="621">

<COLGROUP>
<COL WIDTH="280"></COL>
<COL WIDTH="323"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="289" HEIGHT="30" VALIGN="BOTTOM"></TD>
<TD WIDTH="332" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">(단위 : 원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="621">

<COLGROUP>
<COL WIDTH="63"></COL>
<COL WIDTH="76"></COL>
<COL WIDTH="122"></COL>
<COL WIDTH="158"></COL>
<COL WIDTH="157"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="288" HEIGHT="30" COLSPAN="3" ALIGN="CENTER" VALIGN="MIDDLE">발행일자</TD>
<TD WIDTH="333" HEIGHT="30" COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE">2018년 11월 12일</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="288" HEIGHT="30" COLSPAN="3" ALIGN="CENTER" VALIGN="MIDDLE">주당 발행가액(액면가액)</TD>
<TD WIDTH="167" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">10,000</TD>
<TD WIDTH="166" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">500</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="288" HEIGHT="30" COLSPAN="3" ALIGN="CENTER" VALIGN="MIDDLE">발행총액(발행주식수)</TD>
<TD WIDTH="167" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">50,000,000</TD>
<TD WIDTH="166" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">5,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="288" HEIGHT="30" COLSPAN="3" ALIGN="CENTER" VALIGN="MIDDLE">현재 잔액(현재 주식수)</TD>
<TD WIDTH="167" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">50,000,000</TD>
<TD WIDTH="166" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">5,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="72" HEIGHT="613" ROWSPAN="12" ALIGN="CENTER" VALIGN="MIDDLE">주식의&cr;내용</TD>
<TD WIDTH="216" HEIGHT="30" COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE">이익배당에 관한 사항</TD>
<TD WIDTH="333" HEIGHT="30" COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE">참가적, 누적적 우선주(배당률 : 0%)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="216" HEIGHT="53" COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE">잔여재산분배에 관한 사항</TD>
<TD WIDTH="333" HEIGHT="53" COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE">잔여재산분배에 있어 보통주에 대해 우선권이 있음</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="85" HEIGHT="173" ROWSPAN="5" ALIGN="CENTER" VALIGN="MIDDLE">상환에&cr;관한 사항</TD>
<TD WIDTH="131" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">상환조건</TD>
<TD WIDTH="333" HEIGHT="30" COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="131" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">상환방법</TD>
<TD WIDTH="333" HEIGHT="30" COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="131" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">상환기간</TD>
<TD WIDTH="333" HEIGHT="30" COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="131" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">주당 상환가액</TD>
<TD WIDTH="333" HEIGHT="30" COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="131" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">1년 이내&cr;상환 예정인 경우</TD>
<TD WIDTH="333" HEIGHT="53" COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="85" HEIGHT="327" ROWSPAN="4" ALIGN="CENTER" VALIGN="MIDDLE">전환에&cr;관한 사항</TD>
<TD WIDTH="131" HEIGHT="76" ALIGN="CENTER" VALIGN="MIDDLE">전환조건&cr;(전환비율 변동여부 포함)</TD>
<TD WIDTH="333" HEIGHT="76" COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE">우선주 1주당 보통주 1주로 전환&cr;(1:1)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="131" HEIGHT="145" ALIGN="CENTER" VALIGN="MIDDLE">전환청구기간</TD>

<TD WIDTH="333" HEIGHT="145" COLSPAN="2" VALIGN="MIDDLE">
<P>1) 전환주식의 최초발행일 익일부터 5년이 되는 날까지("전환권 행사기간") 우선주식의 전부 또는 일부를 보통주로 전환가능,</P>
<P>2) 전환권 행사없이 전환권 행사기간이 경과하면 전환권 행사기간 종료일 다음날부터 보통주로 전환</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="131" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">전환으로 발행할&cr;주식의 종류</TD>
<TD WIDTH="333" HEIGHT="53" COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE">보통주</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="131" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">전환으로&cr;발행할 주식수</TD>
<TD WIDTH="333" HEIGHT="53" COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE">5,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="216" HEIGHT="30" COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE">의결권에 관한 사항</TD>
<TD WIDTH="333" HEIGHT="30" COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE">의결권 없음</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="288" HEIGHT="53" COLSPAN="3" ALIGN="CENTER" VALIGN="MIDDLE">기타 투자 판단에 참고할 사항&cr;(주주간 약정 및 재무약정 사항 등)</TD>
<TD WIDTH="333" HEIGHT="53" COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE">-</TD>
</TR>
</TBODY>
</TABLE>
<P></P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="621">

<COLGROUP>
<COL WIDTH="280"></COL>
<COL WIDTH="323"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="289" HEIGHT="30" VALIGN="BOTTOM"></TD>
<TD WIDTH="332" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">(단위 : 원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="621">

<COLGROUP>
<COL WIDTH="63"></COL>
<COL WIDTH="76"></COL>
<COL WIDTH="122"></COL>
<COL WIDTH="158"></COL>
<COL WIDTH="157"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="288" HEIGHT="30" COLSPAN="3" ALIGN="CENTER" VALIGN="MIDDLE">발행일자</TD>
<TD WIDTH="333" HEIGHT="30" COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE">2020년 12월 04일</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="288" HEIGHT="30" COLSPAN="3" ALIGN="CENTER" VALIGN="MIDDLE">주당 발행가액(액면가액)</TD>
<TD WIDTH="167" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">11,000</TD>
<TD WIDTH="166" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">500</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="288" HEIGHT="30" COLSPAN="3" ALIGN="CENTER" VALIGN="MIDDLE">발행총액(발행주식수)</TD>
<TD WIDTH="167" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,100,000,000</TD>
<TD WIDTH="166" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">100,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="288" HEIGHT="30" COLSPAN="3" ALIGN="CENTER" VALIGN="MIDDLE">현재 잔액(현재 주식수)</TD>
<TD WIDTH="167" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,100,000,000</TD>
<TD WIDTH="166" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">100,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="72" HEIGHT="774" ROWSPAN="12" ALIGN="CENTER" VALIGN="MIDDLE">주식의&cr;내용</TD>
<TD WIDTH="216" HEIGHT="30" COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE">이익배당에 관한 사항</TD>
<TD WIDTH="333" HEIGHT="30" COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE">참가적, 누적적 우선주(배당률 : 0%)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="216" HEIGHT="53" COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE">잔여재산분배에 관한 사항</TD>
<TD WIDTH="333" HEIGHT="53" COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE">잔여재산분배에 있어 보통주에 대해 우선권이 있음</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="85" HEIGHT="334" ROWSPAN="5" ALIGN="CENTER" VALIGN="MIDDLE">상환에&cr;관한 사항</TD>
<TD WIDTH="131" HEIGHT="99" ALIGN="CENTER" VALIGN="MIDDLE">상환조건</TD>

<TD WIDTH="333" HEIGHT="99" COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE">
<P>상환은 배당 가능한 이익이 있을 때에만 가능</P>
<P>배당가능이익이 있음에도 불구하고 상환의무를 이행하지 아니한 경우 상환가액에 대하여 15%의 이율에 의한 지연배상금을 가산</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="131" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">상환방법</TD>
<TD WIDTH="333" HEIGHT="53" COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE">상환청구가 있는 날로부터 60일 이내에 현금으로 상환</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="131" HEIGHT="99" ALIGN="CENTER" VALIGN="MIDDLE">상환기간</TD>
<TD WIDTH="333" HEIGHT="99" COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE">발행 후 3년 경과일로부터 청구를 통해 상환 가능하며, 상환청구가 있었음에도 상환되지 아니한 경우에는 상환기간은 상환이 완료될 때까지 연장 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="131" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">주당 상환가액</TD>
<TD WIDTH="333" HEIGHT="30" COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="131" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">1년 이내&cr;상환 예정인 경우</TD>
<TD WIDTH="333" HEIGHT="53" COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="85" HEIGHT="327" ROWSPAN="4" ALIGN="CENTER" VALIGN="MIDDLE">전환에&cr;관한 사항</TD>
<TD WIDTH="131" HEIGHT="76" ALIGN="CENTER" VALIGN="MIDDLE">전환조건&cr;(전환비율 변동여부 포함)</TD>
<TD WIDTH="333" HEIGHT="76" COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE">우선주 1주당 보통주 1주로 전환&cr;(1:1)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="131" HEIGHT="145" ALIGN="CENTER" VALIGN="MIDDLE">전환청구기간</TD>

<TD WIDTH="333" HEIGHT="145" COLSPAN="2" VALIGN="MIDDLE">
<P>1) 전환상환주식의 최초발행일 익일부터 10년이 되는 날까지("전환권 행사기간") 우선주식의 전부 또는 일부를 보통주로 전환가능,</P>
<P>2) 전환권 행사없이 전환권 행사기간이 경과하면 전환권 행사기간 종료일 다음날부터 보통주로 전환</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="131" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">전환으로 발행할&cr;주식의 종류</TD>
<TD WIDTH="333" HEIGHT="53" COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE">보통주</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="131" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">전환으로&cr;발행할 주식수</TD>
<TD WIDTH="333" HEIGHT="53" COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE">100,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="216" HEIGHT="30" COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE">의결권에 관한 사항</TD>
<TD WIDTH="333" HEIGHT="30" COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE">1주당 1개의 의결권</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="288" HEIGHT="53" COLSPAN="3" ALIGN="CENTER" VALIGN="MIDDLE">기타 투자 판단에 참고할 사항&cr;(주주간 약정 및 재무약정 사항 등)</TD>
<TD WIDTH="333" HEIGHT="53" COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE">-</TD>
</TR>
</TBODY>
</TABLE>
<P>&cr;</P>
</SECTION-2>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-0-1-5-0">5. 의결권 현황</TITLE>
<P></P>

<TABLE-GROUP ACLASS="VOT_STK" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="600" BORDER="0">

<COLGROUP>
<COL WIDTH="70"></COL>
<COL WIDTH="142"></COL>
<COL WIDTH="58"></COL>
<COL WIDTH="294"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="79" HEIGHT="30" AUPDATECONT="N">(기준일 : </TD>
<TU ALIGN="CENTER" VALIGN="BOTTOM" WIDTH="151" HEIGHT="30" AUNIT="BASE_DT" AUNITVALUE="20201231">2020년 12월 31일</TU>
<TD VALIGN="BOTTOM" WIDTH="67" HEIGHT="30" AUPDATECONT="N">)</TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="303" HEIGHT="30" AUNIT="STOCK" AUNITVALUE="1">(단위 : 주)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="600" BORDER="1">

<COLGROUP>
<COL WIDTH="229"></COL>
<COL WIDTH="84"></COL>
<COL WIDTH="136"></COL>
<COL WIDTH="115"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="238" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">구     분</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">주식의 종류</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="145" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">주식수</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="124" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">비고</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="238" HEIGHT="60" AUPDATECONT="N">발행주식총수(A)</TD>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30" ACODE="ISU_STK_KND">보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="145" HEIGHT="30" ACODE="ISU_STK">2,867,050</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="124" HEIGHT="30" ACODE="VOT_NOTE">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="N">
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30" ACODE="ISU_STK_KND">우선주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="145" HEIGHT="30" ACODE="ISU_STK">267,000</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="124" HEIGHT="30" ACODE="VOT_NOTE">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="238" HEIGHT="60" AUPDATECONT="N">의결권없는 주식수(B)</TD>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30" ACODE="ISN_STK_KND">보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="145" HEIGHT="30" ACODE="ISN_STK">92,134</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="124" HEIGHT="30" ACODE="VOT_NOTE1">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="N">
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30" ACODE="ISN_STK_KND">우선주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="145" HEIGHT="30" ACODE="ISN_STK">5,000</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="124" HEIGHT="30" ACODE="VOT_NOTE1">계약조건에 의함</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="238" HEIGHT="60" AUPDATECONT="N">정관에 의하여 의결권 행사가 배제된 주식수(C)</TD>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30" ACODE="ISQ_STK_KND">보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="145" HEIGHT="30" ACODE="ISQ_STK">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="124" HEIGHT="30" ACODE="VOT_NOTE2">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="N">
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30" ACODE="ISQ_STK_KND">우선주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="145" HEIGHT="30" ACODE="ISQ_STK">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="124" HEIGHT="30" ACODE="VOT_NOTE2">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="238" HEIGHT="60" AUPDATECONT="N">기타 법률에 의하여&cr;의결권 행사가 제한된 주식수(D)</TD>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30" ACODE="ISJ_STK_KND">보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="145" HEIGHT="30" ACODE="ISJ_STK">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="124" HEIGHT="30" ACODE="VOT_NOTE3">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="N">
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30" ACODE="ISJ_STK_KND">우선주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="145" HEIGHT="30" ACODE="ISJ_STK">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="124" HEIGHT="30" ACODE="VOT_NOTE3">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="238" HEIGHT="60" AUPDATECONT="N">의결권이 부활된 주식수(E)</TD>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30" ACODE="ISB_STK_KND">보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="145" HEIGHT="30" ACODE="ISB_STK">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="124" HEIGHT="30" ACODE="VOT_NOTE4">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="N">
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30" ACODE="ISB_STK_KND">우선주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="145" HEIGHT="30" ACODE="ISB_STK">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="124" HEIGHT="30" ACODE="VOT_NOTE4">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="238" HEIGHT="60" AUPDATECONT="N">의결권을 행사할 수 있는 주식수&cr;(F = A - B - C - D + E)</TD>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30" ACODE="ISH_STK_KND">보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="145" HEIGHT="30" ACODE="ISH_STK">2,774,916</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="124" HEIGHT="30" ACODE="VOT_NOTE5">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="N">
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30" ACODE="ISH_STK_KND">우선주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="145" HEIGHT="30" ACODE="ISH_STK">262,000</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="124" HEIGHT="30" ACODE="VOT_NOTE5">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P></P>
<P></P>
</SECTION-2>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-0-1-6-0">6. 배당에 관한 사항 등</TITLE>
<P></P>
<P>주요배당지표</P>

<TABLE-GROUP ACLASS="DIVIDEND" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="607" BORDER="1" FRAME="BORDER" RULES="ALL">

<COLGROUP>
<COL WIDTH="152"></COL>
<COL WIDTH="104"></COL>
<COL WIDTH="102"></COL>
<COL WIDTH="102"></COL>
<COL WIDTH="102"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="161" HEIGHT="60" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="2">구   분</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="113" HEIGHT="60" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="2">주식의 종류</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="111" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">당기</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="111" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">전기</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="111" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">전전기</TH>
</TR>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="111" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">제5기</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="111" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">제4기</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="111" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">제3기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD COLSPAN="2" VALIGN="MIDDLE" WIDTH="274" HEIGHT="30" AUPDATECONT="N" ALIGN="CENTER">주당액면가액(원)</TD>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X23" ADELIM="1" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X23" ADELIM="2" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X23" ADELIM="3" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD COLSPAN="2" VALIGN="MIDDLE" WIDTH="274" HEIGHT="30" AUPDATECONT="N" ALIGN="CENTER">(연결)당기순이익(백만원)</TD>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X01" ADELIM="1" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X01" ADELIM="2" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X01" ADELIM="3" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD COLSPAN="2" VALIGN="MIDDLE" WIDTH="274" HEIGHT="30" AUPDATECONT="N" ALIGN="CENTER">(별도)당기순이익(백만원)</TD>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X35" ADELIM="1" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X35" ADELIM="2" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X35" ADELIM="3" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD COLSPAN="2" VALIGN="MIDDLE" WIDTH="274" HEIGHT="30" AUPDATECONT="N" ALIGN="CENTER">(연결)주당순이익(원)</TD>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X02" ADELIM="1" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X02" ADELIM="2" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X02" ADELIM="3" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD COLSPAN="2" VALIGN="MIDDLE" WIDTH="274" HEIGHT="30" AUPDATECONT="N" ALIGN="CENTER">현금배당금총액(백만원)</TD>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X24" ADELIM="1" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X24" ADELIM="2" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X24" ADELIM="3" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD COLSPAN="2" VALIGN="MIDDLE" WIDTH="274" HEIGHT="30" AUPDATECONT="N" ALIGN="CENTER">주식배당금총액(백만원)</TD>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X25" ADELIM="1" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X25" ADELIM="2" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X25" ADELIM="3" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD COLSPAN="2" VALIGN="MIDDLE" WIDTH="274" HEIGHT="30" AUPDATECONT="N" ALIGN="CENTER">(연결)현금배당성향(%)</TD>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X05" ADELIM="1" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X05" ADELIM="2" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X05" ADELIM="3" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD ROWSPAN="2" VALIGN="MIDDLE" WIDTH="161" HEIGHT="60" AUPDATECONT="N" ALIGN="CENTER">현금배당수익률(%)</TD>
<TE ALIGN="CENTER" WIDTH="113" HEIGHT="30" ACODE="XQ1" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X31" ADELIM="1" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X31" ADELIM="2" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X31" ADELIM="3" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="N">
<TE ALIGN="CENTER" WIDTH="113" HEIGHT="30" ACODE="XQ1" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X31" ADELIM="1" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X31" ADELIM="2" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X31" ADELIM="3" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD ROWSPAN="2" VALIGN="MIDDLE" WIDTH="161" HEIGHT="60" AUPDATECONT="N" ALIGN="CENTER">주식배당수익률(%)</TD>
<TE ALIGN="CENTER" WIDTH="113" HEIGHT="30" ACODE="XQ2" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X32" ADELIM="1" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X32" ADELIM="2" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X32" ADELIM="3" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="N">
<TE ALIGN="CENTER" WIDTH="113" HEIGHT="30" ACODE="XQ2" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X32" ADELIM="1" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X32" ADELIM="2" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X32" ADELIM="3" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD ROWSPAN="2" VALIGN="MIDDLE" WIDTH="161" HEIGHT="60" AUPDATECONT="N" ALIGN="CENTER">주당 현금배당금(원)</TD>
<TE ALIGN="CENTER" WIDTH="113" HEIGHT="30" ACODE="XQ3" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X33" ADELIM="1" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X33" ADELIM="2" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X33" ADELIM="3" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="N">
<TE ALIGN="CENTER" WIDTH="113" HEIGHT="30" ACODE="XQ3" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X33" ADELIM="1" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X33" ADELIM="2" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X33" ADELIM="3" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD ROWSPAN="2" VALIGN="MIDDLE" WIDTH="161" HEIGHT="60" AUPDATECONT="N" ALIGN="CENTER">주당 주식배당(주)</TD>
<TE ALIGN="CENTER" WIDTH="113" HEIGHT="30" ACODE="XQ4" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X34" ADELIM="1" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X34" ADELIM="2" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X34" ADELIM="3" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="N">
<TE ALIGN="CENTER" WIDTH="113" HEIGHT="30" ACODE="XQ4" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X34" ADELIM="1" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X34" ADELIM="2" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X34" ADELIM="3" VALIGN="MIDDLE">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P></P>

<INSERTION ABASISNUMBER="SE1" AFREQUENCY="0" ADUPLICATION="N">
<COMMENT>◆click◆ 『과거배당이력』 삽입</COMMENT>
<LIBRARYLIST>11011#*과거배당이력.dsl</LIBRARYLIST>
</INSERTION>
<P></P>
<P></P>
<PGBRK></PGBRK>
</SECTION-2>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-0-1-7-0">7. 정관에 관한 사항</TITLE>
<P></P>

<INSERTION ABASISNUMBER="SE1" AFREQUENCY="1" ADUPLICATION="N">
<COMMENT>◆click◆ 『정관변경이력』 삽입</COMMENT>
<LIBRARYLIST>11011#*정관변경이력.dsl</LIBRARYLIST>

<LIBRARY>
<FILENAME ATYPE="dsl">49_정관변경이력</FILENAME>
<P>정관 변경 이력</P>

<TABLE-GROUP ACLASS="ART_BCK" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="599" BORDER="1">

<COLGROUP>
<COL WIDTH="141"></COL>
<COL WIDTH="112"></COL>
<COL WIDTH="171"></COL>
<COL WIDTH="139"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="150" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">정관변경일</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="121" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">해당주총명</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="180" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">주요변경사항</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="148" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">변경이유</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="N">
<TU ALIGN="CENTER" WIDTH="150" HEIGHT="122" AUNIT="ART_DATE" AUNITVALUE="20150324" VALIGN="MIDDLE">2015년 03월 24일</TU>
<TE ALIGN="CENTER" WIDTH="121" HEIGHT="122" ACODE="ART_NAME" VALIGN="MIDDLE">정기주주총회</TE>
<TE WIDTH="180" HEIGHT="122" ACODE="ART_CHN" VALIGN="MIDDLE">정관 제14조&cr;주식매수선택권 행사기간을 부여받은 일로부터 '5년 이상 15년 내'에서 '3년 이상 15년 내'로 변경</TE>
<TE WIDTH="148" HEIGHT="122" ACODE="ART_RSN" VALIGN="MIDDLE">경영상 필요</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU ALIGN="CENTER" WIDTH="150" HEIGHT="214" AUNIT="ART_DATE" AUNITVALUE="20180329" VALIGN="MIDDLE">2018년 03월 29일</TU>
<TE ALIGN="CENTER" WIDTH="121" HEIGHT="214" ACODE="ART_NAME" VALIGN="MIDDLE">정기주주총회</TE>
<TE WIDTH="180" HEIGHT="214" ACODE="ART_CHN" VALIGN="MIDDLE">1. 정관 제14조&cr;주식매수선택권 행사기간을 부여받은 일로부터 '3년 이상 15년내'에서 '3년 이상 7년 내'로 변경&cr;2. 정관 제40조&cr;이사의 임기는 '3년으로 하며'에서 '3년을 초과하지 못하며'로 변경</TE>
<TE WIDTH="148" HEIGHT="214" ACODE="ART_RSN" VALIGN="MIDDLE">1. 타사의 평균행사&cr;기간 반영&cr;&cr;&cr;&cr;2. 상법 규정에 따름&cr;&cr;&cr;</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU ALIGN="CENTER" WIDTH="150" HEIGHT="260" AUNIT="ART_DATE" AUNITVALUE="20190326" VALIGN="MIDDLE">2019년 03월 26일</TU>
<TE ALIGN="CENTER" WIDTH="121" HEIGHT="260" ACODE="ART_NAME" VALIGN="MIDDLE">정기주주총회</TE>
<TE WIDTH="180" HEIGHT="260" ACODE="ART_CHN" VALIGN="MIDDLE">1. 정관 제8조&cr; '주식 및 주권의 종류' 삭제&cr;2. 정관 제8조의 2 &cr;'주식 등의 전자등록' 신설&cr;3. 정관 제14조&cr;주식매수선택권행사기간을 부여받은 일로부터 '3년 이상 7년 내'에서 '2년 이상 7년 내'로 변경 </TE>
<TE WIDTH="148" HEIGHT="260" ACODE="ART_RSN" VALIGN="MIDDLE">1. 상법 규정에 따름&cr;&cr;&cr;2. 상법 규정에 따름&cr;&cr;3. 상장사의 평균 행사 기간 반영&cr;&cr;&cr;&cr;</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU ALIGN="CENTER" WIDTH="150" HEIGHT="283" AUNIT="ART_DATE" AUNITVALUE="20200330" VALIGN="MIDDLE">2020년 03월 30일</TU>
<TE ALIGN="CENTER" WIDTH="121" HEIGHT="283" ACODE="ART_NAME" VALIGN="MIDDLE">정기주주총회</TE>
<TE WIDTH="180" HEIGHT="283" ACODE="ART_CHN" VALIGN="MIDDLE">1. 정관 제2조 7&cr;국내외 동물의약, 생명공학, 제약산업, 자연환경산업, 농수산 및 축산업에 관련한 기술, 특허 및 연관된 기업에 대한 '연구개발 및' 투자로 변경&cr;2. 정관 제4조&cr;'본 회사의 공고는 회사 인터넷 홈페이지(http://www.plsdna.com)게재한다.'로 변경</TE>
<TE WIDTH="148" HEIGHT="283" ACODE="ART_RSN" VALIGN="MIDDLE">1. 사업의 범위 확장&cr;&cr;&cr;&cr;&cr;&cr;&cr;2. 회사 인터넷 홈페이지 도메인 변경&cr;&cr;&cr;</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU ALIGN="CENTER" WIDTH="150" HEIGHT="145" AUNIT="ART_DATE" AUNITVALUE="20200722" VALIGN="MIDDLE">2020년 07월 22일</TU>
<TE ALIGN="CENTER" WIDTH="121" HEIGHT="145" ACODE="ART_NAME" VALIGN="MIDDLE">임시주주총회</TE>
<TE WIDTH="180" HEIGHT="145" ACODE="ART_CHN" VALIGN="MIDDLE">정관 제14조 2&cr;'본 회사는 자기주식을 초과하지 않는 범위 내에서 이사회의 결의로 임직원에게 양도제한부주식을 부여할 수 있다.' 신설</TE>
<TE WIDTH="148" HEIGHT="145" ACODE="ART_RSN" VALIGN="MIDDLE">임직원 포상 제도&cr;신규 도입</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
</LIBRARY>
</INSERTION>
<P></P>
<P></P>
<PGBRK></PGBRK>
</SECTION-2>
</SECTION-1>

<SECTION-1 ACLASS="MANDATORY" APARTSOURCE="SOURCE">
<TITLE ATOC="Y" AASSOCNOTE="D-0-2-0-0">II. 사업의 내용</TITLE>
<P></P>

<INSERTION ABASISNUMBER="SE1" AFREQUENCY="0" ADUPLICATION="N">
<COMMENT>◆click◆『수주상황』 삽입</COMMENT>
<LIBRARYLIST>11011#*_수주상황.dsl</LIBRARYLIST>
</INSERTION>
<P></P>
<P USERMARK="F-16 0XFF0000 B">1. 사업의 개요</P>

<P USERMARK="F-14 0XFF0000">
<SPAN>&cr;</SPAN>
<SPAN USERMARK=" B">가. 업계의 현황&cr;&cr;</SPAN>
<SPAN USERMARK=" 0X000000 B"></SPAN>
<SPAN USERMARK=" 0X000000 B"></SPAN>
<SPAN USERMARK="F-12 0X000000 B"></SPAN>
<SPAN USERMARK="F-12 0X000000">(1) 글로벌 동물의약품 시장&cr;</SPAN>
<SPAN USERMARK="F-12 0X000000"></SPAN>
</P>

<P>
<SPAN>글로벌 동물의약품 시장은 크게 반려동물용 의약품 시장과 가축용 의약품 시장으로 나누어졌습니다. &cr;&cr;반려동물의약품 시장은 반려동물을 또 하나의 가족처럼 여기는 '펫팸(Pet+Family)'족의 증가로 매년 약16%의 높은 성장률(*)을 나타내고 있습니다. </SPAN>
<SPAN></SPAN>
<SPAN>반려동물 가</SPAN>
<SPAN>족들은 기존 반려동물의약품에서 발생하는 부작용과 미미한 유효성때문에 인간과 유사한 수준의 전문화된 의약품을 원하고 있습니다. 노령견의 증가로 반려견 암과 노령견 관련 치료 분야가 성장할 것으로 예상됩니다. &cr;</SPAN>
<SPAN>&cr;가축용 의약품 시장은 중국시장의 빠른 성장으로 인한 글로벌 단백질 소비의 증가로 연간 약 9%의 성장률(*)을 나타내고 있습니다.</SPAN>
<SPAN> &cr;</SPAN>
<SPAN></SPAN>
<SPAN>&cr;</SPAN>
<SPAN>전 세계 동물의약품 시장규모는 2019년 380억달러에서 2023년 610억 달러까지 성장(*)할 것으로 전망됩니다</SPAN>
<SPAN>.&cr;</SPAN>
</P>

<IMAGE>
<IMG WIDTH="298" HEIGHT="405" ALIGN="CENTER" HSPACE="0">전 세계 동물의약품 시장규모.jpg</IMG>
<IMG-CAPTION ATOC="N">전 세계 동물의약품 시장규모</IMG-CAPTION>
</IMAGE>

<P>
<SPAN USERMARK="F-10"></SPAN>
<SPAN USERMARK="F-10"></SPAN>
<SPAN USERMARK="F-10"></SPAN>
<SPAN USERMARK="F-10"></SPAN>
<SPAN USERMARK="F-10"></SPAN>
<SPAN USERMARK="F-10"></SPAN>
<SPAN USERMARK="F-10">(*) ResearchAndMarkets, 2020.01.&cr;</SPAN>
</P>
<P>글로벌 동물의약품 시장은 Zoetis, Elanco, Merck, Boehringer Ingelheim등의 글로벌 동물제약사 상위 8개 업체가 글로벌 동물의약품 시장 매출의 약 66% 정도를 점유하고 있습니다. 2013년 2월에 다국적제약사 화이자(Pfizer)로부터 분사한 동물제약사 Zoetis(NYSE: ZTS)가 뉴욕증시에 상장하여 약 80조원(2021년 2월 12일 기준)의 시장총액을 나타내고 있습니다. 이후 동물제약사와 반려동물 신약 연구개발 전문 회사)들의 미국 증시 상장이 활발히 이루어졌습니다. &cr;</P>
<P>특히 동물혁신의약품 개발이 중요 사업 중 하나로 인식되면서, M&A와 기술라이선스계약이 이전에 비해 활발히 진행되었습니다.</P>
<P>&cr;주요 M&A건으로 미국 제약회사 Merck는 프랑스 디지털 통물 식별, 추적시스템, 모니터링 솔루션 기업인 Antelliq을 24억 달러에 인수하였고  Zoetis도 동물진단장비 기업 Abaxis를 17억 달러에 인수하였습니다. 이외에도 미국의 동물의약품 업체인 Vets First Choice와 치과기자재 유통업체인 Henry Schein의 동물건강사업부가 합병하여 Covetrus 가 탄생하였으며, 시가총액 약 43억 달러(2021년 3월 1일 기준)로 미국 나스닥 시장에서 거래되고 있습니다. 2019년도에는 Elanco가  Bayer동물사업부를 76억달러에 인수한 바 있습니다.&cr;</P>

<P>
<SPAN>                                        <글로벌 동물헬스케어 M&A>&cr;</SPAN>
<SPAN USERMARK="F-10">                                                                                                                          (단위: 백</SPAN>
<SPAN USERMARK="F-10">만달러)</SPAN>
</P>

<TABLE BORDER="1" WIDTH="587" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="83"></COL>
<COL WIDTH="76"></COL>
<COL WIDTH="84"></COL>
<COL WIDTH="134"></COL>
<COL WIDTH="39"></COL>
<COL WIDTH="54"></COL>
<COL WIDTH="54"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="92" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76" USERMARK=" BC0XD7D7D7">
<P>공시일</P>
</TD>

<TD WIDTH="85" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76" USERMARK=" BC0XD7D7D7">
<P>인수기업</P>
</TD>

<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76" USERMARK=" BC0XD7D7D7">
<P>피인수기업</P>
</TD>

<TD WIDTH="143" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76" USERMARK=" BC0XD7D7D7">
<P>피인수기업</P>
<P>사업분야</P>
</TD>

<TD WIDTH="48" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76" USERMARK=" BC0XD7D7D7">
<P>인수&cr;기업</P>
<P>국가</P>
</TD>

<TD WIDTH="63" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76" USERMARK=" BC0XD7D7D7">
<P>피인수&cr;기업</P>
<P>국가</P>
</TD>

<TD WIDTH="63" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76" USERMARK=" BC0XD7D7D7">
<P>거래액</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="92" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>2018.12.14</P>
</TD>

<TD WIDTH="85" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>Merck&Co</P>
</TD>

<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>Antelliq &cr;Holdings</P>
</TD>

<TD WIDTH="143" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>동물관리를 위한 &cr;디지털 식별제품</P>
</TD>

<TD WIDTH="48" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>미국</P>
</TD>

<TD WIDTH="63" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>프랑스</P>
</TD>
<TD WIDTH="63" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">2,400</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="92" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="33">
<P>2018.05.16</P>
</TD>

<TD WIDTH="85" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="33">
<P>Zoetis</P>
</TD>

<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="33">
<P>Abaxis</P>
</TD>

<TD WIDTH="143" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="33">
<P>동물 혈액진단기기</P>
</TD>

<TD WIDTH="48" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="33">
<P>미국</P>
</TD>

<TD WIDTH="63" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="33">
<P>미국</P>
</TD>

<TD WIDTH="63" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="33">
<P>1,717</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="92" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2019.08.20</TD>
<TD WIDTH="85" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">Elanco</TD>
<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">Bayer </TD>
<TD WIDTH="143" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">동물의약품</TD>
<TD WIDTH="48" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">미국</TD>
<TD WIDTH="63" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">독일</TD>
<TD WIDTH="63" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">7,600</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-10">(자료 : 삼정KPMG경제연구원, 2019.04. /  Bayer 홈페이지 )</SPAN>
<SPAN>&cr;&cr;</SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN>가축백신 시장 중에서는 2018년도에 중국과 유럽에서 발생한 아프리카돼지열병으로 중국에서만 약 169조원 규모의 직접적인 손실(*)이 발생하였습니다. 중국 화촹증권에 의하면 중국시장 아프리카돼지열병백신 시장은 약 2.5조원으로 추정됩니다.</SPAN>
<SPAN>&cr;</SPAN>
<SPAN USERMARK="F-10"></SPAN>
<SPAN USERMARK="F-10"></SPAN>
<SPAN USERMARK="F-10">((*)자료 : Global Times, 2019.9.25.) </SPAN>
<SPAN USERMARK="F-9"></SPAN>
<SPAN USERMARK="F-9"> </SPAN>
<SPAN USERMARK="F-10">    </SPAN>
<SPAN USERMARK="F-10"> &cr;                                                       </SPAN>
<SPAN USERMARK="F-10">                        </SPAN>
</P>
<P>해를 거듭할수록 동물 의약품에 대한 수요는 특화되고 증가할 것으로 예상됩니다. &cr;&cr;앞으로 동물의약품 신약개발은 안전한 단백질에 대한 수요 증가, 반려동물 가족과 반려 동물 간의 유대 강화, 반려 동물 가정의 증가와 반려 동물 치료에 대한 인체의약품 수준의 효과를 기대하고 있기 때문에 지속적으로 성장할 것으로 추정됩니다.  </P>

<P>
<SPAN>&cr;</SPAN>
<SPAN></SPAN>
<SPAN>(2) 국내 동물의약품 시장</SPAN>
<SPAN>&cr;</SPAN>&cr;한국동물약품협회에 따르면 2019년 국내 동물의약품 시장규모는 약 1조 2,040억원으로 집계되었습니다.                 &cr;&cr;                                         <국내 동물용 의약품 시장규모>
</P>
<P USERMARK="F-10">                                                                                                                                   (단위 : 억원)</P>

<TABLE BORDER="1" WIDTH="604" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="188"></COL>
<COL WIDTH="127"></COL>
<COL WIDTH="127"></COL>
<COL WIDTH="126"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="197" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>구분</P>
</TD>

<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>2017</P>
</TD>

<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>2018</P>
</TD>
<TD WIDTH="135" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">2019</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="197" VALIGN="MIDDLE" HEIGHT="30">
<P> 수입완제(A)</P>
</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,176</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,407</TD>
<TD WIDTH="135" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,702</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="197" VALIGN="MIDDLE" HEIGHT="30">
<P>  국내생산후 국내소비(B)</P>
</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">4,175</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">4,647</TD>
<TD WIDTH="135" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">4,832</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="197" VALIGN="MIDDLE" HEIGHT="30">
<P>     내수 시장(C)</P>
</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">7,351</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">8,054</TD>
<TD WIDTH="135" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">8,541</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="197" VALIGN="MIDDLE" HEIGHT="30">
<P>   총시장규모(D)</P>
</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">10,415</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">11,251</TD>
<TD WIDTH="135" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">12,040</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-10">(자료 : 한국동물약품협회, 2020)</P>
<P>&cr;수출부분을 살펴보면 2018년 국내 기업들의 동물용 의약품 수출액은 약 3,197억 원으로 집계되었는데, 2011년 1억 달러를 처음 돌파한 이후 2015년 2억 달러를 넘었고, 2018년에는 수출액이 최초로 3억 달러를 돌파하였습니다&cr;</P>
<P>                                           <동물용 의약품 수출 추이></P>
<P USERMARK="F-10">                                                                                                                              (단위 : 개, 억원)</P>

<TABLE ACLASS="NORMAL" WIDTH="600" BORDER="1">

<COLGROUP>
<COL WIDTH="66"></COL>
<COL WIDTH="66"></COL>
<COL WIDTH="66"></COL>
<COL WIDTH="66"></COL>
<COL WIDTH="66"></COL>
<COL WIDTH="66"></COL>
<COL WIDTH="66"></COL>
<COL WIDTH="66"></COL>
</COLGROUP>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="75" HEIGHT="30" USERMARK=" BC0XD7D7D7">구분</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="75" HEIGHT="30" USERMARK=" BC0XD7D7D7">2012년</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="75" HEIGHT="30" USERMARK=" BC0XD7D7D7">2013년</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="75" HEIGHT="30" USERMARK=" BC0XD7D7D7">2014년</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="75" HEIGHT="30" USERMARK=" BC0XD7D7D7">2015년</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="75" HEIGHT="30" USERMARK=" BC0XD7D7D7">2016년</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="75" HEIGHT="30" USERMARK=" BC0XD7D7D7">2017년</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="75" HEIGHT="30" USERMARK=" BC0XD7D7D7">2018년</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="75" HEIGHT="30">업체수</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="75" HEIGHT="30">42</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="75" HEIGHT="30">55</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="75" HEIGHT="30">60</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="75" HEIGHT="30">63</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="75" HEIGHT="30">75</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="75" HEIGHT="30">79</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="75" HEIGHT="30">78</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="75" HEIGHT="30">품목수</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="75" HEIGHT="30">786</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="75" HEIGHT="30">840</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="75" HEIGHT="30">932</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="75" HEIGHT="30">1,039</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="75" HEIGHT="30">1,132</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="75" HEIGHT="30">1,232</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="75" HEIGHT="30">1,257</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="75" HEIGHT="30">수출액</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="75" HEIGHT="30">1,584</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="75" HEIGHT="30">1,670</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="75" HEIGHT="30">1,905</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="75" HEIGHT="30">2,433</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="75" HEIGHT="30">2,745</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="75" HEIGHT="30">3,070</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="75" HEIGHT="30">3,197</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-10">(자료 : 한국약품협회, 2019)</P>
<P>&cr;국내 동물용 의약품 산업은 축산업의 급격한 성장에 힘입어 1970년 초반 동물약품 제조업체가 급속히 증가하였으며 업체 간 과당경쟁 등 유통질서가 문란해져 부작용이 발생하자 정부는 '동물약품 제조업 및 품목허가 지침'을 고시하였습니다. 그 후 동 산업은 원료동물약품을 제조하는 경우 또는 국산 원료를 이용한 신제품 개발, 동물용 위생용품 및 의료용구를 생산하는 경우에 한하여 신규 허가를 하여 신규업체의 진입에 제한을 두었습니다.&cr;&cr;1990년대 접어들면서 규제완화 및 세계무역자유화에 따라 자유경쟁으로 변화하였으며, 2005년 중소기업 고유업종 지정이 해제되면서 대기업의 진입이 자유로워졌습니다.&cr;&cr;2016년 기준으로 우리나라 동물용 의약품 관련 업체 수는 총 514개인데, 이 중 제조업체는 238개소이고 수입업체는 276개소로 수입업체의 비중이 상대적으로 높습니다. 세부 품목별로 보면 동물용의약품 241개소, 동물용 의약외품 73개소, 동물용 의료기기 200개소로 동물용의약품 업체가 전체의 47%를 차지하고 있습니다. 특히 2013년 이후 동물용 의료기기에 대한 관리규정을 정비하고 농림축산검역본부에 전담 조직과 인원이 배치되면서 동물용 의료기기 제조 및 수입업체의 증가세가 두드러지게 나타나고 있습니다.&cr;</P>

<IMAGE>
<IMG WIDTH="600" HEIGHT="191" ALIGN="CENTER" HSPACE="0">동물용 의약품 업체 현황.jpg</IMG>
<IMG-CAPTION ATOC="N">동물용 의약품 업체 현황</IMG-CAPTION>
</IMAGE>

<P USERMARK="F-10">
<SPAN>(자료: 개원모바일사이트, 2016)&cr;</SPAN>
<SPAN USERMARK="F-12"></SPAN>
<SPAN USERMARK="F-12">&cr;동물용 의약품 산업은 특히 축산업의 경기 변동에 매우 민감하게 반응하며 사육 두수의 증감 또는 축산물 소비량은 동물약품산업의 경기에 직접적인 영향을 미칩니다. 최근 국내 동물용 의약품 시장은 2008년 사료가격의 폭등 이후 점차 사료가격이 안정화 추세를 보이면서 생산비 부담이 감소하고 있어 축산 관련 직접비 부담은 크지 않으나, 구제역 등 전염병이 잇달아 발생하면서 소비자의 불안감이 커져 치료나 예방에 관한 간접비의 비중이 높아지고 있습니다. 또한 사료 첨가물 등으로 사용되는 항생물질에 대한 규제 강화와 치료에서 예방으로의 인식전환으로 동물용 의약품에서 백신이 차지하는 비중은 견조한 증가추세를 보이고 있습니다.&cr;&cr;</SPAN>
<SPAN>                                                                                                   (단위: 십억원)</SPAN>
</P>

<IMAGE>
<IMG WIDTH="389" HEIGHT="172" ALIGN="CENTER" HSPACE="0">국내 동물용 백신 시장 추이.jpg</IMG>
<IMG-CAPTION ATOC="N">국내 동물용 백신 시장 추이</IMG-CAPTION>
</IMAGE>

<P USERMARK="F-10">
<SPAN>(자료: 한국동물약품협회, 한국투자증권, 2017)&cr;&cr;</SPAN>
<SPAN USERMARK="F-12">한국동물약품협회에 따르면 국내 동물용 백신 시장 규모는 2010년 이후 연평균 9.3%의 성장을 보이며 동물용 의약품 시장을 이끌고 있습니다. 국내 동물용 백신 시장은 2,200억원으로 추산되며, 영국 조사기관인 MRC는 글로벌 동물용 백신시장은 2022년까지 10조원 시장으로 성장할 것으로 예상합니다.&cr;&cr;</SPAN>
<SPAN USERMARK="F-12"></SPAN>
<SPAN USERMARK="F-12">동물용 백신 시장은 다국적 제약사의 제품을 수입 판매하거나 원액을 수입하여 판매하는 업체가 대부분인데, 이는 백신의 기술 개발 기간이 길고, 제조 설비 구축 및 상업화까지 투자비가 많이 소요되며, 고도의 생산 기술적 노하우가 필요하기 때문에 신규 업체의 초기 시장진입이 쉽지 않기 때문으로 판단됩니다. 따라서 최대 백신 소비국인 미국을 중심으로 독일, 영국 등의 유럽 국가들이 백신 제품의 대부분을 생산하고 있으며, 국내에서는 해외 선진 업체로부터 제품 및 원액을 수입하여 판매하고 있어 수입의존도가 매우 높은 실정입니다.&cr;&cr;다만, 국내에서는 2013년 수의사 처방제를 도입하여 동물용 항생제 사용에 대한 규제를 강화하였고, 2016년 말 발생한 조류독감 이후 정부는 조류독감 및 구제역의 해결방안으로 항생제 사용억제 및 AI백신에 대한 연구 및 한국형 백신 생산체계 구축정책을 발표하였습니다. 실제 국내 동물용 의약품 시장 내 백신이 차지하는 비중은 2010년 23%에서 2016년 31%까지 확대되었습니다.&cr;&cr;현재 정부는 동물약품산업 활성화를 위해 2013년부터 시행중인 '동물용 의약품 산업 </SPAN>
<SPAN USERMARK="F-12">종합지원 사업'과 관련한 </SPAN>
<SPAN USERMARK="F-12">2018년 GMP컨설팅 지원사업을 신설한 바 있으며, 농림축산식품부가 발표한 2020년 예산은 총 81억원으로,</SPAN>
<SPAN USERMARK="F-12 0X0000FF"> </SPAN>
<SPAN USERMARK="F-12">이는 구제역 백신과 식물백신 제조시설 신축 예산이 제외된 금액이지만, 2019년 예산보다 135% 증가한 규모입니다 . </SPAN>
<SPAN USERMARK="F-12 0X0000FF"></SPAN>
<SPAN USERMARK="F-12">이러한 정부정책의 기조는 동 산업에 긍정적인 효과로 작용하여 시장은 더욱 성장할 것으로 전망됩니다.&cr;&cr;(3) 반려견 암 치료 시장&cr;</SPAN>
<SPAN USERMARK="F-12">&cr;</SPAN>
<SPAN USERMARK="F-12">글로벌 반려동물케어시장은 2018년에는 약 159조원에 달하고 이중 약 절반이상은 </SPAN>
<SPAN USERMARK="F-12"> 미</SPAN>
<SPAN USERMARK="F-12">국 반려동물시장이 차지하고 있습니다. &cr;&cr;미국 반려동물협회(APPA, American Pet Products Association)에 따르면 2016년 미국 전체 가정의 68%가 반려동물과 함께 살고 있으며, 그 중 54%의 가정이 반려견과 생활하고 있습니다. 미국 노동 통계청에 따르면 미국 반려동물 가정은 연평균 약 500 달러를 반려동물에 지출하고 있습니다.&cr;&cr;</SPAN>
<SPAN USERMARK="F-12"></SPAN>
<SPAN>                                                                                     (단위: 십억달러)</SPAN>
<SPAN USERMARK="F-12"></SPAN>
</P>

<IMAGE>
<IMG WIDTH="321" HEIGHT="193" ALIGN="CENTER" HSPACE="0">연도별 반려동물 관련 지출 규모.jpg</IMG>
<IMG-CAPTION ATOC="N">연도별 반려동물 관련 지출 규모</IMG-CAPTION>
</IMAGE>

<P USERMARK="F-10">
<SPAN>(자료: APPA, 2018)</SPAN>
<SPAN USERMARK="F-12">&cr;</SPAN>
</P>

<IMAGE>
<IMG WIDTH="296" HEIGHT="152" ALIGN="CENTER" HSPACE="0">반려동물 관련 산업 분포도.jpg</IMG>
<IMG-CAPTION ATOC="N">반려동물 관련 산업 분포도</IMG-CAPTION>
</IMAGE>

<P USERMARK="F-10">
<SPAN USERMARK="F-12"></SPAN>
<SPAN>(자료: APPA, 2018)</SPAN>
<SPAN USERMARK="F-12">&cr;&cr;</SPAN>
<SPAN USERMARK="F-12"></SPAN>
<SPAN USERMARK="F-12"></SPAN>
<SPAN USERMARK="F-12"></SPAN>
<SPAN USERMARK="F-12"></SPAN>
<SPAN USERMARK="F-12"></SPAN>
<SPAN USERMARK="F-12"></SPAN>
<SPAN USERMARK="F-12"></SPAN>
<SPAN USERMARK="F-12">미국 반려동물 의료비 지출은 2014년 150억 달러를 넘어섰으며, 반려동물 관련 평균지출액 또한 의료 및 수술 분야가 가장 큰 부분을 차지하고 있습니다.</SPAN>
<SPAN USERMARK="F-12"> </SPAN>
<SPAN USERMARK="F-12">총 반려견의 1/3에 해당하는 반려견은 일생의 한 시점에서 암에 걸리고, 10살 이상 노령견의 50%는 암으로 인해 사망하는 실정으로, </SPAN>
<SPAN USERMARK="F-12">암은 2살 이상의 반려견 사망률 1위일 정도로 가장 주된 사망 원인이며, 매년 미국에서만 약 6백만 마리의 반려견이 신규로 암에 걸리고 있습니다.</SPAN>
<SPAN USERMARK="F-12"> &cr;</SPAN>
<SPAN USERMARK="F-12"></SPAN>
<SPAN>(*) NC State College of Veterinary Medicine&cr;</SPAN>
<SPAN USERMARK="F-12">&cr;미국 뿐 아니라 중국의 반려동물시장도 성장이 가속화되고 있습니다. 중국 반려동물산업백서에 따르면 중국의 반려동물시장은</SPAN>
<SPAN USERMARK="F-12"> 2020년 330억 달러에 이를 것으로 예상합니다. </SPAN>
<SPAN USERMARK="F-12"></SPAN>
<SPAN USERMARK="F-12"></SPAN>
<SPAN USERMARK="F-12"></SPAN>
<SPAN USERMARK="F-12"></SPAN>
<SPAN USERMARK="F-12"></SPAN>
<SPAN USERMARK="F-12"></SPAN>
<SPAN USERMARK="F-12"> </SPAN>
<SPAN USERMARK="F-12"></SPAN>
<SPAN USERMARK="F-12"></SPAN>
<SPAN USERMARK="F-12">1·2인</SPAN>
<SPAN USERMARK="F-12">가</SPAN>
<SPAN USERMARK="F-12">구의</SPAN>
<SPAN USERMARK="F-12"> 급</SPAN>
<SPAN USERMARK="F-12">증 </SPAN>
<SPAN USERMARK="F-12">및 </SPAN>
<SPAN USERMARK="F-12">인구</SPAN>
<SPAN USERMARK="F-12"> 고</SPAN>
<SPAN USERMARK="F-12">령화</SPAN>
<SPAN USERMARK="F-12">로 </SPAN>
<SPAN USERMARK="F-12">반려</SPAN>
<SPAN USERMARK="F-12">동물</SPAN>
<SPAN USERMARK="F-12">을 키우는 인구가 </SPAN>
<SPAN USERMARK="F-12">2010년 대비 약 15배의 수치로</SPAN>
<SPAN USERMARK="F-12"> 증가하면서 관련 제</SPAN>
<SPAN USERMARK="F-12">품 시장이 지속적으로 확대되고 있는 추세입니다. 중국까지 가세한 폭발적인 시장 추세는 단기에 그치지 않을 것으로 판단됩니다.&cr;</SPAN>
<SPAN USERMARK="F-12">&cr;</SPAN>
<SPAN USERMARK="F-12"></SPAN>
<SPAN USERMARK="F-12">현재 마땅한 반려견 전용 암 치료제는 없으며, 가장 많이 사용하는 반려견 종양치료옵션(방사선 치료, 화학치료, 외과수술)에 드는 비용은 약 1만 달러를 상회합니다. 외과수술의 경우 1회당 평균 약 1,500달러가 소요되며, 연간 미국 반려견 암 관련 외과수술 시장만 약 6억 달러 상당으로 추정됩니다. &cr;</SPAN>
<SPAN>(*) National Canine Cancer Foundation, 2013</SPAN>
<SPAN USERMARK="F-12">.&cr;</SPAN>
<SPAN USERMARK="F-12">&cr;현재 반려견 암 치료는 매우 제한적으로 주로 외과수술에 의존하는 실정으로, 전신마취 후 수술 등은 치료의 보장도 없을뿐더러, 치료과정이 질병 자체보다 더 큰 괴로움을 안겨줄 수 있거나, 치료 도중 사망할 가능성도 큽니다. &cr;</SPAN>
<SPAN>(*) American Veterinary Medical Association, 2013.&cr;</SPAN>
<SPAN USERMARK="F-12">&cr;이러한 반려견 암치료 시장은 생물학, 수의학, 약학 등 다양한 분야의 전문적 지식이 복합적으로 요구되는 고도의 기술산업으로 단기간 기술력을 축적할 수 없으며 진입장벽이 높은 고부가가치 산업으로 판단됩니다. 반려동물 시장의 확대와 반려동물의 가족화인 '펫팸족'의 증가는 동사의 연구개발사업에 긍정적 효과로 작용할 것입니다.&cr;&cr;(4) 돼지 의약품 시장&cr;&cr;중국에 있는 돼지 수는 4.4억 마리에 육박하며 이는 전세계 돼지수의 약 50% 정도로 추정되는 독보적으로 큰 주요 시장입니다. 연간 도축되는 돼지 수가 약 6천만 마리 규모임에도 불구하고 수요를 충족하지 못해 일정 부분은 수입까지 하는 실정입니다.&cr;&cr;현재 중국 정부는 자국 내 돈육의 질을 엄격히 관리하고 있는 실정으로 매년 모든 돼지 농가에 4대 주요 돼지 질병인 구제역, 조류독감, 돼지독감 신종플루, PRRS (청이병:돼지 호흡기 생식기 증후군) 에 대한 백신 접종을 의무화하고 있습니다. 또한 락토파민 성분이 함유된 미국산 돼지고기의 수입을 금지하고 있습니다.&cr;&cr;전 세계적으로 건강한 단백질 소비와 항생제 내성에  대한 높은인식 형성으로 성장촉진용으로 사용중인 항생제를 돼지에 투여하는 것을 지양하는 추세에 있습니다. &cr;&cr;또한 개발도상국의 경우 경제성장, 육류 수요 증가 등의 요인으로 축산업이 확대되고 있으며, 육류 생산량 증가와 동물용 의약품 시장도 확대되는 추세입니다. 특히 베트남의 경우 정부의 돼지 공급 확대 정책 등의 요인으로 연평균 7.8%의 돼지 소비 증가 추세이며, 이에 따라 백신 등 동물용 의약품 수요가 증가할 것으로 예상됩니다.&cr;</SPAN>
<SPAN USERMARK="F-12"></SPAN>
</P>

<IMAGE>
<IMG WIDTH="551" HEIGHT="527" ALIGN="CENTER" HSPACE="0">주요 글로벌 돼지 생산 국가.jpg</IMG>
<IMG-CAPTION ATOC="N">주요 글로벌 돼지 생산 국가</IMG-CAPTION>
</IMAGE>

<P USERMARK="F-10">
<SPAN USERMARK="F-12">&cr;</SPAN>
<SPAN USERMARK="F-12 0X1814FF"></SPAN>
<SPAN USERMARK="F-12"></SPAN>
<SPAN USERMARK="F-16"></SPAN>
<SPAN USERMARK="F-14 0XFF1200 B">나. 회사의 사업&cr;</SPAN>
<SPAN USERMARK="F-14 B">&cr;</SPAN>
<SPAN USERMARK=" B"></SPAN>
<SPAN USERMARK="F-12 B"></SPAN>
<SPAN USERMARK="F-12">(1) 국내 경쟁ㆍ유사 업체&cr;&cr;국내에는 당사와 같이 바이오 3세대 의약품인 핵산의약품 기술 기반의 동물DNA의약품 회사는 전무한 상태이며, 대부분의 동물의약품 회사는 사료첨가제, 항생제, 구충제, 영양제 등을 생산하거나 해외에서 수입하여 판매하고 있는 실정입니다. &cr;</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="625">

<COLGROUP>
<COL WIDTH="101"></COL>
<COL WIDTH="50"></COL>
<COL WIDTH="50"></COL>
<COL WIDTH="69"></COL>
<COL WIDTH="62"></COL>
<COL WIDTH="70"></COL>
<COL WIDTH="160"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="110" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" USERMARK=" BC0XD7D7D7">
<P>업체</P>
</TD>

<TD WIDTH="59" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" USERMARK=" BC0XD7D7D7">
<P>설립</P>
</TD>

<TD WIDTH="59" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" USERMARK=" BC0XD7D7D7">
<P>상장</P>
</TD>

<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" USERMARK=" BC0XD7D7D7">
<P>시가총액&cr;('19.12.)</P>
</TD>

<TD WIDTH="71" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" USERMARK=" BC0XD7D7D7">
<P>매출액</P>
<P>('19)</P>
</TD>

<TD WIDTH="79" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" USERMARK=" BC0XD7D7D7">
<P>영업익</P>
<P>('19)</P>
</TD>

<TD WIDTH="169" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" USERMARK=" BC0XD7D7D7">
<P>주요제품</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="110" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">이지바이오</TD>

<TD WIDTH="59" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">
<P>1988년</P>
</TD>

<TD WIDTH="59" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">
<P>1999년</P>
</TD>

<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="76">
<P>2,888억</P>
</TD>

<TD WIDTH="71" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="76">
<P>16,149억</P>
</TD>

<TD WIDTH="79" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="76">
<P>416억</P>
</TD>

<TD WIDTH="169" VALIGN="MIDDLE" HEIGHT="76">
<P>의약품, 동물약품, 기능성식품의 원료 개발 및 제조, 판매, 수출입업</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="110" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>대한뉴팜</P>
</TD>

<TD WIDTH="59" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>1984년</P>
</TD>

<TD WIDTH="59" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>2002년</P>
</TD>

<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">
<P>1,493억</P>
</TD>

<TD WIDTH="71" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">
<P>1,341억</P>
</TD>

<TD WIDTH="79" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">
<P>207억</P>
</TD>

<TD WIDTH="169" VALIGN="MIDDLE" HEIGHT="53">
<P>동물의약품, 인체의약품, 바이오의약품 등</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="110" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">
<P>㈜CTC바이오</P>
</TD>

<TD WIDTH="59" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">
<P>1996년</P>
</TD>

<TD WIDTH="59" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">
<P>2002년</P>
</TD>

<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="76">
<P>1,178억</P>
</TD>

<TD WIDTH="71" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="76">
<P>1,361억</P>
</TD>

<TD WIDTH="79" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="76">
<P>Δ40억</P>
</TD>

<TD WIDTH="169" VALIGN="MIDDLE" HEIGHT="76">
<P>동물약품, 인체약품, 사료첨가제 및 단미보조사료, 건강기능성식품 등</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="110" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>Komipharm</P>
</TD>

<TD WIDTH="59" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>1972년</P>
</TD>

<TD WIDTH="59" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>2001년</P>
</TD>

<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">
<P>9,744억</P>
</TD>

<TD WIDTH="71" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">
<P>355억</P>
</TD>

<TD WIDTH="79" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">
<P>Δ54억</P>
</TD>

<TD WIDTH="169" VALIGN="MIDDLE" HEIGHT="53">
<P>동물의약품, 인체의약품 등</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="110" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>㈜이글벳</P>
</TD>

<TD WIDTH="59" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>1970년</P>
</TD>

<TD WIDTH="59" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>2000년</P>
</TD>

<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">
<P>848억</P>
</TD>

<TD WIDTH="71" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">
<P>342억</P>
</TD>

<TD WIDTH="79" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">
<P>19억</P>
</TD>

<TD WIDTH="169" VALIGN="MIDDLE" HEIGHT="53">
<P>동물약품, 동물용사료, 건강기능성식품 등</P>
</TD>
</TR>
</TBODY>
</TABLE>

<P USERMARK="F-10">
<SPAN USERMARK="F-12">&cr;(2) </SPAN>
<SPAN USERMARK="F-12">해외 경쟁·유사 업체</SPAN>
<SPAN USERMARK="F-12">&cr;&cr;국내와 달리 해외에선 동사와 유사한 바이오 의약품 기술 기반의 반려동물 의약품 전문 개발 회사가 존재하지만 대부분 재조합 단백질 또는 항체 기술을 기반으로 신약을 개발하고 있습니다. 미국에서는 2013년부터 동 분야의 업체들이 시장의 가치를 인정받으며 미국 증시에 상장하기 시작했습니다.</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="623">

<COLGROUP>
<COL WIDTH="85"></COL>
<COL WIDTH="92"></COL>
<COL WIDTH="98"></COL>
<COL WIDTH="98"></COL>
<COL WIDTH="98"></COL>
<COL WIDTH="98"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="94" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" USERMARK=" BC0XD7D7D7">
<P>구분</P>
</TD>

<TD WIDTH="101" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" USERMARK=" BC0XD7D7D7">
<P>Zoetis</P>
</TD>

<TD WIDTH="107" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" USERMARK=" BC0XD7D7D7">
<P>Phibro Animal</P>
<P>Health</P>
</TD>

<TD WIDTH="107" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" USERMARK=" BC0XD7D7D7">
<P>Aratana</P>
<P>Therapeutics</P>
</TD>

<TD WIDTH="107" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" USERMARK=" BC0XD7D7D7">
<P>Kindred</P>
<P>Biosciences</P>
</TD>

<TD WIDTH="107" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" USERMARK=" BC0XD7D7D7">
<P>동사</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="94" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>주력동물</P>
</TD>

<TD WIDTH="101" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>가축/&cr;반려동물</P>
</TD>

<TD WIDTH="107" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>가축동물</P>
</TD>

<TD WIDTH="107" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>반려동물</P>
</TD>

<TD WIDTH="107" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>반려동물</P>
</TD>

<TD WIDTH="107" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>가축/반려동물</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="94" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="99">
<P>핵심개발</P>
</TD>

<TD WIDTH="101" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="99">
<P>다양</P>
</TD>

<TD WIDTH="107" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="99">
<P>다양</P>
</TD>

<TD WIDTH="107" VALIGN="MIDDLE" HEIGHT="99">
<P>반려견 림프종 퇴행성 관절염</P>
</TD>

<TD WIDTH="107" VALIGN="MIDDLE" HEIGHT="99">
<P>반려견 아토피 피부염,퇴행성 관절염</P>
</TD>
<TD WIDTH="107" VALIGN="MIDDLE" HEIGHT="99" ALIGN="CENTER">돼지DNA면역조절제, 반려견DNA면역항암제</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="94" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">
<P>기업공개</P>
</TD>

<TD WIDTH="101" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">
<P>2013.2</P>
<P>NYSE</P>
<P>(XXTS)</P>
</TD>

<TD WIDTH="107" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">
<P>2014.4</P>
<P>나스닥</P>
<P>(PAHC)</P>
</TD>

<TD WIDTH="107" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">
<P>2013.7</P>
<P>나스닥</P>
<P>(PETX)</P>
</TD>

<TD WIDTH="107" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">
<P>2013.12</P>
<P>나스닥</P>
<P>(KIN)</P>
</TD>

<TD WIDTH="107" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">
<P>2015.07</P>
<P>코넥스</P>
<P>(222670)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="94" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>시가총액</P>
<P>('21.03.01)</P>
</TD>
<TD WIDTH="101" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">74억달러</TD>

<TD WIDTH="107" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">
<P>9.2억달러</P>
</TD>

<TD WIDTH="107" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>(*)</P>
</TD>

<TD WIDTH="107" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">
<P>1.8억달러</P>
</TD>

<TD WIDTH="107" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">
<P>224억원</P>
</TD>
</TR>
</TBODY>
</TABLE>

<P USERMARK="F-10">
<SPAN>(*) 2019년에 Elanco가 2.45억달러에 Aratana Therapeutics를 인수</SPAN>
<SPAN>하였습니다.&cr;</SPAN>
<SPAN USERMARK="F-12">&cr;</SPAN>
<SPAN USERMARK="F-12"></SPAN>
<SPAN USERMARK="F-12">(</SPAN>
<SPAN USERMARK="F-12">3</SPAN>
<SPAN USERMARK="F-12">) 회사의 핵심기술   </SPAN>
<SPAN USERMARK="F-12">&cr;</SPAN>
<SPAN USERMARK="F-12">&cr;(가) 동물DNA의약품 기술 </SPAN>
</P>

<P USERMARK="F-10">
<SPAN USERMARK="F-12">&cr;</SPAN>
<SPAN USERMARK="F-12">3세대 바이오 의약품인 핵산의약품</SPAN>
<SPAN USERMARK="F-12"></SPAN>
<SPAN USERMARK="F-12"></SPAN>
<SPAN USERMARK="F-12"></SPAN>
<SPAN USERMARK="F-12"> </SPAN>
<SPAN USERMARK="F-12"></SPAN>
<SPAN USERMARK="F-12">기술 기반의 동물용</SPAN>
<SPAN USERMARK="F-12"> DNA</SPAN>
<SPAN USERMARK="F-12">의약품을 개발중인</SPAN>
<SPAN USERMARK="F-12"> </SPAN>
<SPAN USERMARK="F-12">당사의 기</SPAN>
<SPAN USERMARK="F-12">술은 미국 나스닥 상장사인 Inovio Pharmaceuticals (NASDAQ:Ino)의 DNA의약품 기술입니다</SPAN>
<SPAN USERMARK="F-12">. 미국 </SPAN>
<SPAN USERMARK="F-12">Inovio</SPAN>
<SPAN USERMARK="F-12">사는 인체용 DNA의약품을 개발하는 제약사이며, 당사는 </SPAN>
<SPAN USERMARK="F-12">Inovio</SPAN>
<SPAN USERMARK="F-12">사</SPAN>
<SPAN USERMARK="F-12">와 동일한 기술 플랫폼으로 동물용 DNA의약품을 개발하고 있습니다. </SPAN>
<SPAN USERMARK="F-12"> &cr;</SPAN>
<SPAN USERMARK="F-12">&cr;</SPAN>
<SPAN USERMARK="F-12">기존에 승인받은 대부분의 가축용 백신은 바이러스 기반의 백신으로 안전성이 상대적으로 낮습니다. 이에 반해 당사의 DNA백신의 경우 바이러스가 아닌 타겟한 바이러스의 항원DNA서열을 이용해 몸에서 바이러스 방어에 필요한 항체와 세포성면역을 유발하기에 안전하고 예방 및 치료까지 가능한 차세대 백신입니다. 당사의 동물DNA의약품 기술은 글로벌 독점특허를 통해 보호받고 있으며 진입장벽이 상당히 높은 고도의 기술입니다.&cr;&cr;(나) CELLECTRA? (</SPAN>
<SPAN USERMARK="F-12">정전압 방식이 아닌 정전류 기반의 Electroporation)  &cr;&cr;정전류를 통과시켜 세포 내로 DNA 의약품을 투여하는 방식으로 DNA의약품의 핵심적인 전달 기술입니다. 당사가 사용하는 Electroporation 기술은 정전류 펄스에 의해 세포막이 일시적으로 열려 플라스미드의 세포 진입을 용이하게 해줍니다. 현재까지 우리가 알고 있는 기술 중 플라스미드 기반의 DNA의약품을 가장 효율적이며 안전하게 세포 내로 전달시키는 기술입니다. &cr;</SPAN>&cr;
</P>
<P USERMARK="F-16 0XFF0000 B">2. 회사의 현황</P>

<P>&cr;(1) 회사의 개요&cr;&cr;
<SPAN>당사는 2014년 1월 설립 후 동년 5월에 미국 Inovio(NASDAQ: INO)의 동물용의약품 자회사인 VGX Animal Health, Inc.의 자산을 100% 인수하였습니다. 동사가 인수한 회사의 전신은 1997년 미국 텍사스주에서 설립된 Applied Veterinary Systems사로 2007년 Inovio사에게 피인수 된 바 있습니다.</SPAN>
<SPAN> Inovio사와 VGX Pharmaceuticals은 2020년 말 기준으로 합병되어, 제출일 현재 Inovio사가 당사의 지분을 약 20% 보유하고 있습니다</SPAN>
<SPAN>.</SPAN>
<SPAN> </SPAN>
<SPAN>당</SPAN>
<SPAN>사는</SPAN>
<SPAN> 특화된 DNA의약품 기술과 DNA의약품 전달기인 CELLECTRA?기술을 사용하여 동물 종별로 특화된 동물용 DNA의약품을 연구·개발 및 생산하는 바이오 벤처기업으로, 2015년 7월 28일 코넥스시장에 상장하였습니다.&cr;&cr;당사의 기본적인 비즈니스 모델은 인수한 해외 자산의 이용 및 국내에서 개발한 기술을 기반으로 혁신 동물신약을 연구·개발 및 생산하여 글로</SPAN>벌 시장에 진출하는 것입니다. 이를 위해 동사는 국내·외 오픈 이노베이션과 비즈니스 협업 및 라이선스 아웃을 통해 회사의 가치를 성장시키기 위해 노력하고 있습니다.&cr;&cr;
<SPAN USERMARK=" 0X0000FF"></SPAN>
<SPAN USERMARK=" 0X0000FF"></SPAN>
<SPAN></SPAN>
<SPAN>(2) 조직도&cr;</SPAN>
</P>

<IMAGE>
<IMG WIDTH="600" HEIGHT="318" ALIGN="CENTER" HSPACE="0">조직도(2020.12.31).jpg</IMG>
<IMG-CAPTION ATOC="N">조직도(2020.12.31)</IMG-CAPTION>
</IMAGE>

<P>
<SPAN>&cr;(3) 보유제품ㆍ파이프라인 및 예상 진행 일정&cr;</SPAN>
<SPAN></SPAN>
</P>

<IMAGE>
<IMG WIDTH="600" HEIGHT="347" ALIGN="CENTER" HSPACE="0">주요 파이프라인 및 예상 진행 일정.jpg</IMG>
<IMG-CAPTION ATOC="N">주요 파이프라인 및 예상 진행 일정</IMG-CAPTION>
</IMAGE>

<P>
<SPAN>&cr;&cr;</SPAN>
<SPAN>(가) LifeTide? SW5.0 (돼지DNA면역조절제) &cr;&cr;돼지DNA면역조절제인 LifeTide? SW5.0는 전 세계에서 소고기와 더불어 가장 소비가 많이 되는 돼지고기를 겨냥한 제품입니다. 동사의 제품은 세계 최초로 2008년 호주, 2012년 뉴질랜드에서 승인된 돼지DNA면역조절제로 전 세계적으로 매년 약 5조원(2021년 예상*) 규모로 소비되는 성장용 목적으로 사용되는 항생제를 대체할 수 있는 제품입니다. 또한 Non-GMO로 인증을 받고 동물복지와 인체건강을 고려하여 개발한 제품으로 현대 소비자가 원하는 좋은 품질의 단백질을 제공하고, 농가에는 탁월한 경제성을 제공할 것 입니다.&cr;</SPAN>
<SPAN USERMARK="F-10">(*) marketsandmarkets, 2016.&cr;</SPAN>
<SPAN>&cr;동사는 2018년 5월 9일 국내검역본부로부터 LifeTide? SW5.0의 동물용 의약품등 수입 품목허가를 득하였으며, 향후 국내판매를 위해 필요한 절차도 준비 중에 있습니다. 2018년 7월 18일 호주의 동물제약사인 APIAM사와 호주 및 뉴질랜드 독점판매계약을 체결하여 호주 및 뉴질랜드 시장에서의 본격적인 매출을 기대하고 있으며, 기승인 받은 이력을 바탕으로 중국, 미국 유럽 등에 라이선스 아웃 계약을 계획하고 있습니다. &cr;&cr;</SPAN>
<SPAN></SPAN>
<SPAN>(나) PLS-D5000 (반려견DNA면역항암제) &cr;&cr;반려견DNA면역항암제 PLS-D5000는 2017년 4월 농림축산식품연구개발사업의 과제 대상으로 선정되어 2018년 12월 31일까지 '플라스미드 DNA백신 기술을 이용한 반려견 항암 면역치료제 개발' 과제를 수행하였습니다. 해당 과제의 연구 결과를 바탕으로 2019년 하반기에 국내판매승인을 목적으로 농림축산검역본부에 임상</SPAN>
<SPAN></SPAN>
<SPAN>허가 신청을 하였습니다.&cr;&cr;</SPAN>
<SPAN>PLS-D5000은 마땅한 치료제가 없는 글로벌 반려견 암 치료 시장을 겨냥함으로써, 동물의약품 분야에 새로운 고부가가치제</SPAN>
<SPAN>품을 창출해 나갈 것으로 기대됩니다. 향후 동 제품의 글로벌 라이선스 아웃 계약 및 파트너쉽도 모색해 나갈 계획입니다.&cr;&cr;</SPAN>(다) PLS-D1000 (반려견DNA면역조절제)&cr;&cr;반려견DNA면역조절제인 PLS-D1000은 7살 이상의 노령견을 대상으로, 기승인 받은 돼지DNA면역조절제(LifeTide? SW5.0)와 같은 기전의 제품으로써 반려견의 DNA를 사용하여 개발 중 입니다.
</P>

<P>
<SPAN>&cr;우리나라에도 이미 1,000만 명 이상이 반려견과 함께 생활하고 있으며, 2020년 예상되는 관련 시장의 규모는 약 6조원(*)으로 향후 시장규모는 더욱 성장할 것이라고 예상되고 있습니다. 7살 이상의 노령견에게 특화된 PLS-D1000의 시장규모는 반려견의 고령화와 더불어 급속한 성장세를 보일 것으로 많은 전문가가 예상하고 있습니다. </SPAN>
<SPAN USERMARK="F-10">(*) 농협경제연구소, 2017.&cr;&cr;</SPAN>
<SPAN>또한 국내 승인 후 글로벌 동물 제약사들과의 라이센싱 아웃 계약을 통해, 현재 전 세계에서 가장 큰 규모의 반려동물 시장인 미국을 필두로 이미 반려동물시장이 성숙된 유럽시장 및 2025년 이후 전 세계에서 가장 큰 반려동물시장을 형성하게 될 중국시장에 진출을 계획하고 있습니다. &cr;&cr;PLS-D1000(반려견DNA면역조절제) 또한 PLS-D5000(반려견DNA면역항암제)와 마찬가지로 2019년 하반기 국내 농림축산검역본부에 임상허가를 신청하였습니다.&cr;</SPAN>
<SPAN>&cr;(라) </SPAN>
<SPAN>PLS-FMD(구제역 3가(A·O</SPAN>
<SPAN>·Asia1)DNA</SPAN>
<SPAN>백신)&cr;</SPAN>
<SPAN>&cr;</SPAN>
<SPAN>당사는 2016년 FMDV(foot-and-mouth disease vaccine) 라이센싱 인 후, 2017년 10월 정부국책과제(3가 구제역DNAvaccine)에 선정되어 2018년 9월까지 목적동물에 대한 면역원성 검증 시험을 수행하였습니다. 이 과제를 통해 효율적 면역반응 유도, 정부 구제역정책과 부합한 신속 대응 및 생산, 해외 수입 대체 등의 효과를 기대하고 있으며, 용량과 투여 횟수의 최적화를 진행하고 있습니다.&cr;&cr;구제역 바이러스가 전 세계적으로 매년 야기하는 직</SPAN>
<SPAN USERMARK=" 0X0000FF"></SPAN>
<SPAN>·간접적인 경제적 손실은 매년 증가하고 있으며, 구제역 바이러스 백신 시장규모는 2025년까지 매년 8%씩 성장하여 총 30억달러(한화 약 3조 6천억원*)를 넘을 것으로 예상되고 있습니다.&cr;</SPAN>
<SPAN USERMARK="F-10">(*) marketwatch, 2019.&cr;</SPAN>
<SPAN>&cr;당사가 개발하는 구제역DNA백신은 오일성분의 부형제를 사용하지 않음으로써, 현재 구제역 백신 접종 시 오일부형제에 의하여 불가피하게 발생하는 주사부위의 이상육 피해(연간 최대 약 2,700억원*)가 발생하지 않는 장점도 있습니다. 당사의 구제역DNA백신은 이상육 발생을 없애고 구제역 예방의 효과도 누릴 수 있는 제품입니다.</SPAN>
<SPAN USERMARK="F-10"></SPAN>
<SPAN USERMARK="F-10"></SPAN>
<SPAN USERMARK="F-10"> &cr;(*) 한국농어민신문, 2018.</SPAN>
<SPAN USERMARK="F-10">&cr;</SPAN>
<SPAN USERMARK="F-10"></SPAN>&cr;
<SPAN>(마) PLS-ASF(아프리카돼지열병DNA백신)&cr;&cr;아프리카돼지열병 바이러스는 2018년 중국에서 처음 발현한 후 1년여 만에 중국의 31개 성에 전파되었으며, 치사율이 거의 100%에 달하는 특성으로 인해 2019년 국내 발발 후 경기 이북 지역 대부분의 양돈농가 폐쇄를 야기하여, 엄청난 피해를 안겨 주었습니다. &cr;&cr;</SPAN>글로벌 동물제약시장에서 전문가들이 많이 구독하는 Animal Pharm 잡지사의 Joseph Harvey 칼럼리스트의 2019년 10월 리포트에 의하면, 중국의 아프리카돼지열병 바이러스에 의한 피해는 2019년 10월 기준으로 모돈의 수는 전년 대비 38.9%, 전체 돼지 수는 전년 대비 41.4%가 감소하는 결과를 초래하며 중국에 전대미문의 손해를 입혔습니다.&cr;
<SPAN USERMARK="F-10">(*) Animal Pharm Agribusiness, 2020.&cr;</SPAN>&cr;
<SPAN>당사는 2019년부터 아프리카돼지열병DNA백신을 개발하여 2020년도에 첫번째 목적동물 챌린지에서 유의미한 결과를 확인하였습니다. </SPAN>
<SPAN>2021년에 추가로 공격접종챌린지가 진행 예정이며, 이 결과에 따라 임상신청을 진행할 예정입니다.</SPAN>
<SPAN>&cr;</SPAN>&cr; 아프리카돼지열병은 전염율 및 치사율이 매우 높아 바이러스가 퍼지지 않은 국가에서는 약독화 하였다고 하여도 기존 바이러스를 이용하는 백신의 공격 접종 임상은 현실적으로 불가능하므로 바이러스를 사용하지 않는 당사의 DNA백신에 대한 기대는 전 세계적으로 증가 추세에 있습니다.&cr;&cr;(4) 연구개발활동&cr;&cr;
<SPAN>(가) 연구개발활동의 개요&cr;&cr;</SPAN>
<SPAN>당사는 2015년 5월 20일 한국산업기술진흥협회로부터 기업부설연구소 인정을 받아 연구소를 통하여 바이오기술 기반 동물DNA의약품의 연구 및 개발활동을 수행하고 있습니다.</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="626">

<COLGROUP>
<COL WIDTH="152"></COL>
<COL WIDTH="169"></COL>
<COL WIDTH="161"></COL>
<COL WIDTH="108"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" BC0XD7D7D7" WIDTH="161" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">연구소명</TD>
<TD USERMARK=" BC0XD7D7D7" WIDTH="178" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">위치</TD>
<TD USERMARK=" BC0XD7D7D7" WIDTH="170" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">연구내용</TD>
<TD USERMARK=" BC0XD7D7D7" WIDTH="117" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">설립일</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="161" HEIGHT="76">(주)플럼라인생명과학 &cr;기업부설연구소</TD>
<TD WIDTH="178" HEIGHT="76">서울시 서초구 반포대로 222</TD>
<TD WIDTH="170" HEIGHT="76">바이오기술 기반 동물&cr;DNA의약품 연구 및 개발</TD>
<TD WIDTH="117" HEIGHT="76" ALIGN="CENTER" VALIGN="MIDDLE">2015.05.20</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN>&cr;(나) 연구개발 담당조직&cr; 1) 연구개발 조직 구성</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="623">

<COLGROUP>
<COL WIDTH="111"></COL>
<COL WIDTH="162"></COL>
<COL WIDTH="323"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" BC0XD7D7D7" WIDTH="120" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">구  분</TD>
<TD USERMARK=" BC0XD7D7D7" WIDTH="171" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">본부/부문</TD>
<TD USERMARK=" BC0XD7D7D7" WIDTH="332" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">주요 업무</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="120" HEIGHT="196" ROWSPAN="5" VALIGN="MIDDLE" ALIGN="CENTER">연구소</TD>
<TD WIDTH="171" HEIGHT="30" VALIGN="MIDDLE">글로벌 신약개발 본부</TD>
<TD WIDTH="332" HEIGHT="30" VALIGN="MIDDLE">연구소 총괄 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="171" HEIGHT="53" VALIGN="MIDDLE">반려동물부문</TD>
<TD WIDTH="332" HEIGHT="53" VALIGN="MIDDLE">반려견 DNA면역조절제, 반려견 DNA 면역항암제 등 연구개발</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="171" HEIGHT="53" VALIGN="MIDDLE">가축부문</TD>
<TD WIDTH="332" HEIGHT="53" VALIGN="MIDDLE">아프리카돼지열병DNA백신, 구제역3가DNA백신 등 연구개발</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="171" HEIGHT="30" VALIGN="MIDDLE">글로벌 임상부문</TD>
<TD WIDTH="332" HEIGHT="30" VALIGN="MIDDLE">글로벌 임상시험</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="171" HEIGHT="30" VALIGN="MIDDLE">연구지원부문</TD>
<TD WIDTH="332" HEIGHT="30" VALIGN="MIDDLE">연구지원</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN></SPAN>
</P>

<IMAGE>
<IMG WIDTH="600" HEIGHT="200" ALIGN="CENTER" HSPACE="0">연구소 조직도.jpg</IMG>
<IMG-CAPTION ATOC="N">연구소 조직도</IMG-CAPTION>
</IMAGE>

<P>
<SPAN>&cr; 2) 연구개발 인력 현황</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="610">

<COLGROUP>
<COL WIDTH="121"></COL>
<COL WIDTH="166"></COL>
<COL WIDTH="68"></COL>
<COL WIDTH="67"></COL>
<COL WIDTH="67"></COL>
<COL WIDTH="67"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="2" ROWSPAN="2" WIDTH="305" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" USERMARK=" BC0XD7D7D7">구  분</TD>
<TD COLSPAN="4" WIDTH="305" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">인  원</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="77" HEIGHT="30" USERMARK=" BC0XD7D7D7">박 사</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="76" HEIGHT="30" USERMARK=" BC0XD7D7D7">석 사</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="76" HEIGHT="30" USERMARK=" BC0XD7D7D7">기 타</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="76" HEIGHT="30" USERMARK=" BC0XD7D7D7">합 계</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="5" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="130" HEIGHT="150">연구소</TD>
<TD VALIGN="MIDDLE" WIDTH="175" HEIGHT="30">글로벌 신약개발 본부</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="77" HEIGHT="30">1</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="76" HEIGHT="30">-</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="76" HEIGHT="30">-</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="76" HEIGHT="30">1</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="175" HEIGHT="30">반려동물부문</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="77" HEIGHT="30">1</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="76" HEIGHT="30">-</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="76" HEIGHT="30">-</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="76" HEIGHT="30">1</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="175" HEIGHT="30">가축부문</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="77" HEIGHT="30">-</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="76" HEIGHT="30">1</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="76" HEIGHT="30">-</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="76" HEIGHT="30">1</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="175" HEIGHT="30">글로벌 임상부문</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="77" HEIGHT="30">-</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="76" HEIGHT="30">1</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="76" HEIGHT="30">-</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="76" HEIGHT="30">1</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="175" HEIGHT="30">연구지원부문</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="77" HEIGHT="30">-</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="76" HEIGHT="30">-</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="76" HEIGHT="30">1</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="76" HEIGHT="30">1</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="2" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="305" HEIGHT="30" USERMARK=" BC0XD7D7D7">합  계</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="77" HEIGHT="30" USERMARK=" BC0XD7D7D7">2</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="76" HEIGHT="30" USERMARK=" BC0XD7D7D7">2</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="76" HEIGHT="30" USERMARK=" BC0XD7D7D7">1</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="76" HEIGHT="30" USERMARK=" BC0XD7D7D7">5</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN>&cr; 3) 핵심 연구인력</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="627">

<COLGROUP>
<COL WIDTH="69"></COL>
<COL WIDTH="54"></COL>
<COL WIDTH="69"></COL>
<COL WIDTH="129"></COL>
<COL WIDTH="261"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">직 위</TD>
<TD WIDTH="63" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">성 명</TD>
<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">담당업무</TD>
<TD WIDTH="138" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">주요 경력</TD>
<TD WIDTH="270" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">주요 연구실적</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="2560">연구소장&cr; (상무)</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="63" HEIGHT="2560">김은진</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="78" HEIGHT="2560">연구총괄</TD>
<TD WIDTH="138" VALIGN="MIDDLE" HEIGHT="2560"> - 에이비온㈜ 부설연구소 : 전문위원&cr; - 서울대학교 생명과학부 &cr;: 연수연구원&cr; - 연세대학교 의생명과학부 : 강사/&cr; 연구조교수</TD>
<TD VALIGN="MIDDLE" WIDTH="270" HEIGHT="2560">논문:&cr;1. Sclerostin inhibits Wnt signaling through tandem interaction with two LRP6 ectodomains (2020, Nature.  Communication.)&cr;2. Cyclized Oligopeptide Targeting LRP5/6-DKK1 Interaction Reduces the Growth of Tumor Burden in a Multiple Myeloma Mouse Model (2017, Yonsei Med. J)&cr;3. The systemic effects of sclerostin overexpression using ΦC31 integrase in mice (2016, Biochem Biophys Res Commun.)&cr;4. Pax6 expressed in osteocytes inhibits canonical Wnt signaling &cr;(2013, Molecules and Cells)&cr;5. miR-182 is a negative regulator of osteoblast proliferation, differentiation, and skeletogenesis through targeting FoxO1(2012, Journal of Bone and Mineral Research)&cr;6. Estimating P-Coverage of Biosynthetic Pathways in DNA Libraries and Screening by Genetic Selection: Biotin Biosynthesis in the Marine Microorganism Chromohalobacter (2008, Molecular BioSystems)&cr;7. Evidence for a Proton Transfer Network and a Required Persulfide-Bond-Forming Cysteine Residue in Ni-Containing Carbon Monoxide Dehydrogenases&cr;(2004, Biochemistry)&cr;8. Ni-Zn-[Fe4-S4]andNi-Ni-[Fe4-S4]clustersinclosedandopena subunits of acetyl-CoA synthase/carbon monoxide dehydrogenase (2003, Nature Structural & Molecular Biology)&cr;&cr;국제 학회발표:&cr;1. DKK1 Inhibiting Oligopeptide Reduces Tumor Burden and Bony Destruction in a Mouse Model for Multiple Myeloma (MOPC315.BM.Luc+) (2015, Endocrine Society's 97th Annual Meeting and Expo, USA)&cr;2. Flavonoid class compounds abrogating sclerostin induced inhibition of Wnt/beta catenin signaling (2014, The America Society of Bone and Mineral Research Annual Meeting, USA)&cr;3.The NXI motif and its neighboring residues of Sclerostin play an important role for the inhibition of Wnt/beta -catenin signaling (2013, International Bone and Mineral Society/The Japan Society of Bone and Mineral Research Joint Meeting, Japan)&cr;4.C165R mutant Sclerostin retained a comparable inhibitory potency to the wild type on wnt-beta catenin signaling despite of inappropriate folding (2013, International Bone and Mineral Society/The Japan Society of Bone and Mineral Research Joint Meeting, Japan)&cr;5.Structure and function of the active loop resign of Sclerostin (2013, Seoul International Congress of Endocrinology and Metabolism, Korea)&cr;6.PEST domain of Sclerostin may not regulate the stability of Sclerostin (2013, Seoul International Congress of Endocrinology and Metabolism, Korea)&cr;7. Cysteine Mutants of Sclerostin Retained a Comparable Inhibitory Potency on Wnt/β-Catenin Signaling Despite of Inappropriate Folding (2012, The America Society of Bone and Mineral Research Annual Meeting, USA)&cr;8. Oliogopeptide based Sclerostin inhibitor abrogated Wnt/b-catenin signaling inhibited by Sclerostin in both MC3T3E1 and INS-1 cells (2012, The America Society of Bone and Mineral Research Annual Meeting, USA)&cr;9. Sequential Expression of Sox11 and Sox4 Is Essential for Osteoblastogenesis and Bone Development (2012, The America Society of Bone and Mineral Research Annual Meeting, USA)&cr;10. Study on structure and Function of Sclerostin by Site Directed Mutagenesis of Cysteine-knot and Finger 2 residues (2011, The America Society of Bone and Mineral Research Annual Meeting, USA)&cr;11. Construction and analysis of cDNA libraries from Marine Microbial sources&cr;(2004, Industry University Cooperative Chemistry Program Symposium, USA)&cr;12. Mutational analysis of particular histidine residues and various ligands to the C-cluster of CODHct (2004, CBI Conference, USA)&cr;13.Characterization of site-directed mutant of Ni-Fe-S containing enzyme Acetyl-CoA Synthase/CODHct (2002, CBI Conference, USA)&cr;14.Crystallization and characterization studies of a subunit and CODHc (2001, CBI Conference, USA) </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="78" HEIGHT="996">책임&cr;연구원</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="63" HEIGHT="996">엄태기</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="78" HEIGHT="996">연구개발</TD>
<TD VALIGN="MIDDLE" WIDTH="138" HEIGHT="996"> - 한양대학교 : 생화학/분자생물학 박사&cr; - 한국생명공학연구원 유전체구조연구센터 : 박사 후 연구원</TD>
<TD VALIGN="MIDDLE" WIDTH="270" HEIGHT="996">논문:&cr;1. Gamma-secretase inhibitor reduces allergic pulmonary inflammation by modulating Th1 and Th2 responses. (2009, Am J Respir Crit Care Med.).&cr;2.Effect of single nucleotide polymorphisms within the interleukin-4 promoter on aspirin intolerance in asthmatics and interleukin-4 promoter activity. (2010, Pharmacogenet Genomics.)&cr;3.The crucial role of GATA-1 in CCR3 gene transcription: modulated balance by multiple GATA elements in the CCR3 regulatory region. (2010,  J Immunol. 2010)&cr;4. CpG methylation at GATA elements in the regulatory region of CCR3 positively correlates with CCR3 transcription. &cr;(2012, Exp Mol Med.)&cr;5.Eosinophil development, regulation of eosinophil-specific genes, and role of eosinophils in the pathogenesis of asthma. (2012, Allergy Asthma Immunol Res.)&cr;6. Different GATA factors dictate CCR3 transcription in allergic inflammatory cells in a cell type-specific manner. (2013, J Immunol.)&cr;7. Epigenetic modification of TLR4 promotes activation of NF-κB by regulating methyl-CpG-binding domain protein 2 and Sp1 in gastric cancer. (2016, Oncotarget.)&cr;8. Olig2 is expressed late in human eosinophil development and controls Siglec-8 expression. (2016, J Leukoc Biol). &cr;9. Tescalcin expression contributes to invasive and metastatic activity in colorectal cancer. (2016, Tumour Biol.)&cr;10. GPNMB promotes proliferation of developing eosinophils. (2017, J Biochem)</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN>&cr;4) 연구개발비용</SPAN>                                                                               (단위: 천원) 
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="619">

<COLGROUP>
<COL WIDTH="87"></COL>
<COL WIDTH="127"></COL>
<COL WIDTH="88"></COL>
<COL WIDTH="88"></COL>
<COL WIDTH="88"></COL>
<COL WIDTH="87"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="2" ROWSPAN="2" WIDTH="232" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" USERMARK=" BC0XD7D7D7">과목</TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">2020년도</TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">2019년도</TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">2018년도</TD>
<TD ROWSPAN="2" WIDTH="96" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" USERMARK=" BC0XD7D7D7">비고</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">(제7기)</TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">(제6기)</TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">(제5기)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="6" WIDTH="96" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="180">비용의&cr; 성격별 분류</TD>
<TD WIDTH="136" VALIGN="MIDDLE" HEIGHT="30">원재료비</TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">118,402</TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">84,049</TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">444,801</TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="136" VALIGN="MIDDLE" HEIGHT="30">인건비</TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">329,977</TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">348,626</TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">328,972</TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="136" VALIGN="MIDDLE" HEIGHT="30">감가상각비</TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">28,255</TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">29,630</TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">29,190</TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="136" VALIGN="MIDDLE" HEIGHT="30">위탁용역비</TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">165,208</TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">28,254</TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">131,536</TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="136" VALIGN="MIDDLE" HEIGHT="30">기타</TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">87,830</TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,461,977</TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">277,169</TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="136" VALIGN="MIDDLE" HEIGHT="30" USERMARK=" BC0XD7D7D7">연구개발비용 합계</TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" BC0XD7D7D7">    729,672</TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" BC0XD7D7D7"> 2,952,536</TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" BC0XD7D7D7"> 1,211,668</TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="6" WIDTH="96" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="180">회계처리&cr;내역</TD>
<TD WIDTH="136" VALIGN="MIDDLE" HEIGHT="30">판매비와관리비</TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">729,672</TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,952,536</TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,211,668</TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="136" VALIGN="MIDDLE" HEIGHT="30">제조경비</TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="136" VALIGN="MIDDLE" HEIGHT="30">개발비(무형자산)</TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="136" VALIGN="MIDDLE" HEIGHT="30">회계처리금액 계</TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">729,672</TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,952,536</TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,211,668</TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="136" VALIGN="MIDDLE" HEIGHT="30">정부보조금</TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="136" VALIGN="MIDDLE" HEIGHT="30" USERMARK=" BC0XD7D7D7">연구개발비용 합계</TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" BC0XD7D7D7">729,672</TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" BC0XD7D7D7">2,952,536</TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" BC0XD7D7D7">1,211,668</TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="2" WIDTH="232" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">연구개발비 / 매출액 비율&cr;[연구개발비용계÷&cr;당기매출액×100]</TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">N/A%</TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">N/A%</TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">N/A%</TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76"></TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<P></P>

<P>
<SPAN>5) 연</SPAN>
<SPAN>구개발실적&cr; 가) 연구개발 진행 현황</SPAN>
<SPAN></SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="680">

<COLGROUP>
<COL WIDTH="54"></COL>
<COL WIDTH="161"></COL>
<COL WIDTH="168"></COL>
<COL WIDTH="55"></COL>
<COL WIDTH="62"></COL>
<COL WIDTH="53"></COL>
<COL WIDTH="64"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="2" WIDTH="63" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="83" USERMARK=" BC0XD7D7D7">구분</TD>
<TD ROWSPAN="2" WIDTH="170" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="83" USERMARK=" BC0XD7D7D7">품목</TD>
<TD ROWSPAN="2" WIDTH="177" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="83" USERMARK=" BC0XD7D7D7">적응증</TD>
<TD ROWSPAN="2" WIDTH="64" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="83" USERMARK=" BC0XD7D7D7">연구&cr;시작일</TD>
<TD COLSPAN="2" WIDTH="133" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">현재 진행단계</TD>
<TD ROWSPAN="2" WIDTH="73" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="83" USERMARK=" BC0XD7D7D7">비고</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="71" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" USERMARK=" BC0XD7D7D7">단계&cr;(국가)</TD>
<TD WIDTH="62" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" USERMARK=" BC0XD7D7D7">승인일</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="4" WIDTH="63" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="212">동물용&cr;바이오&cr;신약</TD>
<TD WIDTH="170" VALIGN="MIDDLE" HEIGHT="53">PLS-D1000 (반려견DNA면역조절제)</TD>
<TD WIDTH="177" VALIGN="MIDDLE" HEIGHT="53">노령견 CD8+ T세포 증가</TD>
<TD WIDTH="64" VALIGN="MIDDLE" HEIGHT="53" ALIGN="CENTER">2018년&cr; 08월</TD>
<TD WIDTH="71" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">임상2상&cr;(한국)</TD>
<TD WIDTH="62" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">-</TD>
<TD WIDTH="73" VALIGN="MIDDLE" HEIGHT="53" ALIGN="CENTER">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="170" VALIGN="MIDDLE" HEIGHT="53">PLS-D5000 (반려견DNA면역항암제)</TD>
<TD WIDTH="177" VALIGN="MIDDLE" HEIGHT="53">B-세포 림프종, 흑색종, &cr;고형암 면역항암제</TD>
<TD WIDTH="64" VALIGN="MIDDLE" HEIGHT="53" ALIGN="CENTER">2017년&cr; 04월</TD>
<TD WIDTH="71" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">임상2상&cr;(한국)</TD>
<TD WIDTH="62" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">-</TD>
<TD WIDTH="73" VALIGN="MIDDLE" HEIGHT="53" ALIGN="CENTER">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="170" VALIGN="MIDDLE" HEIGHT="53">PLS-ASF (아프리카돼지열병DNA백신)</TD>
<TD WIDTH="177" VALIGN="MIDDLE" HEIGHT="53">아프리카돼지열병 감염 예방</TD>
<TD WIDTH="64" VALIGN="MIDDLE" HEIGHT="53" ALIGN="CENTER">2019년&cr; 12월</TD>
<TD WIDTH="71" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">전임상&cr;(한국)</TD>
<TD WIDTH="62" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">-</TD>
<TD WIDTH="73" VALIGN="MIDDLE" HEIGHT="53" ALIGN="CENTER">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="170" VALIGN="MIDDLE" HEIGHT="53">PLS-FMD (구제역3가(A·O·Asia1)DNA백신)</TD>
<TD WIDTH="177" VALIGN="MIDDLE" HEIGHT="53">구제역 감염 예방</TD>
<TD WIDTH="64" VALIGN="MIDDLE" HEIGHT="53" ALIGN="CENTER">2017년&cr; 08월</TD>
<TD WIDTH="71" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">전임상&cr;전단계</TD>
<TD WIDTH="62" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">-</TD>
<TD WIDTH="73" VALIGN="MIDDLE" HEIGHT="53" ALIGN="CENTER">-</TD>
</TR>
</TBODY>
</TABLE>

<P USERMARK=" B">
<SPAN USERMARK=" !B"> * 현재진행 단계는 농림축산검역본부의 동물용의약품 기준입니다.&cr;&cr; ① PLS-D1000 (반려견DNA면역조절제)</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="622">

<COLGROUP>
<COL WIDTH="116"></COL>
<COL WIDTH="488"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="125" VALIGN="MIDDLE" HEIGHT="30" USERMARK=" BC0XD7D7D7" ALIGN="CENTER">구  분</TD>
<TD WIDTH="497" VALIGN="MIDDLE" HEIGHT="30">바이오 신약</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="125" HEIGHT="30" USERMARK=" BC0XD7D7D7" ALIGN="CENTER">적응증</TD>
<TD VALIGN="MIDDLE" WIDTH="497" HEIGHT="30">노령견 면역력 증가</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="125" HEIGHT="30" USERMARK=" BC0XD7D7D7" ALIGN="CENTER">작용기전</TD>
<TD VALIGN="MIDDLE" WIDTH="497" HEIGHT="30">GHRH-GH-IGF1 Axis에 의한 Immuno-modulation</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="125" HEIGHT="30" USERMARK=" BC0XD7D7D7" ALIGN="CENTER">제품의 특성</TD>
<TD VALIGN="MIDDLE" WIDTH="497" HEIGHT="30">DNA 플라스미드 기반의 혁신 동물용의약품</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="125" HEIGHT="30" USERMARK=" BC0XD7D7D7" ALIGN="CENTER">진행경과</TD>
<TD VALIGN="MIDDLE" WIDTH="497" HEIGHT="30">임상 2상(한국)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="125" HEIGHT="30" USERMARK=" BC0XD7D7D7" ALIGN="CENTER">향후계획</TD>
<TD VALIGN="MIDDLE" WIDTH="497" HEIGHT="30">2023년 이후 승인 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="125" HEIGHT="30" USERMARK=" BC0XD7D7D7" ALIGN="CENTER">경쟁제품</TD>
<TD VALIGN="MIDDLE" WIDTH="497" HEIGHT="30">반려견전용으로 시판허가 받은 제품이 없어 특정하기 어려움</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="125" HEIGHT="30" USERMARK=" BC0XD7D7D7" ALIGN="CENTER">관련논문 등</TD>
<TD VALIGN="MIDDLE" WIDTH="497" HEIGHT="30">연구진행과정으로 추후 임상완료 후 논문 게재 및 학회발표 예정</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="125" HEIGHT="30" USERMARK=" BC0XD7D7D7" ALIGN="CENTER">시장규모</TD>
<TD VALIGN="MIDDLE" WIDTH="497" HEIGHT="30"> -</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="125" HEIGHT="30" USERMARK=" BC0XD7D7D7" ALIGN="CENTER">기타사항</TD>
<TD VALIGN="MIDDLE" WIDTH="497" HEIGHT="30"> -</TD>
</TR>
</TBODY>
</TABLE>

<P USERMARK=" B">
<SPAN USERMARK=" !B">&cr; ② PLS-D5000 (반려견DNA면역항암제)</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="620">

<COLGROUP>
<COL WIDTH="116"></COL>
<COL WIDTH="486"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="125" VALIGN="MIDDLE" HEIGHT="30" USERMARK=" BC0XD7D7D7">구  분</TD>
<TD WIDTH="495" VALIGN="MIDDLE" HEIGHT="30">바이오 신약</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="125" HEIGHT="30" USERMARK=" BC0XD7D7D7">적응증</TD>
<TD VALIGN="MIDDLE" WIDTH="495" HEIGHT="30">B-세포 림프종, 흑색종, 고형암 면역항암제</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="125" HEIGHT="53" USERMARK=" BC0XD7D7D7">작용기전</TD>
<TD VALIGN="MIDDLE" WIDTH="495" HEIGHT="53">암세포에서 과발현되어 암세포 증식에 관여하는 TERT를 면역독성 T세포가 항원으로 인식, 공격하여 암세포의 사멸 유도</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="125" HEIGHT="30" USERMARK=" BC0XD7D7D7">제품의 특성</TD>
<TD VALIGN="MIDDLE" WIDTH="495" HEIGHT="30">DNA 플라스미드 기반의 혁신 동물용의약품</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="125" HEIGHT="30" USERMARK=" BC0XD7D7D7">진행경과</TD>
<TD VALIGN="MIDDLE" WIDTH="495" HEIGHT="30">임상 2상(한국)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="125" HEIGHT="30" USERMARK=" BC0XD7D7D7">향후계획</TD>
<TD VALIGN="MIDDLE" WIDTH="495" HEIGHT="30">2024년 이후 승인</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="125" HEIGHT="99" USERMARK=" BC0XD7D7D7">경쟁제품</TD>
<TD VALIGN="MIDDLE" WIDTH="495" HEIGHT="99">현재, 반려견의 B-세포 림프종 치료는 화학요법(chemotherapy), 방사선치료, 면역요법(Immunotherapy)으로 치료하고 있으며, 표준요법으로 CHOP 화학요법으로 치료하고 있음. 방사선 치료는 주로 수술 후 보조요법으로 사용하고 아직 상용화된 면역요법은 없으며 개발단계임.</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="125" HEIGHT="30" USERMARK=" BC0XD7D7D7">관련논문 등</TD>
<TD VALIGN="MIDDLE" WIDTH="495" HEIGHT="30">연구진행과정으로 추후 임상완료 후 논문 게재 및 학회발표 예정</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="125" HEIGHT="76" USERMARK=" BC0XD7D7D7">시장규모</TD>
<TD VALIGN="MIDDLE" WIDTH="495" HEIGHT="76">반려견 항암제 시장 2026년:  US$909Mn(약 1조원)&cr;산정기준:  Coherent Market Insights, CAGR10.9%: 2019-2026&cr;US$1=KRW1,100원 적용</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="125" HEIGHT="30" USERMARK=" BC0XD7D7D7">기타사항</TD>
<TD VALIGN="MIDDLE" WIDTH="495" HEIGHT="30">농기평과제 성공 수행 완료</TD>
</TR>
</TBODY>
</TABLE>

<P USERMARK=" B">
<SPAN USERMARK=" !B">&cr; ③ PLS-ASF (아프리카돼지열병DNA백신) </SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="622">

<COLGROUP>
<COL WIDTH="116"></COL>
<COL WIDTH="488"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="125" VALIGN="MIDDLE" HEIGHT="30" USERMARK=" BC0XD7D7D7">구  분</TD>
<TD WIDTH="497" VALIGN="MIDDLE" HEIGHT="30">바이오 신약</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="125" HEIGHT="30" USERMARK=" BC0XD7D7D7">적응증</TD>
<TD VALIGN="MIDDLE" WIDTH="497" HEIGHT="30">아프리카돼지열병 감염예방</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="125" HEIGHT="76" USERMARK=" BC0XD7D7D7">작용기전</TD>
<TD VALIGN="MIDDLE" WIDTH="497" HEIGHT="76">아프리카돼지열병 바이러스의 150여개의 단백질에서 세포면역원성을 높이는 부분을 선별해서 제작한 백신을 DNA 플라스미드 형태로 주입하고 체내에서 생존율에 주된 영향을 주는 세포면역원성을 유도함</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="125" HEIGHT="30" USERMARK=" BC0XD7D7D7">제품의 특성</TD>
<TD VALIGN="MIDDLE" WIDTH="497" HEIGHT="30">DNA 플라스미드 기반의 혁신 동물용의약품</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="125" HEIGHT="30" USERMARK=" BC0XD7D7D7">진행경과</TD>
<TD VALIGN="MIDDLE" WIDTH="497" HEIGHT="30">전임상(한국)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="125" HEIGHT="30" USERMARK=" BC0XD7D7D7">향후계획</TD>
<TD VALIGN="MIDDLE" WIDTH="497" HEIGHT="30">2025년 이후 승인</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="125" HEIGHT="746" USERMARK=" BC0XD7D7D7">경쟁제품</TD>

<TD VALIGN="MIDDLE" WIDTH="497" HEIGHT="746">
<P>아프리카돼지열병 백신의 연구는 1960년대 이후 꾸준히 진행되고 있으며, 약독화 생백신, 불활화 백신, 재조합 단백질 백신, 바이러스 벡터 백신, 등 현재까지 다양한 시도가 이루어졌으나, 현재까지 상업적으로 적용할 만큼 효과적인 백신은 개발되지 못함&cr;&cr;여러 형태의 각 백신 후보군들은 각각 장단점이 존재하는데 현재 방어능을 확인할 수 있는 것은 약독화 생백신임. 그러나 균주에 따라서 방어능이 다양하게 나타났으며, 만성형의 병증에  해당하는 발열과 관절염등의 병변을 보이고 또한 병원성이 회복될 수 있는 잠재적 가능성과 안전성 면에서 취약함&cr;&cr;2021년 3분기에 베트남에서 최초로 상업용 ASF백신이 출시 될 것으로 발표함. ASF 백신에 사용될 'ASFV-G-Delta I177L'는 미국 USDA 산하 PIADC에서 개발한 유전자 삭제기술을 이용한 약독화 백신임. &cr;&cr;이외에 유전자 삭제기술 이용한 약독화 백신은 현재 연구개발 단계에 있으며 아래의 표와 같음.&cr;</P>

<IMAGE>
<IMG WIDTH="417" HEIGHT="281" ALIGN="CENTER" HSPACE="0">pls-asf 연구개발 단계.jpg</IMG>
<IMG-CAPTION ATOC="N">ASF 백신 연구개발 단계</IMG-CAPTION>
</IMAGE>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="125" HEIGHT="30" USERMARK=" BC0XD7D7D7">관련논문 등</TD>
<TD VALIGN="MIDDLE" WIDTH="497" HEIGHT="30">연구진행과정으로 추후 임상완료 후 논문 게재 및 학회발표 예정</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="125" HEIGHT="30" USERMARK=" BC0XD7D7D7">시장규모</TD>
<TD VALIGN="MIDDLE" WIDTH="497" HEIGHT="30">중국시장(전세계50%) 약 2조5500 억원으로 추정(중국 화촹(華創)증권)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="125" HEIGHT="30" USERMARK=" BC0XD7D7D7">기타사항</TD>
<TD VALIGN="MIDDLE" WIDTH="497" HEIGHT="30">-</TD>
</TR>
</TBODY>
</TABLE>

<P USERMARK=" B">
<SPAN USERMARK=" !B">&cr; ④ PLS-FMD(구제역3가(A·O·Asia1) DNA백신) </SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="621">

<COLGROUP>
<COL WIDTH="116"></COL>
<COL WIDTH="487"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="125" VALIGN="MIDDLE" HEIGHT="30" USERMARK=" BC0XD7D7D7">구  분</TD>
<TD WIDTH="496" VALIGN="MIDDLE" HEIGHT="30">바이오 신약</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="125" HEIGHT="30" USERMARK=" BC0XD7D7D7">적응증</TD>
<TD VALIGN="MIDDLE" WIDTH="496" HEIGHT="30">구제역 감염 예방</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="125" HEIGHT="76" USERMARK=" BC0XD7D7D7">작용기전</TD>
<TD VALIGN="MIDDLE" WIDTH="496" HEIGHT="76">구제역 바이러스의 구조 단백질 부분을 DNA 형태로 제작해 체내에서 발현되는 단백질이 capsid를 형성해 항원항체 반응을 유도하고 세포내에서 발현된 펩타이드가 MHC-1 기전에 의해 세포성 면역성도 동시에 유도함</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="125" HEIGHT="30" USERMARK=" BC0XD7D7D7">제품의 특성</TD>
<TD VALIGN="MIDDLE" WIDTH="496" HEIGHT="30">DNA 플라스미드 기반의 혁신 동물용의약품</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="125" HEIGHT="30" USERMARK=" BC0XD7D7D7">진행경과</TD>
<TD VALIGN="MIDDLE" WIDTH="496" HEIGHT="30">전임상(한국)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="125" HEIGHT="30" USERMARK=" BC0XD7D7D7">향후계획</TD>
<TD VALIGN="MIDDLE" WIDTH="496" HEIGHT="30">2026년 이후 승인</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="125" HEIGHT="356" USERMARK=" BC0XD7D7D7">경쟁제품</TD>

<TD VALIGN="MIDDLE" WIDTH="496" HEIGHT="356">
<P>현재 상용화된 구제역 백신은 불활화 백신으로 영국 메링거잉겔하임, 러시아의 FGBI ARRIAH, 그리고 아르헨티나의 Biogenesis Bago에서 생산한 백신을 수입하고 있음.</P>

<IMAGE>
<IMG WIDTH="487" HEIGHT="167" ALIGN="CENTER" HSPACE="0">백신별 접종방법.jpg</IMG>
<IMG-CAPTION ATOC="N">백신별 접종방법</IMG-CAPTION>
</IMAGE>
<P>다른 형태의 상용화된 구제역 백신 없으며, 최근 국내 파로스 백신의 구제역 재조합단백질 백신인 'PharoVax-FMD' 농림축산검역본부로 부터 제조품목허가를 받음</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="125" HEIGHT="30" USERMARK=" BC0XD7D7D7">관련논문 등</TD>
<TD VALIGN="MIDDLE" WIDTH="496" HEIGHT="30">연구진행과정으로 추후 임상완료 후 논문 게재 및 학회발표 예정</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="125" HEIGHT="99" USERMARK=" BC0XD7D7D7">시장규모</TD>
<TD VALIGN="MIDDLE" WIDTH="496" HEIGHT="99">세계시장: 약 1.16조 &cr;산정기준: MarketWatch 2021 report, 2020 $966.4 Mn,&cr;             9.6% CAGR, 2026 $1675 Mn, US$1=KRW1,100원 적용&cr;국내시장: 약 1천억원 (한국농촌경제신문)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="125" HEIGHT="30" USERMARK=" BC0XD7D7D7">기타사항</TD>
<TD VALIGN="MIDDLE" WIDTH="496" HEIGHT="30">중기청 과제 성공 수행 완료</TD>
</TR>
</TBODY>
</TABLE>

<P USERMARK=" B">
<SPAN USERMARK=" !B">&cr;나) 연구개발 완료 실적&cr;</SPAN>
<SPAN USERMARK=" !B">해당사항이 없습니다.&cr;</SPAN>
<SPAN USERMARK=" !B">&cr;다) 연구개발활동 및 판매 중단 현황&cr;해당사항이 없습니다.&cr;&cr;라) 기타 연구개발 실적</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="677">

<COLGROUP>
<COL WIDTH="164"></COL>
<COL WIDTH="91"></COL>
<COL WIDTH="193"></COL>
<COL WIDTH="193"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="173" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK=" BC0XD7D7D7">연구과제</TD>
<TD WIDTH="100" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK=" BC0XD7D7D7">지원 사업명</TD>
<TD WIDTH="202" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK=" BC0XD7D7D7">연구결과</TD>
<TD WIDTH="202" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK=" BC0XD7D7D7">기대효과</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="173" HEIGHT="99" VALIGN="MIDDLE">플라스미드 DNA백신 기술을 이용한 반려견 항암 면역치료제 개발</TD>
<TD WIDTH="100" HEIGHT="99" VALIGN="MIDDLE">농생명산업 &cr;기술개발사업</TD>
<TD WIDTH="202" HEIGHT="99" VALIGN="MIDDLE">임상시험을 위한 기초자료 확보를 위해 마우스, 실험견, 환견을 대상으로 한 실험 데이터 확보</TD>
<TD WIDTH="202" HEIGHT="99" VALIGN="MIDDLE"> 반려견 고형암 치료에 사용, 전 세계 반려견 항암 치료 시장 대체, 동물복지 향상</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="173" HEIGHT="122" VALIGN="MIDDLE">3가 구제역DNAvaccine의 목적동물 면역원성 검증 시험</TD>
<TD WIDTH="100" HEIGHT="122" VALIGN="MIDDLE">산학연협력&cr;기술개발사업</TD>
<TD WIDTH="202" HEIGHT="122" VALIGN="MIDDLE">전 세계 최초 3가 구제역 DNA백신의 안전성 및 효능을 검증하여 향후 상용화 백신으로 개발하기 위한 기초자료 마련</TD>
<TD WIDTH="202" HEIGHT="122" VALIGN="MIDDLE">효율적 면역반응 유도, 정부 구제역정책과 부합한 신속대응 및 생산, 해외수입 대체</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="173" HEIGHT="53" VALIGN="MIDDLE">바이오 기술 기반 동물&cr;DNA백신 개발</TD>
<TD WIDTH="100" HEIGHT="53" VALIGN="MIDDLE">창업도약패키지 지원사업</TD>
<TD WIDTH="202" HEIGHT="53" VALIGN="MIDDLE">DNA백신의 상용화 및 판매를 위한 기초자료 마련</TD>
<TD WIDTH="202" HEIGHT="53" VALIGN="MIDDLE">면역력 증강 , 전염성 질환 백신 시장 대체 및 시장 확대</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
</P>

<P>
<SPAN>(5) 경영상의 주요계약&cr;</SPAN>
</P>

<P>
<SPAN USERMARK="F-14 0XFF1200 B"></SPAN> 1) 라이센스아웃(License-out) 계약&cr;                                                                                                   (단위: 천USD)
</P>

<TABLE ACLASS="NORMAL" WIDTH="626" BORDER="1" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="75"></COL>
<COL WIDTH="79"></COL>
<COL WIDTH="68"></COL>
<COL WIDTH="78"></COL>
<COL WIDTH="77"></COL>
<COL WIDTH="75"></COL>
<COL WIDTH="51"></COL>
<COL WIDTH="51"></COL>
</COLGROUP>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="84" HEIGHT="53" USERMARK=" BC0XD7D7D7">품목</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="88" HEIGHT="53" USERMARK=" BC0XD7D7D7">계약상대방</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="77" HEIGHT="53" USERMARK=" BC0XD7D7D7">대상지역</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="87" HEIGHT="53" USERMARK=" BC0XD7D7D7">계약&cr;체결일</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="86" HEIGHT="53" USERMARK=" BC0XD7D7D7">계약&cr;종료일</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="84" HEIGHT="53" USERMARK=" BC0XD7D7D7">총계약금액</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="60" HEIGHT="53" USERMARK=" BC0XD7D7D7">수취&cr;금액</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="60" HEIGHT="53" USERMARK=" BC0XD7D7D7">진행&cr;단계</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="84" HEIGHT="53">PLS-ASF</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="88" HEIGHT="53">(주)중한&cr;바이오</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="77" HEIGHT="53">중국</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="87" HEIGHT="53"> 2020년&cr; 8월 24일</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="86" HEIGHT="53">2040년&cr;8월 23일</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="84" HEIGHT="53">
<SPAN USERMARK=" BC0X31FFFF">16,400</SPAN>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="60" HEIGHT="53">-</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="60" HEIGHT="53"> 전임상</TD>
</TR>
</TBODY>
</TABLE>
<P>* 계약조항에 따라 취소 사유 발생시 계약이 해지될 수 있음.&cr; &cr;  2) 라이센스인(License-in)계약&cr;                                                                                                   (단위: 천USD)</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="626">

<COLGROUP>
<COL WIDTH="77"></COL>
<COL WIDTH="77"></COL>
<COL WIDTH="68"></COL>
<COL WIDTH="78"></COL>
<COL WIDTH="77"></COL>
<COL WIDTH="81"></COL>
<COL WIDTH="48"></COL>
<COL WIDTH="48"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" BC0XD7D7D7" WIDTH="86" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">품목</TD>
<TD USERMARK=" BC0XD7D7D7" WIDTH="86" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">계약상대방</TD>
<TD USERMARK=" BC0XD7D7D7" WIDTH="77" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">대상지역</TD>
<TD USERMARK=" BC0XD7D7D7" WIDTH="87" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">계약&cr;체결일</TD>
<TD USERMARK=" BC0XD7D7D7" WIDTH="86" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">계약&cr;종료일</TD>
<TD USERMARK=" BC0XD7D7D7" WIDTH="90" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">총계약금액</TD>
<TD USERMARK=" BC0XD7D7D7" WIDTH="57" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">지급&cr;금액</TD>
<TD USERMARK=" BC0XD7D7D7" WIDTH="57" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">진행&cr;단계</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="86" HEIGHT="76" ALIGN="CENTER" VALIGN="MIDDLE">FMDV</TD>
<TD WIDTH="86" HEIGHT="76" ALIGN="CENTER" VALIGN="MIDDLE">Inovio Pharmaceuticals, Inc. </TD>
<TD WIDTH="77" HEIGHT="76" ALIGN="CENTER" VALIGN="MIDDLE">한국 등</TD>
<TD WIDTH="87" HEIGHT="76" ALIGN="CENTER" VALIGN="MIDDLE">2016년&cr;08월 15일</TD>
<TD WIDTH="86" HEIGHT="76" ALIGN="CENTER" VALIGN="MIDDLE">2039년&cr;08월 15일</TD>
<TD WIDTH="90" HEIGHT="76" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="57" HEIGHT="76" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="57" HEIGHT="76" ALIGN="CENTER" VALIGN="MIDDLE">임상&cr;준비</TD>
</TR>
</TBODY>
</TABLE>
<P>* 임상 진입 시 단계별 마일스톤 지급 발생 예정&cr;</P>
<P>3) 판매계약</P>
<P>                                                                                                   (단위: 천USD)</P>

<TABLE ACLASS="NORMAL" WIDTH="626" BORDER="1" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="78"></COL>
<COL WIDTH="82"></COL>
<COL WIDTH="179"></COL>
<COL WIDTH="48"></COL>
<COL WIDTH="48"></COL>
<COL WIDTH="45"></COL>
<COL WIDTH="38"></COL>
<COL WIDTH="36"></COL>
</COLGROUP>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="87" HEIGHT="53" USERMARK=" BC0XD7D7D7">품목</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="91" HEIGHT="53" USERMARK=" BC0XD7D7D7">계약&cr;상대방</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="188" HEIGHT="53" USERMARK=" BC0XD7D7D7">계약 목적 등</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="57" HEIGHT="53" USERMARK=" BC0XD7D7D7">계약&cr;체결일</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="57" HEIGHT="53" USERMARK=" BC0XD7D7D7">계약&cr;종료일</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="54" HEIGHT="53" USERMARK=" BC0XD7D7D7">계약&cr;금액</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="47" HEIGHT="53" USERMARK=" BC0XD7D7D7">수취금액</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="45" HEIGHT="53" USERMARK=" BC0XD7D7D7">비고</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="87" HEIGHT="76">LifeTide?&cr; SW5.0</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="91" HEIGHT="76">APIAM&cr;(호주)</TD>
<TD WIDTH="188" HEIGHT="76"> LifeTide? SW5.0(돼지DNA면역조절제)의 독점판매계약 체결</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="57" HEIGHT="76">2018년&cr;07월&cr;18일</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="57" HEIGHT="76">2038년&cr;07월&cr;17일</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="54" HEIGHT="76">300</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="47" HEIGHT="76">300</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="45" HEIGHT="76">-</TD>
</TR>
</TBODY>
</TABLE>
<P>* 계약조항에 따라 계약의 해지 및 계약금 반환이 될 수 있음.&cr;</P>
<P>3) 기타계약</P>
<P>                                                                                        (단위: 천USD,백만원)</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="628">

<COLGROUP>
<COL WIDTH="78"></COL>
<COL WIDTH="82"></COL>
<COL WIDTH="179"></COL>
<COL WIDTH="48"></COL>
<COL WIDTH="48"></COL>
<COL WIDTH="45"></COL>
<COL WIDTH="38"></COL>
<COL WIDTH="38"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" BC0XD7D7D7" WIDTH="87" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">품목</TD>
<TD USERMARK=" BC0XD7D7D7" WIDTH="91" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">계약&cr;상대방</TD>

<TD USERMARK=" BC0XD7D7D7" WIDTH="188" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">
<SPAN>계약 목적 등</SPAN>
</TD>
<TD USERMARK=" BC0XD7D7D7" WIDTH="57" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">계약&cr;체결일</TD>
<TD USERMARK=" BC0XD7D7D7" WIDTH="57" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">계약&cr;종료일</TD>
<TD USERMARK=" BC0XD7D7D7" WIDTH="54" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">계약&cr;금액</TD>
<TD USERMARK=" BC0XD7D7D7" WIDTH="47" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">지급&cr;금액</TD>
<TD USERMARK=" BC0XD7D7D7" WIDTH="47" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">비고</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="87" HEIGHT="76" ALIGN="CENTER" VALIGN="MIDDLE">자산인수</TD>
<TD WIDTH="91" HEIGHT="76" VALIGN="MIDDLE">VGX Animal Health</TD>
<TD WIDTH="188" HEIGHT="76" VALIGN="MIDDLE"> 회사 설립을 위한 자산인수 계약</TD>
<TD WIDTH="57" HEIGHT="76" ALIGN="CENTER" VALIGN="MIDDLE">2014년&cr;05월&cr;23일</TD>
<TD WIDTH="57" HEIGHT="76" ALIGN="CENTER" VALIGN="MIDDLE">2039년&cr;05월&cr;22일</TD>
<TD WIDTH="54" HEIGHT="76" ALIGN="RIGHT" VALIGN="MIDDLE">2,000</TD>
<TD WIDTH="47" HEIGHT="76" ALIGN="RIGHT" VALIGN="MIDDLE">2,000</TD>
<TD WIDTH="47" HEIGHT="76" ALIGN="CENTER" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="87" HEIGHT="76" ALIGN="CENTER" VALIGN="MIDDLE">PLS-ASF</TD>
<TD WIDTH="91" HEIGHT="76" ALIGN="CENTER" VALIGN="MIDDLE">Inovio Pharmaceuticals, Inc. </TD>
<TD WIDTH="188" HEIGHT="76"> PLS-ASF(아프리카돼지열병백신)의 공동연구 개발</TD>
<TD WIDTH="57" HEIGHT="76" ALIGN="CENTER" VALIGN="MIDDLE">2019년&cr;05월&cr;13일</TD>
<TD WIDTH="57" HEIGHT="76" ALIGN="CENTER" VALIGN="MIDDLE">완료&cr;시까지</TD>
<TD WIDTH="54" HEIGHT="76" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="47" HEIGHT="76" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="47" HEIGHT="76" ALIGN="CENTER" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="87" HEIGHT="76" ALIGN="CENTER" VALIGN="MIDDLE">LifeTide?&cr; SW5.0</TD>
<TD WIDTH="91" HEIGHT="76" ALIGN="CENTER" VALIGN="MIDDLE">(주)유바이오로직스</TD>
<TD WIDTH="188" HEIGHT="76"> LifeTide?SW5.0(돼지DNA면역조절제)의 위탁생산계약</TD>
<TD WIDTH="57" HEIGHT="76" ALIGN="CENTER" VALIGN="MIDDLE">2020년&cr;08월&cr;25일</TD>
<TD WIDTH="57" HEIGHT="76" ALIGN="CENTER" VALIGN="MIDDLE">완료&cr;시까지</TD>
<TD WIDTH="54" HEIGHT="76" ALIGN="RIGHT" VALIGN="MIDDLE">45</TD>
<TD WIDTH="47" HEIGHT="76" ALIGN="RIGHT" VALIGN="MIDDLE">4.5</TD>
<TD WIDTH="47" HEIGHT="76" ALIGN="CENTER" VALIGN="MIDDLE">-</TD>
</TR>
</TBODY>
</TABLE>
<P>* 임상진입 시 단계별 마일스톤 지급 발생 예정&cr;** 계약조항에 따라 취소 사유 발생시 계약이 해지될 수 있음.&cr;</P>
<P></P>
<PGBRK></PGBRK>
</SECTION-1>

<SECTION-1 ACLASS="MANDATORY" APARTSOURCE="SOURCE">
<TITLE ATOC="Y" AASSOCNOTE="D-0-3-0-0">III. 재무에 관한 사항</TITLE>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-0-3-1-0">1. 요약재무정보</TITLE>
<P></P>

<P>
<SPAN USERMARK=" B">가. 요약 재무상태표</SPAN>
</P>

<TABLE ACLASS="NORMAL" WIDTH="681" BORDER="0" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="672"></COL>
</COLGROUP>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="681" HEIGHT="30">(단위 : 백만원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="683">

<COLGROUP>
<COL WIDTH="255"></COL>
<COL WIDTH="131"></COL>
<COL WIDTH="131"></COL>
<COL WIDTH="130"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="264" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="53">
<P>사업년도</P>
<P>구분</P>
</TH>
<TH WIDTH="140" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="53">2020년&cr;(제7기)</TH>
<TH WIDTH="140" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="53">2019년&cr;(제6기)</TH>
<TH WIDTH="139" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="53">2018년&cr;(제5기)</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="264" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>회계처리 기준</P>
</TD>
<TD WIDTH="140" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">K-GAAP</TD>
<TD WIDTH="140" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">K-GAAP</TD>
<TD WIDTH="139" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">K-GAAP</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="264" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>감사인(감사의견)</P>
</TD>

<TD WIDTH="140" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>신한회계법인</P>
<P>(적정)</P>
</TD>

<TD WIDTH="140" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>우리회계법인</P>
<P>(적정)</P>
</TD>

<TD WIDTH="139" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>신화회계법인</P>
<P>(적정)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="264" VALIGN="MIDDLE" HEIGHT="30">자            산</TD>
<TD WIDTH="140" VALIGN="MIDDLE" HEIGHT="30">　</TD>
<TD WIDTH="140" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">　</TD>
<TD WIDTH="139" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">　</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="264" VALIGN="MIDDLE" HEIGHT="30">I. 유동자산</TD>
<TD WIDTH="140" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">1,554</TD>
<TD WIDTH="140" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">1,424</TD>
<TD WIDTH="139" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">334</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="264" VALIGN="MIDDLE" HEIGHT="30">(1) 당좌자산</TD>
<TD WIDTH="140" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">1,554</TD>
<TD WIDTH="140" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">1,424</TD>
<TD WIDTH="139" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">334</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="264" VALIGN="MIDDLE" HEIGHT="30">Ⅱ. 비유동자산</TD>
<TD WIDTH="140" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">97</TD>
<TD WIDTH="140" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">85</TD>
<TD WIDTH="139" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">137</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="264" VALIGN="MIDDLE" HEIGHT="30">(1) 투자자산</TD>
<TD WIDTH="140" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="140" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="139" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="264" VALIGN="MIDDLE" HEIGHT="30">(2) 유형자산</TD>
<TD WIDTH="140" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">37</TD>
<TD WIDTH="140" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">68</TD>
<TD WIDTH="139" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">94</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="264" VALIGN="MIDDLE" HEIGHT="30">(3) 무형자산</TD>
<TD WIDTH="140" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">3</TD>
<TD WIDTH="140" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT" USERMARK=" 0X1814FF">-</TD>
<TD WIDTH="139" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT" USERMARK=" 0X1814FF">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="264" VALIGN="MIDDLE" HEIGHT="30">(4) 기타비유동자산</TD>
<TD WIDTH="140" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">57</TD>
<TD WIDTH="140" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">17</TD>
<TD WIDTH="139" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">44</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="264" VALIGN="MIDDLE" HEIGHT="30">자      산      총      계</TD>
<TD WIDTH="140" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">1,651</TD>
<TD WIDTH="140" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">1,509</TD>
<TD WIDTH="139" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">472</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="264" VALIGN="MIDDLE" HEIGHT="30">부                        채</TD>
<TD WIDTH="140" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="140" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="139" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="264" VALIGN="MIDDLE" HEIGHT="30">Ⅰ. 유동부채</TD>
<TD WIDTH="140" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">1,334</TD>
<TD WIDTH="140" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">6,115</TD>
<TD WIDTH="139" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">1,825</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="264" VALIGN="MIDDLE" HEIGHT="30">Ⅱ. 비유동부채</TD>
<TD WIDTH="140" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">1,721</TD>
<TD WIDTH="140" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">928</TD>
<TD WIDTH="139" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">792</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="264" VALIGN="MIDDLE" HEIGHT="30">부      채      총      계</TD>
<TD WIDTH="140" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">3,055</TD>
<TD WIDTH="140" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">7,043</TD>
<TD WIDTH="139" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">2,617</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="264" VALIGN="MIDDLE" HEIGHT="30">자                        본</TD>
<TD WIDTH="140" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="140" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="139" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="264" VALIGN="MIDDLE" HEIGHT="30">Ⅰ. 자본금</TD>
<TD WIDTH="140" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">1,567</TD>
<TD WIDTH="140" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">1,318</TD>
<TD WIDTH="139" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">1,308</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="264" VALIGN="MIDDLE" HEIGHT="30">Ⅱ. 자본잉여금</TD>
<TD WIDTH="140" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">18,469</TD>
<TD WIDTH="140" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">13,351</TD>
<TD WIDTH="139" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">12,700</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="264" VALIGN="MIDDLE" HEIGHT="30">Ⅲ. 자본조정</TD>
<TD WIDTH="140" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">2,276</TD>
<TD WIDTH="140" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">1,982</TD>
<TD WIDTH="139" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">1,642</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="264" VALIGN="MIDDLE" HEIGHT="30">Ⅳ. 기타포괄손익누계액</TD>
<TD WIDTH="140" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">26</TD>
<TD WIDTH="140" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">26</TD>
<TD WIDTH="139" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">26</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="264" VALIGN="MIDDLE" HEIGHT="30">Ⅴ. 이익잉여금(결손금)</TD>
<TD WIDTH="140" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">(23,742)</TD>
<TD WIDTH="140" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">(22,211)</TD>
<TD WIDTH="139" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">(17,821)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="264" VALIGN="MIDDLE" HEIGHT="30">자      본      총      계</TD>
<TD WIDTH="140" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">(1,404)</TD>
<TD WIDTH="140" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">(5,534)</TD>
<TD WIDTH="139" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">(2,146)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="264" VALIGN="MIDDLE" HEIGHT="30">부  채  및  자  본  총  계</TD>
<TD WIDTH="140" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">1,651</TD>
<TD WIDTH="140" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">1,509</TD>
<TD WIDTH="139" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">472</TD>
</TR>
</TBODY>
</TABLE>

<P>&cr;
<SPAN USERMARK=" B">나. 요약(포괄) 손익계산서</SPAN>
</P>

<TABLE ACLASS="NORMAL" WIDTH="685" BORDER="0" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="676"></COL>
</COLGROUP>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="685" HEIGHT="30">(단위 : 백만원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="688">

<COLGROUP>
<COL WIDTH="256"></COL>
<COL WIDTH="132"></COL>
<COL WIDTH="132"></COL>
<COL WIDTH="132"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="265" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="53">
<P>사업년도</P>
<P>구분</P>
</TH>
<TH WIDTH="141" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="53">2020년&cr;(제7기)</TH>
<TH WIDTH="141" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="53">2019년&cr;(제6기)</TH>
<TH WIDTH="141" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="53">2018년&cr;(제5기)</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="265" VALIGN="MIDDLE" HEIGHT="30">I. 매출액</TD>
<TD WIDTH="141" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="141" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="141" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="265" VALIGN="MIDDLE" HEIGHT="30">II. 매출원가</TD>
<TD WIDTH="141" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="141" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="141" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="265" VALIGN="MIDDLE" HEIGHT="30">III. 매출총이익</TD>
<TD WIDTH="141" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="141" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="141" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="265" VALIGN="MIDDLE" HEIGHT="30">IV. 판매비와관리비</TD>
<TD WIDTH="141" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">1,604</TD>
<TD WIDTH="141" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,886</TD>
<TD WIDTH="141" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,043</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="265" VALIGN="MIDDLE" HEIGHT="30">V. 영업손실</TD>
<TD WIDTH="141" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">1,604</TD>
<TD WIDTH="141" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,886</TD>
<TD WIDTH="141" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,043</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="265" VALIGN="MIDDLE" HEIGHT="30">VI. 영업외수익</TD>
<TD WIDTH="141" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">451</TD>
<TD WIDTH="141" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">196</TD>
<TD WIDTH="141" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">135</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="265" VALIGN="MIDDLE" HEIGHT="30">VII. 영업외비용</TD>
<TD WIDTH="141" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">378</TD>
<TD WIDTH="141" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">700</TD>
<TD WIDTH="141" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,300</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="265" VALIGN="MIDDLE" HEIGHT="30">VIII. 법인세비용차감전순이익(손실)</TD>
<TD WIDTH="141" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">(1,532)</TD>
<TD WIDTH="141" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(4,390)</TD>
<TD WIDTH="141" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(3,207)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="265" VALIGN="MIDDLE" HEIGHT="30">IX. 법인세비용</TD>
<TD WIDTH="141" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="141" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="141" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">　-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="265" VALIGN="MIDDLE" HEIGHT="30">X. 당기순이익(손실)</TD>
<TD WIDTH="141" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">(1,532)</TD>
<TD WIDTH="141" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(4,390)</TD>
<TD WIDTH="141" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(3,207)</TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<WARNING>※ 아래 『재무제표』단위서식을 클릭하여 해당사항을 선택하면,&cr;    2.연결재무제표 ~ 5.재무제표주석 항목을 삽입할 수 있습니다.</WARNING>
</SECTION-2>

<INSERTION ABASISNUMBER="E1" AFREQUENCY="1" ADUPLICATION="N">
<COMMENT>◆click◆『재무제표』 삽입</COMMENT>
<LIBRARYLIST>11011#*재무제표_*.*</LIBRARYLIST>

<LIBRARY>
<FILENAME ATYPE="dsl">재무제표_직접작성</FILENAME>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-0-3-2-0">2. 연결재무제표</TITLE>
<P>&cr;해당사항 없습니다.</P>
<P></P>
</SECTION-2>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-0-3-3-0">3. 연결재무제표 주석</TITLE>
<P></P>
<P>해당사항 없습니다.&cr;</P>
</SECTION-2>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-0-3-4-0">4. 재무제표</TITLE>
<P>&cr;<재무상태표></P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="815">

<COLGROUP>
<COL WIDTH="291"></COL>
<COL WIDTH="506"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="815" HEIGHT="30" COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE">제 7(당) 기 2020년 12월 31일 현재</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="815" HEIGHT="30" COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE">제 9(전) 기 2019년 12월 31일 현재</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="300" HEIGHT="30" VALIGN="BOTTOM"></TD>
<TD WIDTH="515" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">(단위 : 원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="815">

<COLGROUP>
<COL WIDTH="306"></COL>
<COL WIDTH="116"></COL>
<COL WIDTH="116"></COL>
<COL WIDTH="116"></COL>
<COL WIDTH="116"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="315" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">과                        목</TH>
<TH WIDTH="250" HEIGHT="30" COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">제 7(당) 기</TH>
<TH WIDTH="250" HEIGHT="30" COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">제 6(전) 기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="315" HEIGHT="30">자                        산</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="315" HEIGHT="30">I. 유동자산</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">1,554,000,208</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">1,424,217,024</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P16" WIDTH="315" HEIGHT="30">(1) 당좌자산</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">1,554,000,208</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">1,424,217,024</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P32" WIDTH="315" HEIGHT="30">1. 현금및현금성자산(주석3)</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">1,260,704,443</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">1,268,393,949</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P32" WIDTH="315" HEIGHT="30">2. 기타당좌자산(주석4)</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">293,295,765</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">155,823,075</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P32" WIDTH="315" HEIGHT="30">Ⅱ. 비유동자산</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">96,533,572</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">84,641,330</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="315" HEIGHT="30" USERMARK=" P16">(1) 유형자산(주석7)</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">36,514,145</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">67,892,330</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P16" WIDTH="315" HEIGHT="30">(2) 무형자산(주석8)</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">3,270,427</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="315" HEIGHT="30" USERMARK=" P16">(3) 기타비유동자산(주석5)</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">56,749,000</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">16,749,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P32" WIDTH="315" HEIGHT="30">자      산      총      계</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">1,650,533,780</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">1,508,858,354</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P16" WIDTH="315" HEIGHT="30">부                        채</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P16" WIDTH="315" HEIGHT="30">Ⅰ. 유동부채</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">1,334,287,608</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">6,115,439,415</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="315" HEIGHT="30" USERMARK=" P32">1. 미지급금(주석21)</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">715,213,273</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">4,075,159,441</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="315" HEIGHT="30" USERMARK=" P32">2. 미지급비용</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">22,395,235</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">27,026,475</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="315" HEIGHT="30" USERMARK=" P32">3. 단기차입금(주석9)</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">250,000,000</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="315" HEIGHT="30" USERMARK=" P32">4. 예수금</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">6,119,100</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">880,000,000</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P32" WIDTH="315" HEIGHT="30">5. 기타유동부채</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">340,560,000</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">347,101,240</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P32" WIDTH="315" HEIGHT="30">6. 유동성전환사채(주석10)</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">786,152,259</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P32" WIDTH="315" HEIGHT="30">Ⅱ. 비유동부채</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">1,720,562,627</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">927,494,694</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P32" WIDTH="315" HEIGHT="30">1. 장기미지급금(주석21)</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">489,751,402</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">285,247,972</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="315" HEIGHT="30" USERMARK=" P32">2. 전환사채(주석10)</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">922,966,642</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">336,876,551</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P32" WIDTH="315" HEIGHT="30">3. 퇴직급여충당부채(주석11)</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">307,844,583</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">305,370,171</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="315" HEIGHT="30">부      채      총      계</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">3,054,850,235</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">7,042,934,109</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="315" HEIGHT="30">자                        본</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="315" HEIGHT="30" USERMARK=" P32">Ⅰ. 자본금</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">1,567,025,000</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">1,317,500,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P32" WIDTH="315" HEIGHT="30">1. 보통주자본금(주석13)</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">1,433,525,000</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">1,211,500,000</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P32" WIDTH="315" HEIGHT="30">2. 우선주자본금(주석13)</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">133,500,000</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">106,000,000</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="315" HEIGHT="30" USERMARK=" P32">Ⅱ. 자본잉여금</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">18,469,793,444</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">13,351,432,032</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P32" WIDTH="315" HEIGHT="30">1. 보통주주식발행초과금(주석13)</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">15,071,987,945</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">10,443,650,736</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P32" WIDTH="315" HEIGHT="30">2. 우선주주식발행초과금(주석13)</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">3,086,100,717</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">2,465,340,717</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="315" HEIGHT="30" USERMARK=" P32">3. 전환권대가(주석10)</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">311,704,782</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">442,440,579</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P32" WIDTH="315" HEIGHT="30">Ⅲ. 자본조정</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">2,276,179,828</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">1,982,669,604</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="315" HEIGHT="30" USERMARK=" P32">1. 기타자본조정(주석14)</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">2,276,179,828</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">1,982,669,604</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P32" WIDTH="315" HEIGHT="30">Ⅳ. 기타포괄손익누계액</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">25,511,271</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">25,511,271</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="315" HEIGHT="30" USERMARK=" P32">1. 지분법자본변동(주석6)</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">25,511,271</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">25,511,271</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P32" WIDTH="315" HEIGHT="30">Ⅴ. 결손금</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">23,742,825,998</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">22,211,188,662</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="315" HEIGHT="30" USERMARK=" P32">1. 미처리결손금(주석15)</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">(23,742,825,998)</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">(22,211,188,662)</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="315" HEIGHT="30">자      본      총      계</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">(1,404,316,455)</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">(5,534,075,755)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="315" HEIGHT="30">부  채  및  자  본  총  계</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">1,650,533,780</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">1,508,858,354</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="814">

<COLGROUP>
<COL WIDTH="805"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="814" HEIGHT="33" ALIGN="CENTER">
<SPAN></SPAN>
<SPAN>주석</SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN> 참조</SPAN>
</TD>
</TR>
</TBODY>
</TABLE>
<P>&cr;<손익계산서></P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="814">

<COLGROUP>
<COL WIDTH="291"></COL>
<COL WIDTH="505"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="814" HEIGHT="30" COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE">제 7(당) 기 2020년 1월 1일부터 2020년 12월 31일까지</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="814" HEIGHT="30" COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE">제 6(전) 기 2019년 1월 1일부터 2019년 12월 31일까지</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="300" HEIGHT="30" VALIGN="BOTTOM"></TD>
<TD WIDTH="514" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">(단위 : 원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="815">

<COLGROUP>
<COL WIDTH="241"></COL>
<COL WIDTH="133"></COL>
<COL WIDTH="132"></COL>
<COL WIDTH="132"></COL>
<COL WIDTH="132"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="250" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">과                        목</TH>
<TH WIDTH="283" HEIGHT="30" COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">제 7(당) 기</TH>
<TH WIDTH="282" HEIGHT="30" COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">제 6(전) 기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="250" HEIGHT="30">I. 매출액</TD>
<TD WIDTH="142" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="141" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="141" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="141" HEIGHT="30" ALIGN="RIGHT">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="250" HEIGHT="30">II. 매출원가</TD>
<TD WIDTH="142" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="141" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="141" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="141" HEIGHT="30" ALIGN="RIGHT">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="250" HEIGHT="30">III. 매출총이익</TD>
<TD WIDTH="142" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="141" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="141" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="141" HEIGHT="30" ALIGN="RIGHT">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="250" HEIGHT="30">IV. 판매비와관리비(주석18)</TD>
<TD WIDTH="142" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="141" HEIGHT="30" ALIGN="RIGHT">1,604,433,584</TD>
<TD WIDTH="141" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="141" HEIGHT="30" ALIGN="RIGHT">3,885,699,753</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="250" HEIGHT="30">V. 영업손실</TD>
<TD WIDTH="142" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="141" HEIGHT="30" ALIGN="RIGHT">1,604,433,584</TD>
<TD WIDTH="141" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="141" HEIGHT="30" ALIGN="RIGHT">3,885,699,753</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="250" HEIGHT="30">VI. 영업외수익</TD>
<TD WIDTH="142" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="141" HEIGHT="30" ALIGN="RIGHT">451,072,989</TD>
<TD WIDTH="141" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="141" HEIGHT="30" ALIGN="RIGHT">196,340,904</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P16" WIDTH="250" HEIGHT="30">1. 이자수익</TD>
<TD WIDTH="142" HEIGHT="30" ALIGN="RIGHT">1,797,181</TD>
<TD WIDTH="141" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="141" HEIGHT="30" ALIGN="RIGHT">913,416</TD>
<TD WIDTH="141" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P16" WIDTH="250" HEIGHT="30">2. 외환차익(주석12)</TD>
<TD WIDTH="142" HEIGHT="30" ALIGN="RIGHT">7,532,785</TD>
<TD WIDTH="141" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="141" HEIGHT="30" ALIGN="RIGHT">7,737,624</TD>
<TD WIDTH="141" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P16" WIDTH="250" HEIGHT="30">3. 외화환산이익(주석12)</TD>
<TD WIDTH="142" HEIGHT="30" ALIGN="RIGHT">53,272,911</TD>
<TD WIDTH="141" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="141" HEIGHT="30" ALIGN="RIGHT">39,757,822</TD>
<TD WIDTH="141" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P16" WIDTH="250" HEIGHT="30">4. 수수료수익</TD>
<TD WIDTH="142" HEIGHT="30" ALIGN="RIGHT">368,091,602</TD>
<TD WIDTH="141" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="141" HEIGHT="30" ALIGN="RIGHT">147,789,558</TD>
<TD WIDTH="141" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="250" HEIGHT="30" USERMARK=" P16">5. 유형자산처분이익</TD>
<TD WIDTH="142" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="141" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="141" HEIGHT="30" ALIGN="RIGHT">109,091</TD>
<TD WIDTH="141" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P16" WIDTH="250" HEIGHT="30">6. 잡이익</TD>
<TD WIDTH="142" HEIGHT="30" ALIGN="RIGHT">20,378,510</TD>
<TD WIDTH="141" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="141" HEIGHT="30" ALIGN="RIGHT">33,393</TD>
<TD WIDTH="141" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P16" WIDTH="250" HEIGHT="30">VII. 영업외비용</TD>
<TD WIDTH="142" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="141" HEIGHT="30" ALIGN="RIGHT">378,276,741</TD>
<TD WIDTH="141" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="141" HEIGHT="30" ALIGN="RIGHT">700,842,385</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P16" WIDTH="250" HEIGHT="30">1. 이자비용</TD>
<TD WIDTH="142" HEIGHT="30" ALIGN="RIGHT">342,268,987</TD>
<TD WIDTH="141" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="141" HEIGHT="30" ALIGN="RIGHT">135,644,204</TD>
<TD WIDTH="141" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P16" WIDTH="250" HEIGHT="30">2. 기타의대손상각비</TD>
<TD WIDTH="142" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="141" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="141" HEIGHT="30" ALIGN="RIGHT">5,286,732</TD>
<TD WIDTH="141" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P16" WIDTH="250" HEIGHT="30">3. 외환차손(주석12)</TD>
<TD WIDTH="142" HEIGHT="30" ALIGN="RIGHT">31,970,980</TD>
<TD WIDTH="141" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="141" HEIGHT="30" ALIGN="RIGHT">30,091,562</TD>
<TD WIDTH="141" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P16" WIDTH="250" HEIGHT="30">4. 외화환산손실(주석12)</TD>
<TD WIDTH="142" HEIGHT="30" ALIGN="RIGHT">2,867,700</TD>
<TD WIDTH="141" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="141" HEIGHT="30" ALIGN="RIGHT">31,860,183</TD>
<TD WIDTH="141" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P16" WIDTH="250" HEIGHT="30">5. 유형자산처분손실</TD>
<TD WIDTH="142" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="141" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="141" HEIGHT="30" ALIGN="RIGHT">428,394</TD>
<TD WIDTH="141" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="250" HEIGHT="30" USERMARK=" P16">6. 기부금</TD>
<TD WIDTH="142" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="141" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="141" HEIGHT="30" ALIGN="RIGHT">5,000,000</TD>
<TD WIDTH="141" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="250" HEIGHT="30" USERMARK=" P16">7. 전기오류수정손실</TD>
<TD WIDTH="142" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="141" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="141" HEIGHT="30" ALIGN="RIGHT">21,415,149</TD>
<TD WIDTH="141" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="250" HEIGHT="30" USERMARK=" P16">8. 잡손실</TD>
<TD WIDTH="142" HEIGHT="30" ALIGN="RIGHT">1,169,074</TD>
<TD WIDTH="141" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="141" HEIGHT="30" ALIGN="RIGHT">471,116,161</TD>
<TD WIDTH="141" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="250" HEIGHT="30" USERMARK=" P16">VIII. 법인세비용차감전순손실</TD>
<TD WIDTH="142" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="141" HEIGHT="30" ALIGN="RIGHT">1,531,637,336</TD>
<TD WIDTH="141" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="141" HEIGHT="30" ALIGN="RIGHT">4,390,201,234</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="250" HEIGHT="30" USERMARK=" P16">IX. 법인세비용(주석15)</TD>
<TD WIDTH="142" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="141" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="141" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="141" HEIGHT="30" ALIGN="RIGHT">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="250" HEIGHT="30" USERMARK=" P16">X. 당기순손실</TD>
<TD WIDTH="142" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="141" HEIGHT="30" ALIGN="RIGHT">1,531,637,336</TD>
<TD WIDTH="141" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="141" HEIGHT="30" ALIGN="RIGHT">4,390,201,234</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="250" HEIGHT="30" USERMARK=" P16">XI. 주당손익(주석16)</TD>
<TD WIDTH="142" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="141" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="141" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="141" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="250" HEIGHT="30" USERMARK=" P16">기본주당순손익</TD>
<TD WIDTH="142" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="141" HEIGHT="30" ALIGN="RIGHT">(569)</TD>
<TD WIDTH="141" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="141" HEIGHT="30" ALIGN="RIGHT">(1,898)</TD>
</TR>
</TBODY>
</TABLE>
<P>&cr;<자본변동표></P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="889">

<COLGROUP>
<COL WIDTH="463"></COL>
<COL WIDTH="408"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="889" HEIGHT="30" COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE">제 7(당) 기 2020년 1월 1일부터 2020년 12월 31일까지</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="889" HEIGHT="30" COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE">제 6(전) 기 2019년 1월 1일부터 2019년 12월 31일까지</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="472" HEIGHT="30" VALIGN="BOTTOM"></TD>
<TD WIDTH="417" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">(단위 : 원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="887">

<COLGROUP>
<COL WIDTH="151"></COL>
<COL WIDTH="100"></COL>
<COL WIDTH="109"></COL>
<COL WIDTH="116"></COL>
<COL WIDTH="111"></COL>
<COL WIDTH="122"></COL>
<COL WIDTH="115"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="160" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">과     목</TH>
<TH WIDTH="109" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">자 본 금</TH>
<TH WIDTH="118" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">자  본&cr;잉여금</TH>
<TH WIDTH="125" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">자 본&cr;조 정</TH>
<TH WIDTH="120" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기타포괄&cr;손익누계액</TH>
<TH WIDTH="131" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">이  익&cr;잉여금</TH>
<TH WIDTH="124" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">총   계</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="160" HEIGHT="30" VALIGN="MIDDLE">2019.01.01(전기초)</TD>
<TD WIDTH="109" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,307,500,000</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">12,699,874,453</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,642,492,321</TD>
<TD WIDTH="120" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">25,511,271</TD>
<TD WIDTH="131" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(17,820,987,428)</TD>
<TD WIDTH="124" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(2,145,609,383)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="160" HEIGHT="30" VALIGN="MIDDLE">유상증자</TD>
<TD WIDTH="109" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">10,000,000</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">209,117,000</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="120" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="131" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="124" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">219,117,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="160" HEIGHT="30" VALIGN="MIDDLE">전환사채의 발행</TD>
<TD WIDTH="109" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">442,440,579</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="120" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="131" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="124" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">442,440,579</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="160" HEIGHT="30" VALIGN="MIDDLE">주식기준보상</TD>
<TD WIDTH="109" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">318,762,134</TD>
<TD WIDTH="120" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="131" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="124" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">318,762,134</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="160" HEIGHT="30" VALIGN="MIDDLE">전기오류수정손실</TD>
<TD WIDTH="109" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">21,415,149</TD>
<TD WIDTH="120" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="131" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="124" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">21,415,149</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="160" HEIGHT="30" VALIGN="MIDDLE">당기순손실</TD>
<TD WIDTH="109" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="120" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="131" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(4,390,201,234)</TD>
<TD WIDTH="124" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(4,390,201,234)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="160" HEIGHT="30" VALIGN="MIDDLE">2019.12.31(전기말)</TD>
<TD WIDTH="109" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,317,500,000</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">13,351,432,032</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,982,669,604</TD>
<TD WIDTH="120" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">25,511,271</TD>
<TD WIDTH="131" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(22,211,188,662)</TD>
<TD WIDTH="124" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(5,534,075,755)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="160" HEIGHT="30" VALIGN="MIDDLE">2020.01.01(당기초)</TD>
<TD WIDTH="109" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,317,500,000</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">13,351,432,032</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,982,669,604</TD>
<TD WIDTH="120" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">25,511,271</TD>
<TD WIDTH="131" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(22,211,188,662)</TD>
<TD WIDTH="124" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(5,534,075,755)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="160" HEIGHT="30" VALIGN="MIDDLE">예수금의 출자전환</TD>
<TD WIDTH="109" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">40,000,000</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">840,000,000</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE"></TD>
<TD WIDTH="120" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE"></TD>
<TD WIDTH="131" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE"></TD>
<TD WIDTH="124" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">880,000,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="160" HEIGHT="30" VALIGN="MIDDLE">유상증자</TD>
<TD WIDTH="109" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">86,000,000</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,795,748,350</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE"></TD>
<TD WIDTH="120" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE"></TD>
<TD WIDTH="131" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE"></TD>
<TD WIDTH="124" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,881,748,350</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="160" HEIGHT="30" VALIGN="MIDDLE">미지급금 출자전환</TD>
<TD WIDTH="109" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">101,025,000</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">2,121,525,000</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="120" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="131" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="124" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">2,222,550,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="160" HEIGHT="30" VALIGN="MIDDLE">전환사채 전환</TD>
<TD WIDTH="109" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">22,500,000</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">361,088,062</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="120" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="131" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="124" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">383,588,062</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="160" HEIGHT="30" VALIGN="MIDDLE">주식기준보상</TD>
<TD WIDTH="109" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">293,510,224</TD>
<TD WIDTH="120" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="131" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="124" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">293,510,224</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="160" HEIGHT="30" VALIGN="MIDDLE">당기순손실</TD>
<TD WIDTH="109" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="120" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="131" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(1,531,637,336)</TD>
<TD WIDTH="124" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(1,531,637,336)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="160" HEIGHT="30" VALIGN="MIDDLE">2020.12.31(당기말)</TD>
<TD WIDTH="109" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,567,025,000</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">18,469,793,444</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">2,276,179,828</TD>
<TD WIDTH="120" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">25,511,271</TD>
<TD WIDTH="131" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(23,742,825,998)</TD>
<TD WIDTH="124" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(1,404,316,455)</TD>
</TR>
</TBODY>
</TABLE>
<P>&cr;<현금흐름표></P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="805">

<COLGROUP>
<COL WIDTH="291"></COL>
<COL WIDTH="496"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="805" HEIGHT="30" COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE">제 7(당) 기 2020년 1월 1일부터 2020년 12월 31일까지</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="805" HEIGHT="30" COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE">제 6(전) 기 2019년 1월 1일부터 2019년 12월 31일까지</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="300" HEIGHT="30" VALIGN="BOTTOM"></TD>
<TD WIDTH="505" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">(단위 : 원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="794">

<COLGROUP>
<COL WIDTH="299"></COL>
<COL WIDTH="114"></COL>
<COL WIDTH="111"></COL>
<COL WIDTH="115"></COL>
<COL WIDTH="110"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="308" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">과                        목</TH>
<TH WIDTH="243" HEIGHT="30" COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">제 7(당) 기</TH>
<TH WIDTH="243" HEIGHT="30" COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">제 6(전) 기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="308" HEIGHT="30">I. 영업활동으로 인한 현금흐름</TD>
<TD WIDTH="123" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="120" HEIGHT="30" ALIGN="RIGHT">(2,092,972,183)</TD>
<TD WIDTH="124" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="119" HEIGHT="30" ALIGN="RIGHT">(1,479,028,490)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P16" WIDTH="308" HEIGHT="30">1. 당기순손실</TD>
<TD WIDTH="123" HEIGHT="30" ALIGN="RIGHT">(1,531,637,336)</TD>
<TD WIDTH="120" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="124" HEIGHT="30" ALIGN="RIGHT">(4,390,201,234)</TD>
<TD WIDTH="119" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P16" WIDTH="308" HEIGHT="30">2. 현금의 유출이 없는 비용 등의 가산</TD>
<TD WIDTH="123" HEIGHT="30" ALIGN="RIGHT">687,733,664</TD>
<TD WIDTH="120" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="124" HEIGHT="30" ALIGN="RIGHT">621,089,418</TD>
<TD WIDTH="119" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P32" WIDTH="308" HEIGHT="30">주식보상비용</TD>
<TD WIDTH="123" HEIGHT="30" ALIGN="RIGHT">293,510,224</TD>
<TD WIDTH="120" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="124" HEIGHT="30" ALIGN="RIGHT">318,762,134</TD>
<TD WIDTH="119" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P32" WIDTH="308" HEIGHT="30">퇴직급여</TD>
<TD WIDTH="123" HEIGHT="30" ALIGN="RIGHT">67,262,044</TD>
<TD WIDTH="120" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="124" HEIGHT="30" ALIGN="RIGHT">73,106,276</TD>
<TD WIDTH="119" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P32" WIDTH="308" HEIGHT="30">유형자산감가상각비</TD>
<TD WIDTH="123" HEIGHT="30" ALIGN="RIGHT">34,453,058</TD>
<TD WIDTH="120" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="124" HEIGHT="30" ALIGN="RIGHT">34,918,281</TD>
<TD WIDTH="119" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P32" WIDTH="308" HEIGHT="30">무형자산감가상각비</TD>
<TD WIDTH="123" HEIGHT="30" ALIGN="RIGHT">120,373</TD>
<TD WIDTH="120" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="124" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="119" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="308" HEIGHT="30" USERMARK=" P32">기타의대손상각비</TD>
<TD WIDTH="123" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="120" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="124" HEIGHT="30" ALIGN="RIGHT">5,286,732</TD>
<TD WIDTH="119" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P32" WIDTH="308" HEIGHT="30">유형자산처분손실</TD>
<TD WIDTH="123" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="120" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="124" HEIGHT="30" ALIGN="RIGHT">428,394</TD>
<TD WIDTH="119" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P16" WIDTH="308" HEIGHT="30">이자비용</TD>
<TD WIDTH="123" HEIGHT="30" ALIGN="RIGHT">292,387,965</TD>
<TD WIDTH="120" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="124" HEIGHT="30" ALIGN="RIGHT">135,644,204</TD>
<TD WIDTH="119" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P32" WIDTH="308" HEIGHT="30">외화환산손실</TD>
<TD WIDTH="123" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="120" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="124" HEIGHT="30" ALIGN="RIGHT">31,528,248</TD>
<TD WIDTH="119" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P32" WIDTH="308" HEIGHT="30">전기오류수정손실</TD>
<TD WIDTH="123" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="120" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="124" HEIGHT="30" ALIGN="RIGHT">21,415,149</TD>
<TD WIDTH="119" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P16" WIDTH="308" HEIGHT="30">3. 현금의 유입이 없는 수익 등의 차감</TD>
<TD WIDTH="123" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="120" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="124" HEIGHT="30" ALIGN="RIGHT">(39,866,913)</TD>
<TD WIDTH="119" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P32" WIDTH="308" HEIGHT="30">외화환산이익</TD>
<TD WIDTH="123" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="120" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="124" HEIGHT="30" ALIGN="RIGHT">39,757,822</TD>
<TD WIDTH="119" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P32" WIDTH="308" HEIGHT="30">유형자산처분이익</TD>
<TD WIDTH="123" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="120" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="124" HEIGHT="30" ALIGN="RIGHT">109,091</TD>
<TD WIDTH="119" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P32" WIDTH="308" HEIGHT="30">4. 영업활동으로 인한 자산부채의 변동</TD>
<TD WIDTH="123" HEIGHT="30" ALIGN="RIGHT">(1,249,068,511)</TD>
<TD WIDTH="120" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="124" HEIGHT="30" ALIGN="RIGHT">2,329,950,239</TD>
<TD WIDTH="119" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P32" WIDTH="308" HEIGHT="30">기타당좌자산 감소(증가)</TD>
<TD WIDTH="123" HEIGHT="30" ALIGN="RIGHT">(137,472,690)</TD>
<TD WIDTH="120" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="124" HEIGHT="30" ALIGN="RIGHT">(7,606,608)</TD>
<TD WIDTH="119" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P32" WIDTH="308" HEIGHT="30">미지급금의 증가(감소)</TD>
<TD WIDTH="123" HEIGHT="30" ALIGN="RIGHT">(652,504,420)</TD>
<TD WIDTH="120" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="124" HEIGHT="30" ALIGN="RIGHT">2,029,965,552</TD>
<TD WIDTH="119" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="308" HEIGHT="30" USERMARK=" P32">미지급비용의 증가(감소)</TD>
<TD WIDTH="123" HEIGHT="30" ALIGN="RIGHT">(4,631,240)</TD>
<TD WIDTH="120" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="124" HEIGHT="30" ALIGN="RIGHT">22,425,503</TD>
<TD WIDTH="119" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P16" WIDTH="308" HEIGHT="30">예수금의 증가(감소)</TD>
<TD WIDTH="123" HEIGHT="30" ALIGN="RIGHT">(422,140)</TD>
<TD WIDTH="120" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="124" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="119" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P32" WIDTH="308" HEIGHT="30">기타유동부채의 증가(감소)</TD>
<TD WIDTH="123" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="120" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="124" HEIGHT="30" ALIGN="RIGHT">(82,180)</TD>
<TD WIDTH="119" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P32" WIDTH="308" HEIGHT="30">장기미지급금의 증가(감소)</TD>
<TD WIDTH="123" HEIGHT="30" ALIGN="RIGHT">(389,250,389)</TD>
<TD WIDTH="120" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="124" HEIGHT="30" ALIGN="RIGHT">285,247,972</TD>
<TD WIDTH="119" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P16" WIDTH="308" HEIGHT="30">퇴직금의지급</TD>
<TD WIDTH="123" HEIGHT="30" ALIGN="RIGHT">(64,787,632)</TD>
<TD WIDTH="120" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="124" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="119" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P32" WIDTH="308" HEIGHT="30">II. 투자활동으로 인한 현금흐름</TD>
<TD WIDTH="123" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="120" HEIGHT="30" ALIGN="RIGHT">(46,465,673)</TD>
<TD WIDTH="124" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="119" HEIGHT="30" ALIGN="RIGHT">12,271,634</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P32" WIDTH="308" HEIGHT="30">1. 투자활동으로 인한 현금유입액</TD>
<TD WIDTH="123" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="120" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="124" HEIGHT="30" ALIGN="RIGHT">27,154,547</TD>
<TD WIDTH="119" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P32" WIDTH="308" HEIGHT="30">유형자산의 처분</TD>
<TD WIDTH="123" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="120" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="124" HEIGHT="30" ALIGN="RIGHT">254,547</TD>
<TD WIDTH="119" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P32" WIDTH="308" HEIGHT="30">보증금의 감소</TD>
<TD WIDTH="123" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="120" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="124" HEIGHT="30" ALIGN="RIGHT">26,900,000</TD>
<TD WIDTH="119" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="308" HEIGHT="30" USERMARK=" P32">2. 투자활동으로 인한 현금유출액</TD>
<TD WIDTH="123" HEIGHT="30" ALIGN="RIGHT">(46,465,673)</TD>
<TD WIDTH="120" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="124" HEIGHT="30" ALIGN="RIGHT">(14,882,913)</TD>
<TD WIDTH="119" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P16" WIDTH="308" HEIGHT="30">장기대여금의 증가</TD>
<TD WIDTH="123" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="120" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="124" HEIGHT="30" ALIGN="RIGHT">5,286,732</TD>
<TD WIDTH="119" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P32" WIDTH="308" HEIGHT="30">유형자산의 취득</TD>
<TD WIDTH="123" HEIGHT="30" ALIGN="RIGHT">3,074,873</TD>
<TD WIDTH="120" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="124" HEIGHT="30" ALIGN="RIGHT">9,596,181</TD>
<TD WIDTH="119" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P32" WIDTH="308" HEIGHT="30">무형자산의 취득</TD>
<TD WIDTH="123" HEIGHT="30" ALIGN="RIGHT">3,390,800</TD>
<TD WIDTH="120" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="124" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="119" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P32" WIDTH="308" HEIGHT="30"> 보증금의 증가</TD>
<TD WIDTH="123" HEIGHT="30" ALIGN="RIGHT">40,000,000</TD>
<TD WIDTH="120" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="124" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="119" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P16" WIDTH="308" HEIGHT="30">III. 재무활동으로 인한 현금흐름</TD>
<TD WIDTH="123" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="120" HEIGHT="30" ALIGN="RIGHT">2,131,748,350</TD>
<TD WIDTH="124" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="119" HEIGHT="30" ALIGN="RIGHT">2,549,117,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="308" HEIGHT="30" USERMARK=" P16">1. 재무활동으로 인한 현금유입액</TD>
<TD WIDTH="123" HEIGHT="30" ALIGN="RIGHT">2,131,748,350</TD>
<TD WIDTH="120" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="124" HEIGHT="30" ALIGN="RIGHT">2,549,117,000</TD>
<TD WIDTH="119" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="308" HEIGHT="30" USERMARK=" P32">예수금의 증가</TD>
<TD WIDTH="123" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="120" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="124" HEIGHT="30" ALIGN="RIGHT">880,000,000</TD>
<TD WIDTH="119" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="308" HEIGHT="30" USERMARK=" P16">전환사채의 발행</TD>
<TD WIDTH="123" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="120" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="124" HEIGHT="30" ALIGN="RIGHT">1,450,000,000</TD>
<TD WIDTH="119" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="308" HEIGHT="30" USERMARK=" P32">차입금의 증가</TD>
<TD WIDTH="123" HEIGHT="30" ALIGN="RIGHT">250,000,000</TD>
<TD WIDTH="120" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="124" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="119" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="308" HEIGHT="30" USERMARK=" P32">유상증자</TD>
<TD WIDTH="123" HEIGHT="30" ALIGN="RIGHT">1,881,748,350</TD>
<TD WIDTH="120" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="124" HEIGHT="30" ALIGN="RIGHT">219,117,000</TD>
<TD WIDTH="119" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="308" HEIGHT="30" USERMARK=" P32">2. 재무활동으로 인한 현금유출액</TD>
<TD WIDTH="123" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="120" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="124" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="119" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="308" HEIGHT="30" USERMARK=" P32">IV. 현금의 증가(감소)(I+II+III)</TD>
<TD WIDTH="123" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="120" HEIGHT="30" ALIGN="RIGHT">(7,689,506)</TD>
<TD WIDTH="124" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="119" HEIGHT="30" ALIGN="RIGHT">1,082,360,144</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="308" HEIGHT="30" USERMARK=" P32">V. 기초의 현금</TD>
<TD WIDTH="123" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="120" HEIGHT="30" ALIGN="RIGHT">1,268,393,949</TD>
<TD WIDTH="124" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="119" HEIGHT="30" ALIGN="RIGHT">186,033,805</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="308" HEIGHT="30" USERMARK=" P16">Ⅵ. 기말의 현금</TD>
<TD WIDTH="123" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="120" HEIGHT="30" ALIGN="RIGHT">1,260,704,443</TD>
<TD WIDTH="124" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="119" HEIGHT="30" ALIGN="RIGHT">1,268,393,949</TD>
</TR>
</TBODY>
</TABLE>
<P>&cr;<결손금처리계산서></P>

<TABLE WIDTH="725" BORDER="0" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="103"></COL>
<COL WIDTH="188"></COL>
<COL WIDTH="44"></COL>
<COL WIDTH="106"></COL>
<COL WIDTH="186"></COL>
<COL WIDTH="44"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="2" WIDTH="112" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60">제 7(당)기</TD>

<TD WIDTH="197" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2020년 
<SPAN USERMARK=" 0XFFFFFF">0</SPAN>1월
<SPAN USERMARK=" 0XFFFFFF"> 0</SPAN>1일
</TD>
<TD WIDTH="53" VALIGN="MIDDLE" HEIGHT="30">부터</TD>
<TD ROWSPAN="2" WIDTH="115" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60">제 6(전)기</TD>

<TD WIDTH="195" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2019년 
<SPAN USERMARK=" 0XFFFFFF">0</SPAN>1월
<SPAN USERMARK=" 0XFFFFFF"> 0</SPAN>1일
</TD>
<TD WIDTH="53" VALIGN="MIDDLE" HEIGHT="30">부터</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="197" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2020년 12월 31일</TD>
<TD WIDTH="53" VALIGN="MIDDLE" HEIGHT="30">까지</TD>
<TD WIDTH="195" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2019년 12월 31일</TD>
<TD WIDTH="53" VALIGN="MIDDLE" HEIGHT="30">까지</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="112" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">처리예정일</TD>

<TD WIDTH="197" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">2021년 
<SPAN USERMARK=" 0XFFFFFF">0</SPAN>3월 25일
</TD>
<TD WIDTH="53" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53"></TD>
<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">처리확정일</TD>

<TD WIDTH="195" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">2020년 
<SPAN USERMARK=" 0XFFFFFF">0</SPAN>3월 30일
</TD>
<TD WIDTH="53" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">&cr;</TD>
</TR>
</TBODY>
</TABLE>

<TABLE WIDTH="724" BORDER="0" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="353"></COL>
<COL WIDTH="353"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="362" VALIGN="BOTTOM" HEIGHT="30"></TD>
<TD WIDTH="362" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">(단위 : 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="726" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="221"></COL>
<COL WIDTH="115"></COL>
<COL WIDTH="115"></COL>
<COL WIDTH="115"></COL>
<COL WIDTH="115"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="230" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">과   목</TH>
<TH COLSPAN="2" WIDTH="248" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">제 7(당) 기</TH>
<TH COLSPAN="2" WIDTH="248" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">제 6(당) 기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="230" HEIGHT="30">I. 미처리 결손금</TD>
<TD WIDTH="124" ALIGN="RIGHT" HEIGHT="30"></TD>
<TD WIDTH="124" ALIGN="RIGHT" HEIGHT="30">(23,742,493)</TD>
<TD WIDTH="124" ALIGN="RIGHT" HEIGHT="30"></TD>
<TD WIDTH="124" ALIGN="RIGHT" HEIGHT="30">(22,211,188)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="230" HEIGHT="30">1. 전기이월미처리결손금</TD>
<TD WIDTH="124" ALIGN="RIGHT" HEIGHT="30">(22,211,188)</TD>
<TD WIDTH="124" ALIGN="RIGHT" HEIGHT="30"></TD>
<TD WIDTH="124" ALIGN="RIGHT" HEIGHT="30">(17,820,987)</TD>
<TD WIDTH="124" ALIGN="RIGHT" HEIGHT="30"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="230" HEIGHT="30">2. 당기순손실</TD>
<TD WIDTH="124" ALIGN="RIGHT" HEIGHT="30">(1,531,305)</TD>
<TD WIDTH="124" ALIGN="RIGHT" HEIGHT="30"></TD>
<TD WIDTH="124" ALIGN="RIGHT" HEIGHT="30">(4,390,201)</TD>
<TD WIDTH="124" ALIGN="RIGHT" HEIGHT="30"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="230" HEIGHT="30">3. 지분법이익잉여금변동</TD>
<TD WIDTH="124" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="124" ALIGN="RIGHT" HEIGHT="30"></TD>
<TD WIDTH="124" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="124" ALIGN="RIGHT" HEIGHT="30"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="230" HEIGHT="30">II. 결손금 처리액</TD>
<TD WIDTH="124" ALIGN="RIGHT" HEIGHT="30"></TD>
<TD WIDTH="124" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="124" ALIGN="RIGHT" HEIGHT="30"></TD>
<TD WIDTH="124" ALIGN="RIGHT" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="230" HEIGHT="30">III. 차기이월결손금</TD>
<TD WIDTH="124" ALIGN="RIGHT" HEIGHT="30"></TD>
<TD WIDTH="124" ALIGN="RIGHT" HEIGHT="30">(23,742,493)</TD>
<TD WIDTH="124" ALIGN="RIGHT" HEIGHT="30"></TD>
<TD WIDTH="124" ALIGN="RIGHT" HEIGHT="30">(22,211,188)</TD>
</TR>
</TBODY>
</TABLE>
<P>&cr;</P>
<PGBRK></PGBRK>
</SECTION-2>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-0-3-5-0">5. 재무제표 주석</TITLE>
<P></P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="600">

<COLGROUP>
<COL WIDTH="591"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="600" HEIGHT="30" ALIGN="CENTER">제 7(당) 기  2020년 12월 31일로 종료되는 회계연도</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="600" HEIGHT="30" ALIGN="CENTER">제 6(전) 기  2019년 12월 31일로 종료되는 회계연도</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="600" HEIGHT="30">주식회사 플럼라인생명과학</TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<P>1. 회사의 개요&cr;</P>
<P>주식회사 플럼라인생명과학(이하 "당사")은 2014년 1월 2일에 설립하였습니다. 당사는 생명공학 기반의 동물 바이오 의약품 및 원료의 연구개발, 제조 및 판매 등을 주 영업목적으로 하고 있으며, 당기말 현재 자본금은 1,567,025천원입니다. 당사는 서울특별시 서초구 서초대로 34길 18에 본사를 두고 있습니다. &cr;&cr;보고기간종료일 현재 당사의 주주 내역은 다음과 같습니다.</P>

<TABLE BORDER="1" WIDTH="843" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="362"></COL>
<COL WIDTH="109"></COL>
<COL WIDTH="109"></COL>
<COL WIDTH="109"></COL>
<COL WIDTH="109"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH ROWSPAN="2" WIDTH="371" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">주 주 명</TH>
<TH COLSPAN="2" WIDTH="236" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기말</TH>
<TH COLSPAN="2" WIDTH="236" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전기말</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="118" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">소유주식수(주)</TH>
<TH WIDTH="118" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">지분율(%)</TH>
<TH WIDTH="118" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">소유주식수(주)</TH>
<TH WIDTH="118" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">지분율(%)</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="371" VALIGN="MIDDLE" HEIGHT="30">김앤토니경태</TD>
<TD WIDTH="118" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">693,946</TD>
<TD WIDTH="118" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">22.14%</TD>
<TD WIDTH="118" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">693,946</TD>
<TD WIDTH="118" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">26.34%</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="371" VALIGN="MIDDLE" HEIGHT="30">VGX Pharmaceuticals, LLC.(*1)</TD>
<TD WIDTH="118" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">395,758</TD>
<TD WIDTH="118" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">12.63%</TD>
<TD WIDTH="118" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">395,758</TD>
<TD WIDTH="118" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">15.02%</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="371" VALIGN="MIDDLE" HEIGHT="30">Inovio Pharmaceuticals, Inc.(*2)</TD>
<TD WIDTH="118" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">202,050</TD>
<TD WIDTH="118" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">6.45%</TD>
<TD WIDTH="118" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="118" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">0.00%</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="371" VALIGN="MIDDLE" HEIGHT="30">김주한</TD>
<TD WIDTH="118" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">172,000</TD>
<TD WIDTH="118" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">5.49%</TD>
<TD WIDTH="118" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="118" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">0.00%</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="371" VALIGN="MIDDLE" HEIGHT="30">은행권청년창업재단 IBKC Pioneer 신기술투자조합</TD>
<TD WIDTH="118" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">100,000</TD>
<TD WIDTH="118" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3.19%</TD>
<TD WIDTH="118" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">100,000</TD>
<TD WIDTH="118" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3.80%</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="371" VALIGN="MIDDLE" HEIGHT="30">다담 4차산업 소셜임팩트 투자조합</TD>
<TD WIDTH="118" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">100,000</TD>
<TD WIDTH="118" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3.19%</TD>
<TD WIDTH="118" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="118" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">0.00%</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="371" VALIGN="MIDDLE" HEIGHT="30">SBI-성장사다리 코넥스활성화펀드</TD>
<TD WIDTH="118" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">18,122</TD>
<TD WIDTH="118" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">0.58%</TD>
<TD WIDTH="118" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">18,122</TD>
<TD WIDTH="118" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">0.69%</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="371" VALIGN="MIDDLE" HEIGHT="30">기타</TD>
<TD WIDTH="118" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,452,174</TD>
<TD WIDTH="118" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">46.34%</TD>
<TD WIDTH="118" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,427,174</TD>
<TD WIDTH="118" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">54.16%</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="371" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">합  계</TD>
<TD WIDTH="118" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,134,050</TD>
<TD WIDTH="118" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">100.00%</TD>
<TD WIDTH="118" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,635,000</TD>
<TD WIDTH="118" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">100.00%</TD>
</TR>
</TBODY>
</TABLE>
<P>(*1) VGX Pharmaceuticals, LLC.는 미국 나스닥상장회사인 Inovio Pharmaceuticals, Inc.가 지분 100%를 보유하고 있습니다. &cr;(*2) 당사는 미국법인 Inovio Pharmaceutical, Inc.에 대하여 지급할 매입 채무 전기말 기준 총 2,997백만원 중 2,223백만원의 채무를 재무구조 개선 및 자본확충을 위해 주식인수 대금으로 상계함에 상호 합의하여, 주식인수 대금과 당사의 채무가 정상적으로 상계 처리됨에 따라 신규 주식 202,050주를 발행하였습니다.&cr;(*3) 당사는 전기 발행한 제 2회차 무기명식 이권부 무보증 무담보 사모 전환사채의 전환권 행사에 따라 신규 주식 45,000주를 발행하였습니다.&cr;</P>
<P>2. 중요한 회계처리방침</P>
<P>당사의 재무제표는 한국의 일반기업회계기준에 따라 작성되었으며, 그 중요한 회계처리 방침은 다음과 같습니다.</P>

<P>
<SPAN></SPAN>
</P>
<P>(1) 수익인식&cr;당사는 제품 및 상품 매출에 대하여 재화의 소유에 따른 유의적인 위험과 효익이 이전된 시점에 수익으로 인식하고 있습니다. 기타의 수익에 대해서는 수익가득과정이 완료되고 수익금액을 신뢰성 있게 측정할 수 있으며 경제적 효익의 유입가능성이 매우 높을 경우에 인식하고 있습니다.&cr;</P>
<P>(2) 현금및현금성자산&cr;당사는 큰 거래비용 없이 현금으로 전환이 용이하고 이자율변동에 따른 가치변동이 중요하지 않은 유가증권 및 단기금융상품으로서 취득당시 만기(또는 상환일)가 3개월 이내에 도래하는 것을 현금성자산으로 분류하고 있습니다.</P>
<P>&cr;(3) 금융자산 &cr;당사는 단기적 자금운용목적으로 소유하거나 기한이 1년 이내에 도래하는 금융기관의 정기예금, 정기적금 등을 단기금융상품으로 분류하고, 유동자산에 속하지 아니하는 금융상품을 장기금융상품으로 분류하고 있습니다.</P>
<P> </P>
<P>(4) 대손충당금</P>
<P>당사는 보고기간종료일 현재 매출채권, 대여금, 미수금 등 채권 잔액의 회수가능성에대한 개별분석 및 과거의 대손경험률을 토대로 하여 예상되는 대손추정액을 대손충당금으로 설정하고 있습니다.&cr; </P>
<P>(5) 지분법적용투자주식 </P>
<P>당사는 피투자기업에 대하여 유의적인 영향력을 행사할 수 있는 지분상품은 지분법을 적용하여 평가하고 있습니다. 지분법적용투자주식을 원가로 인식한 후, 지분법적용투자주식의 취득 시점 이후 발생한 지분변동액은 지분법적용투자주식에 가감 처리하며 그 변동이 피투자기업의 당기순손익으로 인하여 발생한 경우에는 지분법손익의과목으로 하여 당기손익으로, 지분법 피투자회사의 중대한 오류 및 회계변경에 의해 전기이월미처분이익잉여금의 증가(또는 감소)로 인한 경우에는 당사의 재무제표에 미치는 영향을 고려하여 당기손익이나 전기이월미처분이익잉여금의 증가(또는 감소)로, 당기손익과 전기이월미처분이익잉여금을 제외한 자본의 증가 또는 감소로 인한 경우에는 지분법자본변동 또는 부의지분법자본변동의 과목으로 하여 기타포괄손익누계액의 증가 또는 감소로 처리하고 있습니다. </P>
<P>또한 지분법적용투자주식의 금액이 "0"이하가 될 경우 지분법적용을 중지하나, 실질적으로 피투자기업에 대한 순투자액의 일부를 구성하는 장기투자항목이 있는 경우에는 그러한 자산의 장부금액이 "0"이 될 때까지 피투자기업의 손실을 계속적으로 반영하여 처리하고 있습니다.&cr;&cr;(6) 유형자산의 평가 및 감가상각방법 &cr;당사는 유형자산에 대해 당해 자산의 구입원가 또는 제작원가 및 경영진이 의도하는 방식으로 자산을 가동하는 데 필요한 장소와 상태에 이르게 하는 데 직접 관련되는 지출을 취득원가(현물출자, 증여, 기타 무상으로 취득한 자산은 공정가치)로 산정하고 있습니다.&cr;&cr;또한, 유형자산의 취득 또는 완성후의 지출이 유형자산으로 인식되기 위한 조건을 충족하는 경우에는 자본적 지출로, 그렇지 않은 경우에는 발생한 기간의 비용으로 인식하고 있습니다.&cr;</P>
<P>한편, 유형자산에 대한 감가상각비는 아래의 내용연수에 따라 정액법에 의하여 계상되고 있습니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="602">

<COLGROUP>
<COL WIDTH="292"></COL>
<COL WIDTH="292"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" BC0XD7D7D7" WIDTH="301" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">구  분</TD>
<TD USERMARK=" BC0XD7D7D7" WIDTH="301" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">내용연수</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="301" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">기계장치</TD>
<TD WIDTH="301" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">5년</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="301" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">비  품</TD>
<TD WIDTH="301" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">5년</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="301" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">시설장치</TD>
<TD WIDTH="301" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">5년</TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<P>(7) 무형자산</P>
<P>무형자산의 취득원가는 구입원가와 자산을 사용할 수 있도록 준비하는데 직접 관련된 지출로 구성되어 있습니다. 회사는 무형자산을 취득원가에서 추정내용연수와 상각방법에 따라 산정된 상각누계액과 손상차손누계액을 차감한 금액으로 표시하고 있습니다.</P>
<P></P>
<P>(8) 정부보조금&cr;회사는 정부기관 등으로부터 수령한 정부보조금 중 상환의무가 있는 부분은 부채로 계상하며, 상환의무가 없는 부분은 보조금을 교부한 목적에 따라 자산 취득에 사용 될 정부보조금을 받는 경우에는 자산의 차감계정으로 회계처리하고 있습니다. 기타의 정부보조금이 특정비의 비용을 보전으로 지급되는 경우에는 특정의 비용과 상계처리하며, 그 외의 경우에는 당기 이익으로 처리하고 있습니다.</P>
<P> </P>
<P>(9) 퇴직급여&cr;당사는 확정급여제도를 운영하고 있으며 임직원 퇴직금지급규정에 따라 보고기간말 현재 1년이상 근속한 전임직원이 일시에 퇴직할 경우에 지급하여야 할 퇴직금 총 추계액을 퇴직급여충당부채로 설정하고 있습니다. </P>
<P></P>
<P>(10) 법인세회계&cr;당사는 자산ㆍ부채의 장부금액과 세무가액의 차이에 따른 일시적차이에 대하여 이연법인세자산과 이연법인세부채를 인식하고 있습니다. 이연법인세자산과 이연법인세부채는 미래에 일시적차이의 소멸 등으로 인하여 미래에 경감되거나 추가적으로 부담할 법인세부담액으로 측정하고 있습니다. 일시적차이의 법인세 효과는 발생한 기간의 법인세 비용에 반영하고 있으며, 자본 항목에 직접 반영되는 항목과 관련된 일시적 차이의 법인세 효과는 관련 자본 항목에 직접 반영하고 있습니다.&cr;&cr;이연법인세자산의 실현가능성은 매 보고기간종료일마다 재검토하여 향후 과세소득의 발생이 거의 확실하여 이연법인세자산의 법인세 절감 효과가 실현될 수 있을 것으로 기대되는 경우에 자산으로 인식하고 있으며, 이월 세액공제와 세액감면에 대하여서는 이월공제가 활용될 수 있는 미래기간에 발생할 것이 거의 확실한 과세소득의 범위 안에서 이연법인세자산을 인식하고 있습니다.&cr;&cr;이연법인세자산과 이연법인세부채는 관련된 자산항목 또는 부채항목의 재무상태표상 분류에 따라 유동자산(유동부채) 또는 기타비유동자산(기타비유동부채)으로 분류하며, 동일한 과세당국과 관련된 이연법인세자산과 부채를 각각 상계하여 표시하고있습니다. </P>
<P></P>
<P>(11) 외화자산 부채의 환산&cr;당사는 화폐성 외화자산 및 부채는 보고기간말 현재의 환율로 환산하고, 이에 따라 발생하는 환산차이는 당기손익에 반영하고 있습니다. 한편, 역사적원가로 측정하는 비화폐성 외화항목은 거래일의 환율을, 공정가치로 측정하는 비화폐성 외화항목은 공정가치가 결정된 날의 환율을 적용하여 인식하고 있습니다.&cr;&cr;(12) 주식기준보상&cr;당사는 주식결제형 주식기준보상거래에 대하여 제공받는 재화나 용역의 공정가치나 부여한 지분상품의 공정가치에 기초한 금액을 가득기간에 배분하여 보상원가와 자본조정으로 처리하고 있습니다. 현금결제형 주식기준보상거래에 대해서는 제공받는 재화나 용역과 그 대가로 부담하는 부채를 부채의 공정가치로 측정하며 매보고기간말과 최종결제일에 부채의 공정가치를 재측정하고 공정가치의 변동액을 보상원가에 반영하고 있습니다. 또한, 기업이나 거래 상대방이 현금결제 방식이나 주식결제 방식을선택할 수 있는 선택형 주식기준보상거래에 대해서는 거래의 실질에 따라 회계처리하고 있습니다.</P>
<P>&cr;(13) 전환사채</P>
<P>당사는 전환사채에 대하여 부채요소와 자본요소를 분리하여 회계처리하고 있습니다.부채요소는 전환권이 없는 일반사채의 공정가치로 인식하고 있으며, 일반사채의 공정가치는 만기일까지 기대되는 미래현금흐름의 현재가치로 측정하고 있습니다. 사채의 발행가액에서 부채부분을 차감한 금액인 자본요소를 전환권대가로 자본잉여금에 계상하고 있습니다. 부채요소는 유효이자율법을 이용하여 상각하고 있으며, 자본요소는 최초 측정후 재측정하지 않습니다.</P>
<P></P>
<P>(14) 전기오류수정손익</P>
<P>전기 또는 그 이전기간의 재무제표를 작성할 때 발생하였던 오류가 당기에 발견되는 경우 당기 손익계산서에 영업외손익 중 전기오류수정손익으로 계상하고 있습니다. 다만, 중대한 오류의 수정은 전기이월미처분이익잉여금에 반영하고 관련 계정잔액을수정하며 중대한 오류의 영향을 받은 회계기간의 재무제표를 재작성하고 있습니다.</P>
<P></P>
<P>(15) 재무제표 확정일과 기관&cr;당사의 재무제표는 2021년 1월 29일자 이사회에서 사실상 확정 되었으며, 2021년 3월 25일 정기주주총회에서 최종 승인될 예정입니다. &cr;&cr;</P>
<P>3. 현금및현금성자산&cr;보고기간종료일 현재 현금및현금성자산의 내역은 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="617">

<COLGROUP>
<COL WIDTH="291"></COL>
<COL WIDTH="308"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="300" HEIGHT="30" VALIGN="BOTTOM"></TD>
<TD WIDTH="317" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">(단위:천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="621" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="198"></COL>
<COL WIDTH="198"></COL>
<COL WIDTH="198"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="207" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구  분</TH>
<TH WIDTH="207" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기말</TH>
<TH WIDTH="207" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전기말</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="207" HEIGHT="30">보통예금</TD>
<TD WIDTH="207" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,195,824</TD>
<TD WIDTH="207" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">23,299</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="207" HEIGHT="30">MMDA 등</TD>
<TD WIDTH="207" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">64,880</TD>
<TD WIDTH="207" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,245,095</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="207" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">합  계</TD>
<TD WIDTH="207" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,260,704</TD>
<TD WIDTH="207" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,268,394</TD>
</TR>
</TBODY>
</TABLE>
<P>&cr;&cr;4. 기타당좌자산&cr;보고기간종료일 현재 기타당좌자산의 내역은 다음과 같습니다.</P>

<TABLE WIDTH="630" BORDER="0" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="291"></COL>
<COL WIDTH="321"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="300" VALIGN="BOTTOM" HEIGHT="30"></TD>
<TD WIDTH="330" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">(단위:천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="630" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="201"></COL>
<COL WIDTH="201"></COL>
<COL WIDTH="201"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="210" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구  분</TH>
<TH WIDTH="210" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기말</TH>
<TH WIDTH="210" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전기말</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="210" VALIGN="MIDDLE" HEIGHT="30">미수금</TD>
<TD WIDTH="210" ALIGN="RIGHT" HEIGHT="30">43,257</TD>
<TD WIDTH="210" ALIGN="RIGHT" HEIGHT="30">15,652</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="210" VALIGN="MIDDLE" HEIGHT="30">
<P>선급금</P>
</TD>
<TD WIDTH="210" ALIGN="RIGHT" HEIGHT="30">219,593</TD>
<TD WIDTH="210" ALIGN="RIGHT" HEIGHT="30">123,615</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="210" VALIGN="MIDDLE" HEIGHT="30">선급비용</TD>
<TD WIDTH="210" ALIGN="RIGHT" HEIGHT="30">30,174</TD>
<TD WIDTH="210" ALIGN="RIGHT" HEIGHT="30">16,422</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="210" VALIGN="MIDDLE" HEIGHT="30">당기법인세자산</TD>
<TD WIDTH="210" ALIGN="RIGHT" HEIGHT="30">272</TD>
<TD WIDTH="210" ALIGN="RIGHT" HEIGHT="30">134</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="210" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">합  계</TD>
<TD WIDTH="210" ALIGN="RIGHT" HEIGHT="30">293,296</TD>
<TD WIDTH="210" ALIGN="RIGHT" HEIGHT="30">155,823</TD>
</TR>
</TBODY>
</TABLE>
<P>&cr;&cr;5. 기타비유동자산</P>
<P>보고기간종료일 현재 기타비유동자산의 내역은 다음과 같습니다.</P>

<TABLE WIDTH="629" BORDER="0" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="291"></COL>
<COL WIDTH="320"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="300" VALIGN="BOTTOM" HEIGHT="30"></TD>
<TD WIDTH="329" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">(단위:천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="629" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="201"></COL>
<COL WIDTH="201"></COL>
<COL WIDTH="200"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="210" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구  분</TH>
<TH WIDTH="210" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기말</TH>
<TH WIDTH="209" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전기말</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="210" VALIGN="MIDDLE" HEIGHT="30">보증금</TD>
<TD WIDTH="210" ALIGN="RIGHT" HEIGHT="30">56,749</TD>
<TD WIDTH="209" ALIGN="RIGHT" HEIGHT="30">16,749</TD>
</TR>
</TBODY>
</TABLE>
<P>&cr;&cr;6. 지분법적용투자주식&cr;(1) 보고기간종료일 현재 피투자기업에 대한 투자주식의 내역은 다음과 같습니다.</P>

<TABLE WIDTH="659" BORDER="0" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="291"></COL>
<COL WIDTH="350"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="300" VALIGN="BOTTOM" HEIGHT="30"><당기말></TD>
<TD WIDTH="359" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">(단위:천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="662" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="243"></COL>
<COL WIDTH="94"></COL>
<COL WIDTH="94"></COL>
<COL WIDTH="93"></COL>
<COL WIDTH="93"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="252" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구  분</TH>
<TH WIDTH="103" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">지분율(%)</TH>
<TH WIDTH="103" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">취득원가</TH>
<TH WIDTH="102" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">순자산가액</TH>
<TH WIDTH="102" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">장부금액</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="252" HEIGHT="30">Plumbline Life Sciences, USA, Inc.</TD>
<TD WIDTH="103" ALIGN="CENTER" HEIGHT="30">100</TD>
<TD WIDTH="103" ALIGN="RIGHT" HEIGHT="30">4,147,500</TD>
<TD WIDTH="102" ALIGN="RIGHT" HEIGHT="30">(998,516)</TD>
<TD WIDTH="102" ALIGN="RIGHT" HEIGHT="30">-</TD>
</TR>
</TBODY>
</TABLE>
<P></P>

<TABLE WIDTH="662" BORDER="0" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="291"></COL>
<COL WIDTH="353"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="300" VALIGN="BOTTOM" HEIGHT="30"><전기말></TD>
<TD WIDTH="362" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">(단위:천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="664" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="244"></COL>
<COL WIDTH="94"></COL>
<COL WIDTH="94"></COL>
<COL WIDTH="94"></COL>
<COL WIDTH="93"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="253" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구  분</TH>
<TH WIDTH="103" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">지분율(%)</TH>
<TH WIDTH="103" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">취득원가</TH>
<TH WIDTH="103" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">순자산가액</TH>
<TH WIDTH="102" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">장부금액</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="253" HEIGHT="30">Plumbline Life Sciences, USA, Inc.</TD>
<TD WIDTH="103" ALIGN="CENTER" HEIGHT="30">100</TD>
<TD WIDTH="103" ALIGN="RIGHT" HEIGHT="30">4,147,500</TD>
<TD WIDTH="103" ALIGN="RIGHT" HEIGHT="30">(1,159,362)</TD>
<TD WIDTH="102" ALIGN="RIGHT" HEIGHT="30">-</TD>
</TR>
</TBODY>
</TABLE>

<P>&cr;
<SPAN USERMARK="F-8"></SPAN>(*) Plumbline Life Sciences, USA, Inc.는 미국에 소재하고 있으며 
<SPAN USERMARK="F-8"></SPAN>전기 이전에 당사 제품의 임상시험을 진행 중에 있었으나,당기말 현재 사실상 휴업상태에 있습니다.&cr;
</P>
<P>(2) 보고기간종료일 현재 피투자기업의 요약재무정보는 다음과 같습니다.</P>

<TABLE WIDTH="664" BORDER="0" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="291"></COL>
<COL WIDTH="355"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="300" VALIGN="BOTTOM" HEIGHT="30"><당기말></TD>
<TD WIDTH="364" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">(단위:천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="663" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="244"></COL>
<COL WIDTH="94"></COL>
<COL WIDTH="93"></COL>
<COL WIDTH="93"></COL>
<COL WIDTH="94"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="253" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구  분</TH>
<TH WIDTH="103" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">자산총액</TH>
<TH WIDTH="102" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">부채총액</TH>
<TH WIDTH="102" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">매출액</TH>
<TH WIDTH="103" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기순손익</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="253" HEIGHT="30">Plumbline Life Sciences, USA, Inc.</TD>
<TD WIDTH="103" ALIGN="RIGHT" HEIGHT="30">152,257</TD>
<TD WIDTH="102" ALIGN="RIGHT" HEIGHT="30">1,150,773</TD>
<TD WIDTH="102" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="103" ALIGN="RIGHT" HEIGHT="30">(477)</TD>
</TR>
</TBODY>
</TABLE>
<P></P>

<TABLE WIDTH="665" BORDER="0" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="291"></COL>
<COL WIDTH="356"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="300" VALIGN="BOTTOM" HEIGHT="30"><전기말></TD>
<TD WIDTH="365" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">(단위:천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="665" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="242"></COL>
<COL WIDTH="95"></COL>
<COL WIDTH="95"></COL>
<COL WIDTH="94"></COL>
<COL WIDTH="94"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="251" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구  분</TH>
<TH WIDTH="104" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">자산총액</TH>
<TH WIDTH="104" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">부채총액</TH>
<TH WIDTH="103" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">매출액</TH>
<TH WIDTH="103" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기순손익</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="251" HEIGHT="30">Plumbline Life Sciences, USA, Inc.</TD>
<TD WIDTH="104" ALIGN="RIGHT" HEIGHT="30">164,080</TD>
<TD WIDTH="104" ALIGN="RIGHT" HEIGHT="30">1,323,442</TD>
<TD WIDTH="103" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="103" ALIGN="RIGHT" HEIGHT="30">(5,552)</TD>
</TR>
</TBODY>
</TABLE>
<P>&cr;(3) 당기 중 지분법적용투자주식은 변동하지 않았으며 전기의 변동내역은 다음과 같습니다.</P>

<TABLE WIDTH="673" BORDER="0" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="291"></COL>
<COL WIDTH="364"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="300" VALIGN="BOTTOM" HEIGHT="30"><전기></TD>
<TD WIDTH="373" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">(단위:천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="674" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="229"></COL>
<COL WIDTH="74"></COL>
<COL WIDTH="74"></COL>
<COL WIDTH="78"></COL>
<COL WIDTH="105"></COL>
<COL WIDTH="60"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="238" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구  분</TH>
<TH WIDTH="83" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기  초</TH>
<TH WIDTH="83" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">취  득</TH>
<TH WIDTH="87" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">지분법손익</TH>
<TH WIDTH="114" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">지분법&cr;이익잉여금변동</TH>
<TH WIDTH="69" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기  말</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="238" HEIGHT="30">Plumbline Life Sciences, USA, Inc.</TD>
<TD WIDTH="83" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="83" ALIGN="RIGHT" HEIGHT="30">53,480</TD>
<TD WIDTH="87" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="114" ALIGN="RIGHT" HEIGHT="30">(53,480)</TD>
<TD WIDTH="69" ALIGN="RIGHT" HEIGHT="30">-</TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<P>(4) 보고기간 중 지분법적용의 중지로 인하여 인식하지 못한 미반영 지분변동액은 다음과 같습니다. </P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="624">

<COLGROUP>
<COL WIDTH="303"></COL>
<COL WIDTH="303"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="312" HEIGHT="30" VALIGN="BOTTOM"></TD>
<TD WIDTH="312" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">(단위:천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" WIDTH="625" BORDER="1" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="246"></COL>
<COL WIDTH="115"></COL>
<COL WIDTH="114"></COL>
<COL WIDTH="114"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="255" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구 분</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="124" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기  초</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="123" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">증  감</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="123" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기  말</TH>
</TR>
</THEAD>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="255" HEIGHT="30">Plumbline Life Sciences, USA, Inc.</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="124" HEIGHT="30">(1,159,362)</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="123" HEIGHT="30">160,846</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="123" HEIGHT="30">(998,516)</TD>
</TR>
</TBODY>
</TABLE>
<P>&cr;</P>
<P>7. 유형자산&cr;당기와 전기 중 당사의 유형자산의 변동내역은 다음과 같습니다.</P>

<TABLE WIDTH="679" BORDER="0" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="291"></COL>
<COL WIDTH="370"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="300" VALIGN="BOTTOM" HEIGHT="30"><당기></TD>
<TD WIDTH="379" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">(단위:천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="705">

<COLGROUP>
<COL WIDTH="109"></COL>
<COL WIDTH="109"></COL>
<COL WIDTH="109"></COL>
<COL WIDTH="108"></COL>
<COL WIDTH="108"></COL>
<COL WIDTH="108"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="118" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">구  분</TD>
<TD WIDTH="118" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">기  초</TD>
<TD WIDTH="118" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">취  득</TD>
<TD WIDTH="117" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">처  분</TD>
<TD WIDTH="117" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">감가상각비</TD>
<TD WIDTH="117" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">기  말</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="118" HEIGHT="30">기계장치</TD>
<TD VALIGN="BOTTOM" ALIGN="RIGHT" WIDTH="118" HEIGHT="30">43,886</TD>
<TD VALIGN="BOTTOM" ALIGN="RIGHT" WIDTH="118" HEIGHT="30">-</TD>
<TD VALIGN="BOTTOM" ALIGN="RIGHT" WIDTH="117" HEIGHT="30">-</TD>
<TD VALIGN="BOTTOM" ALIGN="RIGHT" WIDTH="117" HEIGHT="30">(24,578)</TD>
<TD VALIGN="BOTTOM" ALIGN="RIGHT" WIDTH="117" HEIGHT="30">19,308</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="118" HEIGHT="30">비품</TD>
<TD VALIGN="BOTTOM" ALIGN="RIGHT" WIDTH="118" HEIGHT="30">19,911</TD>
<TD VALIGN="BOTTOM" ALIGN="RIGHT" WIDTH="118" HEIGHT="30">1,175</TD>
<TD VALIGN="BOTTOM" ALIGN="RIGHT" WIDTH="117" HEIGHT="30">-</TD>
<TD VALIGN="BOTTOM" ALIGN="RIGHT" WIDTH="117" HEIGHT="30">(8,362)</TD>
<TD VALIGN="BOTTOM" ALIGN="RIGHT" WIDTH="117" HEIGHT="30">12,724</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="118" HEIGHT="30">시설장치</TD>
<TD VALIGN="BOTTOM" ALIGN="RIGHT" WIDTH="118" HEIGHT="30">4,095</TD>
<TD VALIGN="BOTTOM" ALIGN="RIGHT" WIDTH="118" HEIGHT="30">1,900</TD>
<TD VALIGN="BOTTOM" ALIGN="RIGHT" WIDTH="117" HEIGHT="30">-</TD>
<TD VALIGN="BOTTOM" ALIGN="RIGHT" WIDTH="117" HEIGHT="30">(1,513)</TD>
<TD VALIGN="BOTTOM" ALIGN="RIGHT" WIDTH="117" HEIGHT="30">4,482</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="118" HEIGHT="30" ALIGN="CENTER">합  계</TD>
<TD VALIGN="BOTTOM" ALIGN="RIGHT" WIDTH="118" HEIGHT="30">67,892</TD>
<TD VALIGN="BOTTOM" ALIGN="RIGHT" WIDTH="118" HEIGHT="30">3,075</TD>
<TD VALIGN="BOTTOM" ALIGN="RIGHT" WIDTH="117" HEIGHT="30">-</TD>
<TD VALIGN="BOTTOM" ALIGN="RIGHT" WIDTH="117" HEIGHT="30">(34,453)</TD>
<TD VALIGN="BOTTOM" ALIGN="RIGHT" WIDTH="117" HEIGHT="30">36,514</TD>
</TR>
</TBODY>
</TABLE>
<P></P>

<TABLE WIDTH="632" BORDER="0" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="291"></COL>
<COL WIDTH="323"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="300" VALIGN="BOTTOM" HEIGHT="30"><전기></TD>
<TD WIDTH="332" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">(단위:천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="695">

<COLGROUP>
<COL WIDTH="106"></COL>
<COL WIDTH="103"></COL>
<COL WIDTH="112"></COL>
<COL WIDTH="108"></COL>
<COL WIDTH="113"></COL>
<COL WIDTH="99"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" BC0XD7D7D7" WIDTH="115" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">구  분</TD>
<TD USERMARK=" BC0XD7D7D7" WIDTH="112" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">기  초</TD>
<TD USERMARK=" BC0XD7D7D7" WIDTH="121" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">취  득</TD>
<TD USERMARK=" BC0XD7D7D7" WIDTH="117" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">처  분</TD>
<TD USERMARK=" BC0XD7D7D7" WIDTH="122" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">감가상각비</TD>
<TD USERMARK=" BC0XD7D7D7" WIDTH="108" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">기  말</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="115" HEIGHT="30" VALIGN="MIDDLE">기계장치</TD>
<TD WIDTH="112" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">69,839</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">-</TD>
<TD WIDTH="117" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">-</TD>
<TD WIDTH="122" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">(25,953)</TD>
<TD WIDTH="108" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">43,886</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="115" HEIGHT="30" VALIGN="MIDDLE">비품</TD>
<TD WIDTH="112" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">18,595</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">9,596</TD>
<TD WIDTH="117" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">(574)</TD>
<TD WIDTH="122" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">(7,706)</TD>
<TD WIDTH="108" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">19,911</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="115" HEIGHT="30" VALIGN="MIDDLE">시설장치</TD>
<TD WIDTH="112" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">5,355</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">-</TD>
<TD WIDTH="117" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">-</TD>
<TD WIDTH="122" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">(1,260)</TD>
<TD WIDTH="108" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">4,095</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="115" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">합  계</TD>
<TD WIDTH="112" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">93,789</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">9,596</TD>
<TD WIDTH="117" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">(574)</TD>
<TD WIDTH="122" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">(34,919)</TD>
<TD WIDTH="108" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">67,892</TD>
</TR>
</TBODY>
</TABLE>
<P>&cr;&cr;8. 무형자산&cr;당기와 전기 중 당사의 무형자산의 변동내역은 다음과 같습니다.</P>

<TABLE WIDTH="585" BORDER="0" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="291"></COL>
<COL WIDTH="276"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="300" VALIGN="BOTTOM" HEIGHT="30"><당기></TD>
<TD WIDTH="285" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">(단위:천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="588">

<COLGROUP>
<COL WIDTH="109"></COL>
<COL WIDTH="109"></COL>
<COL WIDTH="109"></COL>
<COL WIDTH="108"></COL>
<COL WIDTH="108"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="118" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">구  분</TD>
<TD WIDTH="118" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">기  초</TD>
<TD WIDTH="118" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">취  득</TD>
<TD WIDTH="117" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">감가상각비</TD>
<TD WIDTH="117" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">기  말</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="118" HEIGHT="30">특허권</TD>
<TD VALIGN="BOTTOM" ALIGN="RIGHT" WIDTH="118" HEIGHT="30">-</TD>
<TD VALIGN="BOTTOM" ALIGN="RIGHT" WIDTH="118" HEIGHT="30">3,390</TD>
<TD VALIGN="BOTTOM" ALIGN="RIGHT" WIDTH="117" HEIGHT="30">(120)</TD>
<TD VALIGN="BOTTOM" ALIGN="RIGHT" WIDTH="117" HEIGHT="30">3,270</TD>
</TR>
</TBODY>
</TABLE>
<P>&cr;&cr;9. 단기차입금</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="760">

<COLGROUP>
<COL WIDTH="291"></COL>
<COL WIDTH="451"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="300" HEIGHT="30" VALIGN="BOTTOM"></TD>
<TD WIDTH="460" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">(단위:천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="771">

<COLGROUP>
<COL WIDTH="162"></COL>
<COL WIDTH="116"></COL>
<COL WIDTH="98"></COL>
<COL WIDTH="107"></COL>
<COL WIDTH="117"></COL>
<COL WIDTH="117"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="171" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">차입종류</TD>
<TD WIDTH="125" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">차입처</TD>
<TD WIDTH="107" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">만기일</TD>
<TD WIDTH="116" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">이자율</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">당기말</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">전기말</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="171" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">기술보증기금대출</TD>
<TD WIDTH="125" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">신한은행</TD>
<TD WIDTH="107" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2021.12.21</TD>
<TD WIDTH="116" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">3.09%</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">150,000</TD>
<TD WIDTH="126" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="171" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">기술보증기금대출</TD>
<TD WIDTH="125" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">신한은행</TD>
<TD WIDTH="107" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2021.12.21</TD>
<TD WIDTH="116" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">3.09%</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">100,000</TD>
<TD WIDTH="126" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="4" WIDTH="519" VALIGN="MIDDLE" HEIGHT="30">                                                          합  계</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">250,000</TD>
<TD WIDTH="126" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">-</TD>
</TR>
</TBODY>
</TABLE>
<P>&cr;&cr;10. 전환사채&cr;(1) 당기말 현재 당사가 발행한 전환사채의 내역은 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="637">

<COLGROUP>
<COL WIDTH="169"></COL>
<COL WIDTH="450"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="178" HEIGHT="30" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER">구  분</TH>
<TH WIDTH="459" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">제1회 전환사채</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="178" HEIGHT="30" VALIGN="MIDDLE">발행일</TD>
<TD WIDTH="459" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2019.3.22</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="178" HEIGHT="30" VALIGN="MIDDLE">액면금액</TD>
<TD WIDTH="459" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,000,000,000원</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="178" HEIGHT="30" VALIGN="MIDDLE">발행가액</TD>
<TD WIDTH="459" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,000,000,000원</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="178" HEIGHT="30" VALIGN="MIDDLE">만기일</TD>
<TD WIDTH="459" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2022.3.21</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="178" HEIGHT="30" VALIGN="MIDDLE">액면이자율</TD>
<TD WIDTH="459" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="178" HEIGHT="76" VALIGN="MIDDLE">만기보장수익률</TD>
<TD WIDTH="459" HEIGHT="76" VALIGN="MIDDLE">4% (단, 채권발행후3년이내 주요 주식시장(코스닥) 기업공개일이 도래하지 않을경우의 사채권에 대한 만기보장수익률은 연8(복리)로 조정한다.</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="178" HEIGHT="53" VALIGN="MIDDLE">전환시 발행할 주식의&cr;종류 및 주식수</TD>
<TD WIDTH="459" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">기명식 보통주 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="178" HEIGHT="30" VALIGN="MIDDLE">전환청구기간</TD>
<TD WIDTH="459" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2020년 3월 22일부터 2022년 3월 17일까지</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="178" HEIGHT="76" VALIGN="MIDDLE">전환가격</TD>
<TD WIDTH="459" HEIGHT="76" VALIGN="MIDDLE">1주당 10,000원(단, 시가를 하회하는 발행가액으로 유상증자를 하는 경우 등 기타 사채발행계약서에 정한 기준에 따라 전환가격은 조정될 수 있음)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="178" HEIGHT="99" VALIGN="MIDDLE">발행자의 매수청구권 및 채권자의 조기상환&cr;청구권(*)</TD>
<TD WIDTH="459" HEIGHT="99" VALIGN="MIDDLE">발행자 및 채권자는 사채발행일로부터 1년이 경과한 날(2020년 3월 22일)로부터사채의 일부 또는 전부에 대하여 원금 상환기일 5영업일 전(2022년 3월 17일)까지 각각 조기매수청구 및 조기상환청구 가능</TD>
</TR>
</TBODY>
</TABLE>
<P>(*) 당사는 전기에 1,000백만원 규모로 발행한 제 1회차 무기명식이권부 무보증 전환사채 계약의 특약조항에 따라 2021년 3월 22일부터 조기상환청구권의 행사가 가능하였으나, 해당 조기상환청구권을 삭제하는 변경 계약을 2021년 2월 8일 체결하였습니다. &cr;(**) 전기 발행한 제 2회차 무기명식 이권부 무보증 무담보 사모 전환사채는 2020년 10월 16일 전환권 행사에 따라 신규 주식 45,000주으로 전환 되었습니다.&cr;&cr;(2) 전기 중 당사가 발행한 전환사채의 내역은 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="717">

<COLGROUP>
<COL WIDTH="169"></COL>
<COL WIDTH="271"></COL>
<COL WIDTH="250"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="178" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" ALIGN="CENTER">구  분</TH>
<TH WIDTH="280" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">제1회 전환사채</TH>
<TH WIDTH="259" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">제2회 전환사채</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="178" VALIGN="MIDDLE" HEIGHT="30">발행일</TD>
<TD WIDTH="280" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2019.3.22</TD>
<TD WIDTH="259" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2019.8.16</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="178" VALIGN="MIDDLE" HEIGHT="30">액면금액</TD>
<TD WIDTH="280" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,000,000,000원</TD>
<TD WIDTH="259" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">450,000,000원</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="178" VALIGN="MIDDLE" HEIGHT="30">발행가액</TD>
<TD WIDTH="280" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,000,000,000원</TD>
<TD WIDTH="259" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">450,000,000원</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="178" VALIGN="MIDDLE" HEIGHT="30">만기일</TD>
<TD WIDTH="280" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2022.3.21</TD>
<TD WIDTH="259" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2022.8.16</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="178" VALIGN="MIDDLE" HEIGHT="30">액면이자율</TD>
<TD WIDTH="280" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
<TD WIDTH="259" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="178" VALIGN="MIDDLE" HEIGHT="122">만기보장수익률</TD>
<TD WIDTH="280" VALIGN="MIDDLE" HEIGHT="122">4%(단, 채권발행후3년이내 주요 주식시장(코스닥) 기업공개일이 도래하지 않을경우의 사채권에 대한 만기보장수익률은 연8(복리)로 조정한다.</TD>
<TD WIDTH="259" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="122">4%</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="178" VALIGN="MIDDLE" HEIGHT="53">전환시 발행할 주식의&cr;종류 및 주식수</TD>
<TD WIDTH="280" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">기명식 보통주 </TD>
<TD WIDTH="259" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">기명식 보통주 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="178" VALIGN="MIDDLE" HEIGHT="53">전환청구기간</TD>
<TD WIDTH="280" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">2020년 3월 22일부터&cr;2022년 3월 17일까지</TD>
<TD WIDTH="259" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">2020년 8월 16일부터&cr;2022년 7월 16일까지</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="178" VALIGN="MIDDLE" HEIGHT="122">전환가격</TD>
<TD WIDTH="280" VALIGN="MIDDLE" HEIGHT="122">1주당 10,000원(단, 시가를 하회하는 발행가액으로 유상증자를 하는 경우 등 기타 사채발행계약서에 정한 기준에 따라 전환가격은 조정될 수 있음)</TD>
<TD WIDTH="259" VALIGN="MIDDLE" HEIGHT="122">1주당 10,000원(단, 시가를 하회하는 발행가액으로 유상증자를 하는 경우 등 기타 사채발행계약서에 정한 기준에 따라 전환가격은 조정될 수 있음)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="178" VALIGN="MIDDLE" HEIGHT="145">발행자의 매수청구권 및 채권자의 조기상환&cr;청구권(*)</TD>
<TD WIDTH="280" VALIGN="MIDDLE" HEIGHT="145">발행자 및 채권자는 사채발행일로부터 1년이 경과한 날(2020년 3월 22일)로부터사채의 일부 또는 전부에 대하여 원금 상환기일 5영업일 전(2022년 3월 17일)까지 각각 조기매수청구 및 조기상환청구 가능</TD>
<TD WIDTH="259" VALIGN="MIDDLE" HEIGHT="145">사채발행일로부터 2년이 경과한 날(2021년 8월 16일)로부터사채의 일부 또는 전부에 대하여 원금 상환기일까지 조기상환청구 가능&cr;</TD>
</TR>
</TBODY>
</TABLE>
<P>(*) 제1회 전환사채에 대한 채권자의 조기상환청구권은 2020년 2월 8일 '사채발행일로부터 2년이 경과한 날(2021년 3월 22일)로부터 사채의 일부 또는 전부에 대하여 원금 상환기일 5영업일 전(2022년 3월 17일)까지 조기상환 청구 가능' 조건으로 변경되었습니다.</P>
<P></P>
<P>(3) 보고기간말 현재 전환사채의 내역은 다음과 같습니다.</P>

<TABLE WIDTH="618" BORDER="0" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="291"></COL>
<COL WIDTH="309"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="300" VALIGN="BOTTOM" HEIGHT="30"><당기></TD>
<TD WIDTH="318" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">(단위:천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="620">

<COLGROUP>
<COL WIDTH="301"></COL>
<COL WIDTH="301"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="310" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">구  분</TD>
<TD WIDTH="310" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">기  초</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="310" HEIGHT="30">전환사채 액면금액</TD>
<TD VALIGN="BOTTOM" ALIGN="RIGHT" WIDTH="310" HEIGHT="30">1,000,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="310" HEIGHT="30">상환할증금</TD>
<TD VALIGN="BOTTOM" ALIGN="RIGHT" WIDTH="310" HEIGHT="30">124,864</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="310" HEIGHT="30">전환권조정</TD>
<TD VALIGN="BOTTOM" ALIGN="RIGHT" WIDTH="310" HEIGHT="30">(201,897)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="310" HEIGHT="30" ALIGN="CENTER">장부금액 합계</TD>
<TD VALIGN="BOTTOM" ALIGN="RIGHT" WIDTH="310" HEIGHT="30">922,967</TD>
</TR>
</TBODY>
</TABLE>
<P></P>

<TABLE WIDTH="618" BORDER="0" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="291"></COL>
<COL WIDTH="309"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="300" VALIGN="BOTTOM" HEIGHT="30"><전기></TD>
<TD WIDTH="318" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">(단위:천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="620">

<COLGROUP>
<COL WIDTH="301"></COL>
<COL WIDTH="301"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="310" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">구  분</TD>
<TD WIDTH="310" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">기  초</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="310" HEIGHT="30">전환사채 액면금액</TD>
<TD VALIGN="BOTTOM" ALIGN="RIGHT" WIDTH="310" HEIGHT="30">1,450,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="310" HEIGHT="30">상환할증금</TD>
<TD VALIGN="BOTTOM" ALIGN="RIGHT" WIDTH="310" HEIGHT="30">181,935</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="310" HEIGHT="30">전환권조정</TD>
<TD VALIGN="BOTTOM" ALIGN="RIGHT" WIDTH="310" HEIGHT="30">(508,906)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="310" HEIGHT="30" ALIGN="CENTER">장부금액 합계</TD>
<TD VALIGN="BOTTOM" ALIGN="RIGHT" WIDTH="310" HEIGHT="30">1,123,029</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="310" HEIGHT="30">유동성대체</TD>
<TD VALIGN="BOTTOM" ALIGN="RIGHT" WIDTH="310" HEIGHT="30">(786,152)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="310" HEIGHT="30">비유동 전환사채 잔액</TD>
<TD VALIGN="BOTTOM" ALIGN="RIGHT" WIDTH="310" HEIGHT="30">336,877</TD>
</TR>
</TBODY>
</TABLE>
<P>&cr;&cr;11. 퇴직급여충당부채</P>
<P>당기와 전기 중 퇴직급여충당부채의 변동내역은 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="629">

<COLGROUP>
<COL WIDTH="291"></COL>
<COL WIDTH="320"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="300" HEIGHT="30" VALIGN="BOTTOM"></TD>
<TD WIDTH="329" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="629">

<COLGROUP>
<COL WIDTH="201"></COL>
<COL WIDTH="201"></COL>
<COL WIDTH="200"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="210" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">구  분</TD>
<TD WIDTH="210" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">당  기</TD>
<TD WIDTH="209" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">전  기</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="210" VALIGN="MIDDLE" HEIGHT="30">기초잔액</TD>
<TD WIDTH="210" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">305,370</TD>
<TD WIDTH="209" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">232,264</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="210" VALIGN="MIDDLE" HEIGHT="30">퇴직급여설정액</TD>
<TD WIDTH="210" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">67,262</TD>
<TD WIDTH="209" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">73,106</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="210" VALIGN="MIDDLE" HEIGHT="30">퇴직급여지급액</TD>
<TD WIDTH="210" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">(64,788)</TD>
<TD WIDTH="209" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="210" VALIGN="MIDDLE" HEIGHT="30">기말잔액</TD>
<TD WIDTH="210" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">307,844</TD>
<TD WIDTH="209" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">305,370</TD>
</TR>
</TBODY>
</TABLE>
<P>&cr;&cr;12. 외화환산</P>

<P>
<SPAN>당기말과 전기말 현재 외화자산의 원화환산액 및 환산손익의 내용은 다음과 같으며 이들의 원화환산시 당기말 현재 환율은 1USD:1,180.0이고, 전기말 현재 환율은 </SPAN>
<SPAN></SPAN>
<SPAN>1USD:1,157.8</SPAN>
<SPAN>입니다. </SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="761">

<COLGROUP>
<COL WIDTH="118"></COL>
<COL WIDTH="174"></COL>
<COL WIDTH="147"></COL>
<COL WIDTH="139"></COL>
<COL WIDTH="138"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="761" VALIGN="MIDDLE" HEIGHT="31" ALIGN="RIGHT" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" COLSPAN="5">(단위: USD, 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH ROWSPAN="2" WIDTH="127" VALIGN="MIDDLE" HEIGHT="62" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">과 목</TH>
<TH COLSPAN="2" WIDTH="339" VALIGN="MIDDLE" HEIGHT="31" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당       기</TH>
<TH COLSPAN="2" WIDTH="295" VALIGN="MIDDLE" HEIGHT="31" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전       기</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="183" VALIGN="MIDDLE" HEIGHT="31" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">외화금액</TH>
<TH WIDTH="156" VALIGN="MIDDLE" HEIGHT="31" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">원화환산액</TH>
<TH WIDTH="148" VALIGN="MIDDLE" HEIGHT="31" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">외화금액</TH>
<TH WIDTH="147" VALIGN="MIDDLE" HEIGHT="31" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">원화환산액</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="127" VALIGN="MIDDLE" HEIGHT="31" ALIGN="CENTER">현금성자산</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="183" HEIGHT="31">US$22,408.66</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="156" HEIGHT="31">24,381</TD>

<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="148" HEIGHT="31">
<SPAN>US$</SPAN>
<SPAN>15,443.60</SPAN>
</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="147" HEIGHT="31">17,881</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="127" VALIGN="MIDDLE" HEIGHT="31" ALIGN="CENTER">미지급금</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="183" HEIGHT="31">US$469,818.53</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="156" HEIGHT="31">511,163</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="148" HEIGHT="31">US$542,524.19</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="147" HEIGHT="31"> 628,134</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="127" VALIGN="MIDDLE" HEIGHT="31" ALIGN="CENTER">장기미지급금</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="183" HEIGHT="31">US$293,406.60</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="156" HEIGHT="31">319,226</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="148" HEIGHT="31">-</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="147" HEIGHT="31">-</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN></SPAN>&cr;&cr;13. 자본금&cr;당사가 발행할 주식의 총수는 당기말 현재 90,000,000주이며, 당기말 현재 발행한 주식의 수 및 1주당 금액은 각각 보통주 2,867,050주와 우선주 267,000주  및 500원입니다.
</P>
<P></P>
<P>(1) 당기와 전기 중 자본금의 변동내역은 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="731">

<COLGROUP>
<COL WIDTH="305"></COL>
<COL WIDTH="408"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="314" HEIGHT="30" VALIGN="BOTTOM"></TD>
<TD WIDTH="417" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="797">

<COLGROUP>
<COL WIDTH="151"></COL>
<COL WIDTH="98"></COL>
<COL WIDTH="97"></COL>
<COL WIDTH="97"></COL>
<COL WIDTH="97"></COL>
<COL WIDTH="97"></COL>
<COL WIDTH="97"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="160" HEIGHT="60" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구  분</TH>
<TH WIDTH="107" HEIGHT="60" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">주식수</TH>
<TH WIDTH="212" HEIGHT="30" COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">자본금</TH>
<TH WIDTH="212" HEIGHT="30" COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">주식발행초과금</TH>
<TH WIDTH="106" HEIGHT="60" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">합  계</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="106" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">보통주</TH>
<TH WIDTH="106" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">우선주</TH>
<TH WIDTH="106" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">보통주</TH>
<TH WIDTH="106" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">우선주</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="160" HEIGHT="30">전기초</TD>
<TD WIDTH="107" HEIGHT="30" ALIGN="RIGHT">2,615,000주</TD>
<TD WIDTH="106" HEIGHT="30" ALIGN="RIGHT">1,201,500</TD>
<TD WIDTH="106" HEIGHT="30" ALIGN="RIGHT">106,000</TD>
<TD WIDTH="106" HEIGHT="30" ALIGN="RIGHT">10,234,533</TD>
<TD WIDTH="106" HEIGHT="30" ALIGN="RIGHT">2,465,341</TD>
<TD WIDTH="106" HEIGHT="30" ALIGN="RIGHT">14,007,374</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="160" HEIGHT="30">유상증자</TD>
<TD WIDTH="107" HEIGHT="30" ALIGN="RIGHT">20,000주</TD>
<TD WIDTH="106" HEIGHT="30" ALIGN="RIGHT">10,000</TD>
<TD WIDTH="106" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="106" HEIGHT="30" ALIGN="RIGHT">209,117</TD>
<TD WIDTH="106" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="106" HEIGHT="30" ALIGN="RIGHT">219,117</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="160" HEIGHT="30">전기말</TD>
<TD WIDTH="107" HEIGHT="30" ALIGN="RIGHT">2,635,000주</TD>
<TD WIDTH="106" HEIGHT="30" ALIGN="RIGHT">1,211,500</TD>
<TD WIDTH="106" HEIGHT="30" ALIGN="RIGHT">106,000</TD>
<TD WIDTH="106" HEIGHT="30" ALIGN="RIGHT">10,443,650</TD>
<TD WIDTH="106" HEIGHT="30" ALIGN="RIGHT">2,465,341</TD>
<TD WIDTH="106" HEIGHT="30" ALIGN="RIGHT">14,226,491</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="160" HEIGHT="30">당기초</TD>
<TD WIDTH="107" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">2,635,000주</TD>
<TD WIDTH="106" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,211,500</TD>
<TD WIDTH="106" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">106,000</TD>
<TD WIDTH="106" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">10,443,650</TD>
<TD WIDTH="106" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">2,465,341</TD>
<TD WIDTH="106" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">14,226,491</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="160" HEIGHT="30">예수금출자전환(*1)</TD>
<TD WIDTH="107" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">80,000주</TD>
<TD WIDTH="106" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">40,000</TD>
<TD WIDTH="106" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="106" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">840,000</TD>
<TD WIDTH="106" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="106" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">880,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="160" HEIGHT="30">유상증자</TD>
<TD WIDTH="107" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">172,000주</TD>
<TD WIDTH="106" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">36,000</TD>
<TD WIDTH="106" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">50,000</TD>
<TD WIDTH="106" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">747,488</TD>
<TD WIDTH="106" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,048,260</TD>
<TD WIDTH="106" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,881,748</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="160" HEIGHT="30">미지급금출자전환(*2)</TD>
<TD WIDTH="107" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">202,050주</TD>
<TD WIDTH="106" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">101,025</TD>
<TD WIDTH="106" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="106" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">2,121,525</TD>
<TD WIDTH="106" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="106" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">2,222,550</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="160" HEIGHT="30">전환우선주전환(*3)</TD>
<TD WIDTH="107" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="106" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">22,500</TD>
<TD WIDTH="106" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(22,500)</TD>
<TD WIDTH="106" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">427,500</TD>
<TD WIDTH="106" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(427,500)</TD>
<TD WIDTH="106" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="160" HEIGHT="30">전환사채전환(*4)</TD>
<TD WIDTH="107" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">45,000주</TD>
<TD WIDTH="106" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">22,500</TD>
<TD WIDTH="106" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="106" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">491,824</TD>
<TD WIDTH="106" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="106" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">514,324</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="160" HEIGHT="30">당기말</TD>
<TD WIDTH="107" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">3,134,050주</TD>
<TD WIDTH="106" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,433,525</TD>
<TD WIDTH="106" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">133,500</TD>
<TD WIDTH="106" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">15,071,987</TD>
<TD WIDTH="106" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">3,086,101</TD>
<TD WIDTH="106" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">19,725,113</TD>
</TR>
</TBODY>
</TABLE>
<P>(*1) 전기 예수금 880백만원이 2020년 1월 3일 보통주로 대체 되었습니다.&cr;(*2) 당사는 미국법인 Inovio Pharmaceutical, Inc.에 대하여 지급할 매입 채무 전기말 기준 총 2,997백만원 중 2,223백만원의 채무를 재무구조 개선 및 자본확충을 위해 주식인수 대금으로 상계함에 상호 합의하여, 주식인수 대금과 당사의 채무가 정상적으로 상계 처리됨에 따라 신규 주식 202,050주를 발행하였습니다.&cr;(*3) 전환우선주 중 45,000주(2차: 2018.3.9)가  당기 중 전환권 행사를 통해 보통주( 45,000주)로 전환 되었습니다.&cr;(*4) 전기 발행한 제 2회차 무기명식 이권부 무보증 무담보 사모 전환사채는 당기(2020년 10월 16일) 중 전환권 행사에 따라 보통주 45,000주로 전환되었습니다.&cr;&cr;(2) 당사가 발행한 전환상환우선주 중 당기말 현재 유효한 내역은 다음과 같습니다.</P>

<TABLE BORDER="1" WIDTH="817" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="214"></COL>
<COL WIDTH="585"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="223" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구  분</TH>
<TH WIDTH="594" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">세부내역</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="223" VALIGN="MIDDLE" HEIGHT="30">성격</TD>
<TD WIDTH="594" VALIGN="MIDDLE" HEIGHT="30">이익배당 및 잔여재산분배에 있어 보통주에 대해 우선권(참가적ㆍ누적적)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="223" VALIGN="MIDDLE" HEIGHT="53">배당률</TD>
<TD WIDTH="594" VALIGN="MIDDLE" HEIGHT="53">우선 배당금은 없고 보통주의 배당률이 우선배당률을 초과할 경우에는 초과하는 부분에 대하여 보통주와 동일한 배당률로 함께 참가하여 배당 받음.</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="223" VALIGN="MIDDLE" HEIGHT="30">전환청구기간</TD>
<TD WIDTH="594" VALIGN="MIDDLE" HEIGHT="30">발행일 익일부터 10년간(1차:2015.2.28 발행, 2차:2015.3.14 발행, 7차: 2020.12.4발행)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="223" VALIGN="MIDDLE" HEIGHT="30">상환기간</TD>
<TD WIDTH="594" VALIGN="MIDDLE" HEIGHT="30">발행 후 3년 이후(1차:2015.2.28 발행, 2차:2015.3.14 발행, 7차: 2020.12.4발행)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="2" WIDTH="223" VALIGN="MIDDLE" HEIGHT="83">전환비율</TD>
<TD WIDTH="594" VALIGN="MIDDLE" HEIGHT="30">우선주 1주당 보통주 1주</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="594" VALIGN="MIDDLE" HEIGHT="53">최초의 전환가격은 발행가격, 최초의 전환비율은 1:1. 전환가격을 하회하는 발행가격으로 회사의 주식으로 전환되는 경우 약정된 산식에 의해 조정함.</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="223" VALIGN="MIDDLE" HEIGHT="53">상환가액</TD>
<TD WIDTH="594" VALIGN="MIDDLE" HEIGHT="53">1주당 발행가격과 납입일로부터 상환가액이 전부 지급되는 날까지 발행가액의 연복리 8%를 적용하여 산정된 금원을 가산한 금액으로 하되 기지급된 배당금을 차감함.</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="223" VALIGN="MIDDLE" HEIGHT="30">주당 발행가액</TD>
<TD WIDTH="594" VALIGN="MIDDLE" HEIGHT="30">10,000원(1차, 2차), 11,000원(7차)</TD>
</TR>
</TBODY>
</TABLE>
<P>&cr;(3) 당사가 발행한 전환우선주 중 당기말 현재 유효한 내역은 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="822">

<COLGROUP>
<COL WIDTH="214"></COL>
<COL WIDTH="590"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="223" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구  분</TH>
<TH WIDTH="599" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">세부내역</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="223" HEIGHT="30" VALIGN="MIDDLE">성격</TD>
<TD WIDTH="599" HEIGHT="30" VALIGN="MIDDLE">이익배당 및 잔여재산분배에 있어 보통주에 대해 우선권(참가적ㆍ누적적)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="223" HEIGHT="53" VALIGN="MIDDLE">배당률</TD>
<TD WIDTH="599" HEIGHT="53" VALIGN="MIDDLE">우선 배당금은 없고 보통주의 배당률이 우선배당률을 초과할 경우에는 초과하는 부분에 대하여 보통주와 동일한 배당률로 함께 참가하여 배당 받음.</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="223" HEIGHT="53" VALIGN="MIDDLE">전환청구기간</TD>
<TD WIDTH="599" HEIGHT="53" VALIGN="MIDDLE">발행일 익일부터 5년간&cr;(1차:2017.7.14 발행, 3차:2018.11.12 발행),</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="223" HEIGHT="83" ROWSPAN="2" VALIGN="MIDDLE">전환조건</TD>
<TD WIDTH="599" HEIGHT="30" VALIGN="MIDDLE">우선주 1주당 보통주 1주</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="599" HEIGHT="53" VALIGN="MIDDLE">최초의 전환가격은 발행가격, 최초의 전환비율은 1:1. 전환가격을 하회하는 발행가격으로 회사의 주식으로 전환되는 경우 약정된 산식에 의해 조정함.</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="223" HEIGHT="30" VALIGN="MIDDLE">주당 발행가액</TD>
<TD WIDTH="599" HEIGHT="30" VALIGN="MIDDLE">10,000원</TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<P>14. 기타자본조정&cr;(1) 보고기간종료일 현재 기타자본조정의 세부 내역은 다음과 같습니다.</P>

<TABLE WIDTH="630" BORDER="0" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="291"></COL>
<COL WIDTH="321"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="300" VALIGN="BOTTOM" HEIGHT="30"></TD>
<TD WIDTH="330" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="631" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="202"></COL>
<COL WIDTH="201"></COL>
<COL WIDTH="201"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="211" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구  분</TH>
<TH WIDTH="210" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기말</TH>
<TH WIDTH="210" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전기말</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="211" HEIGHT="30">주식기준보상</TD>
<TD WIDTH="210" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">995,856</TD>
<TD WIDTH="210" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">995,856</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="211" HEIGHT="30">주식선택권</TD>
<TD WIDTH="210" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,280,291</TD>
<TD WIDTH="210" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">986,780</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="211" HEIGHT="30">기타</TD>
<TD WIDTH="210" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">33</TD>
<TD WIDTH="210" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">33</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="211" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">합  계</TD>
<TD WIDTH="210" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,276,180</TD>
<TD WIDTH="210" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,982,669</TD>
</TR>
</TBODY>
</TABLE>
<P>&cr;(2) 주식기준보상 &cr;당사는 2014년 5월 23일에 VGX Animal Health, Inc.의 라이선스 관련 무형자산을 취득하는 대가로 VGX Pharmaceuticals, LLC.에 USD 2,000,000를 지급하고, 취득일 현재 회사 발행 주식의 20% 지분을 발행할 것을 약정하였으며, 취득일 이후 발행되는 지분이 USD 10,000,000에 달할 때까지 회사에 대한 지분율을 20%로 유지할것을 약정하였습니다. &cr;</P>
<P>당사는 상기 무형자산을 공정가치로 측정하고 현금결제분은 장기미지급금으로, 주식결제형 주식기준보상거래에 대해서는 자본조정으로 회계처리 하였습니다. 장기미지급금은 2016년 중에 전액 상환되었으며 관련 무형자산은 전기 이전에 전액 손상을 인식하였습니다.&cr;</P>
<P>(3) 주식선택권 &cr;① 당사는 임직원 등에게 회사의 주식을 미리 정해진 가격(행사가격)으로 취득할 수 있는 주식선택권을 6차례 부여하였으며 내역은 다음과 같습니다.</P>

<TABLE BORDER="1" WIDTH="1118" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="149"></COL>
<COL WIDTH="151"></COL>
<COL WIDTH="151"></COL>
<COL WIDTH="151"></COL>
<COL WIDTH="151"></COL>
<COL WIDTH="151"></COL>
<COL WIDTH="151"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="158" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구  분</TH>
<TH WIDTH="160" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">1차</TH>
<TH WIDTH="160" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">2차</TH>
<TH WIDTH="160" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">3차</TH>
<TH WIDTH="160" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">4차</TH>
<TH WIDTH="160" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">5차</TH>
<TH WIDTH="160" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">6차</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="158" HEIGHT="30">발행할 주식의 종류</TD>
<TD WIDTH="160" HEIGHT="30">기명식 보통주식</TD>
<TD WIDTH="160" HEIGHT="30">기명식 보통주식</TD>
<TD WIDTH="160" HEIGHT="30">기명식 보통주식</TD>
<TD WIDTH="160" HEIGHT="30">기명식 보통주식</TD>
<TD WIDTH="160" HEIGHT="30">기명식 보통주식</TD>
<TD WIDTH="160" HEIGHT="30">기명식 보통주식</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="158" HEIGHT="30">부여방법</TD>
<TD WIDTH="160" HEIGHT="30">신주발행방식</TD>
<TD WIDTH="160" HEIGHT="30">신주발행방식</TD>
<TD WIDTH="160" HEIGHT="30">신주발행방식</TD>
<TD WIDTH="160" HEIGHT="30">신주발행방식</TD>
<TD WIDTH="160" HEIGHT="30">신주발행방식</TD>
<TD WIDTH="160" HEIGHT="30">신주발행방식</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="158" HEIGHT="30">부여일</TD>
<TD WIDTH="160" HEIGHT="30">2015.7.25</TD>
<TD WIDTH="160" HEIGHT="30">2016.3.24</TD>
<TD WIDTH="160" HEIGHT="30">2017.3.30</TD>
<TD WIDTH="160" HEIGHT="30">2018.03.29</TD>
<TD WIDTH="160" HEIGHT="30">2019.03.26</TD>
<TD WIDTH="160" HEIGHT="30">2020.07.22</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="158" HEIGHT="30">행사가격</TD>
<TD WIDTH="160" HEIGHT="30" VALIGN="MIDDLE">15,000원</TD>
<TD WIDTH="160" HEIGHT="30" VALIGN="MIDDLE">20,000원</TD>
<TD WIDTH="160" HEIGHT="30" VALIGN="MIDDLE">10,000원</TD>
<TD WIDTH="160" HEIGHT="30" VALIGN="MIDDLE">10,000원</TD>
<TD WIDTH="160" HEIGHT="30" VALIGN="MIDDLE">10,000원</TD>
<TD WIDTH="160" HEIGHT="30" VALIGN="MIDDLE">10,000원</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="158" HEIGHT="145">행사가능기간</TD>
<TD WIDTH="160" HEIGHT="145">2020.7.25.~ &cr;2035.7.24.</TD>
<TD WIDTH="160" HEIGHT="145">2019.3.24.~ &cr;2034.3.24.</TD>
<TD WIDTH="160" HEIGHT="145">2020.3.30.~ &cr;2035.3.30.</TD>
<TD WIDTH="160" HEIGHT="145">(임직원)&cr;2021.3.29.~ &cr;2028.3.29.&cr;(자회사피용자)&cr;2021.3.29.~ &cr;2025.3 29.</TD>
<TD WIDTH="160" HEIGHT="145">(임직원)&cr;2022.3.26.~ &cr;2029.3.25.&cr;(자회사피용자)&cr;2021.3.26.~ &cr;2026.3 25.</TD>
<TD WIDTH="160" HEIGHT="145">2023.7.22.~&cr;2030.7.21.</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="158" HEIGHT="122">행사가능조건</TD>
<TD WIDTH="160" HEIGHT="122">행사일 현재 회사의 임직원으로 재직 중이어야 함.</TD>
<TD WIDTH="160" HEIGHT="122">임직원의 경우에는 부여받은 날로부터 3년이상 재임 또는 재직하여야 함.</TD>
<TD WIDTH="160" HEIGHT="122">임직원의 경우에는 부여받은 날로부터 3년이상 재임 또는 재직하여야 함.</TD>
<TD WIDTH="160" HEIGHT="122">임직원의 경우에는 부여받은 날로부터 3년이상 재임 또는 재직하여야 함.</TD>
<TD WIDTH="160" HEIGHT="122">임직원의 경우에는 부여받은 날로부터 3년이상 재임 또는 재직하여야 함.</TD>
<TD WIDTH="160" HEIGHT="122">임직원의 경우에는 부여받은 날로부터 3년이상 재임 또는 재직하여야 함.</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="158" HEIGHT="53">소멸시점</TD>
<TD WIDTH="160" HEIGHT="53">주식선택권 부여 이후 퇴직한 경우</TD>
<TD WIDTH="160" HEIGHT="53">주식선택권 부여 이후 퇴직한 경우</TD>
<TD WIDTH="160" HEIGHT="53">주식선택권 부여 이후 퇴직한 경우</TD>
<TD WIDTH="160" HEIGHT="53">주식선택권 부여 이후 퇴직한 경우</TD>
<TD WIDTH="160" HEIGHT="53">주식선택권 부여 이후 퇴직한 경우</TD>
<TD WIDTH="160" HEIGHT="53">주식선택권 부여 이후 퇴직한 경우</TD>
</TR>
</TBODY>
</TABLE>
<P>&cr;② 주식선택권의 공정가치를 산정하는데 사용된 방법 및 가정은 다음과 같습니다.</P>

<TABLE BORDER="1" WIDTH="1118" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="156"></COL>
<COL WIDTH="150"></COL>
<COL WIDTH="150"></COL>
<COL WIDTH="150"></COL>
<COL WIDTH="150"></COL>
<COL WIDTH="150"></COL>
<COL WIDTH="149"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="165" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구  분</TH>
<TH WIDTH="159" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">1차</TH>
<TH WIDTH="159" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">2차</TH>
<TH WIDTH="159" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">3차</TH>
<TH WIDTH="159" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">4차</TH>
<TH WIDTH="159" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">5차</TH>
<TH WIDTH="158" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">6차</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="165" HEIGHT="30">무위험이자율(*1)</TD>
<TD WIDTH="159" ALIGN="CENTER" HEIGHT="30">2.34%</TD>
<TD WIDTH="159" ALIGN="CENTER" HEIGHT="30">1.51%</TD>
<TD WIDTH="159" ALIGN="CENTER" HEIGHT="30">2.23%</TD>
<TD WIDTH="159" ALIGN="CENTER" HEIGHT="30">2.60%</TD>
<TD WIDTH="159" ALIGN="CENTER" HEIGHT="30">1.87%/1.79%</TD>
<TD WIDTH="158" ALIGN="CENTER" HEIGHT="30">1.34%</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="165" HEIGHT="53">기대행사기간</TD>
<TD WIDTH="159" ALIGN="CENTER" HEIGHT="53">10.5년</TD>
<TD WIDTH="159" ALIGN="CENTER" HEIGHT="53">15년</TD>
<TD WIDTH="159" ALIGN="CENTER" HEIGHT="53">18년</TD>
<TD WIDTH="159" ALIGN="CENTER" HEIGHT="53">임직원 : 10년&cr;자문위원 : 7년</TD>
<TD WIDTH="159" ALIGN="CENTER" HEIGHT="53">임직원 : 7년&cr;자문위원 : 5년</TD>
<TD WIDTH="158" ALIGN="CENTER" HEIGHT="53">10년</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="165" HEIGHT="53">기대주가변동성 또는&cr;기초자산가격변동성</TD>
<TD WIDTH="159" ALIGN="CENTER" HEIGHT="53" VALIGN="MIDDLE">0.33</TD>
<TD WIDTH="159" ALIGN="CENTER" HEIGHT="53" VALIGN="MIDDLE">0.59</TD>
<TD WIDTH="159" ALIGN="CENTER" HEIGHT="53" VALIGN="MIDDLE">0.56</TD>
<TD WIDTH="159" ALIGN="CENTER" HEIGHT="53" VALIGN="MIDDLE">0.40</TD>
<TD WIDTH="159" ALIGN="CENTER" HEIGHT="53" VALIGN="MIDDLE">임직원 : 0.53&cr;자문위원 : 0.31</TD>
<TD WIDTH="158" ALIGN="CENTER" HEIGHT="53" VALIGN="MIDDLE">0.39</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="165" HEIGHT="30">기대배당수익률</TD>
<TD WIDTH="159" ALIGN="CENTER" HEIGHT="30">-</TD>
<TD WIDTH="159" ALIGN="CENTER" HEIGHT="30">-</TD>
<TD WIDTH="159" ALIGN="CENTER" HEIGHT="30">-</TD>
<TD WIDTH="159" ALIGN="CENTER" HEIGHT="30">-</TD>
<TD WIDTH="159" ALIGN="CENTER" HEIGHT="30">-</TD>
<TD WIDTH="158" ALIGN="CENTER" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="165" HEIGHT="53" VALIGN="MIDDLE">공정가액(*2)</TD>
<TD WIDTH="159" ALIGN="CENTER" HEIGHT="53">14,237원</TD>
<TD WIDTH="159" ALIGN="CENTER" HEIGHT="53"> 11,542원</TD>
<TD WIDTH="159" ALIGN="CENTER" HEIGHT="53">6,002원</TD>
<TD WIDTH="159" ALIGN="CENTER" HEIGHT="53" VALIGN="MIDDLE">임직원 : 4,624원&cr;자문위원 : 3,838원</TD>
<TD WIDTH="159" ALIGN="CENTER" HEIGHT="53" VALIGN="MIDDLE">임직원 : 3,407원&cr;자문위원 : 2,872원</TD>
<TD WIDTH="158" ALIGN="CENTER" HEIGHT="53" VALIGN="MIDDLE">3,675.39원</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="165" HEIGHT="30">옵션가격 결정모형</TD>
<TD WIDTH="159" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">블랙ㆍ숄즈 모형</TD>
<TD WIDTH="159" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">블랙ㆍ숄즈 모형</TD>
<TD WIDTH="159" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">블랙ㆍ숄즈 모형</TD>
<TD WIDTH="159" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">블랙ㆍ숄즈 모형</TD>
<TD WIDTH="159" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">이항모형</TD>
<TD WIDTH="158" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">이항모형</TD>
</TR>
</TBODY>
</TABLE>

<P>(*1) 무위험이자율은 기대행사기간의 국고채의 유통수익률을 사용하였습니다.&cr;(*2)
<SPAN> </SPAN>
<SPAN>전기와 전전기에 부여한 주식선택권은 임직원과 연구소 및 자회사피용자의 주식선택권 행사기간 차이로 기대행사기간과 공정가액은</SPAN>
<SPAN> 두가지로 산정되었습니다.&cr;</SPAN>
<SPAN></SPAN>
</P>
<P>③ 당기와 전기 중 주식선택권수량의 변동내역은 다음과 같습니다.</P>

<TABLE WIDTH="628" BORDER="0" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="291"></COL>
<COL WIDTH="319"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="300" VALIGN="BOTTOM" HEIGHT="30"></TD>
<TD WIDTH="328" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">(단위: 주)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="715">

<COLGROUP>
<COL WIDTH="81"></COL>
<COL WIDTH="81"></COL>
<COL WIDTH="81"></COL>
<COL WIDTH="80"></COL>
<COL WIDTH="80"></COL>
<COL WIDTH="80"></COL>
<COL WIDTH="80"></COL>
<COL WIDTH="80"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="90" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구  분</TH>
<TH WIDTH="90" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">1차</TH>
<TH WIDTH="90" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">2차</TH>
<TH WIDTH="89" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">3차</TH>
<TH WIDTH="89" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">4차</TH>
<TH WIDTH="89" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">5차</TH>
<TH WIDTH="89" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">6차</TH>
<TH WIDTH="89" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">합  계</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="90" VALIGN="MIDDLE" HEIGHT="30">전기초</TD>
<TD WIDTH="90" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">25,600</TD>
<TD WIDTH="90" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">2,063</TD>
<TD WIDTH="89" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">31,666</TD>
<TD WIDTH="89" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">170,334</TD>
<TD WIDTH="89" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="89" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="89" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">229,663</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="90" VALIGN="MIDDLE" HEIGHT="30">부여</TD>
<TD WIDTH="90" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="90" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="89" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="89" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="89" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">32,300</TD>
<TD WIDTH="89" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="89" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">32,300</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="90" VALIGN="MIDDLE" HEIGHT="30">소멸</TD>
<TD WIDTH="90" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="90" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="89" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="89" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">(500)</TD>
<TD WIDTH="89" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="89" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="89" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">(500)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="90" VALIGN="MIDDLE" HEIGHT="30">전기말</TD>
<TD WIDTH="90" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">25,600</TD>
<TD WIDTH="90" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">2,063</TD>
<TD WIDTH="89" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">31,666</TD>
<TD WIDTH="89" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">169,834</TD>
<TD WIDTH="89" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">32,300</TD>
<TD WIDTH="89" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="89" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">261,463</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="90" VALIGN="MIDDLE" HEIGHT="30">당기초</TD>
<TD WIDTH="90" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">25,600</TD>
<TD WIDTH="90" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">2,063</TD>
<TD WIDTH="89" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">31,666</TD>
<TD WIDTH="89" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">169,834</TD>
<TD WIDTH="89" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">32,300</TD>
<TD WIDTH="89" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="89" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">261,463</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="90" VALIGN="MIDDLE" HEIGHT="30">부여</TD>
<TD WIDTH="90" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="90" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="89" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="89" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="89" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="89" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">40,000</TD>
<TD WIDTH="89" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">40,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="90" VALIGN="MIDDLE" HEIGHT="30">소멸</TD>
<TD WIDTH="90" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="90" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="89" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="89" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="89" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">(3,000)</TD>
<TD WIDTH="89" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="89" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">(3,000)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="90" VALIGN="MIDDLE" HEIGHT="30">당기말</TD>
<TD WIDTH="90" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">25,600</TD>
<TD WIDTH="90" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">2,063</TD>
<TD WIDTH="89" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">31,666</TD>
<TD WIDTH="89" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">169,834</TD>
<TD WIDTH="89" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">29,300</TD>
<TD WIDTH="89" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">40,000</TD>
<TD WIDTH="89" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">298,463</TD>
</TR>
</TBODY>
</TABLE>
<P>&cr;④ 당기와 전기 중 발생한 보상원가의 내역은 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="628">

<COLGROUP>
<COL WIDTH="291"></COL>
<COL WIDTH="319"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="300" HEIGHT="30" VALIGN="BOTTOM"></TD>
<TD WIDTH="328" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" WIDTH="626" BORDER="1" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="249"></COL>
<COL WIDTH="175"></COL>
<COL WIDTH="175"></COL>
</COLGROUP>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="258" HEIGHT="30" USERMARK=" BC0XD7D7D7">구  분</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="184" HEIGHT="30" USERMARK=" BC0XD7D7D7">당  기</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="184" HEIGHT="30" USERMARK=" BC0XD7D7D7">전  기</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="258" HEIGHT="30">당기 비용으로 인식한 보상원가</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="184" HEIGHT="30">293,509</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="184" HEIGHT="30">318,762</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="258" HEIGHT="30">판매비와관리비</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="184" HEIGHT="30">270,930</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="184" HEIGHT="30">293,436</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="258" HEIGHT="30">경상연구개발비</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="184" HEIGHT="30">22,579</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="184" HEIGHT="30">25,326</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="258" HEIGHT="30">당기 이후 비용으로 인식할 보상원가</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="184" HEIGHT="30">207,719</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="184" HEIGHT="30">362,830</TD>
</TR>
</TBODY>
</TABLE>
<P>&cr;(4) 자기주식&cr;보고기간종료일 현재 당사가 보유하고 있는 자기주식은 92,134주입니다. &cr;</P>
<P></P>
<P>15. 결손금처리계산서 &cr;당기와 전기의 결손금처리계산서는 다음과 같습니다.</P>

<TABLE WIDTH="626" BORDER="0" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="81"></COL>
<COL WIDTH="153"></COL>
<COL WIDTH="39"></COL>
<COL WIDTH="81"></COL>
<COL WIDTH="153"></COL>
<COL WIDTH="65"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="2" WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="60">제 7(당)기</TD>

<TD WIDTH="162" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2020년 
<SPAN USERMARK=" 0XFFFFFF">0</SPAN>1월
<SPAN USERMARK=" 0XFFFFFF"> 0</SPAN>1일
</TD>
<TD WIDTH="48" VALIGN="MIDDLE" HEIGHT="30">부터</TD>
<TD ROWSPAN="2" WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="60">제 6(전)기</TD>

<TD WIDTH="162" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2019년 
<SPAN USERMARK=" 0XFFFFFF">0</SPAN>1월
<SPAN USERMARK=" 0XFFFFFF"> 0</SPAN>1일
</TD>
<TD WIDTH="74" VALIGN="MIDDLE" HEIGHT="30">부터</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="162" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2020년 12월 31일</TD>
<TD WIDTH="48" VALIGN="MIDDLE" HEIGHT="30">까지</TD>
<TD WIDTH="162" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2019년 12월 31일</TD>
<TD WIDTH="74" VALIGN="MIDDLE" HEIGHT="30">까지</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">처리예정일</TD>

<TD WIDTH="162" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2021년 
<SPAN USERMARK=" 0XFFFFFF">0</SPAN>3월 25일
</TD>
<TD WIDTH="48" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30"></TD>
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">처리확정일</TD>

<TD WIDTH="162" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2020년 
<SPAN USERMARK=" 0XFFFFFF">0</SPAN>3월 30일
</TD>
<TD WIDTH="74" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30"></TD>
</TR>
</TBODY>
</TABLE>

<TABLE WIDTH="625" BORDER="0" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="415"></COL>
<COL WIDTH="192"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="424" VALIGN="BOTTOM" HEIGHT="30">회사명 : 주식회사 플럼라인생명과학</TD>
<TD WIDTH="201" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">(단위 : 원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="852" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="188"></COL>
<COL WIDTH="163"></COL>
<COL WIDTH="149"></COL>
<COL WIDTH="155"></COL>
<COL WIDTH="152"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="197" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">과   목</TH>
<TH COLSPAN="2" WIDTH="330" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">제 7(당) 기</TH>
<TH COLSPAN="2" WIDTH="325" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">제 6(전) 기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="197" HEIGHT="30">I. 미처리결손금</TD>
<TD WIDTH="172" ALIGN="RIGHT" HEIGHT="30"></TD>
<TD WIDTH="158" ALIGN="RIGHT" HEIGHT="30">23,742,825,998</TD>
<TD WIDTH="164" ALIGN="RIGHT" HEIGHT="30"></TD>
<TD WIDTH="161" ALIGN="RIGHT" HEIGHT="30">22,211,188,662</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="197" HEIGHT="30"> 1. 전기이월미처리결손금</TD>
<TD WIDTH="172" ALIGN="RIGHT" HEIGHT="30">22,211,188,662</TD>
<TD WIDTH="158" ALIGN="RIGHT" HEIGHT="30"></TD>
<TD WIDTH="164" ALIGN="RIGHT" HEIGHT="30">17,820,987,428</TD>
<TD WIDTH="161" ALIGN="RIGHT" HEIGHT="30"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="197" HEIGHT="30"> 2. 당기순손실</TD>
<TD WIDTH="172" ALIGN="RIGHT" HEIGHT="30">1,531,637,336</TD>
<TD WIDTH="158" ALIGN="RIGHT" HEIGHT="30"></TD>
<TD WIDTH="164" ALIGN="RIGHT" HEIGHT="30">4,390,201,234</TD>
<TD WIDTH="161" ALIGN="RIGHT" HEIGHT="30"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="197" HEIGHT="30">II. 결손금처리액</TD>
<TD WIDTH="172" ALIGN="RIGHT" HEIGHT="30"></TD>
<TD WIDTH="158" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="164" ALIGN="RIGHT" HEIGHT="30"></TD>
<TD WIDTH="161" ALIGN="RIGHT" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="197" HEIGHT="30">III. 차기이월미처리결손금</TD>
<TD WIDTH="172" ALIGN="RIGHT" HEIGHT="30"></TD>
<TD WIDTH="158" ALIGN="RIGHT" HEIGHT="30">23,742,825,998</TD>
<TD WIDTH="164" ALIGN="RIGHT" HEIGHT="30"></TD>
<TD WIDTH="161" ALIGN="RIGHT" HEIGHT="30">22,211,188,662</TD>
</TR>
</TBODY>
</TABLE>

<P>&cr;
<SPAN>16. 법인세비용과 이연법인세자산(부채)&cr;</SPAN>(1) 당기와 전기 중 손익에 반영된 법인세비용의 산출내역은 다음과 같습니다.
</P>

<TABLE WIDTH="625" BORDER="0" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="304"></COL>
<COL WIDTH="303"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="313" VALIGN="BOTTOM" HEIGHT="30"></TD>
<TD WIDTH="312" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="625" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="325"></COL>
<COL WIDTH="137"></COL>
<COL WIDTH="136"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="334" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구  분</TH>
<TH WIDTH="146" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당  기</TH>
<TH WIDTH="145" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전  기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="334" VALIGN="MIDDLE" HEIGHT="30">당기법인세부담액</TD>
<TD WIDTH="146" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="145" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="334" VALIGN="MIDDLE" HEIGHT="30">일시적차이로 인한 이연법인세 변동액</TD>
<TD WIDTH="146" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="145" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="334" VALIGN="MIDDLE" HEIGHT="30">법인세비용</TD>
<TD WIDTH="146" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="145" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<P>(2) 당기와 전기 중 법인세비용차감전순손익과 법인세비용간의 관계는 다음과 같습니다.</P>

<TABLE WIDTH="623" BORDER="0" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="303"></COL>
<COL WIDTH="302"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="312" VALIGN="BOTTOM" HEIGHT="30"></TD>
<TD WIDTH="311" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="624" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="207"></COL>
<COL WIDTH="93"></COL>
<COL WIDTH="93"></COL>
<COL WIDTH="93"></COL>
<COL WIDTH="93"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="216" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구  분</TH>
<TH COLSPAN="2" WIDTH="204" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당  기</TH>
<TH COLSPAN="2" WIDTH="204" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전  기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="216" VALIGN="MIDDLE" HEIGHT="30">법인세비용차감전순손실</TD>
<TD WIDTH="102" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30"></TD>
<TD WIDTH="102" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(1,531,637)</TD>
<TD WIDTH="102" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30"></TD>
<TD WIDTH="102" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(4,390,201)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="216" VALIGN="MIDDLE" HEIGHT="30">적용세율에 따른 법인세</TD>
<TD WIDTH="102" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30"></TD>
<TD WIDTH="102" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(336,960)</TD>
<TD WIDTH="102" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30"></TD>
<TD WIDTH="102" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(965,844)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="216" VALIGN="MIDDLE" HEIGHT="30">조정사항</TD>
<TD WIDTH="102" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30"></TD>
<TD WIDTH="102" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">336,960</TD>
<TD WIDTH="102" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30"></TD>
<TD WIDTH="102" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">965,844</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="216" VALIGN="MIDDLE" HEIGHT="30">- 당기이연법인세자산 미인식</TD>
<TD WIDTH="102" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,260,317</TD>
<TD WIDTH="102" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" 0X1814FF"></TD>
<TD WIDTH="102" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">874,844</TD>
<TD WIDTH="102" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" 0X1814FF"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="216" VALIGN="MIDDLE" HEIGHT="30">- 비과세비용 등</TD>
<TD WIDTH="102" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(923,357)</TD>
<TD WIDTH="102" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" 0X1814FF"></TD>
<TD WIDTH="102" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">91,000</TD>
<TD WIDTH="102" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" 0X1814FF"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="216" VALIGN="MIDDLE" HEIGHT="30">법인세비용</TD>
<TD WIDTH="102" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30"></TD>
<TD WIDTH="102" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="102" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30"></TD>
<TD WIDTH="102" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="216" VALIGN="MIDDLE" HEIGHT="30">유효법인세(*)</TD>
<TD WIDTH="102" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30"></TD>
<TD WIDTH="102" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="102" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30"></TD>
<TD WIDTH="102" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
</TR>
</TBODY>
</TABLE>
<P>&cr;(*) 법인세차감전순손실이 발생하여 유효법인세를 계산하지 아니하였습니다.&cr;</P>
<P>(3) 당기와 전기 중 일시적 차이 및 이연법인세자산(부채)의 증감내역과 상계 전 총액기준 이연법인세자산(부채)의 증감내역은 다음과 같습니다.</P>

<TABLE WIDTH="630" BORDER="0" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="306"></COL>
<COL WIDTH="306"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="315" VALIGN="BOTTOM" HEIGHT="30"><당기></TD>
<TD WIDTH="315" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="628" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="159"></COL>
<COL WIDTH="83"></COL>
<COL WIDTH="83"></COL>
<COL WIDTH="83"></COL>
<COL WIDTH="83"></COL>
<COL WIDTH="83"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH ROWSPAN="2" WIDTH="168" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구  분</TH>
<TH COLSPAN="3" WIDTH="276" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">차감할(가산할) 일시적 차이</TH>
<TH COLSPAN="2" WIDTH="184" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">이연법인세자산(부채)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="92" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기초잔액</TH>
<TH WIDTH="92" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">증감</TH>
<TH WIDTH="92" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기말잔액</TH>
<TH WIDTH="92" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기  초</TH>
<TH WIDTH="92" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기  말</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="168" HEIGHT="30">퇴직급여충당부채</TD>
<TD WIDTH="92" ALIGN="RIGHT" HEIGHT="30">305,370</TD>
<TD WIDTH="92" ALIGN="RIGHT" HEIGHT="30">2,475</TD>
<TD WIDTH="92" ALIGN="RIGHT" HEIGHT="30">307,845</TD>
<TD WIDTH="92" ALIGN="RIGHT" HEIGHT="30">67,181</TD>
<TD WIDTH="92" ALIGN="RIGHT" HEIGHT="30">67,726</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="168" HEIGHT="30">장기대여금</TD>
<TD WIDTH="92" ALIGN="RIGHT" HEIGHT="30">63,346</TD>
<TD WIDTH="92" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="92" ALIGN="RIGHT" HEIGHT="30">63,346</TD>
<TD WIDTH="92" ALIGN="RIGHT" HEIGHT="30">13,936</TD>
<TD WIDTH="92" ALIGN="RIGHT" HEIGHT="30">13,936</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="168" HEIGHT="30">무형자산</TD>
<TD WIDTH="92" ALIGN="RIGHT" HEIGHT="30">1,450,000</TD>
<TD WIDTH="92" ALIGN="RIGHT" HEIGHT="30">(290,000)</TD>
<TD WIDTH="92" ALIGN="RIGHT" HEIGHT="30">1,160,000</TD>
<TD WIDTH="92" ALIGN="RIGHT" HEIGHT="30">319,000</TD>
<TD WIDTH="92" ALIGN="RIGHT" HEIGHT="30">255,200</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="168" HEIGHT="30">미지급비용</TD>
<TD WIDTH="92" ALIGN="RIGHT" HEIGHT="30">27,026</TD>
<TD WIDTH="92" ALIGN="RIGHT" HEIGHT="30">(4,801)</TD>
<TD WIDTH="92" ALIGN="RIGHT" HEIGHT="30">22,225</TD>
<TD WIDTH="92" ALIGN="RIGHT" HEIGHT="30">5,946</TD>
<TD WIDTH="92" ALIGN="RIGHT" HEIGHT="30">4,890</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="168" HEIGHT="30">미지급금</TD>
<TD WIDTH="92" ALIGN="RIGHT" HEIGHT="30">1,071,519</TD>
<TD WIDTH="92" ALIGN="RIGHT" HEIGHT="30">(459,116)</TD>
<TD WIDTH="92" ALIGN="RIGHT" HEIGHT="30">612,403</TD>
<TD WIDTH="92" ALIGN="RIGHT" HEIGHT="30">235,734</TD>
<TD WIDTH="92" ALIGN="RIGHT" HEIGHT="30">134,729</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="168" HEIGHT="30">지분법적용투자주식</TD>
<TD WIDTH="92" ALIGN="RIGHT" HEIGHT="30">4,040,540</TD>
<TD WIDTH="92" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="92" ALIGN="RIGHT" HEIGHT="30">4,040,540</TD>
<TD WIDTH="92" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="92" ALIGN="RIGHT" HEIGHT="30">888,919</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="168" HEIGHT="30">전환사채</TD>
<TD WIDTH="92" ALIGN="RIGHT" HEIGHT="30">(326,972)</TD>
<TD WIDTH="92" ALIGN="RIGHT" HEIGHT="30">249,939</TD>
<TD WIDTH="92" ALIGN="RIGHT" HEIGHT="30">(77,033)</TD>
<TD WIDTH="92" ALIGN="RIGHT" HEIGHT="30">(71,934)</TD>
<TD WIDTH="92" ALIGN="RIGHT" HEIGHT="30">(16,947)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="168" HEIGHT="30">일시적차이 합계</TD>
<TD WIDTH="92" ALIGN="RIGHT" HEIGHT="30">6,630,829</TD>
<TD WIDTH="92" ALIGN="RIGHT" HEIGHT="30">(501,503)</TD>
<TD WIDTH="92" ALIGN="RIGHT" HEIGHT="30">6,129,326</TD>
<TD WIDTH="92" ALIGN="RIGHT" HEIGHT="30">569,863</TD>
<TD WIDTH="92" ALIGN="RIGHT" HEIGHT="30">1,348,453</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="168" HEIGHT="30">이월결손금</TD>
<TD WIDTH="92" ALIGN="RIGHT" HEIGHT="30">13,946,219</TD>
<TD WIDTH="92" ALIGN="RIGHT" HEIGHT="30">1,806,541</TD>
<TD WIDTH="92" ALIGN="RIGHT" HEIGHT="30">15,752,760</TD>
<TD WIDTH="92" ALIGN="RIGHT" HEIGHT="30">3,068,168</TD>
<TD WIDTH="92" ALIGN="RIGHT" HEIGHT="30">3,465,607</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="168" HEIGHT="30">이월세액공제</TD>
<TD WIDTH="92" ALIGN="RIGHT" HEIGHT="30">530,982</TD>
<TD WIDTH="92" ALIGN="RIGHT" HEIGHT="30">84,288</TD>
<TD WIDTH="92" ALIGN="RIGHT" HEIGHT="30">615,270</TD>
<TD WIDTH="92" ALIGN="RIGHT" HEIGHT="30">530,982</TD>
<TD WIDTH="92" ALIGN="RIGHT" HEIGHT="30">615,270</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="168" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">소  계</TD>
<TD WIDTH="92" ALIGN="RIGHT" HEIGHT="30"></TD>
<TD WIDTH="92" ALIGN="RIGHT" HEIGHT="30"></TD>
<TD WIDTH="92" ALIGN="RIGHT" HEIGHT="30"></TD>
<TD WIDTH="92" ALIGN="RIGHT" HEIGHT="30">4,169,013</TD>
<TD WIDTH="92" ALIGN="RIGHT" HEIGHT="30">5,429,330</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="4" WIDTH="444" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">미인식 이연법인세자산(부채)</TD>
<TD WIDTH="92" ALIGN="RIGHT" HEIGHT="30">4,169,013</TD>
<TD WIDTH="92" ALIGN="RIGHT" HEIGHT="30">5,429,330</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="4" WIDTH="444" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">인식한 이연법인세자산(부채)</TD>
<TD WIDTH="92" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="92" ALIGN="RIGHT" HEIGHT="30">-</TD>
</TR>
</TBODY>
</TABLE>
<P></P>

<TABLE WIDTH="632" BORDER="0" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="307"></COL>
<COL WIDTH="307"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="316" VALIGN="BOTTOM" HEIGHT="30"><전기></TD>
<TD WIDTH="316" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="628">

<COLGROUP>
<COL WIDTH="159"></COL>
<COL WIDTH="83"></COL>
<COL WIDTH="83"></COL>
<COL WIDTH="83"></COL>
<COL WIDTH="83"></COL>
<COL WIDTH="83"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="168" HEIGHT="60" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구  분</TH>
<TH WIDTH="276" HEIGHT="30" COLSPAN="3" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">차감할(가산할) 일시적 차이</TH>
<TH WIDTH="184" HEIGHT="30" COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">이연법인세자산(부채)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="92" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기초잔액</TH>
<TH WIDTH="92" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">증감</TH>
<TH WIDTH="92" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기말잔액</TH>
<TH WIDTH="92" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기  초</TH>
<TH WIDTH="92" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기  말</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="168" HEIGHT="30">퇴직급여충당부채</TD>
<TD WIDTH="92" HEIGHT="30" ALIGN="RIGHT">232,264</TD>
<TD WIDTH="92" HEIGHT="30" ALIGN="RIGHT">73,106</TD>
<TD WIDTH="92" HEIGHT="30" ALIGN="RIGHT">305,370</TD>
<TD WIDTH="92" HEIGHT="30" ALIGN="RIGHT">51,098</TD>
<TD WIDTH="92" HEIGHT="30" ALIGN="RIGHT">67,181</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="168" HEIGHT="30">장기대여금</TD>
<TD WIDTH="92" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="92" HEIGHT="30" ALIGN="RIGHT">63,346</TD>
<TD WIDTH="92" HEIGHT="30" ALIGN="RIGHT">63,346</TD>
<TD WIDTH="92" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="92" HEIGHT="30" ALIGN="RIGHT">13,936</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="168" HEIGHT="30">무형자산</TD>
<TD WIDTH="92" HEIGHT="30" ALIGN="RIGHT">1,740,000</TD>
<TD WIDTH="92" HEIGHT="30" ALIGN="RIGHT">(290,000)</TD>
<TD WIDTH="92" HEIGHT="30" ALIGN="RIGHT">1,450,000</TD>
<TD WIDTH="92" HEIGHT="30" ALIGN="RIGHT">382,800</TD>
<TD WIDTH="92" HEIGHT="30" ALIGN="RIGHT">319,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="168" HEIGHT="30">미지급비용</TD>
<TD WIDTH="92" HEIGHT="30" ALIGN="RIGHT">4,601</TD>
<TD WIDTH="92" HEIGHT="30" ALIGN="RIGHT">22,425</TD>
<TD WIDTH="92" HEIGHT="30" ALIGN="RIGHT">27,026</TD>
<TD WIDTH="92" HEIGHT="30" ALIGN="RIGHT">1,012</TD>
<TD WIDTH="92" HEIGHT="30" ALIGN="RIGHT">5,946</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="168" HEIGHT="30">미지급금</TD>
<TD WIDTH="92" HEIGHT="30" ALIGN="RIGHT">1,179,018</TD>
<TD WIDTH="92" HEIGHT="30" ALIGN="RIGHT">(107,499)</TD>
<TD WIDTH="92" HEIGHT="30" ALIGN="RIGHT">1,071,519</TD>
<TD WIDTH="92" HEIGHT="30" ALIGN="RIGHT">259,384</TD>
<TD WIDTH="92" HEIGHT="30" ALIGN="RIGHT">235,734</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="168" HEIGHT="30">지분법적용투자주식</TD>
<TD WIDTH="92" HEIGHT="30" ALIGN="RIGHT">4,040,540</TD>
<TD WIDTH="92" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="92" HEIGHT="30" ALIGN="RIGHT">4,040,540</TD>
<TD WIDTH="92" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="92" HEIGHT="30" ALIGN="RIGHT">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="168" HEIGHT="30">전환사채</TD>
<TD WIDTH="92" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="92" HEIGHT="30" ALIGN="RIGHT">(326,972)</TD>
<TD WIDTH="92" HEIGHT="30" ALIGN="RIGHT">(326,972)</TD>
<TD WIDTH="92" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="92" HEIGHT="30" ALIGN="RIGHT">(71,934)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="168" HEIGHT="30">일시적차이 합계</TD>
<TD WIDTH="92" HEIGHT="30" ALIGN="RIGHT">7,196,423</TD>
<TD WIDTH="92" HEIGHT="30" ALIGN="RIGHT">(565,594)</TD>
<TD WIDTH="92" HEIGHT="30" ALIGN="RIGHT">6,630,829</TD>
<TD WIDTH="92" HEIGHT="30" ALIGN="RIGHT">694,294</TD>
<TD WIDTH="92" HEIGHT="30" ALIGN="RIGHT">569,863</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="168" HEIGHT="30">이월결손금</TD>
<TD WIDTH="92" HEIGHT="30" ALIGN="RIGHT">9,800,772</TD>
<TD WIDTH="92" HEIGHT="30" ALIGN="RIGHT">4,145,447</TD>
<TD WIDTH="92" HEIGHT="30" ALIGN="RIGHT">13,946,219</TD>
<TD WIDTH="92" HEIGHT="30" ALIGN="RIGHT">2,156,170</TD>
<TD WIDTH="92" HEIGHT="30" ALIGN="RIGHT">3,068,168</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="168" HEIGHT="30">이월세액공제</TD>
<TD WIDTH="92" HEIGHT="30" ALIGN="RIGHT">443,705</TD>
<TD WIDTH="92" HEIGHT="30" ALIGN="RIGHT">87,277</TD>
<TD WIDTH="92" HEIGHT="30" ALIGN="RIGHT">530,982</TD>
<TD WIDTH="92" HEIGHT="30" ALIGN="RIGHT">443,705</TD>
<TD WIDTH="92" HEIGHT="30" ALIGN="RIGHT">530,982</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="168" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">소  계</TD>
<TD WIDTH="92" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="92" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="92" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="92" HEIGHT="30" ALIGN="RIGHT">3,294,169</TD>
<TD WIDTH="92" HEIGHT="30" ALIGN="RIGHT">4,169,013</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="444" HEIGHT="30" COLSPAN="4" ALIGN="CENTER" VALIGN="MIDDLE">미인식 이연법인세자산(부채)</TD>
<TD WIDTH="92" HEIGHT="30" ALIGN="RIGHT">3,294,169</TD>
<TD WIDTH="92" HEIGHT="30" ALIGN="RIGHT">4,169,013</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="444" HEIGHT="30" COLSPAN="4" ALIGN="CENTER" VALIGN="MIDDLE">인식한 이연법인세자산(부채)</TD>
<TD WIDTH="92" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="92" HEIGHT="30" ALIGN="RIGHT">-</TD>
</TR>
</TBODY>
</TABLE>
<P>&cr;이연법인세자산에 대한 미래 실현가능성은 회사의 성과, 전반적인 경제환경과 산업에 대한 전망, 향후 예상수익, 세액공제와 이월결손금의 공제가능기간 등 다양한 요소들을 고려하여 평가합니다. 회사는 주기적으로 이러한 사항들을 검토하고 있으며, 누적 손실이 발생하여 당기말 현재 모든 차감할 일시적 차이에 대하여 실현가능성이 없다고 판단하여 이연법인세자산을 인식하지 않았습니다.&cr;</P>
<P>이월결손금에 대한 이연법인세자산은 미래과세소득의 발생이 거의 확실한 경우 인식하고 있습니다. 당기말 현재 이연법인세자산을 인식하지 아니한 차감할 일시적차이, 이월결손금의 내역은 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="627">

<COLGROUP>
<COL WIDTH="291"></COL>
<COL WIDTH="318"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="300" HEIGHT="30" VALIGN="BOTTOM"></TD>
<TD WIDTH="327" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="628" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="273"></COL>
<COL WIDTH="164"></COL>
<COL WIDTH="164"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="282" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구  분</TH>
<TH WIDTH="173" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">만  기</TH>
<TH WIDTH="173" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">금  액</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="282" VALIGN="MIDDLE" HEIGHT="30">차감할 일시적차이</TD>
<TD WIDTH="173" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
<TD WIDTH="173" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">6,129,326</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="8" WIDTH="282" VALIGN="MIDDLE" HEIGHT="240">이월결손금</TD>
<TD WIDTH="173" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2024년</TD>
<TD WIDTH="173" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">820,524</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="173" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2025년</TD>
<TD WIDTH="173" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,387,999</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="173" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2026년</TD>
<TD WIDTH="173" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,681,739</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="173" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2027년</TD>
<TD WIDTH="173" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,971,800</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="173" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2028년</TD>
<TD WIDTH="173" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">938,410</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="173" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2029년</TD>
<TD WIDTH="173" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">4,145,447</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="173" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2030년</TD>
<TD WIDTH="173" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,806,841</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="173" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">합계</TD>
<TD WIDTH="173" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">15,752,760</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="282" VALIGN="MIDDLE" HEIGHT="180" ROWSPAN="6">이월세액공제</TD>
<TD WIDTH="173" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2021년</TD>
<TD WIDTH="173" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">110,686</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="173" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2022년</TD>
<TD WIDTH="173" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">136,427</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="173" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2023년</TD>
<TD WIDTH="173" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">74,586</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="173" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2024년</TD>
<TD WIDTH="173" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">87,277</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="173" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2025년</TD>
<TD WIDTH="173" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">84,288</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="173" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">합계</TD>
<TD WIDTH="173" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">615,270</TD>
</TR>
</TBODY>
</TABLE>
<P>&cr;&cr;17. 주당순손익&cr;(1) 당기와 전기 중 기본주당순이익 산정내역은 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="628">

<COLGROUP>
<COL WIDTH="305"></COL>
<COL WIDTH="305"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="314" HEIGHT="30" VALIGN="BOTTOM"></TD>
<TD WIDTH="314" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">(단위: 원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="630" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="209"></COL>
<COL WIDTH="197"></COL>
<COL WIDTH="197"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="218" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구  분</TH>
<TH WIDTH="206" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당  기</TH>
<TH WIDTH="206" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전  기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="218" VALIGN="MIDDLE" HEIGHT="30">보통주당기순손실</TD>
<TD WIDTH="206" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(1,531,637,336)</TD>
<TD WIDTH="206" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(4,390,201,234)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="218" VALIGN="MIDDLE" HEIGHT="30">가중평균유통보통주식수(주)</TD>
<TD WIDTH="206" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,690,880</TD>
<TD WIDTH="206" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,312,729</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="218" VALIGN="MIDDLE" HEIGHT="30">기본주당순손익</TD>
<TD WIDTH="206" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(569)</TD>
<TD WIDTH="206" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(1,898)</TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<P>(2) 당기와 전기의 가중평균유통보통주식수 산출 내역은 다음과 같습니다.&cr;<당기></P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="625">

<COLGROUP>
<COL WIDTH="130"></COL>
<COL WIDTH="102"></COL>
<COL WIDTH="116"></COL>
<COL WIDTH="116"></COL>
<COL WIDTH="116"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="139" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">구분</TH>
<TH WIDTH="111" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">일자</TH>
<TH WIDTH="125" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">주식수</TH>
<TH WIDTH="125" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">가중치</TH>
<TH WIDTH="125" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">가중평균</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="139" HEIGHT="30">전기이월</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="111" HEIGHT="30">2020-01-01</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="125" HEIGHT="30">2,423,000</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="125" HEIGHT="30">365</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="125" HEIGHT="30">2,423,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="139" HEIGHT="30">예수금 출자전환</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="111" HEIGHT="30">2020-01-03</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="125" HEIGHT="30">80,000</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="125" HEIGHT="30">363</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="125" HEIGHT="30">79,562</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="139" HEIGHT="30">전환권행사</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="111" HEIGHT="30">2020-01-20</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="125" HEIGHT="30">10,000</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="125" HEIGHT="30">346</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="125" HEIGHT="30">9,479</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="139" HEIGHT="30">유상증자</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="111" HEIGHT="30">2020-02-07</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="125" HEIGHT="30">72,000</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="125" HEIGHT="30">328</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="125" HEIGHT="30">64,701</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="139" HEIGHT="30">전환권행사</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="111" HEIGHT="30">2020-02-17</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="125" HEIGHT="30">25,000</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="125" HEIGHT="30">318</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="125" HEIGHT="30">21,781</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="139" HEIGHT="30">미지급금 출자전환</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="111" HEIGHT="30">2020-03-04</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="125" HEIGHT="30">202,050</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="125" HEIGHT="30">302</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="125" HEIGHT="30">167,176</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="139" HEIGHT="30">전환권행사</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="111" HEIGHT="30">2020-03-16</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="125" HEIGHT="30">10,000</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="125" HEIGHT="30">290</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="125" HEIGHT="30">7,945</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="139" HEIGHT="30">전환사채전환</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="111" HEIGHT="30">2020-10-16</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="125" HEIGHT="30">45,000</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="125" HEIGHT="30">76</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="125" HEIGHT="30">9,370</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="139" HEIGHT="30">자기주식</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="111" HEIGHT="30">2020-01-01</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="125" HEIGHT="30">(92,134)</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="125" HEIGHT="30">365</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="125" HEIGHT="30">(92,134)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="4" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="500" HEIGHT="30">가중평균유통보통주식수</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="125" HEIGHT="30">2,690,880</TD>
</TR>
</TBODY>
</TABLE>
<P> </P>
<P><전기></P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="625">

<COLGROUP>
<COL WIDTH="116"></COL>
<COL WIDTH="116"></COL>
<COL WIDTH="116"></COL>
<COL WIDTH="116"></COL>
<COL WIDTH="116"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="125" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구분</TH>
<TH WIDTH="125" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">일자</TH>
<TH WIDTH="125" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">주식수</TH>
<TH WIDTH="125" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">가중치</TH>
<TH WIDTH="125" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">가중평균</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="125" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">전기이월</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2019.1.1</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">2,403,000</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">365</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">2,403,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="125" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">유상증자</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2019.11.28</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">20,000</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">34</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,863</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="125" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">자기주식</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2019.1.1</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(92,134)</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">365</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(92,134)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="500" HEIGHT="30" COLSPAN="4" ALIGN="CENTER" VALIGN="MIDDLE">가중평균유통보통주식수</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">2,312,729</TD>
</TR>
</TBODY>
</TABLE>
<P>&cr;</P>
<P>18. 판매비와관리비&cr;당기와 전기 중 판매비와관리비의 상세내역은 다음과 같습니다.</P>

<TABLE WIDTH="630" BORDER="0" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="291"></COL>
<COL WIDTH="321"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="300" VALIGN="BOTTOM" HEIGHT="30"></TD>
<TD WIDTH="330" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="629" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="201"></COL>
<COL WIDTH="201"></COL>
<COL WIDTH="200"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="210" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구  분</TH>
<TH WIDTH="210" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당  기</TH>
<TH WIDTH="209" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전  기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="210" HEIGHT="30">급여</TD>
<TD WIDTH="210" ALIGN="RIGHT" HEIGHT="30">506,732</TD>
<TD WIDTH="209" ALIGN="RIGHT" HEIGHT="30">585,369</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="210" HEIGHT="30">퇴직급여</TD>
<TD WIDTH="210" ALIGN="RIGHT" HEIGHT="30">67,262</TD>
<TD WIDTH="209" ALIGN="RIGHT" HEIGHT="30">73,106</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="210" HEIGHT="30">지급수수료</TD>
<TD WIDTH="210" ALIGN="RIGHT" HEIGHT="30">178,675</TD>
<TD WIDTH="209" ALIGN="RIGHT" HEIGHT="30">167,694</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="210" HEIGHT="30">연구개발비</TD>
<TD WIDTH="210" ALIGN="RIGHT" HEIGHT="30">759,672</TD>
<TD WIDTH="209" ALIGN="RIGHT" HEIGHT="30">2,952,536</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="210" HEIGHT="30">여비교통비</TD>
<TD WIDTH="210" ALIGN="RIGHT" HEIGHT="30">2,972</TD>
<TD WIDTH="209" ALIGN="RIGHT" HEIGHT="30">7,527</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="210" HEIGHT="30">기타</TD>
<TD WIDTH="210" ALIGN="RIGHT" HEIGHT="30">89,121</TD>
<TD WIDTH="209" ALIGN="RIGHT" HEIGHT="30">99,466</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="210" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">합  계</TD>
<TD WIDTH="210" ALIGN="RIGHT" HEIGHT="30">1,604,434</TD>
<TD WIDTH="209" ALIGN="RIGHT" HEIGHT="30">3,885,698</TD>
</TR>
</TBODY>
</TABLE>
<P>&cr;&cr;19. 부가가치계산에 필요한 항목&cr;당기와 전기 중 판매비와관리비에 포함된 부가가치의 계산에 필요한 사항은 다음과 같습니다.</P>

<TABLE WIDTH="628" BORDER="0" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="291"></COL>
<COL WIDTH="319"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="300" VALIGN="BOTTOM" HEIGHT="30"></TD>
<TD WIDTH="328" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="628" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="201"></COL>
<COL WIDTH="200"></COL>
<COL WIDTH="200"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="210" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구  분</TH>
<TH WIDTH="209" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당  기</TH>
<TH WIDTH="209" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전  기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="210" HEIGHT="30">급여</TD>
<TD WIDTH="209" ALIGN="RIGHT" HEIGHT="30">506,732</TD>
<TD WIDTH="209" ALIGN="RIGHT" HEIGHT="30">585,369</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="210" HEIGHT="30">퇴직급여</TD>
<TD WIDTH="209" ALIGN="RIGHT" HEIGHT="30">67,262</TD>
<TD WIDTH="209" ALIGN="RIGHT" HEIGHT="30">73,106</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="210" HEIGHT="30">복리후생비</TD>
<TD WIDTH="209" ALIGN="RIGHT" HEIGHT="30">22,849</TD>
<TD WIDTH="209" ALIGN="RIGHT" HEIGHT="30">22,846</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="210" HEIGHT="30">세금과공과</TD>
<TD WIDTH="209" ALIGN="RIGHT" HEIGHT="30">7,583</TD>
<TD WIDTH="209" ALIGN="RIGHT" HEIGHT="30">8,016</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="210" HEIGHT="30">감가상각비</TD>
<TD WIDTH="209" ALIGN="RIGHT" HEIGHT="30">6,197</TD>
<TD WIDTH="209" ALIGN="RIGHT" HEIGHT="30">5,288</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="210" HEIGHT="30">임차료</TD>
<TD WIDTH="209" ALIGN="RIGHT" HEIGHT="30">19,592</TD>
<TD WIDTH="209" ALIGN="RIGHT" HEIGHT="30">20,051</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="210" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">합  계</TD>
<TD WIDTH="209" ALIGN="RIGHT" HEIGHT="30">630,215</TD>
<TD WIDTH="209" ALIGN="RIGHT" HEIGHT="30">714,676</TD>
</TR>
</TBODY>
</TABLE>
<P>&cr;</P>
<P>20. 포괄손익계산서&cr;당기와 전기 중 포괄손익계산서는 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="628">

<COLGROUP>
<COL WIDTH="291"></COL>
<COL WIDTH="319"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="300" HEIGHT="30" VALIGN="BOTTOM"></TD>
<TD WIDTH="328" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="630" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="201"></COL>
<COL WIDTH="201"></COL>
<COL WIDTH="201"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="210" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구  분</TH>
<TH WIDTH="210" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당  기</TH>
<TH WIDTH="210" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전  기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="210" HEIGHT="30">당기순손실</TD>
<TD WIDTH="210" ALIGN="RIGHT" HEIGHT="30">(1,531,637)</TD>
<TD WIDTH="210" ALIGN="RIGHT" HEIGHT="30">(4,390,201)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="210" HEIGHT="30">기타포괄손익</TD>
<TD WIDTH="210" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">-</TD>
<TD WIDTH="210" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="210" HEIGHT="30">총포괄손익</TD>
<TD WIDTH="210" ALIGN="RIGHT" HEIGHT="30">(1,531,637)</TD>
<TD WIDTH="210" ALIGN="RIGHT" HEIGHT="30">(4,390,201)</TD>
</TR>
</TBODY>
</TABLE>
<P>&cr;</P>
<P>21. 현금 유ㆍ출입이 없는 중요한 거래 &cr;현금흐름표상의 현금은 재무상태표상의 현금및현금성자산으로 이루어져 있으며, 당기와 전기 중 현금의 유입과 유출이 없는 거래 중 주요사항은 다음과 같습니다.</P>

<TABLE WIDTH="630" BORDER="0" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="291"></COL>
<COL WIDTH="321"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="300" VALIGN="BOTTOM" HEIGHT="30"></TD>
<TD WIDTH="330" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="629" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="201"></COL>
<COL WIDTH="201"></COL>
<COL WIDTH="200"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="210" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구  분</TH>
<TH WIDTH="210" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당  기</TH>
<TH WIDTH="209" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전  기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="210" HEIGHT="30">전환사채의 발행 및 전환</TD>
<TD WIDTH="210" ALIGN="RIGHT" HEIGHT="30">383,588</TD>
<TD WIDTH="209" ALIGN="RIGHT" HEIGHT="30">502,864</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="210" HEIGHT="30">미지급금 출자전환</TD>
<TD WIDTH="210" ALIGN="RIGHT" HEIGHT="30">2,222,550</TD>
<TD WIDTH="209" ALIGN="RIGHT" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="210" HEIGHT="30" ALIGN="CENTER">합  계</TD>
<TD WIDTH="210" ALIGN="RIGHT" HEIGHT="30">2,606,138</TD>
<TD WIDTH="209" ALIGN="RIGHT" HEIGHT="30">502,864</TD>
</TR>
</TBODY>
</TABLE>
<P>&cr;</P>

<P>22. 특수관계자거래&cr;
<SPAN>(1) </SPAN>
<SPAN>지배ㆍ종속기업간의 특수관계&cr;보고기간종료일 현재 당사와 특수관계에 있는 지배ㆍ종속 기업은 다음과 같습니다.</SPAN>
</P>

<TABLE BORDER="1" WIDTH="629" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="114"></COL>
<COL WIDTH="244"></COL>
<COL WIDTH="244"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="123" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구  분</TH>
<TH WIDTH="253" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기말</TH>
<TH WIDTH="253" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전기말</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="123" VALIGN="MIDDLE" HEIGHT="53" ALIGN="CENTER">지분법적용&cr;피투자기업</TD>
<TD WIDTH="253" VALIGN="MIDDLE" HEIGHT="53" ALIGN="CENTER">Plumbline Life Sciences, USA, Inc.</TD>
<TD WIDTH="253" VALIGN="MIDDLE" HEIGHT="53" ALIGN="CENTER">Plumbline Life Sciences, USA, Inc.</TD>
</TR>
</TBODY>
</TABLE>

<P>&cr;(2) 당
<SPAN>사</SPAN>
<SPAN>는</SPAN>
<SPAN> </SPAN>당기 중 특수관계자와의 자금거래를 포함한 거래내역은 없습니다. &cr;
</P>

<P>(3) 당기말 및 전기말 특수관계자에 대한 채권잔액은 존재하지 않으나, 당사는 전전기 당사의 자회사인 Plumbline Life Sciences, USA, Inc.가 부담하고 있
<SPAN>는 채무 중 </SPAN>
<SPAN>628,135천원</SPAN>
<SPAN> 대하여 대위변제를 실시하기로 약정함에 따라 동 금액에 대해</SPAN>서는 미지급금으로 계상하였습니다. 동 대위변제로 인하여 발생하는 종속기업에 대한 구상채권에 대해서 당사는 전기 중 전액 비용으로 처리하였으며 당기말 현재 채무 잔액은 272,430천원입니다.&cr;
</P>

<P USERMARK=" 0X0000FF">
<SPAN USERMARK=" 0X000000">(4) 주요경영진에 대한 보상</SPAN>
<SPAN USERMARK=" 0X000000"></SPAN>
</P>
<P>당기와 전기 중 주요경영진에 대한 보상내역은 다음과 같습니다.</P>

<TABLE WIDTH="631" BORDER="0" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="291"></COL>
<COL WIDTH="322"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="300" VALIGN="BOTTOM" HEIGHT="30"></TD>
<TD WIDTH="331" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="633" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="202"></COL>
<COL WIDTH="202"></COL>
<COL WIDTH="202"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="211" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구  분</TH>
<TH WIDTH="211" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당  기</TH>
<TH WIDTH="211" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전  기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="211" HEIGHT="30">단기급여</TD>
<TD WIDTH="211" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">185,700</TD>
<TD WIDTH="211" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">215,861</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="211" HEIGHT="30">퇴직급여</TD>
<TD WIDTH="211" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">31,950</TD>
<TD WIDTH="211" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">57,124</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="211" HEIGHT="30">주식보상비용</TD>
<TD WIDTH="211" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">19,103</TD>
<TD WIDTH="211" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">84,818</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="211" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">합  계</TD>
<TD WIDTH="211" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">236,753</TD>
<TD WIDTH="211" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">357,803</TD>
</TR>
</TBODY>
</TABLE>
<P>&cr;</P>

<P>23. 약정사항
<SPAN>&cr;</SPAN>
<SPAN>(1) 전기 이전에 Inovio Pharmaceuticals Inc.와 라이선스와 관련하여 체결한 주요 약정의 당기말 현재 내역은 다음과 같습니다.</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="628">

<COLGROUP>
<COL WIDTH="291"></COL>
<COL WIDTH="319"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="300" HEIGHT="30" VALIGN="BOTTOM"></TD>
<TD WIDTH="328" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">(단위: 천 USD)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="627" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="148"></COL>
<COL WIDTH="105"></COL>
<COL WIDTH="104"></COL>
<COL WIDTH="234"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="157" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구  분</TH>
<TH WIDTH="114" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">약정 금액</TH>
<TH WIDTH="113" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기 지급액</TH>
<TH WIDTH="243" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">비  고</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="157" HEIGHT="30">특허 유지 대행</TD>
<TD WIDTH="114" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">연간 50</TD>
<TD WIDTH="113" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="243" HEIGHT="30">특허 사용기간</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="157" HEIGHT="30">로열티</TD>
<TD WIDTH="114" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">5%</TD>
<TD WIDTH="113" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="243" HEIGHT="30">기준금액: 제품 매출액</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="157" HEIGHT="30">Milestone payment</TD>
<TD WIDTH="114" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">3,750</TD>
<TD WIDTH="113" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="243" HEIGHT="30">임상 승인 진행 단계에 따라 지급</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN></SPAN>
<SPAN>&cr;(2) </SPAN>
<SPAN>타인으로부터</SPAN>
<SPAN> 제공받은 지급보증은 다음과 같습니다.</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="628">

<COLGROUP>
<COL WIDTH="291"></COL>
<COL WIDTH="319"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="300" HEIGHT="30" VALIGN="BOTTOM"></TD>
<TD WIDTH="328" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="837">

<COLGROUP>
<COL WIDTH="201"></COL>
<COL WIDTH="200"></COL>
<COL WIDTH="200"></COL>
<COL WIDTH="200"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="210" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구  분</TH>
<TH WIDTH="209" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">보증액</TH>
<TH WIDTH="209" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">지급보증내역</TH>
<TH WIDTH="209" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">보증제공처</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="210" HEIGHT="30" VALIGN="MIDDLE">기술보증기금</TD>
<TD WIDTH="209" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">250,000</TD>
<TD WIDTH="209" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">대출지급보증</TD>
<TD WIDTH="209" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">신한은행</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="210" HEIGHT="30" VALIGN="MIDDLE">서울보증보험</TD>
<TD WIDTH="209" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">6,100</TD>
<TD WIDTH="209" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">이행보증</TD>
<TD WIDTH="209" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE"></TD>
</TR>
</TBODY>
</TABLE>
<P>&cr;</P>

<P>24. 계속기업관련 중요한 불확실성&cr;당사는 2020년 12월 31일로 종료되는 보고기간에 영업손실  1,604백만원과 당기순손실 1,532백만원이 발생하였습니다. 또한 보고기간말 현재 누적 결손금이 
<SPAN> 23,743백만원이며  </SPAN>
<SPAN>총부채가 총자산을 1,404백만원만큼 초과하고 있습니다</SPAN>
<SPAN>. 이러한 상황은 회사의 계속기업으로서의 존속능력에 의문을 불러일으킬 만한 중요한 불확실성이 존재함을 의미합니다.</SPAN>&cr;
<SPAN></SPAN>
<SPAN></SPAN>
</P>

<P>당사의 경영진은 회사의 재무상태을 지속적으로 모니터링하고 있으며 필요시 유상증자 등 재무활동을 통한 재무상태 개선 계획을 고려하고 있습니다. &cr;&cr;한편, 당사가 영위하고 있는 생명공학 기반의 동물 바이오 사업은 영업활동의 변동성과 불확실성이 일반기업보다 클 수 있으며, 당사가 계획 중인 자금조달 계획이 차질이 있는 경우에는 당사의 재무상태나 경영성과 등이 큰 폭으로 변동할 중요한 불확실성을 내포하고 있습니다. 이러한 불확실성이 당사의 재무상태에 미칠 영향은 현재로서는 측정할 수 없으며 본 재무제표는 이러한 변동가능성으로 발생 가능한 조정사항은 반영되지 않았습니다. &cr;&cr;
<SPAN USERMARK=" 0X1814FF"></SPAN>
</P>
<P>25. 보고기간 후 사건</P>
<P>(1) 제 1회차 전환사채 조기상환청구권을 삭제하는 변경 계약체결</P>
<P>당사는 전기에 1,000백만원 규모로 발행한 제 1회차 무기명식이권부 무보증 전환사채 계약의 특약조항에 따라 2021년 3월 22일부터 조기상환청구권의 행사가 가능하였으나, 해당 조기상환청구권을 삭제하는 변경 계약을 2021년 2월 8일 체결하였습니다. </P>
<P>&cr;</P>
</SECTION-2>
</LIBRARY>
</INSERTION>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-0-3-6-0">6. 기타 재무에 관한 사항</TITLE>

<INSERTION ABASISNUMBER="SE2" AFREQUENCY="0" ADUPLICATION="N">
<COMMENT>◆click◆『진행률적용 수주계약 현황』 삽입</COMMENT>
<LIBRARYLIST>11011#*진행률적용수주계약현황*.dsl</LIBRARYLIST>
</INSERTION>
<P></P>

<TABLE-GROUP ACLASS="SUB_PIS" ADELETETABLE="N">
<TITLE ATOC="N">채무증권 발행실적</TITLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="747" BORDER="0">

<COLGROUP>
<COL WIDTH="70"></COL>
<COL WIDTH="138"></COL>
<COL WIDTH="58"></COL>
<COL WIDTH="445"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="79" HEIGHT="30" AUPDATECONT="N">(기준일 : </TD>
<TU ALIGN="CENTER" VALIGN="BOTTOM" WIDTH="147" HEIGHT="30" AUNIT="BASE_DT" AUNITVALUE="20201231">2020년 12월 31일</TU>
<TD VALIGN="BOTTOM" WIDTH="67" HEIGHT="30" AUPDATECONT="N">)</TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="454" HEIGHT="30" AUNIT="WONPERCENT" AUNITVALUE="2">(단위 : 천원, %)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="1039" BORDER="1">

<COLGROUP>
<COL WIDTH="156"></COL>
<COL WIDTH="69"></COL>
<COL WIDTH="69"></COL>
<COL WIDTH="128"></COL>
<COL WIDTH="141"></COL>
<COL WIDTH="54"></COL>
<COL WIDTH="81"></COL>
<COL WIDTH="128"></COL>
<COL WIDTH="54"></COL>
<COL WIDTH="69"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="N" ADELETE="N">
<TH WIDTH="165" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">발행회사</TH>
<TH WIDTH="78" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">증권종류</TH>
<TH WIDTH="78" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">발행방법</TH>
<TH WIDTH="137" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">발행일자</TH>
<TH WIDTH="150" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">권면(전자등록)총액</TH>
<TH WIDTH="63" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">이자율</TH>
<TH WIDTH="90" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">평가등급&cr;(평가기관)</TH>
<TH WIDTH="137" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">만기일</TH>
<TH WIDTH="63" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">상환&cr;여부</TH>
<TH WIDTH="78" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">주관회사</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="N">
<TE WIDTH="165" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="BSS_PIS_CMPY">(주)플럼라인생명과학</TE>
<TU WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUNIT="BSS_PIS_KNN" AUNITVALUE="3">회사채</TU>
<TU WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUNIT="BSS_PIS_STC" AUNITVALUE="2">사모</TU>
<TU WIDTH="137" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUNIT="BSS_PIS_DAT" AUNITVALUE="20190322">2019년 03월 22일</TU>
<TE WIDTH="150" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_PIS_MON">1,000,000</TE>
<TE WIDTH="63" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_PIS_RATE">4</TE>
<TE WIDTH="90" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="BSS_PIS_LEV">-</TE>
<TU WIDTH="137" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUNIT="BSS_PIS_LAS" AUNITVALUE="20220321">2022년 03월 21일</TU>
<TE WIDTH="63" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="BSS_PIS_REC">미상환</TE>
<TE WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="BSS_PIS_SUC">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="165" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">합  계</TD>
<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">-</TD>
<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">-</TD>
<TD WIDTH="137" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">-</TD>
<TE WIDTH="150" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_PIS_MONT">1,000,000</TE>
<TE WIDTH="63" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_PIS_RATET">-</TE>
<TE WIDTH="90" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="BSS_PIS_LEVT">-</TE>
<TD WIDTH="137" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">-</TD>
<TE WIDTH="63" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="BSS_PIS_RECT">-</TE>
<TE WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="BSS_PIS_SUCT">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P>(*) 제2회차 무기명식 이권부 무보증 무담보 사모 전환사채는 2020년 10월 16일 전환권 행사에 따라 보통주(45,000주)로 전환 되었습니다.&cr;</P>

<INSERTION ABASISNUMBER="LE0" AFREQUENCY="0" ADUPLICATION="Y">
<COMMENT>◆click◆ 『사채관리계약 주요내용 및 충족여부 등』 삽입</COMMENT>
<LIBRARYLIST>11011#*사채관리계약주요내용.dsl</LIBRARYLIST>
</INSERTION>
<P></P>

<TABLE-GROUP ACLASS="SUB_BLC" ADELETETABLE="N">
<TITLE ATOC="N">기업어음증권 미상환 잔액</TITLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="820" BORDER="0">

<COLGROUP>
<COL WIDTH="70"></COL>
<COL WIDTH="142"></COL>
<COL WIDTH="58"></COL>
<COL WIDTH="514"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="79" HEIGHT="30" AUPDATECONT="N">(기준일 : </TD>
<TU ALIGN="CENTER" VALIGN="BOTTOM" WIDTH="151" HEIGHT="30" AUNIT="BASE_DT" AUNITVALUE="20201231">2020년 12월 31일</TU>
<TD VALIGN="BOTTOM" WIDTH="67" HEIGHT="30" AUPDATECONT="N">)</TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="523" HEIGHT="30" AUNIT="WON" AUNITVALUE="2">(단위 : 천원)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="820" BORDER="1">

<COLGROUP>
<COL WIDTH="45"></COL>
<COL WIDTH="43"></COL>
<COL WIDTH="71"></COL>
<COL WIDTH="71"></COL>
<COL WIDTH="71"></COL>
<COL WIDTH="70"></COL>
<COL WIDTH="70"></COL>
<COL WIDTH="70"></COL>
<COL WIDTH="70"></COL>
<COL WIDTH="70"></COL>
<COL WIDTH="70"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="N" ADELETE="N">
<TH WIDTH="106" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" COLSPAN="2">잔여만기</TH>
<TH WIDTH="80" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">10일 이하</TH>
<TH WIDTH="80" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">10일초과&cr;30일이하</TH>
<TH WIDTH="80" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">30일초과&cr;90일이하</TH>
<TH WIDTH="79" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">90일초과&cr;180일이하</TH>
<TH WIDTH="79" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">180일초과&cr;1년이하</TH>
<TH WIDTH="79" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">1년초과&cr;2년이하</TH>
<TH WIDTH="79" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">2년초과&cr;3년이하</TH>
<TH WIDTH="79" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">3년 초과</TH>
<TH WIDTH="79" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">합 계</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="54" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="90" AUPDATECONT="N" ROWSPAN="3">미상환 잔액</TD>
<TD WIDTH="52" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">공모</TD>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BL_DA10">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BL_DA30">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BL_DA90">-</TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BL_DA180">-</TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BL_DA365">-</TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BL_DA730">-</TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BL_DA1095">-</TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BL_DA1111">-</TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BL_DATT">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="52" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">사모</TD>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BC_DA10">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BC_DA30">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BC_DA90">-</TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BC_DA180">-</TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BC_DA365">-</TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BC_DA730">-</TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BC_DA1095">-</TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BC_DA1111">-</TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BC_DATT">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="52" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">합계</TD>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BLC_DA10">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BLC_DA30">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BLC_DA90">-</TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BLC_DA180">-</TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BLC_DA365">-</TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BLC_DA730">-</TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BLC_DA1095">-</TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BLC_DA1111">-</TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BLC_DATT">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P>상기 기업어음증권 미상환 잔액 해당사항 없습니다.&cr;</P>

<TABLE-GROUP ACLASS="SUB_ELPN" ADELETETABLE="N">
<TITLE ATOC="N">단기사채 미상환 잔액</TITLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="759" BORDER="0">

<COLGROUP>
<COL WIDTH="70"></COL>
<COL WIDTH="142"></COL>
<COL WIDTH="58"></COL>
<COL WIDTH="453"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="79" HEIGHT="30" AUPDATECONT="N">(기준일 : </TD>
<TU ALIGN="CENTER" VALIGN="BOTTOM" WIDTH="151" HEIGHT="30" AUNIT="BASE_DT" AUNITVALUE="20201231">2020년 12월 31일</TU>
<TD VALIGN="BOTTOM" WIDTH="67" HEIGHT="30" AUPDATECONT="N">)</TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="462" HEIGHT="30" AUNIT="WON" AUNITVALUE="2">(단위 : 천원)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="760" BORDER="1">

<COLGROUP>
<COL WIDTH="45"></COL>
<COL WIDTH="46"></COL>
<COL WIDTH="73"></COL>
<COL WIDTH="73"></COL>
<COL WIDTH="73"></COL>
<COL WIDTH="72"></COL>
<COL WIDTH="72"></COL>
<COL WIDTH="72"></COL>
<COL WIDTH="72"></COL>
<COL WIDTH="72"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="N" ADELETE="N">
<TH WIDTH="109" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" COLSPAN="2">잔여만기</TH>
<TH WIDTH="82" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">10일 이하</TH>
<TH WIDTH="82" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">10일초과&cr;30일이하</TH>
<TH WIDTH="82" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">30일초과&cr;90일이하</TH>
<TH WIDTH="81" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">90일초과&cr;180일이하</TH>
<TH WIDTH="81" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">180일초과&cr;1년이하</TH>
<TH WIDTH="81" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">합 계</TH>
<TH WIDTH="81" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">발행 한도</TH>
<TH WIDTH="81" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">잔여 한도</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="54" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="90" AUPDATECONT="N" ROWSPAN="3">미상환 잔액</TD>
<TD WIDTH="55" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">공모</TD>
<TE WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_EL_DA10">-</TE>
<TE WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_EL_DA30">-</TE>
<TE WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_EL_DA90">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_EL_DA180">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_EL_DA365">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_EL_DATT">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_EL_PUB">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_EL_REM">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="55" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">사모</TD>
<TE WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_EP_DA10">-</TE>
<TE WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_EP_DA30">-</TE>
<TE WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_EP_DA90">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_EP_DA180">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_EP_DA365">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_EP_DATT">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_EP_PUB">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_EP_REM">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="55" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">합계</TD>
<TE WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_ELP_DA10">-</TE>
<TE WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_ELP_DA30">-</TE>
<TE WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_ELP_DA90">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_ELP_DA180">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_ELP_DA365">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_ELP_DATT">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_ELP_PUB">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_ELP_REM">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P>상기 단기사채 미상환 잔액 해당사항 없습니다.&cr;</P>

<TABLE-GROUP ACLASS="SUB_CNC" ADELETETABLE="N">
<TITLE ATOC="N">회사채 미상환 잔액</TITLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="762" BORDER="0">

<COLGROUP>
<COL WIDTH="70"></COL>
<COL WIDTH="142"></COL>
<COL WIDTH="58"></COL>
<COL WIDTH="456"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="79" HEIGHT="30" AUPDATECONT="N">(기준일 : </TD>
<TU ALIGN="CENTER" VALIGN="BOTTOM" WIDTH="151" HEIGHT="30" AUNIT="BASE_DT" AUNITVALUE="20201231">2020년 12월 31일</TU>
<TD VALIGN="BOTTOM" WIDTH="67" HEIGHT="30" AUPDATECONT="N">)</TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="465" HEIGHT="30" AUNIT="WON" AUNITVALUE="2">(단위 : 천원)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="761" BORDER="1">

<COLGROUP>
<COL WIDTH="45"></COL>
<COL WIDTH="46"></COL>
<COL WIDTH="73"></COL>
<COL WIDTH="73"></COL>
<COL WIDTH="73"></COL>
<COL WIDTH="73"></COL>
<COL WIDTH="72"></COL>
<COL WIDTH="72"></COL>
<COL WIDTH="72"></COL>
<COL WIDTH="72"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="N" ADELETE="N">
<TH WIDTH="109" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" COLSPAN="2">잔여만기</TH>
<TH WIDTH="82" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">1년 이하</TH>
<TH WIDTH="82" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">1년초과&cr;2년이하</TH>
<TH WIDTH="82" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">2년초과&cr;3년이하</TH>
<TH WIDTH="82" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">3년초과&cr;4년이하</TH>
<TH WIDTH="81" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">4년초과&cr;5년이하</TH>
<TH WIDTH="81" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">5년초과&cr;10년이하</TH>
<TH WIDTH="81" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">10년초과</TH>
<TH WIDTH="81" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">합 계</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="54" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="90" AUPDATECONT="N" ROWSPAN="3">미상환 잔액</TD>
<TD WIDTH="55" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">공모</TD>
<TE WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CN_DA1">-</TE>
<TE WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CN_DA2">-</TE>
<TE WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CN_DA3">-</TE>
<TE WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CN_DA4">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CN_DA5">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CN_DA10">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CN_DA11">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CN_DATT">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="55" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">사모</TD>
<TE WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CC_DA1">-</TE>
<TE WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CC_DA2">1,000,000</TE>
<TE WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CC_DA3">-</TE>
<TE WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CC_DA4">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CC_DA5">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CC_DA10">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CC_DA11">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CC_DATT">1,000,000</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="55" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">합계</TD>
<TE WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CNC_DA1">-</TE>
<TE WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CNC_DA2">1,000,000</TE>
<TE WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CNC_DA3">-</TE>
<TE WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CNC_DA4">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CNC_DA5">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CNC_DA10">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CNC_DA11">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CNC_DATT">1,000,000</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P></P>

<TABLE-GROUP ACLASS="SUB_NEF" ADELETETABLE="N">
<TITLE ATOC="N">신종자본증권 미상환 잔액</TITLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="757" BORDER="0">

<COLGROUP>
<COL WIDTH="70"></COL>
<COL WIDTH="142"></COL>
<COL WIDTH="58"></COL>
<COL WIDTH="451"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="79" HEIGHT="30" AUPDATECONT="N">(기준일 : </TD>
<TU ALIGN="CENTER" VALIGN="BOTTOM" WIDTH="151" HEIGHT="30" AUNIT="BASE_DT" AUNITVALUE="20201231">2020년 12월 31일</TU>
<TD VALIGN="BOTTOM" WIDTH="67" HEIGHT="30" AUPDATECONT="N">)</TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="460" HEIGHT="30" AUNIT="WON" AUNITVALUE="2">(단위 : 천원)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="758" BORDER="1">

<COLGROUP>
<COL WIDTH="45"></COL>
<COL WIDTH="46"></COL>
<COL WIDTH="73"></COL>
<COL WIDTH="72"></COL>
<COL WIDTH="72"></COL>
<COL WIDTH="72"></COL>
<COL WIDTH="72"></COL>
<COL WIDTH="72"></COL>
<COL WIDTH="72"></COL>
<COL WIDTH="72"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="N" ADELETE="N">
<TH WIDTH="109" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" COLSPAN="2">잔여만기</TH>
<TH WIDTH="82" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">1년 이하</TH>
<TH WIDTH="81" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">1년초과&cr;5년이하</TH>
<TH WIDTH="81" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">5년초과&cr;10년이하</TH>
<TH WIDTH="81" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">10년초과&cr;15년이하</TH>
<TH WIDTH="81" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">15년초과&cr;20년이하</TH>
<TH WIDTH="81" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">20년초과&cr;30년이하</TH>
<TH WIDTH="81" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">30년초과</TH>
<TH WIDTH="81" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">합 계</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="54" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="90" AUPDATECONT="N" ROWSPAN="3">미상환 잔액</TD>
<TD WIDTH="55" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">공모</TD>
<TE WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NE_DA1">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NE_DA5">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NE_DA10">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NE_DA15">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NE_DA20">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NE_DA30">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NE_DA31">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NE_DATT">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="55" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">사모</TD>
<TE WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NF_DA1">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NF_DA5">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NF_DA10">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NF_DA15">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NF_DA20">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NF_DA30">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NF_DA31">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NF_DATT">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="55" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">합계</TD>
<TE WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NEF_DA1">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NEF_DA5">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NEF_DA10">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NEF_DA15">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NEF_DA20">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NEF_DA30">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NEF_DA31">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NEF_DATT">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P>상기 신종자본증권 미상환 잔액 해당사항 없습니다.&cr;</P>

<TABLE-GROUP ACLASS="SUB_CEF" ADELETETABLE="N">
<TITLE ATOC="N">조건부자본증권 미상환 잔액</TITLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="912" BORDER="0">

<COLGROUP>
<COL WIDTH="70"></COL>
<COL WIDTH="142"></COL>
<COL WIDTH="58"></COL>
<COL WIDTH="606"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="79" HEIGHT="30" AUPDATECONT="N">(기준일 : </TD>
<TU ALIGN="CENTER" VALIGN="BOTTOM" WIDTH="151" HEIGHT="30" AUNIT="BASE_DT" AUNITVALUE="20201231">2020년 12월 31일</TU>
<TD VALIGN="BOTTOM" WIDTH="67" HEIGHT="30" AUPDATECONT="N">)</TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="615" HEIGHT="30" AUNIT="WON" AUNITVALUE="2">(단위 : 천원)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="912" BORDER="1">

<COLGROUP>
<COL WIDTH="45"></COL>
<COL WIDTH="46"></COL>
<COL WIDTH="72"></COL>
<COL WIDTH="72"></COL>
<COL WIDTH="72"></COL>
<COL WIDTH="71"></COL>
<COL WIDTH="71"></COL>
<COL WIDTH="71"></COL>
<COL WIDTH="71"></COL>
<COL WIDTH="71"></COL>
<COL WIDTH="71"></COL>
<COL WIDTH="71"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="N" ADELETE="N">
<TH WIDTH="109" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" COLSPAN="2">잔여만기</TH>
<TH WIDTH="81" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">1년 이하</TH>
<TH WIDTH="81" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">1년초과&cr;2년이하</TH>
<TH WIDTH="81" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">2년초과&cr;3년이하</TH>
<TH WIDTH="80" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">3년초과&cr;4년이하</TH>
<TH WIDTH="80" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">4년초과&cr;5년이하</TH>
<TH WIDTH="80" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">5년초과&cr;10년이하</TH>
<TH WIDTH="80" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">10년초과&cr;20년이하</TH>
<TH WIDTH="80" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">20년초과&cr;30년이하</TH>
<TH WIDTH="80" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">30년초과</TH>
<TH WIDTH="80" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">합 계</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="54" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="90" AUPDATECONT="N" ROWSPAN="3">미상환 잔액</TD>
<TD WIDTH="55" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">공모</TD>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CE_DA1">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CE_DA2">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CE_DA3">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CE_DA4">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CE_DA5">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CE_DA10">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CE_DA20">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CE_DA30">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CE_DA31">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CE_DATT">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="55" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">사모</TD>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CF_DA1">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CF_DA2">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CF_DA3">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CF_DA4">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CF_DA5">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CF_DA10">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CF_DA20">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CF_DA30">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CF_DA31">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CF_DATT">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="55" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">합계</TD>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CEF_DA1">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CEF_DA2">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CEF_DA3">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CEF_DA4">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CEF_DA5">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CEF_DA10">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CEF_DA20">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CEF_DA30">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CEF_DA31">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CEF_DATT">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P>상기 조건부자본증권 미상환 잔액 해당사항 없습니다.</P>
<P></P>
<PGBRK></PGBRK>
</SECTION-2>
</SECTION-1>

<SECTION-1 ACLASS="MANDATORY" APARTSOURCE="SOURCE">
<TITLE ATOC="Y" AASSOCNOTE="D-0-4-0-0">IV. 이사의 경영진단 및 분석의견</TITLE>
<P>&cr;</P>

<P>
<SPAN USERMARK="F-16 0XFF0000 B">1. 예측정보에 대한 주의사항 &cr;</SPAN>
<SPAN USERMARK=" 0XFF0000">&cr;</SPAN>
<SPAN>회사가 본 보고서에서 미래에 발생할 것으로 예상 ·예측한 활동, 사건 또는 현상은 당해 공시서류 작성시점의 사건 및 재무성과에 대하여 회사의 견해를 반영한 것입니다. 동 예측정보는 미래 사업환경과 관련된 다양한 가정에 기초하고 있으며, 동 가정들은 결과적으로 부정확한 것으로 판명될 수도 있습니다. 또한, 이러한 가정들에는 예측정보에서 기재한 예상치와 실제 결과 간에 중요한 차이를 초래할 수 있는 위험, 불확실성 및 기타 요인을 포함하고 있습니다. 이러한 중요한 차이를 초래할 수 있는 요인에는 회사 내부경영과 관련된 요인과 외부환경에 관한 요인이 포함되어 있으며, 이에 한하지 않습니다.&cr;</SPAN>
<SPAN USERMARK=" 0XFF0000"></SPAN>
</P>
<P>회사는 동 예측정보 작성시점 이후에 발생하는 위험 또는 불확실성을 반영하기 위하여 예측정보에 기재한 사항을 수정하는 정정보고서를 공시할 의무는 없습니다. 결론적으로 본 보고서 상에 회사가 예상한 결과 또는 사항이 실현되거나 회사가 당초에 예상한 영향이 발생한다는 확신을 제공할 수 없습니다. 본 보고서에 기재된 예측정보는 본 보고서 작성시점을 기준으로 작성한 것이며, 회사가 이러한 위험요인이나 예측정보를 수정할 예정이 없음을 유의하시기 바랍니다.&cr;</P>

<P>
<SPAN USERMARK="F-16 0XFF0000 B">2. 개요&cr;</SPAN>&cr; 당사는 2014년 01월 02일에 설립되었으며, 주업종은 동물의약품 연구·개발, 제조, 매매업으로, 본사는 서울시 서초구 서초대로 34길 18, 4층에 위치하고 있으며, 기업부설연구소는 서울시 서초구 반포대로 222, 성의회관 13층에 위치하고 있습니다. 당사는 2015년 07월 28일에 주권을 한국거래소가 운영하는 코넥스시장에 상장한 공개법인입니다. &cr;
</P>
<P> 국내 대부분의 동물의약품 회사는 사료첨가제, 항생제, 구충제, 영양제 등을 생산하거나 해외에서 수입하여 판매하고 있는 실정입니다. 당사와 같은 핵산 바이오 기술 기반으로 반려동물 및 가축동물 혁신 의약품을 전문으로 개발·생산하는 업체는 없는 상황입니다. 국내와 달리 해외에선 당사와 유사한 반려동물 혁신 의약품 전문개발 회사가 존재하며, 특히 2013년부터 동 분야의 업체들의 시장 가치를 인정받으며 미국 증시에 상장하기 시작했습니다. </P>
<P>  </P>

<P> 당사는 전 세계에서 최초이자 유일하게 승인된 돼지용 DNA 의약품을 보유하고 있습니다. LifeTide?SW5 돼지DNA면역조절제는 2008년 호주 및 2012년 뉴질랜드에서 승인 받았으며, 2018년 국내 검역본부로부터 수입품목허가를 받았습니다. 이와 같이 검증된 기술력을 바탕으로 현재 반려동물 치료제 개발에 중심을 두고 있으며, 특히 현재까지 마땅한 치료제가 없는 반려견 암 치료 분야에 있어서 새로운 시장 창출과 더불어 선도적인 역할을 하게 될 것으로 기대하고 있습니다.&cr;&cr;
<SPAN USERMARK="F-16 0XFF0000 B">3. 재무상태 및 영업실적</SPAN>
</P>

<P>&cr;
<SPAN USERMARK=" B">가. 재무상태</SPAN>
</P>

<TABLE ACLASS="NORMAL" WIDTH="766" BORDER="0" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="757"></COL>
</COLGROUP>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="766" HEIGHT="30"><주요 재무실적></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="766" HEIGHT="30">(단위 : 백만원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="770">

<COLGROUP>
<COL WIDTH="184"></COL>
<COL WIDTH="184"></COL>
<COL WIDTH="183"></COL>
<COL WIDTH="183"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="193" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="53">
<P>사업년도</P>
<P>구분</P>
</TH>

<TH WIDTH="193" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="53">
<P>2020년</P>
<P>(제7기)</P>
</TH>

<TH WIDTH="192" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="53">
<P>2019년</P>
<P>(제6기)</P>
</TH>

<TH WIDTH="192" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="53">
<P>2018년</P>
<P>(제5기)</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="193" VALIGN="MIDDLE" HEIGHT="30">
<P>매출액</P>
</TD>
<TD WIDTH="193" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="192" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="192" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="193" VALIGN="MIDDLE" HEIGHT="30">
<P>영업이익</P>
</TD>
<TD WIDTH="193" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(1,604)</TD>
<TD WIDTH="192" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(3,886)</TD>
<TD WIDTH="192" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(2,043)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="193" VALIGN="MIDDLE" HEIGHT="30">
<P>당기순이익(손실)</P>
</TD>
<TD WIDTH="193" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(1,531)</TD>
<TD WIDTH="192" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(4,390)</TD>
<TD WIDTH="192" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(3,207)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="193" VALIGN="MIDDLE" HEIGHT="30">
<P>자산총계</P>
</TD>
<TD WIDTH="193" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,650</TD>
<TD WIDTH="192" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,509</TD>
<TD WIDTH="192" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">472</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="193" VALIGN="MIDDLE" HEIGHT="30">
<P>부채총계</P>
</TD>
<TD WIDTH="193" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,054</TD>
<TD WIDTH="192" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">7,043</TD>
<TD WIDTH="192" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,617</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="193" VALIGN="MIDDLE" HEIGHT="30">
<P>자본총계</P>
</TD>
<TD WIDTH="193" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(1,404)</TD>
<TD WIDTH="192" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(5,534)</TD>
<TD WIDTH="192" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(2,146)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="193" VALIGN="MIDDLE" HEIGHT="30">
<P>영업현금흐름</P>
</TD>
<TD WIDTH="193" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(2,093)</TD>
<TD WIDTH="192" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(1,479)</TD>
<TD WIDTH="192" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(1,535)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="193" VALIGN="MIDDLE" HEIGHT="30">
<P>투자현금흐름</P>
</TD>
<TD WIDTH="193" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(46)</TD>
<TD WIDTH="192" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">12</TD>
<TD WIDTH="192" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(141)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="193" VALIGN="MIDDLE" HEIGHT="30">
<P>재무현금흐름</P>
</TD>
<TD WIDTH="193" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,132</TD>
<TD WIDTH="192" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,549</TD>
<TD WIDTH="192" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,845</TD>
</TR>
</TBODY>
</TABLE>

<P>&cr;
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN> 당사는 보고서 제출일 현재까지 실질적인 매출이 발생하지 않고 있습니다. 동물의약품 기술매각(라이선스 아웃)에 관한 협의를 진행 중에 있으며, 2018년 5월 검역본부로부터 수입품목허가를 받은 돼지면역조절제(LifeTide?SW5)를 호주 및 뉴질랜드로 판매하는 독점판매계약을 2018년 07월에 호주의 APIAM사와 체결하여 계약금으로 미화 300,000달러를 수령하였습니다. </SPAN>
<SPAN>또한 중한바이오와 PLS-ASF 아프리카돼지열병DNA백신의 중국시장 독점 기술라이선스 계약을 2020년 8월에 체결하였습니다</SPAN>
<SPAN>.  </SPAN>
<SPAN>계약조건에 따라 계약후 12개월안에 계약금을 지불하기로 했습니다</SPAN>
<SPAN>.  이 외 추가적으로 효력이 발생한 계약은 없습니다. </SPAN>
</P>
<P></P>

<TABLE ACLASS="NORMAL" WIDTH="770" BORDER="0" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="761"></COL>
</COLGROUP>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="770" HEIGHT="30"><부채비율, 유동비율 및 차입금의존도></TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="772">

<COLGROUP>
<COL WIDTH="184"></COL>
<COL WIDTH="184"></COL>
<COL WIDTH="184"></COL>
<COL WIDTH="184"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="193" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="53">
<P>구 분</P>
</TH>

<TH WIDTH="193" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="53">
<P>2020년</P>
<P>(제7기)</P>
</TH>

<TH WIDTH="193" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="53">
<P>2019년</P>
<P>(제6기)</P>
</TH>

<TH WIDTH="193" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="53">
<P>2018년</P>
<P>(제5기)</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="193" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>부채비율</P>
</TD>
<TD WIDTH="193" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-217.53%</TD>
<TD WIDTH="193" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-127.26%</TD>
<TD WIDTH="193" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-121.98%</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="193" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>유동비율</P>
</TD>
<TD WIDTH="193" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">116.47%</TD>
<TD WIDTH="193" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">23.29%</TD>
<TD WIDTH="193" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">18.31%</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="193" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>차입금의존도</P>
</TD>
<TD WIDTH="193" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">15.15%</TD>

<TD WIDTH="193" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>N/A</P>
</TD>

<TD WIDTH="193" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>N/A</P>
</TD>
</TR>
</TBODY>
</TABLE>

<P>&cr;
<SPAN></SPAN>
<SPAN> 상</SPAN>
<SPAN>기에</SPAN>
<SPAN> 언급된 상황을 종합적으로 고려해 볼 때, 당사는 연구·개발 기업으로 아직까지는 매출이 발생되지 않고 적자를 지속적으로 시현하고 있어 자기자본의 규모 감소 및 재무 안정성 지표가 악화되었으나, 유상증자를 통한 자기자본 확충 및 추가 유상증자를 위한 노력을 지속하고 있어 개선될 것으로 전망됩니다.&cr;</SPAN>
<SPAN USERMARK=" 0X0000FF">&cr;</SPAN>
<SPAN></SPAN>
<SPAN USERMARK=" B">나. 영업실적</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="770">

<COLGROUP>
<COL WIDTH="761"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="770" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE"><요약손익계산서></TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" WIDTH="771" BORDER="0" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="762"></COL>
</COLGROUP>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="771" HEIGHT="30">(단위 : 백만원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="771">

<COLGROUP>
<COL WIDTH="256"></COL>
<COL WIDTH="160"></COL>
<COL WIDTH="160"></COL>
<COL WIDTH="159"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="265" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>사업년도</P>
<P>구분</P>
</TH>
<TH WIDTH="169" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">2020년&cr;(제7기)</TH>
<TH WIDTH="169" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">2019년&cr;(제6기)</TH>
<TH WIDTH="168" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">2018년&cr;(제5기)</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="265" HEIGHT="30" VALIGN="MIDDLE">I. 매출액</TD>
<TD WIDTH="169" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="169" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="168" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="265" HEIGHT="30" VALIGN="MIDDLE">II. 매출원가</TD>
<TD WIDTH="169" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="169" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="168" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="265" HEIGHT="30" VALIGN="MIDDLE">III. 매출총이익</TD>
<TD WIDTH="169" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="169" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="168" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="265" HEIGHT="30" VALIGN="MIDDLE">IV. 판매비와관리비</TD>
<TD WIDTH="169" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,607</TD>
<TD WIDTH="169" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">3,886</TD>
<TD WIDTH="168" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">2,043</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="265" HEIGHT="30" VALIGN="MIDDLE">V. 영업손실</TD>
<TD WIDTH="169" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,607</TD>
<TD WIDTH="169" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">3,886</TD>
<TD WIDTH="168" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">2,043</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="265" HEIGHT="30" VALIGN="MIDDLE">VI. 영업외수익</TD>
<TD WIDTH="169" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">454</TD>
<TD WIDTH="169" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">196</TD>
<TD WIDTH="168" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">135</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="265" HEIGHT="30" VALIGN="MIDDLE">VII. 영업외비용</TD>
<TD WIDTH="169" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">378</TD>
<TD WIDTH="169" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">700</TD>
<TD WIDTH="168" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,300</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="265" HEIGHT="30" VALIGN="MIDDLE">VIII. 법인세비용차감전순이익(손실)</TD>
<TD WIDTH="169" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(1,531)</TD>
<TD WIDTH="169" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(4,390)</TD>
<TD WIDTH="168" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(3,207)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="265" HEIGHT="30" VALIGN="MIDDLE">IX. 법인세비용</TD>
<TD WIDTH="169" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="169" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="168" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="265" HEIGHT="30" VALIGN="MIDDLE">X. 당기순이익(손실)</TD>
<TD WIDTH="169" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(1,531)</TD>
<TD WIDTH="169" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(4,390)</TD>
<TD WIDTH="168" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(3,207)</TD>
</TR>
</TBODY>
</TABLE>

<P>&cr; 당사는 보고서 제출일 현재 가시적인 재무성과를 나타내고 있지 않습니다. 당사는 현재 보유하고 있는 파이프라인 및 신규 개발 예정인 파이프라인을 통해서 수익성을 제고해 나갈 계획이지만, 당사가 영위하고 있는 생명공학 기반의 동물 바이오 사업은 영업활동의 변동성과 불확실성이 일반기업보다 클 수 있으며, 시장 상황에 따라 흑자 전환시점이 늦춰질 수 있어, 이는 당사 재무지표에 부정적인 요인으로 작용할 수 있습니다.&cr;&cr;
<SPAN USERMARK=" B">다. 유동성</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="779">

<COLGROUP>
<COL WIDTH="770"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="779" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE"><요약현금흐름표></TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" WIDTH="780" BORDER="0" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="771"></COL>
</COLGROUP>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="780" HEIGHT="30">(단위 : 백만원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="781">

<COLGROUP>
<COL WIDTH="256"></COL>
<COL WIDTH="163"></COL>
<COL WIDTH="163"></COL>
<COL WIDTH="163"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="265" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="53">
<P>구 분</P>
</TH>
<TH WIDTH="172" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="53">2020년&cr;(제7기)</TH>
<TH WIDTH="172" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="53">2019년&cr;(제6기)</TH>
<TH WIDTH="172" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="53">2018년&cr;(제5기)</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="265" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>영업활동 현금흐름</P>
</TD>
<TD WIDTH="172" ALIGN="RIGHT" HEIGHT="30">(2,093)</TD>
<TD WIDTH="172" ALIGN="RIGHT" HEIGHT="30">(1,479)</TD>
<TD WIDTH="172" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(1,535)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="265" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>투자활동 현금흐름</P>
</TD>
<TD WIDTH="172" ALIGN="RIGHT" HEIGHT="30">(46)</TD>
<TD WIDTH="172" ALIGN="RIGHT" HEIGHT="30">12</TD>
<TD WIDTH="172" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(141)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="265" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>재무활동 현금흐름</P>
</TD>
<TD WIDTH="172" ALIGN="RIGHT" HEIGHT="30">2,132</TD>
<TD WIDTH="172" ALIGN="RIGHT" HEIGHT="30">2,549</TD>
<TD WIDTH="172" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,844</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="265" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>현금의 증감</P>
</TD>
<TD WIDTH="172" ALIGN="RIGHT" HEIGHT="30">(7)</TD>
<TD WIDTH="172" ALIGN="RIGHT" HEIGHT="30">186</TD>
<TD WIDTH="172" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">168</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="265" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>기말의 현금</P>
</TD>
<TD WIDTH="172" ALIGN="RIGHT" HEIGHT="30">1,261</TD>
<TD WIDTH="172" ALIGN="RIGHT" HEIGHT="30">1,268</TD>
<TD WIDTH="172" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">186</TD>
</TR>
</TBODY>
</TABLE>

<P>&cr;자금지출과 관련하여서 추후 일정 규모를 초과하는 자금지출에 대한 결정이 있을 경우 공시 등을 통해 공표될 예정입니다.&cr;&cr;
<SPAN USERMARK="F-16 0XFF0000 B">4. 부외거래&cr;</SPAN>&cr;해당사항 없습니다.&cr;
</P>

<P>
<SPAN USERMARK="F-16 0XFF0000 B">5. 종업원의 현황</SPAN>
</P>

<TABLE ACLASS="NORMAL" WIDTH="600" BORDER="0" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="591"></COL>
</COLGROUP>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="600" HEIGHT="30">(단위 : 백만원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="605">

<COLGROUP>
<COL WIDTH="43"></COL>
<COL WIDTH="58"></COL>
<COL WIDTH="62"></COL>
<COL WIDTH="62"></COL>
<COL WIDTH="58"></COL>
<COL WIDTH="62"></COL>
<COL WIDTH="62"></COL>
<COL WIDTH="58"></COL>
<COL WIDTH="59"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">

<TH ROWSPAN="2" WIDTH="52" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="60">
<P>성별</P>
</TH>

<TH COLSPAN="4" WIDTH="276" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">
<P>직원수</P>
</TH>

<TH ROWSPAN="2" WIDTH="71" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="60">
<P>평균근속연수</P>
</TH>

<TH ROWSPAN="2" WIDTH="71" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="60">
<P>연간급여총액</P>
</TH>

<TH ROWSPAN="2" WIDTH="67" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="60">
<P>1인평균급여액</P>
</TH>

<TH ROWSPAN="2" WIDTH="68" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="60">
<P>비고</P>
</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="67" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">
<P>정규직</P>
</TH>

<TH WIDTH="71" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">
<P>계약직</P>
</TH>

<TH WIDTH="71" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">
<P>기타</P>
</TH>

<TH WIDTH="67" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">
<P>합계</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="52" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">
<P>남</P>
</TD>
<TD WIDTH="67" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3</TD>
<TD WIDTH="71" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="71" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="67" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3</TD>

<TD WIDTH="71" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">
<P>4년</P>
</TD>
<TD WIDTH="71" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">219</TD>
<TD WIDTH="67" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">73</TD>

<TD WIDTH="68" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">
<P>-</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="52" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">
<P>여</P>
</TD>
<TD WIDTH="67" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">4</TD>
<TD WIDTH="71" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="71" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="67" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">4</TD>

<TD WIDTH="71" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">
<P>3.25년</P>
</TD>
<TD WIDTH="71" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">201</TD>
<TD WIDTH="67" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">50</TD>

<TD WIDTH="68" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">
<P>-</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="52" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">
<P>합계</P>
</TD>
<TD WIDTH="67" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">7</TD>
<TD WIDTH="71" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="71" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="67" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">7</TD>

<TD WIDTH="71" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">
<P>3.57년</P>
</TD>
<TD WIDTH="71" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">420</TD>
<TD WIDTH="67" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">60</TD>

<TD WIDTH="68" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">
<P>-</P>
</TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<PGBRK></PGBRK>
</SECTION-1>

<SECTION-1 ACLASS="MANDATORY" APARTSOURCE="SOURCE">
<TITLE ATOC="Y" AASSOCNOTE="D-0-5-0-0">V. 감사인의 감사의견 등</TITLE>
<P></P>
<WARNING>※ 회계감사인의 감사(검토)의견, 회계감사인과의 감사/비감사 용역 체결현황이 있을 경우&cr;    아래 『회계감사인의 감사의견』단위서식을 클릭하여 삽입하신 후 입력하세요.</WARNING>

<INSERTION ABASISNUMBER="SE1" AFREQUENCY="1" ADUPLICATION="N">
<COMMENT>◆click◆『회계감사인의 감사의견』 삽입</COMMENT>
<LIBRARYLIST>11011#*회계감사인의감사의견.dsl</LIBRARYLIST>

<LIBRARY>
<FILENAME ATYPE="dsl">25_회계감사인의감사의견</FILENAME>
<P>1. 회계감사인의 명칭 및 감사의견(검토의견 포함한다. 이하 이 조에서 같다)을 다음의 표에 따라 기재한다.</P>

<TABLE-GROUP ACLASS="AUD_OPN" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="591" BORDER="1">

<COLGROUP>
<COL WIDTH="104"></COL>
<COL WIDTH="99"></COL>
<COL WIDTH="69"></COL>
<COL WIDTH="175"></COL>
<COL WIDTH="99"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="113" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">사업연도</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="108" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">감사인</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="78" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">감사의견</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="184" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">강조사항 등</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="108" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">핵심감사사항</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TE ALIGN="CENTER" WIDTH="113" HEIGHT="30" ACODE="OPN_YEAR1" VALIGN="MIDDLE">제7기(당기)</TE>
<TE ALIGN="CENTER" WIDTH="108" HEIGHT="30" ACODE="OPN_AUR1" VALIGN="MIDDLE">신한회계법인</TE>
<TE ALIGN="CENTER" WIDTH="78" HEIGHT="30" ACODE="OPN_CMT1" VALIGN="MIDDLE">적정</TE>
<TE ALIGN="CENTER" WIDTH="184" HEIGHT="30" ACODE="OPN_EMP1" VALIGN="MIDDLE">재무제표에 대한 주석 24</TE>
<TE ALIGN="CENTER" WIDTH="108" HEIGHT="30" ACODE="OPN_POT1" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TE ALIGN="CENTER" WIDTH="113" HEIGHT="30" ACODE="OPN_YEAR2" VALIGN="MIDDLE">제6기(전기)</TE>
<TE ALIGN="CENTER" WIDTH="108" HEIGHT="30" ACODE="OPN_AUR2" VALIGN="MIDDLE">우리회계법인</TE>
<TE ALIGN="CENTER" WIDTH="78" HEIGHT="30" ACODE="OPN_CMT2" VALIGN="MIDDLE">적정</TE>
<TE ALIGN="CENTER" WIDTH="184" HEIGHT="30" ACODE="OPN_EMP2" VALIGN="MIDDLE">재무제표에 대한 주석 23</TE>
<TE ALIGN="CENTER" WIDTH="108" HEIGHT="30" ACODE="OPN_POT2" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TE ALIGN="CENTER" WIDTH="113" HEIGHT="30" ACODE="OPN_YEAR3" VALIGN="MIDDLE">제5기(전전기)</TE>
<TE ALIGN="CENTER" WIDTH="108" HEIGHT="30" ACODE="OPN_AUR3" VALIGN="MIDDLE">신화회계법인</TE>
<TE ALIGN="CENTER" WIDTH="78" HEIGHT="30" ACODE="OPN_CMT3" VALIGN="MIDDLE">적정</TE>
<TE ALIGN="CENTER" WIDTH="184" HEIGHT="30" ACODE="OPN_EMP3" VALIGN="MIDDLE">재무제표에 대한 주석 24</TE>
<TE ALIGN="CENTER" WIDTH="108" HEIGHT="30" ACODE="OPN_POT3" VALIGN="MIDDLE">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P></P>

<P>
<SPAN>2. </SPAN>
<SPAN>감사용역 체결현황은 다음의 표에 따라 기재한다.</SPAN>
<SPAN></SPAN>
</P>

<TABLE-GROUP ACLASS="AUD_SIGK" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="553" BORDER="1">

<COLGROUP>
<COL WIDTH="104"></COL>
<COL WIDTH="99"></COL>
<COL WIDTH="69"></COL>
<COL WIDTH="70"></COL>
<COL WIDTH="39"></COL>
<COL WIDTH="70"></COL>
<COL WIDTH="39"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="113" HEIGHT="60" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="2">사업연도</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="108" HEIGHT="60" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="2">감사인</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="78" HEIGHT="60" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="2">내 용</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="127" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" COLSPAN="2">감사계약내역</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="127" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" COLSPAN="2">실제수행내역</TH>
</TR>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="79" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">보수</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="48" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">시간</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="79" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">보수</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="48" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">시간</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TE ALIGN="CENTER" WIDTH="113" HEIGHT="30" ACODE="SIGK_YEAR1" VALIGN="MIDDLE">제7기(당기)</TE>
<TE ALIGN="CENTER" WIDTH="108" HEIGHT="30" ACODE="SIGK_AUR1" VALIGN="MIDDLE">신한회계법인</TE>
<TE ALIGN="CENTER" WIDTH="78" HEIGHT="30" ACODE="SIGK_CNT1" VALIGN="MIDDLE">지정</TE>
<TE ALIGN="RIGHT" WIDTH="79" HEIGHT="30" ACODE="SIGK_CPAY1" VALIGN="MIDDLE">28백만원</TE>
<TE ALIGN="RIGHT" WIDTH="48" HEIGHT="30" ACODE="SIGK_CTIM1" VALIGN="MIDDLE">315</TE>
<TE ALIGN="RIGHT" WIDTH="79" HEIGHT="30" ACODE="SIGK_FPAY1" VALIGN="MIDDLE">28백만원</TE>
<TE ALIGN="RIGHT" WIDTH="48" HEIGHT="30" ACODE="SIGK_FTIM1" VALIGN="MIDDLE">315</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TE ALIGN="CENTER" WIDTH="113" HEIGHT="30" ACODE="SIGK_YEAR2" VALIGN="MIDDLE">제6기(전기)</TE>
<TE ALIGN="CENTER" WIDTH="108" HEIGHT="30" ACODE="SIGK_AUR2" VALIGN="MIDDLE">우리회계법인</TE>
<TE ALIGN="CENTER" WIDTH="78" HEIGHT="30" ACODE="SIGK_CNT2" VALIGN="MIDDLE">자유선임</TE>
<TE ALIGN="RIGHT" WIDTH="79" HEIGHT="30" ACODE="SIGK_CPAY2" VALIGN="MIDDLE">20백만원</TE>
<TE ALIGN="RIGHT" WIDTH="48" HEIGHT="30" ACODE="SIGK_CTIM2" VALIGN="MIDDLE">296</TE>
<TE ALIGN="RIGHT" WIDTH="79" HEIGHT="30" ACODE="SIGK_FPAY2" VALIGN="MIDDLE">20백만원</TE>
<TE ALIGN="RIGHT" WIDTH="48" HEIGHT="30" ACODE="SIGK_FTIM2" VALIGN="MIDDLE">296</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TE ALIGN="CENTER" WIDTH="113" HEIGHT="30" ACODE="SIGK_YEAR3" VALIGN="MIDDLE">제5기(전전기)</TE>
<TE ALIGN="CENTER" WIDTH="108" HEIGHT="30" ACODE="SIGK_AUR3" VALIGN="MIDDLE">신화회계법인</TE>
<TE ALIGN="CENTER" WIDTH="78" HEIGHT="30" ACODE="SIGK_CNT3" VALIGN="MIDDLE">지정</TE>
<TE ALIGN="RIGHT" WIDTH="79" HEIGHT="30" ACODE="SIGK_CPAY3" VALIGN="MIDDLE">23백만원</TE>
<TE ALIGN="RIGHT" WIDTH="48" HEIGHT="30" ACODE="SIGK_CTIM3" VALIGN="MIDDLE">206</TE>
<TE ALIGN="RIGHT" WIDTH="79" HEIGHT="30" ACODE="SIGK_FPAY3" VALIGN="MIDDLE">23백만원</TE>
<TE ALIGN="RIGHT" WIDTH="48" HEIGHT="30" ACODE="SIGK_FTIM3" VALIGN="MIDDLE">206</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P></P>

<P>
<SPAN>3.</SPAN>
<SPAN> 회계감사인과의 비감사용역 계약체결 현황은 다음의 표에 따라 기재한다.</SPAN>
<SPAN></SPAN>
</P>

<TABLE-GROUP ACLASS="AUD_SIGL" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="600" BORDER="1">

<COLGROUP>
<COL WIDTH="138"></COL>
<COL WIDTH="92"></COL>
<COL WIDTH="69"></COL>
<COL WIDTH="106"></COL>
<COL WIDTH="71"></COL>
<COL WIDTH="70"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="147" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">사업연도</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="101" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">계약체결일</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="78" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">용역내용</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="115" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">용역수행기간</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="80" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">용역보수</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="79" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">비고</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TE ALIGN="CENTER" WIDTH="147" HEIGHT="60" ACODE="SIGL_YEAR1" VALIGN="MIDDLE" ROWSPAN="2">제7기(당기)</TE>
<TE ALIGN="CENTER" WIDTH="101" HEIGHT="30" ACODE="SIGL_CRT1" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="78" HEIGHT="30" ACODE="SIGL_CNT1" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="115" HEIGHT="30" ACODE="SIGL_TIM1" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="80" HEIGHT="30" ACODE="SIGL_PAY1" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="79" HEIGHT="30" ACODE="SIGL_NOTE1" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="101" HEIGHT="30" ACODE="SIGL_CRT1" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="78" HEIGHT="30" ACODE="SIGL_CNT1" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="115" HEIGHT="30" ACODE="SIGL_TIM1" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="80" HEIGHT="30" ACODE="SIGL_PAY1" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="79" HEIGHT="30" ACODE="SIGL_NOTE1" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TE ALIGN="CENTER" WIDTH="147" HEIGHT="60" ACODE="SIGL_YEAR2" VALIGN="MIDDLE" ROWSPAN="2">제6기(전기)</TE>
<TE ALIGN="CENTER" WIDTH="101" HEIGHT="30" ACODE="SIGL_CRT2" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="78" HEIGHT="30" ACODE="SIGL_CNT2" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="115" HEIGHT="30" ACODE="SIGL_TIM2" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="80" HEIGHT="30" ACODE="SIGL_PAY2" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="79" HEIGHT="30" ACODE="SIGL_NOTE2" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="101" HEIGHT="30" ACODE="SIGL_CRT2" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="78" HEIGHT="30" ACODE="SIGL_CNT2" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="115" HEIGHT="30" ACODE="SIGL_TIM2" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="80" HEIGHT="30" ACODE="SIGL_PAY2" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="79" HEIGHT="30" ACODE="SIGL_NOTE2" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TE ALIGN="CENTER" WIDTH="147" HEIGHT="60" ACODE="SIGL_YEAR3" VALIGN="MIDDLE" ROWSPAN="2">제5기(전전기)</TE>
<TE ALIGN="CENTER" WIDTH="101" HEIGHT="30" ACODE="SIGL_CRT3" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="78" HEIGHT="30" ACODE="SIGL_CNT3" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="115" HEIGHT="30" ACODE="SIGL_TIM3" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="80" HEIGHT="30" ACODE="SIGL_PAY3" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="79" HEIGHT="30" ACODE="SIGL_NOTE3" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="101" HEIGHT="30" ACODE="SIGL_CRT3" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="78" HEIGHT="30" ACODE="SIGL_CNT3" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="115" HEIGHT="30" ACODE="SIGL_TIM3" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="80" HEIGHT="30" ACODE="SIGL_PAY3" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="79" HEIGHT="30" ACODE="SIGL_NOTE3" VALIGN="MIDDLE">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
</LIBRARY>
</INSERTION>
<P></P>

<INSERTION ABASISNUMBER="SE1" AFREQUENCY="0" ADUPLICATION="N">
<COMMENT>◆click◆『내부감사기구가 회계감사인과 논의한 결과』 삽입</COMMENT>
<LIBRARYLIST>11011#*회계감사인과논의한결과.dsl</LIBRARYLIST>
</INSERTION>
<P></P>

<INSERTION ABASISNUMBER="SE1" AFREQUENCY="0" ADUPLICATION="N">
<COMMENT>◆click◆『조정협의회내용 및 재무제표 불일치정보』 삽입</COMMENT>
<LIBRARYLIST>11011#*조정협의회내용및재무제표불일치정보.dsl</LIBRARYLIST>
</INSERTION>
<P></P>
<P></P>
<PGBRK></PGBRK>
</SECTION-1>

<SECTION-1 ACLASS="MANDATORY" APARTSOURCE="SOURCE">
<TITLE ATOC="Y">VI. 이사회 등 회사의 기관에 관한 사항</TITLE>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-0-6-1-0">1. 이사회에 관한 사항</TITLE>
<P></P>
<P></P>
<P>사외이사 및 그 변동현황</P>

<TABLE-GROUP ACLASS="OUT_DIR" ADELETETABLE="N">

<TABLE ACLASS="NORMAL" AFIXTABLE="Y" WIDTH="600" BORDER="0">

<COLGROUP>
<COL WIDTH="291"></COL>
<COL WIDTH="291"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="300" HEIGHT="30" AUPDATECONT="N" VALIGN="MIDDLE"></TD>
<TD WIDTH="300" HEIGHT="30" AUPDATECONT="N" VALIGN="MIDDLE" ALIGN="RIGHT">(단위 : 명)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="599" BORDER="1">

<COLGROUP>
<COL WIDTH="121"></COL>
<COL WIDTH="120"></COL>
<COL WIDTH="100"></COL>
<COL WIDTH="100"></COL>
<COL WIDTH="113"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="130" HEIGHT="60" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="2">이사의 수</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="129" HEIGHT="60" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="2">사외이사 수</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="340" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" COLSPAN="3">사외이사 변동현황</TH>
</TR>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="109" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">선임</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="109" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">해임</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="122" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">중도퇴임</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TE ALIGN="RIGHT" WIDTH="130" HEIGHT="30" ACODE="DIR_NUM" VALIGN="MIDDLE">4</TE>
<TE ALIGN="RIGHT" WIDTH="129" HEIGHT="30" ACODE="ODIR_NUM" VALIGN="MIDDLE">2</TE>
<TE ALIGN="RIGHT" WIDTH="109" HEIGHT="30" ACODE="ODIR_PRE" VALIGN="MIDDLE">1</TE>
<TE ALIGN="RIGHT" WIDTH="109" HEIGHT="30" ACODE="ODIR_DIS" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="122" HEIGHT="30" ACODE="ODIR_RET" VALIGN="MIDDLE">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P></P>
<P></P>

<INSERTION ABASISNUMBER="SE1" AFREQUENCY="1" ADUPLICATION="Y">
<COMMENT>◆click◆『사외이사 교육실시 현황』 삽입</COMMENT>
<LIBRARYLIST>11011#*_사외이사_교육_*.dsl</LIBRARYLIST>

<LIBRARY>
<FILENAME ATYPE="dsl">40_02_사외이사_교육_미실시내역</FILENAME>
<P>사외이사 교육 미실시 내역</P>

<TABLE-GROUP ACLASS="ODRT_EDU_NOT" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="600" BORDER="1">

<COLGROUP>
<COL WIDTH="191"></COL>
<COL WIDTH="391"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="N" ADELETE="N">
<TH WIDTH="200" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">사외이사 교육 실시여부</TH>
<TH WIDTH="400" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">사외이사 교육 미실시 사유</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="200" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">미실시</TD>
<TE WIDTH="400" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="ODRT_EDU_NOT_DTL">내부지침 수립 예정</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P></P>
</LIBRARY>
</INSERTION>
<P></P>
</SECTION-2>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-0-6-2-0">2. 감사제도에 관한 사항</TITLE>

<INSERTION ABASISNUMBER="SE1" AFREQUENCY="0" ADUPLICATION="Y">
<COMMENT>◆click◆『감사위원회 위원의 인적사항 및 사외이사 여부』 삽입</COMMENT>
<LIBRARYLIST>11011#*감사위원현황.dsl</LIBRARYLIST>
</INSERTION>

<INSERTION ABASISNUMBER="E1" AFREQUENCY="1" ADUPLICATION="Y">
<COMMENT>◆click◆『감사위원회(감사) 교육실시 현황』 삽입</COMMENT>
<LIBRARYLIST>11011#*_감사*_교육_*.dsl</LIBRARYLIST>

<LIBRARY>
<FILENAME ATYPE="dsl">41_04_감사_교육_미실시내역</FILENAME>
<P>감사 교육 미실시 내역</P>

<TABLE-GROUP ACLASS="ADT_EDU_NOT" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="600" BORDER="1">

<COLGROUP>
<COL WIDTH="191"></COL>
<COL WIDTH="391"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="N" ADELETE="N">
<TH WIDTH="200" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">감사 교육 실시여부</TH>
<TH WIDTH="400" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">감사 교육 미실시 사유</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="200" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">미실시</TD>
<TE WIDTH="400" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="ADT_EDU_NOT_DTL">내부지침 수립 예정</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P></P>
</LIBRARY>
</INSERTION>
<P></P>

<INSERTION ABASISNUMBER="E1" AFREQUENCY="1" ADUPLICATION="Y">
<COMMENT>◆click◆『감사위원회(감사) 지원조직 현황』 삽입</COMMENT>
<LIBRARYLIST>11011#*_감사*_지원조직_*.dsl</LIBRARYLIST>

<LIBRARY>
<FILENAME ATYPE="dsl">42_02_감사_지원조직_현황</FILENAME>
<P>감사 지원조직 현황</P>

<TABLE-GROUP ACLASS="ADT_OGN" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="599" BORDER="1">

<COLGROUP>
<COL WIDTH="141"></COL>
<COL WIDTH="141"></COL>
<COL WIDTH="141"></COL>
<COL WIDTH="140"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="N" ADELETE="N">
<TH WIDTH="150" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">부서(팀)명</TH>
<TH WIDTH="150" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">직원수(명)</TH>
<TH WIDTH="150" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">직위(근속연수)</TH>
<TH WIDTH="149" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">주요 활동내역</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="N">
<TE WIDTH="150" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="ADT_OGN_NM">연구소</TE>
<TE WIDTH="150" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="ADT_OGN_CNT">1</TE>
<TE WIDTH="150" VALIGN="MIDDLE" HEIGHT="30" ACODE="ADT_OGN_PST" ALIGN="CENTER">상무이사(4년)</TE>
<TE WIDTH="149" VALIGN="MIDDLE" HEIGHT="30" ACODE="ADT_OGN_DTL" ALIGN="CENTER">총괄지원</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P></P>
</LIBRARY>
</INSERTION>
<P></P>

<INSERTION ABASISNUMBER="E1" AFREQUENCY="1" ADUPLICATION="Y">
<COMMENT>◆click◆『준법지원인 등 지원조직 현황』 삽입</COMMENT>
<LIBRARYLIST>11011#*_준법지원인등_지원조직_*.dsl</LIBRARYLIST>

<LIBRARY>
<FILENAME ATYPE="dsl">43_01_준법지원인등_지원조직_현황</FILENAME>
<P>준법지원인 등 지원조직 현황</P>

<TABLE-GROUP ACLASS="CPO_OGN" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="599" BORDER="1">

<COLGROUP>
<COL WIDTH="141"></COL>
<COL WIDTH="141"></COL>
<COL WIDTH="141"></COL>
<COL WIDTH="140"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="N" ADELETE="N">
<TH WIDTH="150" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">부서(팀)명</TH>
<TH WIDTH="150" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">직원수(명)</TH>
<TH WIDTH="150" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">직위(근속연수)</TH>
<TH WIDTH="149" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">주요 활동내역</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="N">
<TE WIDTH="150" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="CPO_OGN_NM">-</TE>
<TE WIDTH="150" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="CPO_OGN_CNT">1</TE>
<TE WIDTH="150" VALIGN="MIDDLE" HEIGHT="30" ACODE="CPO_OGN_PST" ALIGN="CENTER">사외이사(4년)</TE>
<TE WIDTH="149" VALIGN="MIDDLE" HEIGHT="30" ACODE="CPO_OGN_DTL" ALIGN="CENTER">법률자문</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P></P>
</LIBRARY>
</INSERTION>
<P></P>
</SECTION-2>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-0-6-3-0">3. 주주의 의결권 행사에 관한 사항</TITLE>
<P></P>

<P>
<SPAN USERMARK=" B">가. 주주의 의결권행사에 관한 사항</SPAN>
</P>
<P>  </P>
<P>(1) 집중투표제의 배제여부  &cr;</P>
<P>당사는 보고서 제출일 현재 정관 제39조에 의거하여 집중투표제를 적용하지 않습니다.</P>

<TABLE WIDTH="594" BORDER="1" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="90"></COL>
<COL WIDTH="486"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="99" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">
<P>구 분</P>
</TH>

<TH WIDTH="495" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">
<P>내 용</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="99" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">
<P>해당조항</P>
</TD>

<TD WIDTH="495" VALIGN="MIDDLE" HEIGHT="76">
<P>정관 제 39 조 (이사의 선임)</P>
<P>③ 2인 이상의 이사를 선임하는 경우 상법에서 규정하는 집중투표제는 적용하지 아니한다.</P>
</TD>
</TR>
</TBODY>
</TABLE>
<P>  </P>
<P>(2) 서면투표제 또는 전자투표제의 채택여부&cr;</P>
<P>당사 정관 제35조에 서면투표제를 통한 의결권 행사를 인정하고 있습니다.</P>

<TABLE WIDTH="594" BORDER="1" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="90"></COL>
<COL WIDTH="486"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="99" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">
<P>구 분</P>
</TH>

<TH WIDTH="495" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">
<P>내 용</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="99" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="191">
<P>해당조항</P>
</TD>

<TD WIDTH="495" VALIGN="MIDDLE" HEIGHT="191">
<P>정관 제 35 조 (서면에 의한 의결권의 행사)</P>
<P>① 주주는 총회에 출석하지 아니하고 서면에 의하여 의결권을 행사할 수 있다. 다만 총회 소집을 결정하기 위한 이사회 결의 시 서면결의를 하지 않기로 한 경우에는 그러하지 아니한다.</P>
<P>② 회사는 제1항에 따른 서면결의의 경우 총회의 소집통지서에 주주의 의결권 행사에 필요한 서면과 참고자료를 첨부하여야 한다.</P>
<P>③ 서면에 의하여 의결권을 행사하고자 하는 주주는 제2항의 서면에 필요한 사 항을 기재하여 총회일의 전일까지 회사에 제출하여야 한다.</P>
</TD>
</TR>
</TBODY>
</TABLE>
<P>  &cr;(3) 소수주주권의 행사여부  &cr;&cr;해당사항 없습니다.</P>
<P></P>
<PGBRK></PGBRK>
</SECTION-2>
</SECTION-1>

<SECTION-1 ACLASS="MANDATORY" APARTSOURCE="SOURCE">
<TITLE ATOC="Y" AASSOCNOTE="D-0-7-0-0">VII. 주주에 관한 사항</TITLE>
<P></P>
<P USERMARK="F-16">1. 최대주주 및 특수관계인의 주식소유 현황</P>
<P></P>

<TABLE-GROUP ACLASS="BSH_SPCL" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="605" BORDER="0">

<COLGROUP>
<COL WIDTH="71"></COL>
<COL WIDTH="143"></COL>
<COL WIDTH="70"></COL>
<COL WIDTH="285"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="80" HEIGHT="30" AUPDATECONT="N">(기준일 : </TD>
<TU ALIGN="CENTER" VALIGN="BOTTOM" WIDTH="152" HEIGHT="30" AUNIT="SH5_CUR_DT" AUNITVALUE="20201231">2020년 12월 31일</TU>
<TD VALIGN="BOTTOM" WIDTH="79" HEIGHT="30" AUPDATECONT="N">)</TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="294" HEIGHT="30" AUNIT="STOCKPERCENT" AUNITVALUE="1">(단위 : 주, %)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="741" BORDER="1" FRAME="BORDER" RULES="ALL">

<COLGROUP>
<COL WIDTH="235"></COL>
<COL WIDTH="69"></COL>
<COL WIDTH="54"></COL>
<COL WIDTH="91"></COL>
<COL WIDTH="54"></COL>
<COL WIDTH="73"></COL>
<COL WIDTH="54"></COL>
<COL WIDTH="39"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="N" ADELETE="N">
<TH ROWSPAN="3" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="244" HEIGHT="90" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">성 명</TH>
<TH ROWSPAN="3" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="78" HEIGHT="90" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">관 계</TH>
<TH ROWSPAN="3" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="90" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">주식의&cr;종류</TH>
<TH COLSPAN="4" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="308" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">소유주식수 및 지분율</TH>
<TH ROWSPAN="3" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="48" HEIGHT="90" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">비고</TH>
</TR>

<TR ACOPY="N" ADELETE="N">
<TH COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="163" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">기 초</TH>
<TH COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="145" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">기 말</TH>
</TR>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="100" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">주식수</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">지분율</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="82" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">주식수</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">지분율</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="N">
<TE ALIGN="CENTER" WIDTH="244" HEIGHT="30" ACODE="SH5_NM_T" VALIGN="MIDDLE">김앤토니경태</TE>
<TE ALIGN="CENTER" WIDTH="78" HEIGHT="30" ACODE="SH5_RET" VALIGN="MIDDLE">본인</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="STK_KND">보통주</TE>
<TE ALIGN="RIGHT" WIDTH="100" HEIGHT="30" ACODE="SH5_BGN_CNT" VALIGN="MIDDLE">  693,946</TE>
<TE ALIGN="RIGHT" WIDTH="63" HEIGHT="30" ACODE="SH5_BGN_RT" VALIGN="MIDDLE">26.34</TE>
<TE ALIGN="RIGHT" WIDTH="82" HEIGHT="30" ACODE="SH5_END_CNT" VALIGN="MIDDLE">  693,946</TE>
<TE ALIGN="RIGHT" WIDTH="63" HEIGHT="30" ACODE="SH5_END_RT" VALIGN="MIDDLE">22.14</TE>
<TE ALIGN="CENTER" WIDTH="48" HEIGHT="30" ACODE="NOTE5" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="244" HEIGHT="30" ACODE="SH5_NM_T" VALIGN="MIDDLE">신병희</TE>
<TE ALIGN="CENTER" WIDTH="78" HEIGHT="30" ACODE="SH5_RET" VALIGN="MIDDLE">친인척</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="STK_KND">보통주</TE>
<TE ALIGN="RIGHT" WIDTH="100" HEIGHT="30" ACODE="SH5_BGN_CNT" VALIGN="MIDDLE">     2,987</TE>
<TE ALIGN="RIGHT" WIDTH="63" HEIGHT="30" ACODE="SH5_BGN_RT" VALIGN="MIDDLE">0.11</TE>
<TE ALIGN="RIGHT" WIDTH="82" HEIGHT="30" ACODE="SH5_END_CNT" VALIGN="MIDDLE">     2,987</TE>
<TE ALIGN="RIGHT" WIDTH="63" HEIGHT="30" ACODE="SH5_END_RT" VALIGN="MIDDLE">0.10</TE>
<TE ALIGN="CENTER" WIDTH="48" HEIGHT="30" ACODE="NOTE5" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="244" HEIGHT="30" ACODE="SH5_NM_T" VALIGN="MIDDLE">신소연</TE>
<TE ALIGN="CENTER" WIDTH="78" HEIGHT="30" ACODE="SH5_RET" VALIGN="MIDDLE">친인척</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="STK_KND">보통주</TE>
<TE ALIGN="RIGHT" WIDTH="100" HEIGHT="30" ACODE="SH5_BGN_CNT" VALIGN="MIDDLE">        149</TE>
<TE ALIGN="RIGHT" WIDTH="63" HEIGHT="30" ACODE="SH5_BGN_RT" VALIGN="MIDDLE">0.01</TE>
<TE ALIGN="RIGHT" WIDTH="82" HEIGHT="30" ACODE="SH5_END_CNT" VALIGN="MIDDLE">        149</TE>
<TE ALIGN="RIGHT" WIDTH="63" HEIGHT="30" ACODE="SH5_END_RT" VALIGN="MIDDLE">0.005</TE>
<TE ALIGN="CENTER" WIDTH="48" HEIGHT="30" ACODE="NOTE5" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="244" HEIGHT="30" ACODE="SH5_NM_T" VALIGN="MIDDLE">신용욱</TE>
<TE ALIGN="CENTER" WIDTH="78" HEIGHT="30" ACODE="SH5_RET" VALIGN="MIDDLE">친인척</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="STK_KND">보통주</TE>
<TE ALIGN="RIGHT" WIDTH="100" HEIGHT="30" ACODE="SH5_BGN_CNT" VALIGN="MIDDLE">        149</TE>
<TE ALIGN="RIGHT" WIDTH="63" HEIGHT="30" ACODE="SH5_BGN_RT" VALIGN="MIDDLE">0.01</TE>
<TE ALIGN="RIGHT" WIDTH="82" HEIGHT="30" ACODE="SH5_END_CNT" VALIGN="MIDDLE">        149</TE>
<TE ALIGN="RIGHT" WIDTH="63" HEIGHT="30" ACODE="SH5_END_RT" VALIGN="MIDDLE">0.005</TE>
<TE ALIGN="CENTER" WIDTH="48" HEIGHT="30" ACODE="NOTE5" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="244" HEIGHT="30" ACODE="SH5_NM_T" VALIGN="MIDDLE">김균</TE>
<TE ALIGN="CENTER" WIDTH="78" HEIGHT="30" ACODE="SH5_RET" VALIGN="MIDDLE">사내이사</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="STK_KND">보통주</TE>
<TE ALIGN="RIGHT" WIDTH="100" HEIGHT="30" ACODE="SH5_BGN_CNT" VALIGN="MIDDLE">5,000</TE>
<TE ALIGN="RIGHT" WIDTH="63" HEIGHT="30" ACODE="SH5_BGN_RT" VALIGN="MIDDLE">0.19</TE>
<TE ALIGN="RIGHT" WIDTH="82" HEIGHT="30" ACODE="SH5_END_CNT" VALIGN="MIDDLE">5,000</TE>
<TE ALIGN="RIGHT" WIDTH="63" HEIGHT="30" ACODE="SH5_END_RT" VALIGN="MIDDLE">0.16</TE>
<TE ALIGN="CENTER" WIDTH="48" HEIGHT="30" ACODE="NOTE5" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="244" HEIGHT="30" ACODE="SH5_NM_T" VALIGN="MIDDLE">김주현</TE>
<TE ALIGN="CENTER" WIDTH="78" HEIGHT="30" ACODE="SH5_RET" VALIGN="MIDDLE">사외이사</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="STK_KND">보통주</TE>
<TE ALIGN="RIGHT" WIDTH="100" HEIGHT="30" ACODE="SH5_BGN_CNT" VALIGN="MIDDLE">1,730</TE>
<TE ALIGN="RIGHT" WIDTH="63" HEIGHT="30" ACODE="SH5_BGN_RT" VALIGN="MIDDLE">0.07</TE>
<TE ALIGN="RIGHT" WIDTH="82" HEIGHT="30" ACODE="SH5_END_CNT" VALIGN="MIDDLE">1,730</TE>
<TE ALIGN="RIGHT" WIDTH="63" HEIGHT="30" ACODE="SH5_END_RT" VALIGN="MIDDLE">0.06</TE>
<TE ALIGN="CENTER" WIDTH="48" HEIGHT="30" ACODE="NOTE5" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="244" HEIGHT="30" ACODE="SH5_NM_T" VALIGN="MIDDLE">VGX Pharmaceuticals</TE>
<TE ALIGN="CENTER" WIDTH="78" HEIGHT="30" ACODE="SH5_RET" VALIGN="MIDDLE">관계회사</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="STK_KND">보통주</TE>
<TE ALIGN="RIGHT" WIDTH="100" HEIGHT="30" ACODE="SH5_BGN_CNT" VALIGN="MIDDLE">395,758</TE>
<TE ALIGN="RIGHT" WIDTH="63" HEIGHT="30" ACODE="SH5_BGN_RT" VALIGN="MIDDLE">15.02</TE>
<TE ALIGN="RIGHT" WIDTH="82" HEIGHT="30" ACODE="SH5_END_CNT" VALIGN="MIDDLE">395,758</TE>
<TE ALIGN="RIGHT" WIDTH="63" HEIGHT="30" ACODE="SH5_END_RT" VALIGN="MIDDLE">12.63</TE>
<TE ALIGN="CENTER" WIDTH="48" HEIGHT="30" ACODE="NOTE5" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="244" HEIGHT="30" ACODE="SH5_NM_T" VALIGN="MIDDLE">INOVIO PHARMACEUTICALS, INC.</TE>
<TE ALIGN="CENTER" WIDTH="78" HEIGHT="30" ACODE="SH5_RET" VALIGN="MIDDLE">관계회사</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="STK_KND">보통주</TE>
<TE ALIGN="RIGHT" WIDTH="100" HEIGHT="30" ACODE="SH5_BGN_CNT" VALIGN="MIDDLE">0</TE>
<TE ALIGN="RIGHT" WIDTH="63" HEIGHT="30" ACODE="SH5_BGN_RT" VALIGN="MIDDLE">0.00</TE>
<TE ALIGN="RIGHT" WIDTH="82" HEIGHT="30" ACODE="SH5_END_CNT" VALIGN="MIDDLE">202,050</TE>
<TE ALIGN="RIGHT" WIDTH="63" HEIGHT="30" ACODE="SH5_END_RT" VALIGN="MIDDLE">6.45</TE>
<TE ALIGN="CENTER" WIDTH="48" HEIGHT="30" ACODE="NOTE5" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD ROWSPAN="2" COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="322" HEIGHT="60" AUPDATECONT="N">계</TD>
<TE ALIGN="CENTER" WIDTH="63" HEIGHT="30" ACODE="SH5_STK_KNDT" VALIGN="MIDDLE">보통주</TE>
<TE ALIGN="RIGHT" WIDTH="100" HEIGHT="30" ACODE="STK_CNT_BIML" VALIGN="MIDDLE">1,099,719</TE>
<TE ALIGN="RIGHT" WIDTH="63" HEIGHT="30" ACODE="STK_RATE_BIML" VALIGN="MIDDLE">41.74</TE>
<TE ALIGN="RIGHT" WIDTH="82" HEIGHT="30" ACODE="STK_CNT_GIML" VALIGN="MIDDLE">1,301,769</TE>
<TE ALIGN="RIGHT" WIDTH="63" HEIGHT="30" ACODE="STK_RATE_GIML" VALIGN="MIDDLE">41.54</TE>
<TE ALIGN="CENTER" WIDTH="48" HEIGHT="30" ACODE="NOTE4" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="N">
<TE ALIGN="CENTER" WIDTH="63" HEIGHT="30" ACODE="SH5_STK_KNDT" VALIGN="MIDDLE">우선주</TE>
<TE ALIGN="RIGHT" WIDTH="100" HEIGHT="30" ACODE="STK_CNT_BIML" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="63" HEIGHT="30" ACODE="STK_RATE_BIML" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="82" HEIGHT="30" ACODE="STK_CNT_GIML" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="63" HEIGHT="30" ACODE="STK_RATE_GIML" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="48" HEIGHT="30" ACODE="NOTE4" VALIGN="MIDDLE">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P>주) 상기 기초의 지분율은 2019년 12월 31일 발행주식총수(2,635,000주)에 대한 지분율이며, 기말의 지분율은 2020년 12월 31일 발행주식총수(3,134,050주)에 대한 지분율이며, 김균 사내이사는 2020년 09월 30일 사임하였습니다.&cr;</P>
<P USERMARK="F-16">최대주주의 주요경력 및 개요</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="763">

<COLGROUP>
<COL WIDTH="87"></COL>
<COL WIDTH="99"></COL>
<COL WIDTH="472"></COL>
<COL WIDTH="69"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="96" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>직책명</P>
</TH>

<TH WIDTH="108" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>성 명</P>
<P>(생년월일)</P>
</TH>

<TH WIDTH="481" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>주요경력</P>
</TH>

<TH WIDTH="78" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>담당업무</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="96" HEIGHT="191" ALIGN="CENTER" VALIGN="MIDDLE">
<P>대표이사</P>
<P>(상근/등기)</P>
</TD>

<TD WIDTH="108" HEIGHT="191" ALIGN="CENTER" VALIGN="MIDDLE">
<P>김앤토니경태</P>
<P>(1971.11.18)</P>
</TD>

<TD WIDTH="481" HEIGHT="191" VALIGN="MIDDLE">
<P>前) SK 증권 국제영업부 (1993년 ~ 1995년)</P>
<P>前) Bank of America 지점장 (1999년 ~ 2002년)</P>
<P>前) Wells Fargo Bank 지점장 (2002년 ~ 2002년)</P>
<P>前) VGX Pharmaceuticals(現, Inovio) (2005년 ~ 2008년)</P>
<P>前) VGX 인터내셔널 (現, 진원생명과학) 전무이사 (2006년 ~ 2008년)</P>
<P>前) Walton International 대표이사 (2009년 ~ 2011년)</P>
<P>前) Inovio Asia Consultant (2011년 ~ 2013년)</P>
<P>前) ㈜플럼라인생명과학 대표이사 (2014년 ~ 현재)</P>
</TD>

<TD WIDTH="78" HEIGHT="191" ALIGN="CENTER" VALIGN="MIDDLE">
<P>경영총괄</P>
</TD>
</TR>
</TBODY>
</TABLE>

<INSERTION ABASISNUMBER="LE0" AFREQUENCY="0" ADUPLICATION="Y">
<COMMENT>◆복수click가능◆『최대주주가 법인 또는 투자조합 등 단체인 경우』 삽입</COMMENT>
<LIBRARYLIST>11011#*최대주주가단체인경우.dsl</LIBRARYLIST>
</INSERTION>
<P></P>

<P USERMARK="F-16">최대주주의 최대주주(법인 또는 단체)의 개요&cr;
<SPAN USERMARK="F-12">&cr;해당사항 없습니다.&cr;</SPAN>
</P>

<INSERTION ABASISNUMBER="LE0" AFREQUENCY="0" ADUPLICATION="Y">
<COMMENT>◆복수click가능◆『최대주주의 최대주주(최대출자자)가 법인 또는 단체인 경우』 삽입</COMMENT>
<LIBRARYLIST>11011#*최대주주의최대출자자가단체인경우.dsl</LIBRARYLIST>
</INSERTION>
<P></P>

<P USERMARK="F-16">최대주주 변동현황&cr;
<SPAN USERMARK="F-12">&cr;해당사항 없습니다.</SPAN>&cr;
</P>

<INSERTION ABASISNUMBER="SE1" AFREQUENCY="0" ADUPLICATION="N">
<COMMENT>◆click◆『최대주주 변동내역』 삽입</COMMENT>
<LIBRARYLIST>11011#*최대주주변동내역.dsl</LIBRARYLIST>
</INSERTION>
<P></P>
<P USERMARK="F-GL11 P256">주식 소유현황</P>

<TABLE-GROUP ACLASS="SH5_PRE_STT" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="601" BORDER="0">

<COLGROUP>
<COL WIDTH="70"></COL>
<COL WIDTH="142"></COL>
<COL WIDTH="63"></COL>
<COL WIDTH="290"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="79" HEIGHT="30" AUPDATECONT="N">(기준일 : </TD>
<TU ALIGN="CENTER" VALIGN="BOTTOM" WIDTH="151" HEIGHT="30" AUNIT="BASE_DT" AUNITVALUE="20201231">2020년 12월 31일</TU>
<TD VALIGN="BOTTOM" WIDTH="72" HEIGHT="30" AUPDATECONT="N">)</TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="299" HEIGHT="30" AUNIT="STOCK" AUNITVALUE="1">(단위 : 주)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="602" BORDER="1">

<COLGROUP>
<COL WIDTH="111"></COL>
<COL WIDTH="174"></COL>
<COL WIDTH="114"></COL>
<COL WIDTH="72"></COL>
<COL WIDTH="86"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="N" ADELETE="N">
<TH WIDTH="120" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">구분</TH>
<TH WIDTH="183" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">주주명</TH>
<TH WIDTH="123" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">소유주식수</TH>
<TH WIDTH="81" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">지분율</TH>
<TH WIDTH="95" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">비고</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="143" ROWSPAN="4" AUPDATECONT="N">5% 이상 주주</TD>
<TE WIDTH="183" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="SH5_NM">김앤토니경태</TE>
<TE WIDTH="123" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="SH5_TOT_CNT">693,946</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="SH5_TOT_RT">22.14</TE>
<TD WIDTH="95" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">최대주주</TD>
</TR>

<TR ACOPY="Y" ADELETE="N">
<TE WIDTH="183" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="SH5_NM">VGX Pharmaceuticals</TE>
<TE WIDTH="123" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="SH5_TOT_CNT">395,758</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="SH5_TOT_RT">12.63</TE>
<TD WIDTH="95" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE WIDTH="183" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACODE="SH5_NM">INOVIO PHARMACEUTICALS, INC.</TE>
<TE WIDTH="123" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53" ACODE="SH5_TOT_CNT">202,050</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53" ACODE="SH5_TOT_RT">6.45</TE>
<TD WIDTH="95" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE WIDTH="183" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="SH5_NM">김주한</TE>
<TE WIDTH="123" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="SH5_TOT_CNT">172,000</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="SH5_TOT_RT">5.49</TE>
<TD WIDTH="95" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="303" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" COLSPAN="2" AUPDATECONT="N">우리사주조합</TD>
<TE WIDTH="123" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="SH5_WOO_CNT">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="SH5_WOO_RT">-</TE>
<TD WIDTH="95" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P></P>

<INSERTION ABASISNUMBER="SE1" AFREQUENCY="1" ADUPLICATION="N">
<COMMENT>◆click◆『소액주주현황』 삽입</COMMENT>
<LIBRARYLIST>11011#*소액주주현황.dsl</LIBRARYLIST>

<LIBRARY>
<FILENAME ATYPE="dsl">10_소액주주현황</FILENAME>

<TABLE-GROUP ACLASS="SH4_PRE_STT" ADELETETABLE="N">
<TITLE ATOC="N">소액주주현황</TITLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="601" BORDER="0">

<COLGROUP>
<COL WIDTH="70"></COL>
<COL WIDTH="142"></COL>
<COL WIDTH="58"></COL>
<COL WIDTH="295"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="79" HEIGHT="30" AUPDATECONT="N">(기준일 : </TD>
<TU ALIGN="CENTER" VALIGN="BOTTOM" WIDTH="151" HEIGHT="30" AUNIT="BASE_DT" AUNITVALUE="20201231">2020년 12월 31일</TU>
<TD VALIGN="BOTTOM" WIDTH="67" HEIGHT="30" AUPDATECONT="N">)</TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="304" HEIGHT="30" AUNIT="STOCK" AUNITVALUE="1">(단위 : 주)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="604" BORDER="1">

<COLGROUP>
<COL WIDTH="69"></COL>
<COL WIDTH="66"></COL>
<COL WIDTH="66"></COL>
<COL WIDTH="66"></COL>
<COL WIDTH="68"></COL>
<COL WIDTH="70"></COL>
<COL WIDTH="67"></COL>
<COL WIDTH="60"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="N" ADELETE="N">
<TH WIDTH="78" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="83" ROWSPAN="2">구 분</TH>
<TH WIDTH="225" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30" COLSPAN="3">주주</TH>
<TH WIDTH="232" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30" COLSPAN="3">소유주식</TH>
<TH WIDTH="69" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="83" ROWSPAN="2">비 고</TH>
</TR>

<TR ACOPY="N" ADELETE="N">
<TH WIDTH="75" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">소액&cr;주주수</TH>
<TH WIDTH="75" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">전체&cr;주주수</TH>
<TH WIDTH="75" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">비율&cr;(%)</TH>
<TH WIDTH="77" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">소액&cr;주식수</TH>
<TH WIDTH="79" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">총발행&cr;주식수</TH>
<TH WIDTH="76" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">비율&cr;(%)</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" AUPDATECONT="N">소액주주</TD>
<TE WIDTH="75" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53" ACODE="SH4_JJ_CNT">551</TE>
<TE WIDTH="75" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53" ACODE="SH4_JJ_CNTT">562</TE>
<TE WIDTH="75" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53" ACODE="SH4_JJ_RT">98.04</TE>
<TE WIDTH="77" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53" ACODE="SH4_BB_CNT">1,568,147</TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53" ACODE="SH4_BB_CNTT">3,134,050</TE>
<TE WIDTH="76" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53" ACODE="SH4_BB_RT">50.04</TE>
<TE WIDTH="69" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACODE="NOTE">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P>주) 최대주주 및 특수관계인의 보유 주식 및 5%이상 보유 주주의 주식 및 자기주식(92,134주)을 제외한 소액주주 현황입니다.</P>
</LIBRARY>
</INSERTION>
<P></P>
<P></P>
<PGBRK></PGBRK>
</SECTION-1>

<SECTION-1 ACLASS="MANDATORY" APARTSOURCE="SOURCE">
<TITLE ATOC="Y">VIII. 임원 및 직원 등에 관한 사항</TITLE>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-0-8-1-0">1. 임원 및 직원 등의 현황</TITLE>
<P></P>
<P>임원 현황</P>

<TABLE-GROUP ACLASS="SH5_DRCT_STT" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="931" BORDER="0">

<COLGROUP>
<COL WIDTH="71"></COL>
<COL WIDTH="143"></COL>
<COL WIDTH="99"></COL>
<COL WIDTH="582"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="80" HEIGHT="30" AUPDATECONT="N">(기준일 : </TD>
<TU ALIGN="CENTER" VALIGN="BOTTOM" WIDTH="152" HEIGHT="30" AUNIT="BASE_DT" AUNITVALUE="20201231">2020년 12월 31일</TU>
<TD VALIGN="BOTTOM" WIDTH="108" HEIGHT="30" AUPDATECONT="N">)</TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="591" HEIGHT="30" AUNIT="STOCK" AUNITVALUE="1">(단위 : 주)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="1115" BORDER="1" FRAME="BORDER" RULES="ALL">

<COLGROUP>
<COL WIDTH="62"></COL>
<COL WIDTH="39"></COL>
<COL WIDTH="92"></COL>
<COL WIDTH="73"></COL>
<COL WIDTH="64"></COL>
<COL WIDTH="52"></COL>
<COL WIDTH="42"></COL>
<COL WIDTH="171"></COL>
<COL WIDTH="65"></COL>
<COL WIDTH="66"></COL>
<COL WIDTH="69"></COL>
<COL WIDTH="120"></COL>
<COL WIDTH="83"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="N" ADELETE="N">
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="71" HEIGHT="83" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">성명</TH>
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="48" HEIGHT="83" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">성별</TH>
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="101" HEIGHT="83" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">출생년월</TH>
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="82" HEIGHT="83" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">직위</TH>
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="73" HEIGHT="83" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">등기임원&cr;여부</TH>
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="61" HEIGHT="83" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">상근&cr;여부</TH>
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="51" HEIGHT="83" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">담당&cr;업무</TH>
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="180" HEIGHT="83" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">주요경력</TH>
<TH COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="149" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">소유주식수</TH>
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="78" HEIGHT="83" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">최대주주와의&cr;관계</TH>
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="129" HEIGHT="83" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">재직기간</TH>
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="92" HEIGHT="83" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">임기&cr;만료일</TH>
</TR>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="74" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">의결권&cr;있는 주식</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="75" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">의결권&cr;없는 주식</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="N">
<TE ALIGN="CENTER" WIDTH="71" HEIGHT="115" ACODE="SH5_NM_T" VALIGN="MIDDLE">김앤토니경태</TE>
<TU ALIGN="CENTER" WIDTH="48" HEIGHT="115" AUNIT="SH5_SEX" AUNITVALUE="1" VALIGN="MIDDLE">남</TU>
<TU ALIGN="CENTER" WIDTH="101" HEIGHT="115" AUNIT="SH5_BIH" AUNITVALUE="197111" VALIGN="MIDDLE">1971년 11월</TU>
<TE ALIGN="CENTER" WIDTH="82" HEIGHT="115" ACODE="SH5_LEV" VALIGN="MIDDLE">대표이사</TE>
<TU ALIGN="CENTER" WIDTH="73" HEIGHT="115" AUNIT="SH5_REG_DRCT" AUNITVALUE="1" VALIGN="MIDDLE">등기임원</TU>
<TU ALIGN="CENTER" WIDTH="61" HEIGHT="115" AUNIT="SH5_FUL" AUNITVALUE="1" VALIGN="MIDDLE">상근</TU>
<TE ALIGN="CENTER" WIDTH="51" HEIGHT="115" ACODE="SH5_OBJ" VALIGN="MIDDLE">경영총괄</TE>

<TE WIDTH="180" HEIGHT="115" ACODE="SH5_SKL" VALIGN="MIDDLE">
<P USERMARK="F-GL11">前) VGX Pharmaceuticals(現, Inovio) 이사</P>
<P USERMARK="F-GL11">現) ㈜플럼라인생명과학 대표이사</P>
</TE>
<TE ALIGN="RIGHT" WIDTH="74" HEIGHT="115" ACODE="SH5_STK_VOTY" VALIGN="MIDDLE">693,946</TE>
<TE ALIGN="RIGHT" WIDTH="75" HEIGHT="115" ACODE="SH5_STK_VOTN" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="78" HEIGHT="115" ACODE="SH5_RLTN" VALIGN="MIDDLE">본인</TE>
<TE WIDTH="129" HEIGHT="115" ACODE="SH5_PER" VALIGN="MIDDLE">2014년 ~ 현재</TE>
<TU ALIGN="CENTER" WIDTH="92" HEIGHT="115" AUNIT="SH5_FIH" AUNITVALUE="20230329" VALIGN="MIDDLE">2023년 03월 29일</TU>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="71" HEIGHT="76" ACODE="SH5_NM_T" VALIGN="MIDDLE">김균</TE>
<TU ALIGN="CENTER" WIDTH="48" HEIGHT="76" AUNIT="SH5_SEX" AUNITVALUE="1" VALIGN="MIDDLE">남</TU>
<TU ALIGN="CENTER" WIDTH="101" HEIGHT="76" AUNIT="SH5_BIH" AUNITVALUE="196602" VALIGN="MIDDLE">1966년 02월</TU>
<TE ALIGN="CENTER" WIDTH="82" HEIGHT="76" ACODE="SH5_LEV" VALIGN="MIDDLE">사내이사</TE>
<TU ALIGN="CENTER" WIDTH="73" HEIGHT="76" AUNIT="SH5_REG_DRCT" AUNITVALUE="1" VALIGN="MIDDLE">등기임원</TU>
<TU ALIGN="CENTER" WIDTH="61" HEIGHT="76" AUNIT="SH5_FUL" AUNITVALUE="1" VALIGN="MIDDLE">상근</TU>
<TE ALIGN="CENTER" WIDTH="51" HEIGHT="76" ACODE="SH5_OBJ" VALIGN="MIDDLE">재무총괄</TE>
<TE WIDTH="180" HEIGHT="76" ACODE="SH5_SKL" VALIGN="MIDDLE">前) SC제일은행 이사 &cr;現) ㈜플럼라인생명과학 상무이사</TE>
<TE ALIGN="RIGHT" WIDTH="74" HEIGHT="76" ACODE="SH5_STK_VOTY" VALIGN="MIDDLE">5,000</TE>
<TE ALIGN="RIGHT" WIDTH="75" HEIGHT="76" ACODE="SH5_STK_VOTN" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="78" HEIGHT="76" ACODE="SH5_RLTN" VALIGN="MIDDLE">해당없음</TE>
<TE WIDTH="129" HEIGHT="76" ACODE="SH5_PER" VALIGN="MIDDLE">2015년 ~ 2020년 09월 30일</TE>
<TU ALIGN="CENTER" WIDTH="92" HEIGHT="76" AUNIT="SH5_FIH" AUNITVALUE="-" VALIGN="MIDDLE">-</TU>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="71" HEIGHT="76" ACODE="SH5_NM_T" VALIGN="MIDDLE">이상준</TE>
<TU ALIGN="CENTER" WIDTH="48" HEIGHT="76" AUNIT="SH5_SEX" AUNITVALUE="1" VALIGN="MIDDLE">남</TU>
<TU ALIGN="CENTER" WIDTH="101" HEIGHT="76" AUNIT="SH5_BIH" AUNITVALUE="195405" VALIGN="MIDDLE">1954년 05월</TU>
<TE ALIGN="CENTER" WIDTH="82" HEIGHT="76" ACODE="SH5_LEV" VALIGN="MIDDLE">사외이사</TE>
<TU ALIGN="CENTER" WIDTH="73" HEIGHT="76" AUNIT="SH5_REG_DRCT" AUNITVALUE="1" VALIGN="MIDDLE">등기임원</TU>
<TU ALIGN="CENTER" WIDTH="61" HEIGHT="76" AUNIT="SH5_FUL" AUNITVALUE="2" VALIGN="MIDDLE">비상근</TU>
<TE ALIGN="CENTER" WIDTH="51" HEIGHT="76" ACODE="SH5_OBJ" VALIGN="MIDDLE">연구자문</TE>
<TE WIDTH="180" HEIGHT="76" ACODE="SH5_SKL" VALIGN="MIDDLE">前) (주)노바렉스 대표이사&cr;前) 안전성평가연구소장</TE>
<TE ALIGN="RIGHT" WIDTH="74" HEIGHT="76" ACODE="SH5_STK_VOTY" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="75" HEIGHT="76" ACODE="SH5_STK_VOTN" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="78" HEIGHT="76" ACODE="SH5_RLTN" VALIGN="MIDDLE">해당없음</TE>
<TE WIDTH="129" HEIGHT="76" ACODE="SH5_PER" VALIGN="MIDDLE">2020년 ~ 현재</TE>
<TU ALIGN="CENTER" WIDTH="92" HEIGHT="76" AUNIT="SH5_FIH" AUNITVALUE="20230329" VALIGN="MIDDLE">2023년 03월 29일</TU>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="71" HEIGHT="53" ACODE="SH5_NM_T" VALIGN="MIDDLE">김주현</TE>
<TU ALIGN="CENTER" WIDTH="48" HEIGHT="53" AUNIT="SH5_SEX" AUNITVALUE="1" VALIGN="MIDDLE">남</TU>
<TU ALIGN="CENTER" WIDTH="101" HEIGHT="53" AUNIT="SH5_BIH" AUNITVALUE="197201" VALIGN="MIDDLE">1972년 01월</TU>
<TE ALIGN="CENTER" WIDTH="82" HEIGHT="53" ACODE="SH5_LEV" VALIGN="MIDDLE">사외이사</TE>
<TU ALIGN="CENTER" WIDTH="73" HEIGHT="53" AUNIT="SH5_REG_DRCT" AUNITVALUE="1" VALIGN="MIDDLE">등기임원</TU>
<TU ALIGN="CENTER" WIDTH="61" HEIGHT="53" AUNIT="SH5_FUL" AUNITVALUE="2" VALIGN="MIDDLE">비상근</TU>
<TE ALIGN="CENTER" WIDTH="51" HEIGHT="53" ACODE="SH5_OBJ" VALIGN="MIDDLE">법률자문</TE>
<TE WIDTH="180" HEIGHT="53" ACODE="SH5_SKL" VALIGN="MIDDLE">現) 법률사무소 로서브 변호사</TE>
<TE ALIGN="RIGHT" WIDTH="74" HEIGHT="53" ACODE="SH5_STK_VOTY" VALIGN="MIDDLE">1,730</TE>
<TE ALIGN="RIGHT" WIDTH="75" HEIGHT="53" ACODE="SH5_STK_VOTN" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="78" HEIGHT="53" ACODE="SH5_RLTN" VALIGN="MIDDLE">해당없음</TE>
<TE WIDTH="129" HEIGHT="53" ACODE="SH5_PER" VALIGN="MIDDLE">2016년 ~ 현재</TE>
<TU ALIGN="CENTER" WIDTH="92" HEIGHT="53" AUNIT="SH5_FIH" AUNITVALUE="20230329" VALIGN="MIDDLE">2023년 03월 29일</TU>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="71" HEIGHT="53" ACODE="SH5_NM_T" VALIGN="MIDDLE">황진호</TE>
<TU ALIGN="CENTER" WIDTH="48" HEIGHT="53" AUNIT="SH5_SEX" AUNITVALUE="1" VALIGN="MIDDLE">남</TU>
<TU ALIGN="CENTER" WIDTH="101" HEIGHT="53" AUNIT="SH5_BIH" AUNITVALUE="195010" VALIGN="MIDDLE">1950년 10월</TU>
<TE ALIGN="CENTER" WIDTH="82" HEIGHT="53" ACODE="SH5_LEV" VALIGN="MIDDLE">감사</TE>
<TU ALIGN="CENTER" WIDTH="73" HEIGHT="53" AUNIT="SH5_REG_DRCT" AUNITVALUE="1" VALIGN="MIDDLE">등기임원</TU>
<TU ALIGN="CENTER" WIDTH="61" HEIGHT="53" AUNIT="SH5_FUL" AUNITVALUE="2" VALIGN="MIDDLE">비상근</TU>
<TE ALIGN="CENTER" WIDTH="51" HEIGHT="53" ACODE="SH5_OBJ" VALIGN="MIDDLE">총괄자문</TE>
<TE WIDTH="180" HEIGHT="53" ACODE="SH5_SKL" VALIGN="MIDDLE">前) 증권감독원 부국장</TE>
<TE ALIGN="RIGHT" WIDTH="74" HEIGHT="53" ACODE="SH5_STK_VOTY" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="75" HEIGHT="53" ACODE="SH5_STK_VOTN" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="78" HEIGHT="53" ACODE="SH5_RLTN" VALIGN="MIDDLE">해당없음</TE>
<TE WIDTH="129" HEIGHT="53" ACODE="SH5_PER" VALIGN="MIDDLE">2019년 ~ 현재</TE>
<TU ALIGN="CENTER" WIDTH="92" HEIGHT="53" AUNIT="SH5_FIH" AUNITVALUE="20220325" VALIGN="MIDDLE">2022년 03월 25일</TU>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P></P>

<INSERTION ABASISNUMBER="SE1" AFREQUENCY="0" ADUPLICATION="N">
<COMMENT>◆click◆『등기임원후보자 및 해임대상자』 삽입</COMMENT>
<LIBRARYLIST>11011#*등기임원후보자및해임대상자.dsl</LIBRARYLIST>
</INSERTION>
<P>주) 2020년 03월 30일 정기 주주총회에서 김앤토니경태 대표이사와 김주현 사외이사가 재선임되었으며, 이상준 사외이사가 신규 선임 되었습니다.&cr;김균 사내이사는 2020년 09년 30일 사임 하였습니다.&cr;&cr;직원 현황</P>

<TABLE-GROUP ACLASS="EMPLOYEE" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="854" BORDER="0">

<COLGROUP>
<COL WIDTH="71"></COL>
<COL WIDTH="143"></COL>
<COL WIDTH="117"></COL>
<COL WIDTH="487"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="80" HEIGHT="30" AUPDATECONT="N">(기준일 : </TD>
<TU ALIGN="CENTER" VALIGN="BOTTOM" WIDTH="152" HEIGHT="30" AUNIT="BASE_DT" AUNITVALUE="20201231">2020년 12월 31일</TU>
<TD VALIGN="BOTTOM" WIDTH="126" HEIGHT="30" AUPDATECONT="N">)</TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="496" HEIGHT="30" AUNIT="WON" AUNITVALUE="3">(단위 : 백만원)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="854" BORDER="1" FRAME="BORDER" RULES="ALL">

<COLGROUP>
<COL WIDTH="70"></COL>
<COL WIDTH="33"></COL>
<COL WIDTH="62"></COL>
<COL WIDTH="62"></COL>
<COL WIDTH="62"></COL>
<COL WIDTH="61"></COL>
<COL WIDTH="51"></COL>
<COL WIDTH="65"></COL>
<COL WIDTH="62"></COL>
<COL WIDTH="63"></COL>
<COL WIDTH="25"></COL>
<COL WIDTH="25"></COL>
<COL WIDTH="25"></COL>
<COL WIDTH="62"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="681" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" COLSPAN="10">직원</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="102" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" COLSPAN="3">소속 외&cr;근로자</TH>
<TH ROWSPAN="4" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="71" HEIGHT="189" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">비고</TH>
</TR>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="79" HEIGHT="136" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="3">사업부문</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="42" HEIGHT="136" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="3">성별</TH>
<TH COLSPAN="5" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="343" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">직 원 수</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="74" HEIGHT="136" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="3">평 균&cr;근속연수</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="71" HEIGHT="136" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="3">연간급여&cr;총 액</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="72" HEIGHT="136" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="3">1인평균&cr;급여액</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="34" HEIGHT="136" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="3">남</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="34" HEIGHT="136" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="3">여</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="34" HEIGHT="136" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="3">계</TH>
</TR>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="142" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" COLSPAN="2">기간의 정함이&cr;없는 근로자</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="141" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" COLSPAN="2">기간제&cr;근로자</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="60" HEIGHT="106" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="2">합 계</TH>
</TR>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="71" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">전체</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="71" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">(단시간&cr;근로자)</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="71" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">전체</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="70" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">(단시간&cr;근로자)</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="N">
<TE ALIGN="CENTER" WIDTH="79" HEIGHT="30" ACODE="EMP_OPR" VALIGN="MIDDLE">경영</TE>
<TU ALIGN="CENTER" WIDTH="42" HEIGHT="30" AUNIT="EMP_SEX" AUNITVALUE="1" VALIGN="MIDDLE">남</TU>
<TE ALIGN="RIGHT" WIDTH="71" HEIGHT="30" ACODE="EMP_REO" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="71" HEIGHT="30" ACODE="EMP_REOS" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="71" HEIGHT="30" ACODE="EMP_COC" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="70" HEIGHT="30" ACODE="EMP_COCS" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="60" HEIGHT="30" ACODE="EMP_CN" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="74" HEIGHT="30" ACODE="EMP_AVY" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="71" HEIGHT="30" ACODE="EMP_AIC" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="72" HEIGHT="30" ACODE="EMP_VIC" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="34" HEIGHT="150" ACODE="EMP_MAN" VALIGN="MIDDLE" ROWSPAN="5">-</TE>
<TE ALIGN="RIGHT" WIDTH="34" HEIGHT="150" ACODE="EMP_WOM" VALIGN="MIDDLE" ROWSPAN="5">-</TE>
<TE ALIGN="RIGHT" WIDTH="34" HEIGHT="150" ACODE="EMP_MW_TOTAL" VALIGN="MIDDLE" ROWSPAN="5">-</TE>
<TE ALIGN="CENTER" WIDTH="71" HEIGHT="30" ACODE="NOTE" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="79" HEIGHT="30" ACODE="EMP_OPR" VALIGN="MIDDLE">경영</TE>
<TU ALIGN="CENTER" WIDTH="42" HEIGHT="30" AUNIT="EMP_SEX" AUNITVALUE="2" VALIGN="MIDDLE">여</TU>
<TE ALIGN="RIGHT" WIDTH="71" HEIGHT="30" ACODE="EMP_REO" VALIGN="MIDDLE">1</TE>
<TE ALIGN="RIGHT" WIDTH="71" HEIGHT="30" ACODE="EMP_REOS" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="71" HEIGHT="30" ACODE="EMP_COC" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="70" HEIGHT="30" ACODE="EMP_COCS" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="60" HEIGHT="30" ACODE="EMP_CN" VALIGN="MIDDLE">1</TE>
<TE ALIGN="RIGHT" WIDTH="74" HEIGHT="30" ACODE="EMP_AVY" VALIGN="MIDDLE">4년</TE>
<TE ALIGN="RIGHT" WIDTH="71" HEIGHT="30" ACODE="EMP_AIC" VALIGN="MIDDLE">43</TE>
<TE ALIGN="RIGHT" WIDTH="72" HEIGHT="30" ACODE="EMP_VIC" VALIGN="MIDDLE">43</TE>
<TE ALIGN="CENTER" WIDTH="71" HEIGHT="30" ACODE="NOTE" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="79" HEIGHT="30" ACODE="EMP_OPR" VALIGN="MIDDLE">연구</TE>
<TU ALIGN="CENTER" WIDTH="42" HEIGHT="30" AUNIT="EMP_SEX" AUNITVALUE="1" VALIGN="MIDDLE">남</TU>
<TE ALIGN="RIGHT" WIDTH="71" HEIGHT="30" ACODE="EMP_REO" VALIGN="MIDDLE">2</TE>
<TE ALIGN="RIGHT" WIDTH="71" HEIGHT="30" ACODE="EMP_REOS" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="71" HEIGHT="30" ACODE="EMP_COC" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="70" HEIGHT="30" ACODE="EMP_COCS" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="60" HEIGHT="30" ACODE="EMP_CN" VALIGN="MIDDLE">2</TE>
<TE ALIGN="RIGHT" WIDTH="74" HEIGHT="30" ACODE="EMP_AVY" VALIGN="MIDDLE">3년</TE>
<TE ALIGN="RIGHT" WIDTH="71" HEIGHT="30" ACODE="EMP_AIC" VALIGN="MIDDLE">93</TE>
<TE ALIGN="RIGHT" WIDTH="72" HEIGHT="30" ACODE="EMP_VIC" VALIGN="MIDDLE">47</TE>
<TE ALIGN="CENTER" WIDTH="71" HEIGHT="30" ACODE="NOTE" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="79" HEIGHT="30" ACODE="EMP_OPR" VALIGN="MIDDLE">연구</TE>
<TU ALIGN="CENTER" WIDTH="42" HEIGHT="30" AUNIT="EMP_SEX" AUNITVALUE="2" VALIGN="MIDDLE">여</TU>
<TE ALIGN="RIGHT" WIDTH="71" HEIGHT="30" ACODE="EMP_REO" VALIGN="MIDDLE">3</TE>
<TE ALIGN="RIGHT" WIDTH="71" HEIGHT="30" ACODE="EMP_REOS" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="71" HEIGHT="30" ACODE="EMP_COC" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="70" HEIGHT="30" ACODE="EMP_COCS" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="60" HEIGHT="30" ACODE="EMP_CN" VALIGN="MIDDLE">3</TE>
<TE ALIGN="RIGHT" WIDTH="74" HEIGHT="30" ACODE="EMP_AVY" VALIGN="MIDDLE">3년</TE>
<TE ALIGN="RIGHT" WIDTH="71" HEIGHT="30" ACODE="EMP_AIC" VALIGN="MIDDLE">158</TE>
<TE ALIGN="RIGHT" WIDTH="72" HEIGHT="30" ACODE="EMP_VIC" VALIGN="MIDDLE">53</TE>
<TE ALIGN="CENTER" WIDTH="71" HEIGHT="30" ACODE="NOTE" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD ALIGN="CENTER" WIDTH="121" HEIGHT="30" AUPDATECONT="N" COLSPAN="2" VALIGN="MIDDLE">합 계</TD>
<TE ALIGN="RIGHT" WIDTH="71" HEIGHT="30" ACODE="EMP_REOT" VALIGN="MIDDLE">6</TE>
<TE ALIGN="RIGHT" WIDTH="71" HEIGHT="30" ACODE="EMP_REOST" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="71" HEIGHT="30" ACODE="EMP_COCT" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="70" HEIGHT="30" ACODE="EMP_COCST" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="60" HEIGHT="30" ACODE="EMP_CNT" VALIGN="MIDDLE">6</TE>
<TE ALIGN="RIGHT" WIDTH="74" HEIGHT="30" ACODE="EMP_AVYT" VALIGN="MIDDLE">2.7년</TE>
<TE ALIGN="RIGHT" WIDTH="71" HEIGHT="30" ACODE="EMP_AICT" VALIGN="MIDDLE">294</TE>
<TE ALIGN="RIGHT" WIDTH="72" HEIGHT="30" ACODE="EMP_VICT" VALIGN="MIDDLE">42</TE>
<TE ALIGN="CENTER" WIDTH="71" HEIGHT="30" ACODE="NOTET" VALIGN="MIDDLE">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>

<INSERTION ABASISNUMBER="E0" AFREQUENCY="0" ADUPLICATION="N">
<COMMENT>* 직원 현황 표는 미등기임원을 포함하여 작성한다</COMMENT>
<LIBRARYLIST></LIBRARYLIST>
</INSERTION>
<P></P>
<P>미등기임원 보수 현황</P>

<TABLE-GROUP ACLASS="UNRESISTER" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="787" BORDER="0">

<COLGROUP>
<COL WIDTH="71"></COL>
<COL WIDTH="143"></COL>
<COL WIDTH="117"></COL>
<COL WIDTH="420"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="80" HEIGHT="30" AUPDATECONT="N">(기준일 : </TD>
<TU ALIGN="CENTER" VALIGN="BOTTOM" WIDTH="152" HEIGHT="30" AUNIT="BASE_DT" AUNITVALUE="20201231">2020년 12월 31일</TU>
<TD VALIGN="BOTTOM" WIDTH="126" HEIGHT="30" AUPDATECONT="N">)</TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="429" HEIGHT="30" AUNIT="WON" AUNITVALUE="3">(단위 : 백만원)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="786" BORDER="1">

<COLGROUP>
<COL WIDTH="110"></COL>
<COL WIDTH="110"></COL>
<COL WIDTH="156"></COL>
<COL WIDTH="155"></COL>
<COL WIDTH="210"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="N" ADELETE="N">
<TH WIDTH="119" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">구 분</TH>
<TH WIDTH="119" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">인원수</TH>
<TH WIDTH="165" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">연간급여 총액</TH>
<TH WIDTH="164" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">1인평균 급여액</TH>
<TH WIDTH="219" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">비고</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="119" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">미등기임원</TD>
<TE WIDTH="119" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="URT_CNT">1</TE>
<TE WIDTH="165" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="URT_PAY_TOT">90</TE>
<TE WIDTH="164" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="URT_PAY_AVR">90</TE>
<TE WIDTH="219" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="URT_NOTE">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P></P>
<P></P>
</SECTION-2>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-0-8-2-0">2. 임원의 보수 등</TITLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="Y" WIDTH="600" BORDER="0">

<COLGROUP>
<COL WIDTH="591"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="600" HEIGHT="30" AUPDATECONT="N"><이사ㆍ감사 전체의 보수현황></TD>
</TR>
</TBODY>
</TABLE>
<P>1. 주주총회 승인금액</P>

<TABLE-GROUP ACLASS="SUB_CMP" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="602" BORDER="0">

<COLGROUP>
<COL WIDTH="291"></COL>
<COL WIDTH="293"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="300" HEIGHT="30" AUPDATECONT="N"></TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="302" HEIGHT="30" AUNIT="WON" AUNITVALUE="3">(단위 : 백만원)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="602" BORDER="1">

<COLGROUP>
<COL WIDTH="169"></COL>
<COL WIDTH="78"></COL>
<COL WIDTH="199"></COL>
<COL WIDTH="120"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="N" ADELETE="N">
<TH WIDTH="178" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">구 분</TH>
<TH WIDTH="87" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">인원수</TH>
<TH WIDTH="208" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">주주총회 승인금액</TH>
<TH WIDTH="129" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">비고</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="N">
<TE WIDTH="178" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="PRT_PAY_SUB">이사</TE>
<TE WIDTH="87" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="PRT_PAY_NUM">4</TE>
<TE WIDTH="208" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="PRT_PAY_KMY">1,000</TE>
<TE WIDTH="129" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="NOTE">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE WIDTH="178" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="PRT_PAY_SUB">감사</TE>
<TE WIDTH="87" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="PRT_PAY_NUM">1</TE>
<TE WIDTH="208" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="PRT_PAY_KMY">100</TE>
<TE WIDTH="129" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="NOTE">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>

<P>주) 상기 이사 1인 2020년 09월 30일 사임하였습니다.&cr;&cr;
<SPAN>2</SPAN>
<SPAN>. 보수지급금액</SPAN>
</P>
<P>2-1. 이사ㆍ감사 전체</P>

<TABLE-GROUP ACLASS="SUB_CMPT" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="602" BORDER="0">

<COLGROUP>
<COL WIDTH="291"></COL>
<COL WIDTH="293"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="300" HEIGHT="30" AUPDATECONT="N"></TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="302" HEIGHT="30" AUNIT="WON" AUNITVALUE="3">(단위 : 백만원)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="602" BORDER="1">

<COLGROUP>
<COL WIDTH="142"></COL>
<COL WIDTH="142"></COL>
<COL WIDTH="141"></COL>
<COL WIDTH="141"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="N" ADELETE="N">
<TH WIDTH="151" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">인원수</TH>
<TH WIDTH="151" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">보수총액</TH>
<TH WIDTH="150" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">1인당 평균보수액</TH>
<TH WIDTH="150" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">비고</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TE WIDTH="151" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="TRT_PAY_NUM">5</TE>
<TE WIDTH="151" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="TRT_PAY_SUM">218</TE>
<TE WIDTH="150" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="TRT_PAY_VIC">44</TE>
<TE WIDTH="150" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="NOTE5">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P>주) 인원수와 보수총액에 2020년 09월 30일 사임한 사내이사의 수와 보수액이 포함되어 있습니다.&cr;</P>
<P>2-2. 유형별</P>

<TABLE-GROUP ACLASS="SUB_CMPP" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="602" BORDER="0">

<COLGROUP>
<COL WIDTH="291"></COL>
<COL WIDTH="293"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="300" HEIGHT="30" AUPDATECONT="N"></TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="302" HEIGHT="30" AUNIT="WON" AUNITVALUE="3">(단위 : 백만원)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="602" BORDER="1">

<COLGROUP>
<COL WIDTH="236"></COL>
<COL WIDTH="81"></COL>
<COL WIDTH="80"></COL>
<COL WIDTH="80"></COL>
<COL WIDTH="80"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="N" ADELETE="N">
<TH WIDTH="245" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">구 분</TH>
<TH WIDTH="90" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">인원수</TH>
<TH WIDTH="89" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">보수총액</TH>
<TH WIDTH="89" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">1인당&cr;평균보수액</TH>
<TH WIDTH="89" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">비고</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="245" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" AUPDATECONT="N">등기이사&cr;(사외이사, 감사위원회 위원 제외)</TD>
<TE WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53" ACODE="RRT_PAY_NUM">2</TE>
<TE WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53" ACODE="RRT_PAY_SUM">185</TE>
<TE WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53" ACODE="RRT_PAY_VIC">93</TE>
<TE WIDTH="89" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACODE="NOTE1">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="245" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" AUPDATECONT="N">사외이사&cr;(감사위원회 위원 제외)</TD>
<TE WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53" ACODE="ORT_PAY_NUM">2</TE>
<TE WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53" ACODE="ORT_PAY_SUM">33</TE>
<TE WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53" ACODE="ORT_PAY_VIC">17</TE>
<TE WIDTH="89" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACODE="NOTE2">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="245" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">감사위원회 위원</TD>
<TE WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="GRT_PAY_NUM">-</TE>
<TE WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="GRT_PAY_SUM">-</TE>
<TE WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="GRT_PAY_VIC">-</TE>
<TE WIDTH="89" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="NOTE3">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="245" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">감사</TD>
<TE WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="AUD_PAY_NUM">1</TE>
<TE WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="AUD_PAY_SUM">-</TE>
<TE WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="AUD_PAY_VIC">-</TE>
<TE WIDTH="89" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="NOTE4">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P>주) 등기이사의 수와 보수총액에 2020년 09월 30일 사임한 등기이사의 수와 보수액이 포함되어 있습니다. &cr;</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="Y" WIDTH="600" BORDER="0">

<COLGROUP>
<COL WIDTH="591"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="600" HEIGHT="30" AUPDATECONT="N"><보수지급금액 5억원 이상인 이사ㆍ감사의 개인별 보수현황></TD>
</TR>
</TBODY>
</TABLE>
<P>1. 개인별 보수지급금액</P>

<TABLE-GROUP ACLASS="SUB_CMPK" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="602" BORDER="0">

<COLGROUP>
<COL WIDTH="291"></COL>
<COL WIDTH="293"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="300" HEIGHT="30" AUPDATECONT="N"></TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="302" HEIGHT="30" AUNIT="WON" AUNITVALUE="3">(단위 : 백만원)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="603" BORDER="1">

<COLGROUP>
<COL WIDTH="116"></COL>
<COL WIDTH="116"></COL>
<COL WIDTH="115"></COL>
<COL WIDTH="220"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="N" ADELETE="N">
<TH WIDTH="125" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">이름</TH>
<TH WIDTH="125" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">직위</TH>
<TH WIDTH="124" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">보수총액</TH>
<TH WIDTH="229" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">보수총액에 포함되지 않는 보수</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="N">
<TE WIDTH="125" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="CMPK_NM">-</TE>
<TE WIDTH="125" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="CMPK_LEV">-</TE>
<TE WIDTH="124" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="CMPK_PAY">-</TE>
<TE WIDTH="229" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="CMPK_NOTPAY">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>

<P>상기 표에 해당사항 없습니다.&cr;
<SPAN></SPAN>
</P>
<P>2. 산정기준 및 방법</P>
<P>해당사항 없습니다.&cr;</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="Y" WIDTH="600" BORDER="0">

<COLGROUP>
<COL WIDTH="591"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="600" HEIGHT="30" AUPDATECONT="N"><보수지급금액 5억원 이상 중 상위 5명의 개인별 보수현황></TD>
</TR>
</TBODY>
</TABLE>
<P>1. 개인별 보수지급금액</P>

<TABLE-GROUP ACLASS="SUB_CMPK_HIGH" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="602" BORDER="0">

<COLGROUP>
<COL WIDTH="291"></COL>
<COL WIDTH="293"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="300" HEIGHT="30" AUPDATECONT="N"></TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="302" HEIGHT="30" AUNIT="WON" AUNITVALUE="3">(단위 : 백만원)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="602" BORDER="1">

<COLGROUP>
<COL WIDTH="85"></COL>
<COL WIDTH="67"></COL>
<COL WIDTH="157"></COL>
<COL WIDTH="257"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="N" ADELETE="N">
<TH WIDTH="94" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">이름</TH>
<TH WIDTH="76" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">직위</TH>
<TH WIDTH="166" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">보수총액</TH>
<TH WIDTH="266" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">보수총액에 포함되지 않는 보수</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="N">
<TE WIDTH="94" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="CMPK_NM">-</TE>
<TE WIDTH="76" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="CMPK_LEV">-</TE>
<TE WIDTH="166" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="CMPK_PAY">-</TE>
<TE WIDTH="266" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="CMPK_NOTPAY">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P>상기 표에 해당사항 없습니다.&cr;&cr;2. 산정기준 및 방법</P>
<P>해당사항 없습니다.&cr;</P>

<INSERTION ABASISNUMBER="SE1" AFREQUENCY="0" ADUPLICATION="N">
<COMMENT>◆click◆『주식매수선택권의 부여 및 행사현황』 삽입</COMMENT>
<LIBRARYLIST>11011#*주식매수선택권의부여및행사현황.dsl</LIBRARYLIST>
</INSERTION>
<P></P>
<PGBRK></PGBRK>
</SECTION-2>
</SECTION-1>

<SECTION-1 ACLASS="MANDATORY" APARTSOURCE="SOURCE">
<TITLE ATOC="Y" AASSOCNOTE="D-0-9-0-0">IX. 계열회사 등에 관한 사항</TITLE>
<P></P>

<INSERTION ABASISNUMBER="SE1" AFREQUENCY="1" ADUPLICATION="N">
<COMMENT>◆click◆『타법인출자 현황』 삽입</COMMENT>
<LIBRARYLIST>11011#*타법인출자현황.dsl</LIBRARYLIST>

<LIBRARY>
<FILENAME ATYPE="dsl">6_타법인출자현황</FILENAME>
<P>타법인출자 현황</P>

<TABLE-GROUP ACLASS="INV_PRT" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="819" BORDER="0">

<COLGROUP>
<COL WIDTH="71"></COL>
<COL WIDTH="143"></COL>
<COL WIDTH="204"></COL>
<COL WIDTH="365"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="80" HEIGHT="30" AUPDATECONT="N">(기준일 : </TD>
<TU ALIGN="CENTER" VALIGN="BOTTOM" WIDTH="152" HEIGHT="30" AUNIT="BASE_DT" AUNITVALUE="20201231">2020년 12월 31일</TU>
<TD VALIGN="BOTTOM" WIDTH="213" HEIGHT="30" AUPDATECONT="N">)</TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="374" HEIGHT="30" AUNIT="WONSTOCKPERCENT" AUNITVALUE="7">(단위 : 백만원, 주, %)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="944" BORDER="1">

<COLGROUP>
<COL WIDTH="175"></COL>
<COL WIDTH="36"></COL>
<COL WIDTH="35"></COL>
<COL WIDTH="35"></COL>
<COL WIDTH="59"></COL>
<COL WIDTH="49"></COL>
<COL WIDTH="43"></COL>
<COL WIDTH="43"></COL>
<COL WIDTH="42"></COL>
<COL WIDTH="42"></COL>
<COL WIDTH="61"></COL>
<COL WIDTH="48"></COL>
<COL WIDTH="43"></COL>
<COL WIDTH="49"></COL>
<COL WIDTH="49"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="N" ADELETE="N">
<TH ROWSPAN="3" WIDTH="184" ALIGN="CENTER" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" VALIGN="MIDDLE" HEIGHT="113" AUPDATECONT="N">법인명</TH>
<TH ROWSPAN="3" WIDTH="45" ALIGN="CENTER" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" VALIGN="MIDDLE" HEIGHT="113" AUPDATECONT="N">최초취득일자</TH>
<TH ROWSPAN="3" WIDTH="44" ALIGN="CENTER" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" VALIGN="MIDDLE" HEIGHT="113" AUPDATECONT="N">출자&cr;목적</TH>
<TH ROWSPAN="3" WIDTH="44" ALIGN="CENTER" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" VALIGN="MIDDLE" HEIGHT="113" AUPDATECONT="N">최초취득금액</TH>
<TH COLSPAN="3" WIDTH="178" ALIGN="CENTER" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N">기초잔액</TH>
<TH COLSPAN="3" WIDTH="154" ALIGN="CENTER" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N">증가(감소)</TH>
<TH COLSPAN="3" WIDTH="179" ALIGN="CENTER" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N">기말잔액</TH>
<TH COLSPAN="2" WIDTH="116" ALIGN="CENTER" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N">최근사업연도&cr;재무현황</TH>
</TR>

<TR ACOPY="N" ADELETE="N">
<TH ROWSPAN="2" WIDTH="68" ALIGN="CENTER" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" VALIGN="MIDDLE" HEIGHT="60" AUPDATECONT="N">수량</TH>
<TH ROWSPAN="2" WIDTH="58" ALIGN="CENTER" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" VALIGN="MIDDLE" HEIGHT="60" AUPDATECONT="N">지분율</TH>
<TH ROWSPAN="2" WIDTH="52" ALIGN="CENTER" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" VALIGN="MIDDLE" HEIGHT="60" AUPDATECONT="N">장부&cr;가액</TH>
<TH COLSPAN="2" WIDTH="103" ALIGN="CENTER" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N">취득(처분)</TH>
<TH ROWSPAN="2" WIDTH="51" ALIGN="CENTER" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" VALIGN="MIDDLE" HEIGHT="60" AUPDATECONT="N">평가&cr;손익</TH>
<TH ROWSPAN="2" WIDTH="70" ALIGN="CENTER" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" VALIGN="MIDDLE" HEIGHT="60" AUPDATECONT="N">수량</TH>
<TH ROWSPAN="2" WIDTH="57" ALIGN="CENTER" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" VALIGN="MIDDLE" HEIGHT="60" AUPDATECONT="N">지분율</TH>
<TH ROWSPAN="2" WIDTH="52" ALIGN="CENTER" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" VALIGN="MIDDLE" HEIGHT="60" AUPDATECONT="N">장부&cr;가액</TH>
<TH ROWSPAN="2" WIDTH="58" ALIGN="CENTER" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" VALIGN="MIDDLE" HEIGHT="60" AUPDATECONT="N">총자산</TH>
<TH ROWSPAN="2" WIDTH="58" ALIGN="CENTER" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" VALIGN="MIDDLE" HEIGHT="60" AUPDATECONT="N">당기&cr;순손익</TH>
</TR>

<TR ACOPY="N" ADELETE="N">
<TH WIDTH="52" ALIGN="CENTER" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N">수량</TH>
<TH WIDTH="51" ALIGN="CENTER" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N">금액</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="N">
<TE WIDTH="184" ALIGN="CENTER" HEIGHT="53" VALIGN="MIDDLE" ACODE="INV_PRM">Plumbline Life Sciences, &cr;USA, Inc.</TE>
<TU WIDTH="45" ALIGN="CENTER" HEIGHT="53" VALIGN="MIDDLE" AUNIT="INV_GET" AUNITVALUE="-">-</TU>
<TE WIDTH="44" ALIGN="CENTER" HEIGHT="53" VALIGN="MIDDLE" ACODE="INV_OBJ" USERMARK="F-10">-</TE>
<TE WIDTH="44" ALIGN="RIGHT" HEIGHT="53" VALIGN="MIDDLE" ACODE="INV_GTM" USERMARK="F-10">-</TE>
<TE WIDTH="68" ALIGN="RIGHT" HEIGHT="53" VALIGN="MIDDLE" ACODE="INV_BTN" USERMARK="F-10">3,620,000</TE>
<TE WIDTH="58" ALIGN="RIGHT" HEIGHT="53" VALIGN="MIDDLE" ACODE="INV_BPR" USERMARK="F-10">100</TE>
<TE WIDTH="52" ALIGN="RIGHT" HEIGHT="53" VALIGN="MIDDLE" ACODE="INV_BTM" USERMARK="F-10">-</TE>
<TE WIDTH="52" ALIGN="RIGHT" HEIGHT="53" VALIGN="MIDDLE" ACODE="INV_PTN" USERMARK="F-10">-</TE>
<TE WIDTH="51" ALIGN="RIGHT" HEIGHT="53" VALIGN="MIDDLE" ACODE="INV_PTM" USERMARK="F-10">-</TE>
<TE WIDTH="51" ALIGN="RIGHT" HEIGHT="53" VALIGN="MIDDLE" ACODE="INV_PPM" USERMARK="F-10">-</TE>
<TE WIDTH="70" ALIGN="RIGHT" HEIGHT="53" VALIGN="MIDDLE" ACODE="INV_LTN" USERMARK="F-10">3,620,000</TE>
<TE WIDTH="57" ALIGN="RIGHT" HEIGHT="53" VALIGN="MIDDLE" ACODE="INV_LPR" USERMARK="F-10">100</TE>
<TE WIDTH="52" ALIGN="RIGHT" HEIGHT="53" VALIGN="MIDDLE" ACODE="INV_LTM" USERMARK="F-10">-</TE>
<TE WIDTH="58" ALIGN="RIGHT" HEIGHT="53" VALIGN="MIDDLE" ACODE="INV_NTM" USERMARK="F-10">152</TE>
<TE WIDTH="58" ALIGN="RIGHT" HEIGHT="53" VALIGN="MIDDLE" ACODE="INV_TPM" USERMARK="F-10">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD COLSPAN="4" WIDTH="317" ALIGN="CENTER" HEIGHT="49" AUPDATECONT="N" VALIGN="MIDDLE">합 계</TD>
<TE WIDTH="68" ALIGN="RIGHT" HEIGHT="49" VALIGN="MIDDLE" ACODE="INV_BTNT" USERMARK="F-10">3,620,000</TE>
<TE WIDTH="58" ALIGN="RIGHT" HEIGHT="49" VALIGN="MIDDLE" ACODE="INV_BPRT" USERMARK="F-10">100</TE>
<TE WIDTH="52" ALIGN="RIGHT" HEIGHT="49" VALIGN="MIDDLE" ACODE="INV_BTMT" USERMARK="F-10">-</TE>
<TE WIDTH="52" ALIGN="RIGHT" HEIGHT="49" VALIGN="MIDDLE" ACODE="INV_PTNT" USERMARK="F-10">-</TE>
<TE WIDTH="51" ALIGN="RIGHT" HEIGHT="49" VALIGN="MIDDLE" ACODE="INV_PTMT" USERMARK="F-10">-</TE>
<TE WIDTH="51" ALIGN="RIGHT" HEIGHT="49" VALIGN="MIDDLE" ACODE="INV_PPMT" USERMARK="F-10">-</TE>
<TE WIDTH="70" ALIGN="RIGHT" HEIGHT="49" VALIGN="MIDDLE" ACODE="INV_LTNT" USERMARK="F-10">3,620,000</TE>
<TE WIDTH="57" ALIGN="RIGHT" HEIGHT="49" VALIGN="MIDDLE" ACODE="INV_LPRT" USERMARK="F-10">100</TE>
<TE WIDTH="52" ALIGN="RIGHT" HEIGHT="49" VALIGN="MIDDLE" ACODE="INV_LTMT" USERMARK="F-10">-</TE>
<TE WIDTH="58" ALIGN="RIGHT" HEIGHT="49" VALIGN="MIDDLE" ACODE="INV_NTMT" USERMARK="F-10">152</TE>
<TE WIDTH="58" ALIGN="RIGHT" HEIGHT="49" VALIGN="MIDDLE" ACODE="INV_TPMT" USERMARK="F-10">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>

<P>
<SPAN>주1) Plumbline Life Sciences, USA, Inc.는 미국에 소재하고 있으며 전기 이전에 당사 제품의 임상시험을 진행 중에 있었으나, 당기말 현재 사실상 휴업상태에 있습니다. 최근사업연도 재무현황은 2019년 12월 31일 기준 원달러환율(USD 1 = KRW 1,157.80)을</SPAN>
<SPAN> 적</SPAN>
<SPAN>용하였습니다.&cr;주2) 당기말 및 전기말 특수관계자에 대한 채권잔액은 존재하지 않으나, 당사는 전기 당사의 자회사인 Plumbline Life Sciences, USA, Inc.가 부담하고 있는 채무 중 628,135천원(전기말: 1,179,018천원)에 대하여 대위변제를 실시하기로 약정함에 따라서 동 금액에 대해서는 미지급금으로 계상하였습니다. 동 대위변제로 인하여 발생하는 종속기업에 대한 구상채권에 대해서 당사는 전기 중 전액 비용으로 처리하였습니다. </SPAN>
<SPAN></SPAN>
</P>
</LIBRARY>
</INSERTION>
<P></P>
<PGBRK></PGBRK>
</SECTION-1>

<SECTION-1 ACLASS="MANDATORY" APARTSOURCE="SOURCE">
<TITLE ATOC="Y" AASSOCNOTE="D-0-10-0-0">X. 이해관계자와의 거래내용</TITLE>
<P></P>
<P USERMARK="F-16 0XFF0000 B">1. 이해관계자 등과의 거래내용</P>
<P>    </P>
<P USERMARK=" B">가. 가지급금ㆍ대여금(증권 대여 포함) 및 가수금 내역</P>
<P>&cr;해당사항 없습니다. </P>
<P>  </P>
<P USERMARK=" B">나. 담보제공 내역</P>
<P>&cr;해당사항 없습니다.</P>
<P>  </P>
<P USERMARK=" B">다. 채무보증 내역</P>

<P>
<SPAN>&cr;</SPAN>당기말 및 전기말 특수관계자에 대한 채권잔액은 존재하지 않으나, 당사는 전전기 당사의 자회사인 Plumbline Life Sciences, USA, Inc.가 부담하고 있
<SPAN>는 채무 중 </SPAN>
<SPAN>628,135천원</SPAN>
<SPAN> 대하여 대위변제를 실시하기로 약정함에 따라 동 금액에 대해</SPAN>서는 미지급금으로 계상하였습니다. 동 대위변제로 인하여 발생하는 종속기업에 대한 구상채권에 대해서 당사는 전기 중 전액 비용으로 처리하였으며 당기말 현재 채무 잔액은 272,430천원입니다.&cr;
<SPAN></SPAN>
</P>
<P USERMARK=" B">라. 매출ㆍ매입거래</P>
<P>&cr;해당사항 없습니다. </P>
<P>  </P>
<P USERMARK=" B">마. 증권 등 매수 또는 매도 내역</P>
<P>&cr;해당사항 없습니다. </P>
<P>  </P>
<P USERMARK=" B">바. 부동산 매매 및 임대차 내역</P>
<P>&cr;해당사항 없습니다.  </P>
<P>  </P>
<P USERMARK=" B">사. 차입금 내역</P>
<P>&cr;해당사항 없습니다.&cr;</P>
<P></P>
<PGBRK></PGBRK>
</SECTION-1>

<SECTION-1 ACLASS="MANDATORY" APARTSOURCE="SOURCE">
<TITLE ATOC="Y" AASSOCNOTE="D-0-11-0-0">XI. 그 밖에 투자자 보호를 위하여 필요한 사항</TITLE>
<P>&cr;&cr;견질 또는 담보용 어음ㆍ수표 현황</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" WIDTH="600" BORDER="0">

<COLGROUP>
<COL WIDTH="291"></COL>
<COL WIDTH="291"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="BOTTOM" WIDTH="300" HEIGHT="30">(기준일 : 2020년 12월 31일)</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="300" HEIGHT="30">(단위 : 백만원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" WIDTH="600" BORDER="1" FRAME="BORDER" RULES="ALL">

<COLGROUP>
<COL WIDTH="141"></COL>
<COL WIDTH="141"></COL>
<COL WIDTH="141"></COL>
<COL WIDTH="141"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="150" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">제 출 처</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="150" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">매 수</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="150" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">금 액</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="150" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">비 고</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="150" HEIGHT="30" VALIGN="MIDDLE">은 행</TD>
<TD ALIGN="RIGHT" WIDTH="150" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="RIGHT" WIDTH="150" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="CENTER" WIDTH="150" HEIGHT="30" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="150" HEIGHT="30" VALIGN="MIDDLE">금융기관(은행제외)</TD>
<TD ALIGN="RIGHT" WIDTH="150" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="RIGHT" WIDTH="150" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="CENTER" WIDTH="150" HEIGHT="30" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="150" HEIGHT="30" VALIGN="MIDDLE">법 인</TD>
<TD ALIGN="RIGHT" WIDTH="150" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="RIGHT" WIDTH="150" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="CENTER" WIDTH="150" HEIGHT="30" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="150" HEIGHT="30" VALIGN="MIDDLE">기타(개인)</TD>
<TD ALIGN="RIGHT" WIDTH="150" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="RIGHT" WIDTH="150" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="CENTER" WIDTH="150" HEIGHT="30" VALIGN="MIDDLE">-</TD>
</TR>
</TBODY>
</TABLE>
<P>상기 표에 해당사항 없습니다.</P>

<INSERTION ABASISNUMBER="SE1" AFREQUENCY="0" ADUPLICATION="N">
<COMMENT>◆click◆『신용보강 제공 현황』 삽입</COMMENT>
<LIBRARYLIST>11011#*신용보강제공현황.dsl</LIBRARYLIST>
</INSERTION>
<P></P>

<INSERTION ABASISNUMBER="SE1" AFREQUENCY="0" ADUPLICATION="N">
<COMMENT>◆click◆『장래매출채권 유동화 현황 및 채무비중』 삽입</COMMENT>
<LIBRARYLIST>11011#*장래매출채권유동화현황및채무비중.dsl</LIBRARYLIST>
</INSERTION>
<P></P>

<INSERTION ABASISNUMBER="SE1" AFREQUENCY="0" ADUPLICATION="N">
<COMMENT>◆click◆『단기매매차익 미환수 현황』 삽입</COMMENT>
<LIBRARYLIST>11011#*단기매매차익미환수현황.dsl</LIBRARYLIST>
</INSERTION>
<P></P>

<INSERTION ABASISNUMBER="SE1" AFREQUENCY="1" ADUPLICATION="N">
<COMMENT>◆click◆『공모자금의 사용내역』 삽입</COMMENT>
<LIBRARYLIST>11011#*공모자금의사용내역.dsl</LIBRARYLIST>

<LIBRARY>
<FILENAME ATYPE="dsl">18_공모자금의사용내역</FILENAME>
<P>공모자금의 사용내역</P>

<TABLE-GROUP ACLASS="FUND" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="641" BORDER="0">

<COLGROUP>
<COL WIDTH="71"></COL>
<COL WIDTH="143"></COL>
<COL WIDTH="59"></COL>
<COL WIDTH="332"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="80" HEIGHT="30" AUPDATECONT="N">(기준일 : </TD>
<TU ALIGN="CENTER" VALIGN="BOTTOM" WIDTH="152" HEIGHT="30" AUNIT="BASE_DT" AUNITVALUE="20201231">2020년 12월 31일</TU>
<TD VALIGN="BOTTOM" WIDTH="68" HEIGHT="30" AUPDATECONT="N">)</TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="341" HEIGHT="30" AUNIT="WON" AUNITVALUE="3">(단위 : 백만원)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="641" BORDER="1" FRAME="BORDER" RULES="ALL">

<COLGROUP>
<COL WIDTH="77"></COL>
<COL WIDTH="46"></COL>
<COL WIDTH="46"></COL>
<COL WIDTH="74"></COL>
<COL WIDTH="73"></COL>
<COL WIDTH="62"></COL>
<COL WIDTH="61"></COL>
<COL WIDTH="130"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="86" HEIGHT="83" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="2">구 분</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="55" HEIGHT="83" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="2">회차</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="55" HEIGHT="83" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="2">납입일</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="165" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" COLSPAN="2">증권신고서 등의&cr; 자금사용 계획</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="141" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" COLSPAN="2">실제 자금사용&cr; 내역</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="139" HEIGHT="83" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="2">차이발생 사유 등</TH>
</TR>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="83" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">사용용도</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="82" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">조달금액</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="71" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">내용</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="70" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">금액</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="N">
<TE ALIGN="CENTER" WIDTH="86" HEIGHT="30" ACODE="PO_TYPE" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="55" HEIGHT="30" ACODE="MO_SEQ" VALIGN="MIDDLE">-</TE>
<TU ALIGN="CENTER" WIDTH="55" HEIGHT="30" AUNIT="PYM_DT" VALIGN="MIDDLE" AUNITVALUE="-">-</TU>
<TE ALIGN="RIGHT" WIDTH="83" HEIGHT="30" ACODE="PLA_USE" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="82" HEIGHT="30" ACODE="PLA_AMT" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="71" HEIGHT="30" ACODE="BRK_CON" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="70" HEIGHT="30" ACODE="BRK_AMT" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="139" HEIGHT="30" ACODE="PS_AMT_PL" VALIGN="MIDDLE">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P>상기 표에 해당사항 없습니다.&cr;</P>
</LIBRARY>
</INSERTION>
<P></P>

<INSERTION ABASISNUMBER="SE1" AFREQUENCY="1" ADUPLICATION="N">
<COMMENT>◆click◆『사모자금의 사용내역』 삽입</COMMENT>
<LIBRARYLIST>11011#*사모자금의사용내역.dsl</LIBRARYLIST>

<LIBRARY>
<FILENAME ATYPE="dsl">19_사모자금의사용내역</FILENAME>
<P>사모자금의 사용내역</P>

<TABLE-GROUP ACLASS="FUND_SA" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="641" BORDER="0">

<COLGROUP>
<COL WIDTH="71"></COL>
<COL WIDTH="143"></COL>
<COL WIDTH="59"></COL>
<COL WIDTH="332"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="80" HEIGHT="30" AUPDATECONT="N">(기준일 : </TD>
<TU ALIGN="CENTER" VALIGN="BOTTOM" WIDTH="152" HEIGHT="30" AUNIT="BASE_DT" AUNITVALUE="20201231">2020년 12월 31일</TU>
<TD VALIGN="BOTTOM" WIDTH="68" HEIGHT="30" AUPDATECONT="N">)</TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="341" HEIGHT="30" AUNIT="WON" AUNITVALUE="3">(단위 : 백만원)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="970" BORDER="1" FRAME="BORDER" RULES="ALL">

<COLGROUP>
<COL WIDTH="41"></COL>
<COL WIDTH="36"></COL>
<COL WIDTH="133"></COL>
<COL WIDTH="209"></COL>
<COL WIDTH="65"></COL>
<COL WIDTH="202"></COL>
<COL WIDTH="64"></COL>
<COL WIDTH="148"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="50" HEIGHT="106" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="2">구 분</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="45" HEIGHT="106" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="2">회차</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="142" HEIGHT="106" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="2">납입일</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="292" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" COLSPAN="2">주요사항보고서의&cr; 자금사용 계획</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="284" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" COLSPAN="2">실제 자금사용&cr; 내역</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="157" HEIGHT="106" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="2">차이발생 사유 등</TH>
</TR>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="218" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">사용용도</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="74" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">조달금액</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="211" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">내용</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="73" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">금액</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="N">
<TE ALIGN="CENTER" WIDTH="50" HEIGHT="30" ACODE="PO_TYPE" VALIGN="MIDDLE">1</TE>
<TE ALIGN="CENTER" WIDTH="45" HEIGHT="30" ACODE="MO_SEQ" VALIGN="MIDDLE">1</TE>
<TU ALIGN="CENTER" WIDTH="142" HEIGHT="30" AUNIT="PYM_DT" VALIGN="MIDDLE" AUNITVALUE="20200103">2020년 01월 03일</TU>
<TE ALIGN="CENTER" WIDTH="218" HEIGHT="30" ACODE="PLA_USE" VALIGN="MIDDLE">R&D 활동 및 회사 운영 자금</TE>
<TE ALIGN="RIGHT" WIDTH="74" HEIGHT="30" ACODE="PLA_AMT" VALIGN="MIDDLE">880</TE>
<TE ALIGN="CENTER" WIDTH="211" HEIGHT="30" ACODE="BRK_CON" VALIGN="MIDDLE">R&D 활동 및 회사 운영 자금</TE>
<TE ALIGN="RIGHT" WIDTH="73" HEIGHT="30" ACODE="BRK_AMT" VALIGN="MIDDLE">880</TE>
<TE ALIGN="CENTER" WIDTH="157" HEIGHT="30" ACODE="PS_AMT_PL" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="50" HEIGHT="30" ACODE="PO_TYPE" VALIGN="MIDDLE">2</TE>
<TE ALIGN="CENTER" WIDTH="45" HEIGHT="30" ACODE="MO_SEQ" VALIGN="MIDDLE">2</TE>
<TU ALIGN="CENTER" WIDTH="142" HEIGHT="30" AUNIT="PYM_DT" VALIGN="MIDDLE" AUNITVALUE="20200207">2020년 02월 07일</TU>
<TE ALIGN="CENTER" WIDTH="218" HEIGHT="30" ACODE="PLA_USE" VALIGN="MIDDLE">R&D 활동 및 회사 운영 자금</TE>
<TE ALIGN="RIGHT" WIDTH="74" HEIGHT="30" ACODE="PLA_AMT" VALIGN="MIDDLE">792</TE>
<TE ALIGN="CENTER" WIDTH="211" HEIGHT="30" ACODE="BRK_CON" VALIGN="MIDDLE">R&D 활동 및 회사 운영 자금</TE>
<TE ALIGN="RIGHT" WIDTH="73" HEIGHT="30" ACODE="BRK_AMT" VALIGN="MIDDLE">792</TE>
<TE ALIGN="CENTER" WIDTH="157" HEIGHT="30" ACODE="PS_AMT_PL" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="50" HEIGHT="76" ACODE="PO_TYPE" VALIGN="MIDDLE">3</TE>
<TE ALIGN="CENTER" WIDTH="45" HEIGHT="76" ACODE="MO_SEQ" VALIGN="MIDDLE">3</TE>
<TU ALIGN="CENTER" WIDTH="142" HEIGHT="76" AUNIT="PYM_DT" VALIGN="MIDDLE" AUNITVALUE="20200304">2020년 03월 04일</TU>
<TE ALIGN="CENTER" WIDTH="218" HEIGHT="76" ACODE="PLA_USE" VALIGN="MIDDLE">재무구조 개선 및 자본확충을 위한 금전채권의 주금납입금 상계</TE>
<TE ALIGN="RIGHT" WIDTH="74" HEIGHT="76" ACODE="PLA_AMT" VALIGN="MIDDLE">2,223</TE>
<TE ALIGN="CENTER" WIDTH="211" HEIGHT="76" ACODE="BRK_CON" VALIGN="MIDDLE">재무구조 개선 및 자본확충을 위한 금전채권의 주금납입금 상계</TE>
<TE ALIGN="RIGHT" WIDTH="73" HEIGHT="76" ACODE="BRK_AMT" VALIGN="MIDDLE">2,223</TE>
<TE ALIGN="CENTER" WIDTH="157" HEIGHT="76" ACODE="PS_AMT_PL" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="50" HEIGHT="99" ACODE="PO_TYPE" VALIGN="MIDDLE">4</TE>
<TE ALIGN="CENTER" WIDTH="45" HEIGHT="99" ACODE="MO_SEQ" VALIGN="MIDDLE">4</TE>
<TU ALIGN="CENTER" WIDTH="142" HEIGHT="99" AUNIT="PYM_DT" VALIGN="MIDDLE" AUNITVALUE="20201204">2020년 12월 04일</TU>
<TE ALIGN="CENTER" WIDTH="218" HEIGHT="99" ACODE="PLA_USE" VALIGN="MIDDLE">R&D 활동 및 회사 운영 자금</TE>
<TE ALIGN="RIGHT" WIDTH="74" HEIGHT="99" ACODE="PLA_AMT" VALIGN="MIDDLE">1,100</TE>
<TE ALIGN="CENTER" WIDTH="211" HEIGHT="99" ACODE="BRK_CON" VALIGN="MIDDLE">R&D 활동 및 회사 운영 자금</TE>
<TE ALIGN="RIGHT" WIDTH="73" HEIGHT="99" ACODE="BRK_AMT" VALIGN="MIDDLE">200</TE>
<TE WIDTH="157" HEIGHT="99" ACODE="PS_AMT_PL" VALIGN="MIDDLE">차액은 2021년 R&D 활동 및 회사 운영 자금으로 사용예정임.</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
</LIBRARY>
</INSERTION>
<P></P>

<INSERTION ABASISNUMBER="SE1" AFREQUENCY="0" ADUPLICATION="N">
<COMMENT>◆click◆『미사용자금의 운용내역』 삽입</COMMENT>
<LIBRARYLIST>11011#*미사용자금의운용내역.dsl</LIBRARYLIST>
</INSERTION>
<P></P>
<P>외국지주회사의 자회사 현황</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" WIDTH="700" BORDER="0">

<COLGROUP>
<COL WIDTH="291"></COL>
<COL WIDTH="391"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="BOTTOM" WIDTH="300" HEIGHT="30">(기준일 : 2020년 12월 31일)</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="400" HEIGHT="30">(단위 : )</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" WIDTH="701" BORDER="1" FRAME="BORDER" RULES="ALL">

<COLGROUP>
<COL WIDTH="134"></COL>
<COL WIDTH="71"></COL>
<COL WIDTH="71"></COL>
<COL WIDTH="71"></COL>
<COL WIDTH="71"></COL>
<COL WIDTH="71"></COL>
<COL WIDTH="70"></COL>
<COL WIDTH="70"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="143" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구 분</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="80" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">A지주회사</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="80" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">B법인</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="80" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">C법인</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="80" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">D법인</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="80" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">...</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="79" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">연결조정</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="79" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">연결 후&cr;금액</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="143" HEIGHT="30" VALIGN="MIDDLE">매출액</TD>
<TD ALIGN="RIGHT" WIDTH="80" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="RIGHT" WIDTH="80" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="RIGHT" WIDTH="80" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="RIGHT" WIDTH="80" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="RIGHT" WIDTH="80" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="RIGHT" WIDTH="79" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="RIGHT" WIDTH="79" HEIGHT="30" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="143" HEIGHT="30" VALIGN="MIDDLE">  내부 매출액</TD>
<TD ALIGN="RIGHT" WIDTH="80" HEIGHT="30" VALIGN="MIDDLE">(    - )</TD>
<TD ALIGN="RIGHT" WIDTH="80" HEIGHT="30" VALIGN="MIDDLE">(    - )</TD>
<TD ALIGN="RIGHT" WIDTH="80" HEIGHT="30" VALIGN="MIDDLE">(    - )</TD>
<TD ALIGN="RIGHT" WIDTH="80" HEIGHT="30" VALIGN="MIDDLE">(    - )</TD>
<TD ALIGN="RIGHT" WIDTH="80" HEIGHT="30" VALIGN="MIDDLE">(    - )</TD>
<TD ALIGN="RIGHT" WIDTH="79" HEIGHT="30" VALIGN="MIDDLE">(    - )</TD>
<TD ALIGN="RIGHT" WIDTH="79" HEIGHT="30" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="143" HEIGHT="30" VALIGN="MIDDLE">  순 매출액</TD>
<TD ALIGN="RIGHT" WIDTH="80" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="RIGHT" WIDTH="80" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="RIGHT" WIDTH="80" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="RIGHT" WIDTH="80" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="RIGHT" WIDTH="80" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="RIGHT" WIDTH="79" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="RIGHT" WIDTH="79" HEIGHT="30" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="143" HEIGHT="30" VALIGN="MIDDLE">영업손익</TD>
<TD ALIGN="RIGHT" WIDTH="80" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="RIGHT" WIDTH="80" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="RIGHT" WIDTH="80" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="RIGHT" WIDTH="80" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="RIGHT" WIDTH="80" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="RIGHT" WIDTH="79" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="RIGHT" WIDTH="79" HEIGHT="30" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="143" HEIGHT="30" VALIGN="MIDDLE">계속사업손익</TD>
<TD ALIGN="RIGHT" WIDTH="80" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="RIGHT" WIDTH="80" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="RIGHT" WIDTH="80" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="RIGHT" WIDTH="80" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="RIGHT" WIDTH="80" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="RIGHT" WIDTH="79" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="RIGHT" WIDTH="79" HEIGHT="30" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="143" HEIGHT="30" VALIGN="MIDDLE">당기순손익</TD>
<TD ALIGN="RIGHT" WIDTH="80" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="RIGHT" WIDTH="80" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="RIGHT" WIDTH="80" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="RIGHT" WIDTH="80" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="RIGHT" WIDTH="80" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="RIGHT" WIDTH="79" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="RIGHT" WIDTH="79" HEIGHT="30" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="143" HEIGHT="30" VALIGN="MIDDLE">자산총액</TD>
<TD ALIGN="RIGHT" WIDTH="80" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="RIGHT" WIDTH="80" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="RIGHT" WIDTH="80" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="RIGHT" WIDTH="80" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="RIGHT" WIDTH="80" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="RIGHT" WIDTH="79" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="RIGHT" WIDTH="79" HEIGHT="30" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="143" HEIGHT="30" VALIGN="MIDDLE">  현금및현금성자산</TD>
<TD ALIGN="RIGHT" WIDTH="80" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="RIGHT" WIDTH="80" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="RIGHT" WIDTH="80" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="RIGHT" WIDTH="80" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="RIGHT" WIDTH="80" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="RIGHT" WIDTH="79" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="RIGHT" WIDTH="79" HEIGHT="30" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="143" HEIGHT="30" VALIGN="MIDDLE">  유동자산</TD>
<TD ALIGN="RIGHT" WIDTH="80" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="RIGHT" WIDTH="80" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="RIGHT" WIDTH="80" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="RIGHT" WIDTH="80" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="RIGHT" WIDTH="80" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="RIGHT" WIDTH="79" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="RIGHT" WIDTH="79" HEIGHT="30" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="143" HEIGHT="30" VALIGN="MIDDLE">  단기금융상품</TD>
<TD ALIGN="RIGHT" WIDTH="80" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="RIGHT" WIDTH="80" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="RIGHT" WIDTH="80" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="RIGHT" WIDTH="80" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="RIGHT" WIDTH="80" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="RIGHT" WIDTH="79" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="RIGHT" WIDTH="79" HEIGHT="30" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="143" HEIGHT="30" VALIGN="MIDDLE">부채총액</TD>
<TD ALIGN="RIGHT" WIDTH="80" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="RIGHT" WIDTH="80" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="RIGHT" WIDTH="80" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="RIGHT" WIDTH="80" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="RIGHT" WIDTH="80" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="RIGHT" WIDTH="79" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="RIGHT" WIDTH="79" HEIGHT="30" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="143" HEIGHT="30" VALIGN="MIDDLE">자기자본</TD>
<TD ALIGN="RIGHT" WIDTH="80" HEIGHT="30" VALIGN="MIDDLE"></TD>
<TD ALIGN="RIGHT" WIDTH="80" HEIGHT="30" VALIGN="MIDDLE"></TD>
<TD ALIGN="RIGHT" WIDTH="80" HEIGHT="30" VALIGN="MIDDLE"></TD>
<TD ALIGN="RIGHT" WIDTH="80" HEIGHT="30" VALIGN="MIDDLE"></TD>
<TD ALIGN="RIGHT" WIDTH="80" HEIGHT="30" VALIGN="MIDDLE"></TD>
<TD ALIGN="RIGHT" WIDTH="79" HEIGHT="30" VALIGN="MIDDLE"></TD>
<TD ALIGN="RIGHT" WIDTH="79" HEIGHT="30" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="143" HEIGHT="30" VALIGN="MIDDLE">자본금</TD>
<TD ALIGN="RIGHT" WIDTH="80" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="RIGHT" WIDTH="80" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="RIGHT" WIDTH="80" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="RIGHT" WIDTH="80" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="RIGHT" WIDTH="80" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="RIGHT" WIDTH="79" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="RIGHT" WIDTH="79" HEIGHT="30" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="143" HEIGHT="30" VALIGN="MIDDLE">감사인</TD>
<TD ALIGN="CENTER" WIDTH="80" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="CENTER" WIDTH="80" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="CENTER" WIDTH="80" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="CENTER" WIDTH="80" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="CENTER" WIDTH="80" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="CENTER" WIDTH="79" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="CENTER" WIDTH="79" HEIGHT="30" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="143" HEIGHT="30" VALIGN="MIDDLE">감사ㆍ검토 의견</TD>
<TD ALIGN="CENTER" WIDTH="80" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="CENTER" WIDTH="80" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="CENTER" WIDTH="80" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="CENTER" WIDTH="80" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="CENTER" WIDTH="80" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="CENTER" WIDTH="79" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="CENTER" WIDTH="79" HEIGHT="30" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="143" HEIGHT="30" VALIGN="MIDDLE">비  고</TD>
<TD ALIGN="CENTER" WIDTH="80" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="CENTER" WIDTH="80" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="CENTER" WIDTH="80" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="CENTER" WIDTH="80" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="CENTER" WIDTH="80" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="CENTER" WIDTH="79" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="CENTER" WIDTH="79" HEIGHT="30" VALIGN="MIDDLE">-</TD>
</TR>
</TBODY>
</TABLE>
<P>&cr;상기 표에 해당사항 없습니다.&cr;</P>

<INSERTION ABASISNUMBER="LE0" AFREQUENCY="0" ADUPLICATION="Y">
<COMMENT>◆click◆『합병등 전후의 재무사항 비교표』 삽입</COMMENT>
<LIBRARYLIST>11011#*합병등전후의재무사항비교표.dsl</LIBRARYLIST>
</INSERTION>
<P></P>

<INSERTION ABASISNUMBER="SE1" AFREQUENCY="0" ADUPLICATION="Y">
<COMMENT>◆click◆『보호예수 현황』 삽입</COMMENT>
<LIBRARYLIST>11011#*보호예수현황.dsl</LIBRARYLIST>
</INSERTION>
<P></P>

<INSERTION ABASISNUMBER="SE1" AFREQUENCY="0" ADUPLICATION="Y">
<COMMENT>◆click◆『특례상장기업 관리종목 지정유예 현황』 삽입</COMMENT>
<LIBRARYLIST>11011#*특례상장기업관리종목지정유예현황.dsl</LIBRARYLIST>
</INSERTION>
<P></P>
<P></P>
<PGBRK></PGBRK>
</SECTION-1>

<SECTION-1 ACLASS="MANDATORY" APARTSOURCE="SOURCE">
<TITLE ATOC="Y">【 전문가의 확인 】</TITLE>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-3-0-1-0">1. 전문가의 확인</TITLE>
<P>&cr;해당사항 없습니다.&cr;</P>
</SECTION-2>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-3-0-2-0">2. 전문가와의 이해관계</TITLE>
<P>&cr;해당사항 없습니다.</P>
</SECTION-2>
</SECTION-1>
</BODY>
</DOCUMENT>